Prevalence Estimate Name,Publication Date,Grade of Estimate Scope,Country or Area,Specific Geography,Sampling Start Date,Sampling End Date,Sample Frame (groups of interest),Sample Frame (age),Denominator Value,Serum positive prevalence,"Serum pos prevalence, 95pct CI Lower","Serum pos prevalence, 95pct CI Upper",Sampling Method,Test Manufacturer,Test Type (granular),Isotype(s) Reported,Sensitivity,Specificity,Overall Risk of Bias (JBI),Source Type,First Author Full Name,Lead Institution,URL,Date Created,Last modified time
210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_July_Adults,2/20/2021,Local,Albania,Albania,"June 27, 2020","July 3, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),266,7.50%,4.30%,10.70%,Stratified probability,Euroimmun,,IgG,,,High,Preprint,Genc Sulcebe,University of Medicine and University Hospital Center of Tirana,https://doi.org/10.1101/2021.02.18.21251776,3/21/2021,3/31/2021
210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_December_Adults,2/20/2021,Local,Albania,Albania,"December 21, 2020","December 28, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),815,48.20%,44.80%,51.70%,Stratified probability,Euroimmun,,IgG,,,High,Preprint,Genc Sulcebe,University of Medicine and University Hospital Center of Tirana,https://doi.org/10.1101/2021.02.18.21251776,3/21/2021,3/31/2021
201204_Andorra_ISGlobal_Overall,12/4/2020,National,Andorra,Andorra,"May 4, 2020","May 28, 2020",Household and community samples,Multiple groups,70494,11.00%,,,Self-referral,"nCOV 2019 IgG/IgM- Zhuhai Livzon Diagnostics, Inc.",,"IgG,IgM",90.60%,99.20%,Moderate,Preprint,Cristina Royo-Cebrecos,ISGlobal,https://www.researchsquare.com/article/rs-119323/v1,1/23/2021,4/26/2021
"200718_BuenosAires_MinisterofHealth,BuenosAiresCity_Homeless",7/18/2020,Sublocal,Argentina,Argentina; Buenos Aires; Buenos Aires,"June 10, 2020","July 1, 2020",Persons living in slums,Multiple groups,60,36.00%,,,Convenience,Laboratio Lemos,ELISA,IgG,95.00%,100.00%,High,Preprint,Silvana Figar,"Minister of Health, Buenos Aires City",https://www.medrxiv.org/content/10.1101/2020.07.14.20153858v1,7/17/2020,4/26/2021
200909_BuenosAires_InstitutoNacionalDeEpidemiologia_Overall,9/9/2020,Sublocal,Argentina,Argentina; Buenos Aires; Buenos Aires,"June 3, 2020","July 6, 2020",Health care workers and caregivers,Multiple groups,738,0.75%,0.00%,8.13%,Stratified probability,CONICET,ELISA,"IgG,IgM",,,Moderate,Preprint,Andrea Silva,Instituto Nacional de Epidemiologia,https://www.medrxiv.org/content/10.1101/2020.09.07.20189050v1,11/10/2020,4/26/2021
201201_BuenosAires_HospitalGeneraldeNiñosPedrodeElizalde_overall,12/1/2020,Sublocal,Argentina,Argentina; Province of Buenos Aires; Autonomous City of Buenos Aires,"June 8, 2020","June 9, 2020",Health care workers and caregivers,Adults (18-64 years),116,0.90%,0.10%,5.50%,Simplified probability,Snibe (Shenzen New Industries),,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Claudia Insúa,Hospital General de Niños Pedro de Elizalde,https://dx.doi.org/10.5546/aap.2020.eng.381,1/25/2021,4/26/2021
210107_BuenosAires_UniversityOfBuenosAires_Primary,1/7/2021,Sublocal,Argentina,Argentina,"March 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),317,3.00%,2.00%,5.00%,Stratified non-probability,NR,,Not reported,85.00%,95.00%,High,Journal Article (Peer-Reviewed),Puia Sebastian ,University of Buenos Aires,https://dx.doi.org/10.1016/j.jobcr.2021.01.006,2/18/2021,3/31/2021
200828_VillaAzul_MinisterioDeSaludDeLaProvinciaDeBuenosAires_overall,8/28/2020,Sublocal,Argentina,Argentina; Buenos Aires; Quilmes,"July 15, 2020","July 16, 2020",Household and community samples,Multiple groups,284,14.80%,11.10%,19.50%,Stratified non-probability,COVIDAR,,IgG,95.00%,100.00%,Moderate,Preprint,Laura Muñoz,Ministerio de Salud de la Provincia de Buenos Aires,https://preprints.scielo.org/index.php/scielo/preprint/view/1147,4/21/2021,4/25/2021
210121_BarrioMugica_MinistryOfHealthOfTheCityOfBuenosAires,1/21/2021,Sublocal,Argentina,Argentina; Buenos Aires; Buenos Aires,"June 10, 2020","June 26, 2020",Persons living in slums,Multiple groups,873,53.40%,52.80%,54.10%,Simplified probability,Laboratio Lemos,,IgG,90.00%,100.00%,Low,Journal Article (Peer-Reviewed),Silvana Figar,Ministry of Health of the City of Buenos Aires,https://www.medicinabuenosaires.com/revistas/vol81-21/destacado/original_7453.pdf,4/21/2021,4/21/2021
210121_BarrioMugica_MinistryOfHealthOfTheCityOfBuenosAirer_male,1/21/2021,Sublocal,Argentina,Argentina; Buenos Aires; Buenos Aires,"June 10, 2020","June 26, 2020",Persons living in slums,Multiple groups,873,53.40%,52.80%,54.10%,Simplified probability,Laboratio Lemos,,IgG,90.00%,100.00%,,Journal Article (Peer-Reviewed),Silvana Figar,Ministry of Health of the City of Buenos Aires,https://www.medicinabuenosaires.com/revistas/vol81-21/destacado/original_7453.pdf,4/21/2021,4/21/2021
200630_Yerevan_ArmeniaMinistryofHealth_HCWs,6/30/2020,Local,Armenia,Armenia; Yerevan; Yerevan,,"June 29, 2020",Health care workers and caregivers,Adults (18-64 years),380,16.05%,,,Convenience,Not reported,Not reported,Not reported,100.00%,99.80%,High,News and Media,Anna Grigoryan,Ministry of Health of the Republic of Armenia,https://www.google.com/url?rct=j&sa=t&url=https://armenpress.am/eng/news/1020040/&ct=ga&cd=CAEYFioTMTc0ODAyMDA0NzI0ODEyNTQxODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHN-cSj3u7JgQAyBjN07fSTGAdlgA,7/31/2020,4/26/2021
200803_NewSouthWales_UniversityOfSydney_IndividualsInEducationalSetting,8/3/2020,Regional,Australia,Australia; New South Wales,"January 25, 2020","April 10, 2020",Contacts of COVID patients,Multiple groups,173,2.31%,,,Convenience,Author-designed,immunofluorescence assay (IFA),"IgG,IgA,IgM",91.30%,98.90%,Moderate,Journal Article (Peer-Reviewed),Kristine Macartney,University of Sydney,https://dx.doi.org/10.1016/S2352-4642(20)30251-0,10/16/2020,4/26/2021
200914_Australia_AustralianNationalUniversity_ElectiveSurgeryPatients_Overall_TestAdj,10/3/2020,National,Australia,Australia,"May 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,2991,0.28%,0.00%,0.71%,Unclear,In House,,"IgG,IgM,IgA",100.00%,98.91%,Unclear,Journal Article (Peer-Reviewed),Sarah Hicks,Australian National University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665523/pdf/jiaa623.pdf,2/13/2021,4/26/2021
210203_Sydney_Children'sHospitalAtWestmead_GeneralPathology_overall_TestAdj,2/3/2021,Local,Australia,Australia; New South Wales; Sydney,"April 20, 2020","May 22, 2020",Residual sera,Multiple groups,3231,0.15%,0.04%,0.41%,Stratified probability,N/A - Authors designed,,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/18/2021,3/31/2021
210203_Sydney_Children'sHospitalAtWestmead_PlasmapheresisDonors_overall_TestAdj,2/3/2021,Local,Australia,Australia; New South Wales; Sydney,"May 5, 2020","June 2, 2020",Blood donors,Adults (18-64 years),1548,0.29%,0.04%,0.75%,Stratified probability,N/A - Authors designed,,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/18/2021,3/31/2021
210203_Sydney_Children'sHospitalAtWestmead_AntenatalScreening_overall_TestAdj,2/3/2021,Local,Australia,Australia; New South Wales; Sydney,"May 4, 2020","May 23, 2020",Pregnant or parturient women,Adults (18-64 years),560,0.79%,0.04%,1.88%,Stratified probability,N/A - Authors designed,,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/18/2021,4/12/2021
210109_Australia_AustralianNationalUniversity_overall_adj,1/9/2021,National,Australia,"Australia; New South Wales, South Australia, Victoria and Western Australia","June 2, 2020","July 17, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,2991,0.16%,0.00%,0.47%,Sequential,N/A - in house,,IgG,100.00%,98.90%,Low,Journal Article (Peer-Reviewed),Nicholas Coatsworth ,Australian National University,https://onlinelibrary.wiley.com/doi/full/10.1111/ans.16564,3/19/2021,4/5/2021
200720_Tyrol_InnsbruckClinicalMicrobiologyLaboratory_Physicians_IgG,7/20/2020,Regional,Austria,Austria; Tyrol,"March 20, 2020","March 27, 2020",Health care workers and caregivers,Adults (18-64 years),377,0.30%,0.01%,1.50%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Dorothea Orth-Höller,Innsbruck Clinical Microbiology Laboratory,https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1793690,7/31/2020,4/26/2021
200726_Vienna_MedicalUniversityofVienna_hcw,7/26/2020,Sublocal,Austria,Austria,"March 15, 2020","March 29, 2020",Health care workers and caregivers,Adults (18-64 years),235,25.50%,20.40%,31.50%,Convenience,ImmunoDiagnostics,ELISA,"IgM,IgG",,,High,Preprint,Thomas Reiter,Medical University of Vienna,https://www.medrxiv.org/content/10.1101/2020.07.21.20136218v1,9/27/2020,4/26/2021
200822_Ischgl_MedicalUniversityofInnsbruck_GenPop,8/22/2020,Local,Austria,Austria; Tyrol; Ischgl,"April 21, 2020","April 27, 2020",Household and community samples,Multiple groups,1473,42.40%,39.80%,44.70%,Entire sample,"Abbott, EUROIMMUN","ELISA,Immunoassay ",IgG,,100.00%,Moderate,Preprint,Ludwig Knabl, Medical University of Innsbruck ,https://www.medrxiv.org/content/10.1101/2020.08.20.20178533v1,10/16/2020,4/26/2021
200819_Autria_UniversityHospitalKrems_hcw_ELISA_IgGIgM,8/19/2020,Sublocal,Austria,Austria,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),130,2.30%,,,Convenience,Epitope Diagnostics,ELISA,"IgG,IgM",,,High,Preprint,Klaus Hackner,Karl Landsteiner University of Health Sciences,https://www.researchsquare.com/article/rs-50887/v1,10/18/2020,4/26/2021
200808_Vienna_MedicalUniversityOfVienna_HCP,9/2/2020,Sublocal,Austria,Austria; Vienna; Vienna,"April 1, 2020","June 4, 2020",Health care workers and caregivers,Adults (18-64 years),62,3.20%,0.40%,11.20%,Convenience,"Roche, Abbott","Electro chemiluminescence immunoassay,Chemiluminescence Immunoassay","Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Thorsten Fuereder,Medical University of Vienna,https://dx.doi.org/10.1136/esmoopen-2020-000889,11/5/2020,4/26/2021
200808_Vienna_MedicalUniversityOfVienna_Patients,9/2/2020,Sublocal,Austria,Austria; Vienna; Vienna,"March 21, 2020","June 4, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,84,2.40%,0.30%,8.30%,Convenience,"Roche, Abbott","Electro chemiluminescence immunoassay,Chemiluminescence Immunoassay","Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Thorsten Fuereder,Medical University of Vienna,https://dx.doi.org/10.1136/esmoopen-2020-000889,11/5/2020,4/26/2021
201104_Austria_DanubePrivateUniversity_IgG_Overall,11/4/2020,Local,Austria,Austria,"June 1, 2020","June 15, 2020",Household and community samples,Multiple groups,835,8.50%,,,Entire sample,N/A - Author Designed,,IgG,,,High,Preprint,Dennis Ladage,Danube Private University,https://www.medrxiv.org/content/10.1101/2020.11.03.20219121v1,1/17/2021,4/26/2021
201222_Vienna_MedicalUniversityofVienna_overall,12/22/2020,Sublocal,Austria,Austria,"April 2, 2020","April 17, 2020",Household and community samples,Adults (18-64 years),1655,10.15%,,,Convenience,Euroimmun Medizinische Labordiagnostika,,"IgA,IgG",,,High,Preprint,Angelika Wagner,Medical University of Vienna,https://www.medrxiv.org/content/10.1101/2020.12.22.20248604v1,1/23/2021,4/26/2021
210129_Vienna_WroclawMedicalUniversity_overall,1/29/2021,Local,Austria,Austria,"May 18, 2020","July 2, 2020",Students and Daycares,Children and Youth (0-17 years),2042,1.20%,,,Convenience,"1) Beijing Wantai Biological Pharmacy Enterprise

2) N/A - author designed

3) EUROIMMUN

4) EUROIMMUN
",,"Total Antibody,IgG",90.87%,98.80%,Moderate,Journal Article (Peer-Reviewed),Zsolt Szépfalusi,Wroclaw Medical University,https://dx.doi.org/10.1111/pai.13459,2/15/2021,3/28/2021
210203_Austria_MedicalUniversityOfVienna_Overall,2/3/2021,National,Austria,Austria,"May 11, 2020","December 21, 2020",Health care workers and caregivers,Adults (18-64 years),3301,0.51%,,,Convenience,"LFA: TAmiRNA GmbH Austria
Roche
Diasorin",,"IgA,IgM,IgG",,,High,Preprint,Iris Leister,Medical University of Vienna,10.1101/2021.02.01.21250898,2/17/2021,4/4/2021
210107_Austria_UniversityCollegeLondon_PaediatricHCW,1/27/2021,Sublocal,Austria,Austria,"July 17, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),196,0.00%,0.00%,1.92%,Convenience,"Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)",,IgG,100.00%,88.70%,High,Journal Article (Peer-Reviewed),D. Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,3/28/2021
210108_Linz_OrdensklinikumLinzBarmherzigeSchwestern_OverallHCW,1/8/2021,Sublocal,Austria,Austria; Upper Austria; Linz,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),1757,2.00%,,,Convenience,"1) Roche Diagnostics
2) Abbott Diagnostics",,IgG,100.00%,99.50%,Moderate,Journal Article (Peer-Reviewed),Margot Egger,Ordensklinikum Linz Barmherzige Schwestern and Konventhospital Barmherzige Brueder Linz  ,https://dx.doi.org/10.1515/cclm-2020-1681,3/19/2021,3/30/2021
210222_Vorarlberg_VorarlbergInstituteforVascularInvestigationandTreatment,2/22/2021,Regional,Austria,Austria; Vorarlberg,"June 26, 2020","January 20, 2021",Health care workers and caregivers,Adults (18-64 years),395,18.00%,,,Convenience,Technoclone,,IgG,,,High,Preprint,Michele Atzl,Vorarlberg Institute for Vascular Investigation and Treatment,https://www.medrxiv.org/content/10.1101/2021.02.19.21252045v1,3/24/2021,3/31/2021
210212_Ischgl_MedicalUniversityofInnsbruck_overall,2/12/2021,Local,Austria,Austria; Tyrol; Ischgl,"April 21, 2020","April 27, 2020",Household and community samples,Multiple groups,451,43.70%,,,Entire sample,"1) Euroimmun
2)Abbott",,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Jens Lehmann, Medical University of Innsbruck,https://dx.doi.org/10.1017/S0950268821000418,3/27/2021,4/11/2021
210409_Vienna_MedicalUniversityofVienna,4/9/2021,,Austria,Austria; NR; Vienna,"March 22, 2020","March 31, 2021",Health care workers and caregivers,Adults (18-64 years),235,25.50%,20.40%,31.50%,Unclear,NR,,,,,,Journal Article (Peer-Reviewed),Thomas Reiter,Medical University of Vienna,https://dx.doi.org/10.1007/s00508-021-01848-5,4/23/2021,4/25/2021
200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers,6/15/2020,Sublocal,Belgium,Belgium; Limburg; Genk,"April 22, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),3056,6.40%,5.50%,7.30%,Convenience,Multi-G,LFIA: Lateral flow immunoassay,IgG,92.20%,97.00%,High,Journal Article (Peer-Reviewed),Deborah Steensels,ZiekenhuisOost-Limburg,https://jamanetwork.com/journals/jama/fullarticle/2767382,6/18/2020,4/26/2021
200625_Brussels_UniversitéLibredeBruxelles_OverallHCW,6/25/2020,Local,Belgium,Belgium; Brussels; City of Brussels,"April 15, 2020","May 18, 2020",Health care workers and caregivers,Adults (18-64 years),326,11.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Charlotte Martin,Université Libre de Bruxelles,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30313-3/fulltext,7/20/2020,4/26/2021
200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1,7/30/2020,National,Belgium,"Belgium; Wallonia, Brussels, Flanders","March 30, 2020","April 5, 2020",Household and community samples,Multiple groups,3910,2.90%,2.30%,3.40%,Stratified non-probability,EUROIMMUN,ELISA,IgG,,99.20%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v2,9/27/2020,4/26/2021
200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2,7/30/2020,National,Belgium,"Belgium; Wallonia, Brussels, Flanders","April 20, 2020","April 26, 2020",Household and community samples,Multiple groups,3397,6.00%,5.10%,7.10%,Stratified non-probability,EUROIMMUN,ELISA,IgG,,99.20%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v2,9/27/2020,4/26/2021
200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3,7/30/2020,National,Belgium,"Belgium; Wallonia, Brussels, Flanders","May 18, 2020","May 25, 2020",Household and community samples,Multiple groups,3242,6.90%,5.90%,8.00%,Stratified non-probability,EUROIMMUN,ELISA,IgG,,99.20%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v2,9/27/2020,4/26/2021
200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4,7/30/2020,National,Belgium,"Belgium; Wallonia, Brussels, Flanders","June 8, 2020","June 13, 2020",Household and community samples,Multiple groups,2960,5.50%,4.70%,6.50%,Stratified non-probability,EUROIMMUN,ELISA,IgG,,99.20%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v2,9/27/2020,4/26/2021
200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5,7/30/2020,National,Belgium,"Belgium; Wallonia, Brussels, Flanders","June 29, 2020","July 4, 2020",Household and community samples,Multiple groups,3023,4.50%,3.70%,5.40%,Stratified non-probability,EUROIMMUN,ELISA,IgG,,99.20%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v2,9/27/2020,4/26/2021
200730_Belgium_IrisHospitalsSouth_HCW_UnAdj,7/30/2020,Local,Belgium,Belgium; Brussels; City of Brussels,"May 25, 2020","June 19, 2020",Health care workers and caregivers,Multiple groups,1485,14.61%,,,Convenience,DiaSorin,Chemiluminescence Immunoassay,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Laurent Blairon,Iris Hospitals South,https://dx.doi.org/10.1016/j.jinf.2020.07.033,10/4/2020,4/26/2021
200811_Belgium_universitairesSaint-Luc_Overall,8/10/2020,Local,Belgium,Belgium,"April 16, 2020","May 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,149,2.70%,,,Convenience,"""SNIBE – Shenzhen New Industries Biomedical Engineering Co., Ltd""",Chemiluminescence Immunoassay,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Silvia Berardis,Cliniques universitaires Saint-Luc,https://www.sciencedirect.com/science/article/pii/S1569199320308213,10/24/2020,4/26/2021
201018_Belgium_UniversityHospitalsLeuven_Overall_unadj,10/18/2020,Sublocal,Belgium,Belgium; Limburg; Lanaken,"April 14, 2020","April 16, 2020",Multiple populations,Multiple groups,188,18.60%,,,Convenience,"SureScreen Diagnostics, Derby, UK",,"IgG,IgM",74.70%,95.10%,High,Journal Article (Peer-Reviewed),Frank Buntinx,University of Leuven,http://dx.doi.org/10.1080/17843286.2020.1834285,1/15/2021,4/26/2021
201217_Belgium_Sciensano_Overall,12/17/2020,National,Belgium,Belgium,"April 22, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),850,9.53%,,,Unclear,Euroimmun Medizinische Labordiagnostika,,IgG,,,Unclear,Journal Article (Peer-Reviewed),Els Duysburgh,Sciensano,https://dx.doi.org/10.1016/S1473-3099(20)30943-9,1/25/2021,4/26/2021
210120_Antwerp_UniversityofAntwerp_primary,1/20/2021,Local,Belgium,Belgium,"June 3, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),431,3.20%,1.90%,5.40%,Convenience,"Euroimmune, AG, Lubeck",,IgG,80.00%,98.50%,High,Journal Article (Peer-Reviewed),Kawtar El Abdellati,University of Antwerp,https://dx.doi.org/10.1192/bjo.2020.172,2/6/2021,4/2/2021
210407_Belgium_UniversityofAntwerp_c1_PopAdj,4/7/2021,National,Belgium,Belgium; NR; NR,"March 30, 2020","April 5, 2020",Residual sera,Multiple groups,3910,1.83%,1.00%,2.61%,Simplified probability,Euroimmun,,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/8/2021,4/26/2021
210407_Belgium_UniversityofAntwerp_c2_PopAdj,4/7/2021,National,Belgium,Belgium; NR; NR,"April 20, 2020","April 26, 2020",Residual sera,Multiple groups,3397,5.25%,4.22%,6.35%,Simplified probability,Euroimmun,,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/8/2021,4/26/2021
210407_Belgium_UniversityofAntwerp_c3_PopAdj,4/7/2021,National,Belgium,Belgium; NR; NR,"May 18, 2020","May 25, 2020",Residual sera,Multiple groups,3242,6.20%,5.05%,7.31%,Simplified probability,Euroimmun,,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/8/2021,4/26/2021
210407_Belgium_UniversityofAntwerp_c4_PopAdj,4/7/2021,National,Belgium,Belgium; NR; NR,"June 8, 2020","June 13, 2020",Residual sera,Multiple groups,2960,4.74%,3.65%,5.85%,Simplified probability,Euroimmun,,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/8/2021,4/26/2021
210407_Belgium_UniversityofAntwerp_c5_PopAdj,4/7/2021,National,Belgium,Belgium; NR; NR,"June 29, 2020","July 4, 2020",Residual sera,Multiple groups,3023,3.66%,2.64%,4.70%,Simplified probability,Euroimmun,,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/8/2021,4/26/2021
210407_Belgium_UniversityofAntwerp_c6_PopAdj,4/7/2021,National,Belgium,Belgium; NR; NR,"September 7, 2020","September 12, 2020",Residual sera,Multiple groups,3047,3.28%,2.29%,4.32%,Simplified probability,Euroimmun,,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/8/2021,4/26/2021
210407_Belgium_UniversityofAntwerp_c7_PopAdj,4/7/2021,National,Belgium,Belgium; NR; NR,"October 12, 2020","October 17, 2020",Residual sera,Multiple groups,2966,4.18%,3.12%,5.20%,Simplified probability,Euroimmun,,IgG,84.90%,98.70%,Moderate,Preprint,Sereina Herzog,University of Antwerp,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5,4/8/2021,4/26/2021
210326_Flanders_UniversityofAntwerp,3/26/2021,Regional,Belgium,Belgium; Flanders; NR,"December 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),698,13.40%,10.80%,16.40%,Convenience,In-House (University of Antwerp),,IgG,,99.00%,Moderate,Preprint,Joachim Marlën,University of Antwerp,https://www.medrxiv.org/content/10.1101/2021.03.26.21254327v1,4/16/2021,4/16/2021
200517_SaoPaolo_GrupoFleury_GenPop,5/17/2020,Sublocal,Brazil,Brazil; São Paulo; São Paulo,"May 4, 2020","May 12, 2020",Household and community samples,Not reported,520,5.19%,,,Stratified probability,Not reported,Not reported,Not reported,90.00%,,Unclear,News and Media,Phillippe Watanabe,Grupo Fleury,https://www1.folha.uol.com.br/equilibrioesaude/2020/05/nos-bairros-de-sp-mais-afetados-pela-covid-19-so-5-tiveram-contato-com-o-virus.shtml,6/1/2020,4/26/2021
200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPopUrban,6/16/2020,Regional,Brazil,Brazil; Espírito Santo,"May 13, 2020","May 15, 2020",Household and community samples,Multiple groups,4612,2.10%,1.67%,2.52%,Stratified probability,Celer Technologies Inc.,Rapid immunochromatographic test,"IgG,IgM",86.40%,97.63%,Moderate,Preprint,Cristiana Gomes,Secretaria de Estado da Saúde do Espírito Santo,https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf,6/18/2020,4/26/2021
200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPop2Sub-urban,6/16/2020,Regional,Brazil,Brazil; Espírito Santo,"May 13, 2020","May 15, 2020",Household and community samples,Multiple groups,1163,0.26%,0.05%,0.75%,Stratified probability,Celer Technologies Inc.,Rapid immunochromatographic test,"IgG,IgM",86.40%,97.63%,Moderate,Preprint,Cristiana Gomes,Secretaria de Estado da Saúde do Espírito Santo,https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf,6/18/2020,4/26/2021
200629_SaoPaulo_UniversidadedeSaoPaulo_GenPopulation,6/29/2020,Local,Brazil,Brazil; São Paulo; São Paulo,"May 4, 2020","May 12, 2020",Household and community samples,Multiple groups,517,4.70%,3.00%,6.60%,Simplified probability,SNIBE – Shenzhen New Industries Biomedical Engineering Co.,Chemiluminescence Immunoassay,"IgG,IgM",100.00%,99.50%,Moderate,Preprint,Beatriz Tess,Universidade de São Paulo,http://medrxiv.org/cgi/content/short/2020.06.29.20142331,6/29/2020,4/26/2021
200706_RiodeJaneiro_UniversidadedoEstadodoRiodeJaneiro_BloodDonors_OverallAdj,7/6/2020,Local,Brazil,Brazil; Rio de Janeiro; Rio de Janeiro,"April 14, 2020","April 27, 2020",Blood donors,Adults (18-64 years),2857,3.30%,2.60%,4.10%,Sequential,MedLevensohn,Rapid immunochromatographic test,"IgG,IgM",85.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Amorim Filho,Universidade do Estado do Rio de Janeiro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334006/,7/9/2020,4/26/2021
200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round1_GenPop,8/7/2020,Regional,Brazil,"Brazil; Rio Grande do Sul; Ijui, Passo Fundo, Caxias, Canoas, Porto Alegre, Pelotas, Santa Maria, Santa Cruz do Sul, Uruguaiana","April 11, 2020","April 13, 2020",Household and community samples,Multiple groups,4151,0.05%,0.01%,0.17%,Stratified probability,Wondfo Biotech Co.,LFIA: Lateral flow immunoassay,"IgM,IgG",84.80%,99.00%,Low,Journal Article (Peer-Reviewed),Mariângela Silveira,Universidade Federal de Pelotas,https://www.nature.com/articles/s41591-020-0992-3,7/16/2020,4/26/2021
200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round2_GenPop,8/7/2020,Regional,Brazil,"Brazil; Rio Grande do Sul; Ijui, Passo Fundo, Caxias, Canoas, Porto Alegre, Pelotas, Santa Maria, Santa Cruz do Sul, Uruguaiana","April 25, 2020","April 27, 2020",Household and community samples,Multiple groups,4501,0.14%,0.05%,0.29%,Stratified probability,Wondfo Biotech Co.,LFIA: Lateral flow immunoassay,"IgM,IgG",84.80%,99.00%,Low,Journal Article (Peer-Reviewed),Mariângela Silveira,Universidade Federal de Pelotas,https://www.nature.com/articles/s41591-020-0992-3,7/16/2020,4/26/2021
200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round3_GenPop,8/7/2020,Regional,Brazil,"Brazil; Rio Grande do Sul; Ijui, Passo Fundo, Caxias, Canoas, Porto Alegre, Pelotas, Santa Maria, Santa Cruz do Sul, Uruguaiana","May 9, 2020","May 11, 2020",Household and community samples,Multiple groups,4500,0.22%,0.11%,0.41%,Stratified probability,Wondfo Biotech Co.,LFIA: Lateral flow immunoassay,"IgM,IgG",84.80%,99.00%,Low,Journal Article (Peer-Reviewed),Mariângela Silveira,Universidade Federal de Pelotas,https://www.nature.com/articles/s41591-020-0992-3,7/16/2020,4/26/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr19,7/3/2020,Local,Brazil,Brazil; Piaui; Teresina,"April 19, 2020","April 19, 2020",Household and community samples,Not reported,900,0.56%,0.18%,1.30%,Stratified probability,Wondfo Biotech Co.,RDT,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/29/2020,4/26/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr26,7/3/2020,Local,Brazil,Brazil; Piaui; Teresina,"April 26, 2020","April 26, 2020",Household and community samples,Not reported,900,0.89%,0.39%,1.75%,Stratified probability,Wondfo Biotech Co.,RDT,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/29/2020,4/26/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May3,7/3/2020,Local,Brazil,Brazil; Piaui; Teresina,"May 3, 2020","May 3, 2020",Household and community samples,Not reported,900,1.44%,0.77%,2.45%,Stratified probability,Wondfo Biotech Co.,RDT,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/29/2020,4/26/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May10,7/3/2020,Local,Brazil,Brazil; Piaui; Teresina,"May 10, 2020","May 10, 2020",Household and community samples,Not reported,900,2.00%,1.19%,3.14%,Stratified probability,Wondfo Biotech Co.,RDT,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/29/2020,4/26/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May17,7/3/2020,Local,Brazil,Brazil; Piaui; Teresina,"May 17, 2020","May 17, 2020",Household and community samples,Not reported,900,3.78%,2.63%,5.24%,Stratified probability,Wondfo Biotech Co.,RDT,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/29/2020,4/26/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May24,7/3/2020,Local,Brazil,Brazil; Piaui; Teresina,"May 24, 2020","May 24, 2020",Household and community samples,Not reported,900,5.78%,4.30%,7.30%,Stratified probability,Wondfo Biotech Co.,RDT,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/29/2020,4/26/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May31,7/3/2020,Local,Brazil,Brazil; Piaui; Teresina,"May 31, 2020","May 31, 2020",Household and community samples,Not reported,900,8.33%,6.61%,10.33%,Stratified probability,Wondfo Biotech Co.,RDT,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/29/2020,4/26/2021
200901_Maranhao_FederalUniversityOfMaranhao_Overall_Popadj,9/1/2020,Regional,Brazil,Brazil; Maranhao,"July 27, 2020","August 8, 2020",Household and community samples,Multiple groups,3156,40.40%,35.60%,45.30%,Stratified probability,Roche Diagnostics,Chemiluminescence Immunoassay,"IgG,IgM",89.20%,99.70%,Moderate,Preprint,Antonio daSilva,Federal University of Maranhao,https://www.medrxiv.org/content/10.1101/2020.08.28.20180463v1,11/5/2020,4/26/2021
200916_Lajeado_UniversidadedoValedodoTaquari_Survey1,9/16/2020,Local,Brazil,Brazil; Rio Grande do Sul; Lajeado,"May 30, 2020","June 4, 2020",Household and community samples,Multiple groups,1450,4.03%,3.08%,5.18%,Stratified probability,Guangzhou Wondfo Biotech,LFIA: Lateral flow immunoassay,"IgM,IgG",76.24%,99.57%,Moderate,Journal Article (Peer-Reviewed),Rafael Picon,Universidade do Vale do Taquari,http://dx.doi.org/10.1016/j.ijid.2020.09.028,11/12/2020,4/26/2021
200916_Lajeado_UniversidadedoValedodoTaquari_Survey2,9/16/2020,Local,Brazil,Brazil; Rio Grande do Sul; Lajeado,"June 13, 2020","June 17, 2020",Household and community samples,Multiple groups,1127,2.59%,1.75%,3.70%,Stratified probability,Guangzhou Wondfo Biotech,LFIA: Lateral flow immunoassay,"IgM,IgG",76.24%,99.57%,Moderate,Journal Article (Peer-Reviewed),Rafael Picon,Universidade do Vale do Taquari,http://dx.doi.org/10.1016/j.ijid.2020.09.028,11/12/2020,4/26/2021
200930_Sergipe_FederalUniversityofSergipe_OverallIgG,9/30/2020,Regional,Brazil,Brazil; Sergipe,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,471,13.59%,,,Convenience,Boditech Med Inc. ,immunofluorescence assay (IFA),IgG,95.80%,97.00%,High,Preprint,Mônica de Melo,Federal University of Sergipe,https://www.medrxiv.org/content/medrxiv/early/2020/09/30/2020.09.24.20200873.full.pdf,11/23/2020,4/26/2021
201006_Brazil_FederalUniversityofSergipe_genpop_IgG,10/6/2020,Regional,Brazil,"Brazil; Sergipe; Aracaju, Simão Dias, Itabaiana, Itabaianinha, Nossa Senhora do, São Cristóvão, Estância, Lagarto, Tobias Barreto, Nossa Senhora da Glória","May 2, 2020","May 9, 2020",Household and community samples,Multiple groups,2635,8.30%,7.20%,9.40%,Convenience,Boditech Med Inc.,,IgG,,,High,Journal Article (Peer-Reviewed),Lysandro Pinto Borges,Federal University of Fergipe ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541966/,12/19/2020,4/26/2021
200901_Petrópolis_CentrodeTerapiaOncológica_HCW_IGGorIGM,9/1/2020,Sublocal,Brazil,Brazil; Rio de Janeiro; Petrópolis,"April 9, 2020","April 29, 2020",Health care workers and caregivers,Adults (18-64 years),61,4.91%,,,Convenience,NR,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),P. Ismael Amaral Silva,Centro de Terapia Oncológica,http://dx.doi.org/10.1016/j.annonc.2020.08.1825,1/4/2021,4/26/2021
201026_Brazil_UniversidadeFederaldePelotas_General,10/26/2020,National,Brazil,Brazil,"May 14, 2020","June 24, 2020",Household and community samples,Multiple groups,89362,2.31%,,,Stratified probability,"Wondfo Biotech, Co., Guangzhou, China",,"IgG,IgM",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),Bernardo Horta,Universidade Federal de Pelotas,https://dx.doi.org/10.26633/RPSP.2020.135,1/11/2021,4/26/2021
201027_Cuiabá_UniversidadeFederaldeMatoGrosso_Overall,10/27/2020,Sublocal,Brazil,Brazil; Mato Grosso; Cuiabá,"April 1, 2020","July 31, 2020",Residual sera,Multiple groups,6392,22.10%,,,Entire sample,Carlos Chagas Laboratory,,"IgG,IgM",,,High,Preprint,Cristiane Coimbra de Paula,Universidade Federal de Mato Grosso (UFMT),https://www.medrxiv.org/content/10.1101/2020.10.26.20219683v1,1/15/2021,4/26/2021
201021_SaoPaulo_AdolfoLutzCentralInstitute,10/21/2020,Sublocal,Brazil,Brazil; State of Sao Paulo; Sao Paulo,"June 5, 2020","July 31, 2020",Multiple populations,Multiple groups,406,8.60%,,,Convenience,"Guangzhou Wondfo Biotech Co., Ltd., China; Roche Diagnostics, Rotkreuz, Switzerland",,"IgG,IgM",,,High,Preprint,Valéria Oliveira Silva,Adolfo Lutz Central Institute,https://www.medrxiv.org/content/10.1101/2020.10.19.20213421v1,1/16/2021,4/26/2021
201213_SaoPaulo_ FaculdadeDeMedicinaDaUniversidade_Overall,12/13/2020,Sublocal,Brazil,Brazil; São Paulo State; São Paulo ,"May 14, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),4987,14.10%,13.10%,15.00%,Convenience,Wondfo-China,,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Silvia Costa,Faculdade De Medicina da Universidade,https://dx.doi.org/10.1093/cid/ciaa1845,1/23/2021,4/26/2021
201119_SaoPaulo_ClínicaDeReumatologia_RheumaticPatients,11/19/2020,Local,Brazil,Brazil; State of Sao Paulo; São Paulo,"March 15, 2020","August 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),100,21.00%,,,Convenience,Snibe Diagnostics,,"IgG,IgM",,,High,Preprint,Felipe Santana,Clínica de Reumatologia,https://www.researchsquare.com/article/rs-97191/v1,1/23/2021,4/26/2021
201113_SaoPaulo_UniversidadeSaoPaulo_primary,11/13/2020,Sublocal,Brazil,Brazil; State of Sao Paulo; Sao Paulo,"June 30, 2020","August 4, 2020",Residual sera,Multiple groups,439,13.90%,,,Sequential,"DiaSorin S.p.A., Roche Diagnostics",,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Luanda Mara da Silva Oliveira,Universidade de São Paulo,https://dx.doi.org/10.1590/S1678-9946202062091,1/23/2021,4/26/2021
201130_Sergipe_FederalUniversityofSergipe_residualsera_primary,11/30/2020,Local,Brazil,Brazil; Sergipe; Aracaju,"January 15, 2020","April 15, 2020",Residual sera,Multiple groups,987,1.60%,,,Sequential,"Nantong Egens Biotechnology CO, Ltd., China and Bodytech Med Inc.",,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Ricardo Queiroz Gurgel,Federal University of Sergipe,http://dx.doi.org/10.1016/j.jinf.2020.11.037,1/29/2021,4/26/2021
210106_EspiritoSanto_SecretariadeEstadodaSaúdedoEspíritoSanto_primary,1/6/2021,Regional,Brazil,Brazil; Espirito Santo,"December 1, 2019","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,7370,2.85%,,,Convenience, Abbott Laboratories,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lorenzzo Lyrio Stringari,Secretaria de Estado da Saúde do Espírito Santo,https://dx.doi.org/10.1371/journal.pone.0244937,1/30/2021,3/29/2021
0128_XikrinofBacaja_InstitutodeCiênciasBiológicasdaUniversidadeFederaldoPará_overall,1/28/2021,Local,Brazil,Brazil; Pará; Xikrin of Bacaja Villages,"September 1, 2020","September 30, 2020",Household and community samples,Multiple groups,100,73.00%,,,Unclear,"Euroimmun, Brazil","Rapid immunochromatographic test,ELISA",IgG,,,High,Journal Article (Peer-Reviewed),Eliene Putira Sacuema Rodrigues,Instituto de Ciências Biológicas da Universidade Federal do Pará,https://dx.doi.org/10.1186/s12939-021-01392-8,3/9/2021,4/9/2021
210129_Botuacato_InstitutoButantan_Primary,1/29/2021,Sublocal,Brazil,Brazil; Sao Paolo; Botucato,"June 22, 2020","July 8, 2020",Assisted living and long-term care facilities,Multiple groups,209,11.50%,7.10%,16.60%,Convenience,"Guangzhou Wondfo Biotech Co., Ltd",,"IgG,IgM",86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Eliana Nogueira Castro de Barros,Instituto Butantan,https://dx.doi.org/10.1590/S1678-9946202163010,3/18/2021,3/31/2021
210116_SaoPaulo_UniversityOfSãoPaulo_overall_IgG,1/16/2021,Sublocal,Brazil,Brazil,"May 20, 2020","May 22, 2020",Household and community samples,Multiple groups,938,5.80%,,,Convenience,EUROIMMUN,,IgG,,,High,Journal Article (Peer-Reviewed),Bruno Caramelli,University of São Paulo,https://dx.doi.org/10.7189/jogh.11.05001,3/26/2021,4/10/2021
210209_Sergipe_FederalUniversityofSergipe,2/9/2021,Regional,Brazil,"Brazil; Sergipe; Aracaji, Itabaiana, Lagarto, Larangeiras, Nossa Senhora da Gloria, Sao Cristovao","September 15, 2020","October 6, 2020",Students and Daycares,Adults (18-64 years),276,22.50%,17.90%,27.70%,Convenience,"iChroma II, BioSys + Kovalent",,"IgG,IgM",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Adriano Antunes de Souza Araújo,Federal University of Sergipe,https://dx.doi.org/10.17179/excli2021-3459,3/27/2021,4/2/2021
210115_Manaus_UniversidadedeSãoPaulo_Feb_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Amazonas; Manaus,"February 7, 2020","February 13, 2020",Blood donors,Multiple groups,821,0.40%,0.00%,3.30%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_SaoPaulo_UniversidadedeSãoPaulo_Feb_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"February 8, 2020","February 29, 2020",Blood donors,Multiple groups,799,1.00%,0.00%,2.90%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_Manaus_UniversidadedeSãoPaulo_Mar_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Amazonas; Manaus,"March 6, 2020","March 12, 2020",Blood donors,Multiple groups,832,0.00%,0.00%,0.80%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_SaoPaulo_UniversidadedeSãoPaulo_Mar_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"March 9, 2020","March 21, 2020",Blood donors,Multiple groups,2454,2.80%,1.80%,3.90%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_Manaus_UniversidadedeSãoPaulo_Apr_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Amazonas; Manaus,"April 6, 2020","April 17, 2020",Blood donors,Multiple groups,829,5.00%,2.90%,7.40%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_SaoPaulo_UniversidadedeSãoPaulo_Apr_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"April 8, 2020","April 30, 2020",Blood donors,Multiple groups,900,4.00%,1.80%,6.60%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_Manaus_UniversidadedeSãoPaulo_May_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Amazonas; Manaus,"May 5, 2020","May 14, 2020",Blood donors,Multiple groups,901,43.40%,38.40%,48.60%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_SaoPaulo_UniversidadedeSãoPaulo_May_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"May 8, 2020","May 21, 2020",Blood donors,Multiple groups,826,4.70%,2.60%,7.30%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_Manaus_UniversidadedeSãoPaulo_Jun_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Amazonas; Manaus,"June 5, 2020","June 15, 2020",Blood donors,Multiple groups,911,55.40%,50.70%,60.10%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_SaoPaulo_UniversidadedeSãoPaulo_Jun_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"June 8, 2020","June 20, 2020",Blood donors,Multiple groups,880,13.10%,10.30%,16.30%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_Manaus_UniversidadedeSãoPaulo_Jul_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Amazonas; Manaus,"July 6, 2020","July 15, 2020",Blood donors,Multiple groups,1147,49.00%,44.20%,53.60%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_SaoPaulo_UniversidadedeSãoPaulo_Jul_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"July 13, 2020","July 25, 2020",Blood donors,Multiple groups,879,10.60%,8.10%,13.50%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_SaoPaulo_UniversidadedeSãoPaulo_DonorsTestOverall,1/16/2021,Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"July 1, 2020","July 31, 2020",Blood donors,Multiple groups,1000,13.30%,,,Unclear,Abbott Laboratories; Roche Diagnostics,,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_Manaus_UniversidadedeSãoPaulo_Aug_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Amazonas; Manaus,"August 8, 2020","August 19, 2020",Blood donors,Multiple groups,881,45.60%,41.10%,50.10%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_SaoPaulo_UniversidadedeSãoPaulo_Aug_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"August 10, 2020","August 29, 2020",Blood donors,Multiple groups,906,15.50%,12.30%,18.20%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_Manaus_UniversidadedeSãoPaulo_Sept_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Amazonas; Manaus,"September 5, 2020","September 14, 2020",Blood donors,Multiple groups,868,47.30%,42.10%,52.50%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_SaoPaulo_UniversidadedeSãoPaulo_Sept_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"September 7, 2020","September 29, 2020",Blood donors,Multiple groups,933,15.10%,12.30%,18.20%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_Manaus_UniversidadedeSãoPaulo_Oct_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Amazonas; Manaus,"October 10, 2020","October 17, 2020",Blood donors,Multiple groups,882,44.60%,39.30%,50.00%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210115_SaoPaulo_UniversidadedeSãoPaulo_Oct_PopTestAdj,1/16/2021,Local,Brazil,Brazil; Sao Paulo State; Sao Paulo,"October 12, 2020","October 24, 2020",Blood donors,Multiple groups,877,18.20%,15.00%,21.70%,Sequential,Abbott Laboratories,,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/6/2021,4/26/2021
210329_PortoAlegre_UniversidadeFederaldeCienciasdaSaudedePortoAlegre_HCW_July,3/29/2021,Local,Brazil,Brazil; Rio Grande do Sul; Porto Alegre,"July 20, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),1163,5.50%,,,Unclear,Biosensor,,"IgG,IgM",94.30%,95.10%,Moderate,Journal Article (Peer-Reviewed),Ana Dubiela,Universidade Federal de Ciencias da Saude de Porto Alegre,https://dx.doi.org/10.1017/ice.2021.139,4/17/2021,4/17/2021
210324_SaoPaulo_UniversityofSaoPaulo_overall,3/24/2021,Sublocal,Brazil,Brazil,"June 17, 2020","July 8, 2020",Health care workers and caregivers,Multiple groups,1996,5.51%,,,Convenience,Unclear,,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Maura Salaroli de Oliveira,University of São Paulo,https://dx.doi.org/10.1016/j.ajic.2021.03.010,4/18/2021,4/18/2021
210326_RiodeJaneiro_InstitutoD’OrdePesquisaeEnsino,3/26/2021,Sublocal,Brazil,Brazil; Rio de Janeiro; Rio de Janeiro,"June 30, 2020","August 28, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),114,30.70%,,,Sequential,Beijing LEPU-Medical Technology,,"IgG,IgM",66.00%,97.00%,,Journal Article (Peer-Reviewed),Thaís Cleto-Yamane,Instituto D’Or de Pesquisa e Ensino,https://dx.doi.org/10.1007/s00431-021-04044-9,4/23/2021,4/24/2021
200602_Biguacu_SecretariaMunicipaldeSaude_primary,6/2/2020,Local,Brazil,Brazil,"May 30, 2020","May 30, 2020",Household and community samples,Multiple groups,217,0.40%,,,Stratified probability,NR,,Not reported,,,Unclear,News and Media,Ozias Alves Jr,Secretaria Municipal de Saude,http://jbfoco.com.br/2020/06/confira-um-estudo-sobre-a-pandemia-de-covid-19-em-biguacu-em-graficos/,4/23/2021,4/25/2021
201027_FernandoNoronha_UniversidadeFederaldoCeará,10/27/2020,Local,Brazil,Brazil; State of Pernambuco; Fernando de Noronha,"May 22, 2020","May 31, 2020",Household and community samples,Multiple groups,904,4.30%,3.20%,5.90%,Simplified probability,"Guangzhou Wondfo Biotech Co., Ltd.",,"IgG,IgM",,,Moderate,Preprint,Mozart Julio Tabosa Sales,Universidade Federal do Ceará,https://www.medrxiv.org/content/10.1101/2020.10.22.20216010v1.full-text,4/27/2021,4/27/2021
200928_BaixadaSantistaMetropolitanRegion_UniversidadeSantaCecília_overall_Phase 2,9/28/2020,Local,Brazil,Brazil; São Paulo state; Baixada Santista,"May 13, 2020","May 15, 2020",Household and community samples,Multiple groups,2415,2.20%,,,Stratified probability,Wondfo,,Total Antibody,,,High,Preprint,Arthur Chioro,Baixada Santista Metropolitan Region ,https://preprints.scielo.org/index.php/scielo/preprint/view/1270,4/27/2021,4/27/2021
200527_Varna_MedicalDiagnosticLaboratory_IgG/IgM,5/27/2020,Local,Bulgaria,Bulgaria; Varna;  Varna,"March 26, 2020","April 20, 2020",Residual sera,Multiple groups,586,4.80%,3.20%,6.80%,Self-referral,"""Zhejiang Orient Gene Biotech Co., LTD""",LFIA: Lateral flow immunoassay,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Denitsa Tsaneva-Damyanova,"Medical Diagnostic Laboratory ""STATUS"" ",https://www.tandfonline.com/doi/pdf/10.1080/13102818.2020.1772105?needAccess=true,7/20/2020,4/26/2021
200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OverallPopAdj,7/15/2020,Regional,Canada,Canada; British Columbia,"March 5, 2020","March 13, 2020",Residual sera,Multiple groups,869,0.28%,0.03%,0.95%,Stratified probability,"Abbott, Ortho-Clinical Diagnostics",Chemiluminescence Immunoassay,"IgA,IgM,IgG",,,Moderate,Preprint,Danuta Skowronski,British Columbia Centre for Disease Control,https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1,7/16/2020,4/26/2021
200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OverallPopAdj,7/15/2020,Regional,Canada,Canada; British Columbia,"May 15, 2020","May 27, 2020",Residual sera,Multiple groups,885,0.55%,0.15%,1.37%,Stratified probability,"Abbott, Ortho-Clinical Diagnostics, Siemens Healthineers",Chemiluminescence Immunoassay,"IgA,IgM,IgG",,,Moderate,Preprint,Danuta Skowronski,British Columbia Centre for Disease Control,https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1,7/16/2020,4/26/2021
200805_Quebec_Héma-Québec_BloodDonors,"8/5/2020, 8/5/2020",Regional,Canada,Canada; Quebec,"May 25, 2020","July 9, 2020",Blood donors,Adults (18-64 years),7691,2.23%,,,Stratified probability,Not reported,Not reported,Not reported,,,Unclear,"Institutional Report, Institutional Report","Héma-Québec, COVID-19 Immunity Task Force ",Héma-Québec,"https://www.hema-quebec.qc.ca/publications/communiques/archives/2020/communiques-2020/etude-seroprevalence-resultats.en.html, https://www.covid19immunitytaskforce.ca/the-covid-19-immunity-task-force-welcomes-the-results-of-the-blood-donor-seroprevalence-study-led-by-hema-quebec/",8/5/2020,4/26/2021
200819_Canada_CBS_BloodDonors_Overall_Adjusted,8/19/2020,National,Canada,Canada; Nine Canadian provinces,"May 9, 2020","June 18, 2020",Blood donors,Multiple groups,37737,0.70%,0.60%,0.79%,Sequential,Abbott,chemiluminescent microparticle immunoassay,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,https://www.covid19immunitytaskforce.ca/wp-content/uploads/2020/09/COVID-19-Public-Report_2.pdf,10/2/2020,4/26/2021
201106_BC_BCChildrensHospital_Overall_Adj,11/6/2020,Local,Canada,Canada; British Columbia; Vancouver,"May 17, 2020","June 19, 2020",Multiple populations,Adults (18-64 years),276,0.60%,0.00%,2.71%,Convenience,"Ortho-Clinical Diagnostics, Meso Scale Diagnostics",Chemiluminescence Immunoassay,"IgA,IgG,IgM,Total Antibody",,,High,Preprint,Abdelilah Majdoubi,BC Children’s Hospital ,https://www.medrxiv.org/content/10.1101/2020.10.05.20206664v7,11/23/2020,4/26/2021
210205_Ontario_PublicHealthOntario_July,2/2/2021,Regional,Canada,Canada; Ontario,"July 4, 2020","July 31, 2020",Residual sera,Multiple groups,7001,1.39%,,,Stratified non-probability,Abbott Laboratories,,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,12/7/2020,4/26/2021
210205_Ontario_PublicHealthOntario_August,2/2/2021,Regional,Canada,Canada; Ontario,"August 1, 2020","August 21, 2020",Residual sera,Multiple groups,5764,1.56%,,,Stratified non-probability,Abbott Laboratories,,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,12/7/2020,4/26/2021
201017_Vancouver_UniversityofBritishColumbia_LTCF_overall,10/17/2020,Sublocal,Canada,Canada; British Columbia; Vancouver,"May 4, 2020","May 14, 2020",Assisted living and long-term care facilities,Multiple groups,291,39.00%,,,Convenience,"DiaSorin, Ortho Vitros , Abbott, Siemens ",,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Rohit Vijh,University of British Columbia,https://dx.doi.org/10.1016/j.ajic.2020.10.009,12/17/2020,4/26/2021
201027_Montreal_ShrinersHospital_sample_unadj,10/27/2020,Sublocal,Canada,Canada; Quebec; Montreal,"June 10, 2020","July 27, 2020",Multiple populations,Multiple groups,199,11.00%,,,Convenience,Omega Diagnostics,,IgG,,97.00%,High,Journal Article (Peer-Reviewed),Ghalib Bardai,Shriners Hospital for Children,https://doi.org/10.1111/pan.14047,12/18/2020,4/26/2021
210112_Canada_CBS_BloodDonors_Overall_PopAdjTestAdj,1/12/2021,National,Canada,Canada; Nine Canadian provinces,"November 7, 2020","November 25, 2020",Blood donors,Multiple groups,17049,1.51%,1.31%,1.71%,Sequential,Abbott,,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,https://slack-files.com/files-pri-safe/T011KSPAYPR-F01K401T9J9/covid-19_report_november_2020_final_12jan2021-1.pdf?c=1611144789-a5afc223a057856a,1/20/2021,4/26/2021
201218_Canada_CBS_BloodDonors_Overall_PopTestAdj,12/18/2020,National,Canada,Canada; Nine Canadian provinces,"October 12, 2020","October 31, 2020",Blood donors,Multiple groups,16811,0.88%,0.73%,1.04%,Sequential,Abbott,,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,1/21/2021,4/26/2021
201203_Edmonton_UniversityofAlberta_Children,12/3/2020,Local,Canada,Canada; Alberta; Edmonton,"August 14, 2020","October 23, 2020",Household and community samples,Children and Youth (0-17 years),565,1.60%,,,Convenience,Abbott Laboratories,,IgG,84.20%,100.00%,High,Preprint,Emilie Manny,University of Alberta,https://poseidon01.ssrn.com/delivery.php?ID=579098091025087124113094013092119126025046084059055038121105001063029013061117127066089088099029120125126127122027092067006090071077064116068026070083111035094021057114045098065076072116064007032059100097072054064094007027094015098095104082088098074069111094090004070124099079094007105068078&EXT=pdf&INDEX=TRUE,1/30/2021,4/26/2021
210205_Ontario_PublicHealthOntario_March_Apr_primary,2/2/2021,Regional,Canada,Canada; Ontario,"March 27, 2020","April 30, 2020",Residual sera,Multiple groups,827,0.60%,,,Stratified non-probability,"Abbott Laboratories, USA",,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,2/5/2021,4/26/2021
210205_Ontario_PublicHealthOntario_June_primary,2/2/2021,Regional,Canada,Canada; Ontario,"June 5, 2020","June 30, 2020",Residual sera,Multiple groups,7023,1.50%,,,Stratified non-probability,"Abbott Laboratories, USA",,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,2/5/2021,4/26/2021
210205_Ontario_PublicHealthOntario_May_primary,2/2/2021,Regional,Canada,Canada; Ontario,"May 5, 2020","May 30, 2020",Residual sera,Multiple groups,1061,1.90%,,,Stratified non-probability,"Abbott Laboratories, USA",,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,2/5/2021,4/26/2021
210208_Canada_CBS_BloodDonors_Overall_PopTestAdj,2/8/2021,National,Canada,"Canada; Nine Canadian provinces
","December 10, 2020","December 23, 2020",Blood donors,Multiple groups,16961,1.37%,1.18%,1.56%,Sequential,Abbott,,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,2/19/2021,4/20/2021
210125_Canada_UniversityofToronto_Phase1_Overall_Popdj_sp,1/25/2021,National,Canada,Canada; Nine Canadian provinces and two territories,"May 15, 2020","June 15, 2020",Household and community samples,Multiple groups,7068,1.70%,,,Stratified non-probability,"Network Biology Collaborative
Centre at Sinai Health",,IgG,,,Moderate,Preprint,Xuyang Tang,University of Toronto,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3752659,2/23/2021,4/20/2021
210125_Canada_UniversityofToronto_Phase2_Overall_PopAdj,1/25/2021,National,Canada,Canada,"August 15, 2020","September 15, 2020",Household and community samples,Multiple groups,1899,1.87%,,,Stratified non-probability,"Network Biology Collaborative
Centre at Sinai Health",,IgG,,,High,Preprint,Xuyang Tang,University of Toronto,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3752659,2/26/2021,4/20/2021
201123_Quebec_InstitutNationaldeSantePublique_overall,11/23/2020,Regional,Canada,Canada; Quebec,"July 6, 2020","September 24, 2020",Health care workers and caregivers,Multiple groups,2056,11.72%,,,Stratified non-probability,DiaSorin,,IgG,88.40%,,High,Institutional Report,Nicholas Brousseau,Institut National de Sante Publique,https://www.inspq.qc.ca/publications/3084-etude-seroprevalence-travailleurs-sante-centres-hospitaliers-quebec-covid19,3/3/2021,4/26/2021
210131_Calgary_UniversityOfCalgary_overall,1/31/2021,Local,Canada,Canada; Alberta; Calgary,"July 30, 2020","November 18, 2020",Household and community samples,Children and Youth (0-17 years),911,0.30%,0.10%,1.00%,Self-referral,Abbott,,IgG,76.10%,,Moderate,Institutional Report,James Kellner,University of Calgary,https://prism.ucalgary.ca/bitstream/handle/1880/113084/AB3C%20Aim%203%201st%20Interim%20Report-final.pdf?sequence=5&isAllowed=y,3/10/2021,3/29/2021
210201_Canada_UniversityofOttawa_Overall_adj,2/1/2021,National,Canada,Canada,"May 9, 2020","July 21, 2020",Blood donors,Multiple groups,74642,0.70%,0.63%,0.76%,Self-referral,Abbott,,IgG,92.70%,99.90%,Low,Journal Article (Peer-Reviewed),Sahar Saeed,University of Ottawa,http://dx.doi.org/10.1111/trf.16296,3/21/2021,3/29/2021
210216_Toronto_UniversityHealthNetwork_Abbott,2/16/2021,Sublocal,Canada,Canada; Ontario; Toronto,"April 17, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),996,1.40%,,,Convenience,Abbott Laboratories,,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Victor Ferreira,University Health Network,https://dx.doi.org/10.1371/journal.pone.0247258,3/22/2021,3/29/2021
210315_Vancouver_BCChildren’sHospitalResearchInstitute_Overall,3/15/2021,Local,Canada,Canada; British Colombia; Vancouver,"May 17, 2020","June 19, 2020",Household and community samples,Adults (18-64 years),276,0.60%,0.00%,2.71%,Convenience,"1) Meso Scale Diagnostics 
2) Ortho-Clinical Diagnostics",,Total Antibody,,,High,Journal Article (Peer-Reviewed),Abdelilah Majdoubi,BC Children’s Hospital Research Institute,https://dx.doi.org/10.1172/jci.insight.146316,4/10/2021,4/10/2021
200710_Santiago_UniversidadDeChile_AllStudents,7/10/2020,Sublocal,Chile,Chile; Santiago; Vitacura,"May 4, 2020","May 19, 2020",Students and Daycares,Children and Youth (0-17 years),1009,9.90%,8.60%,11.50%,Stratified probability,Genrui Biotech,Colloidal gold,"IgG,IgM",91.01%,95.37%,High,Journal Article (Peer-Reviewed),Juan Pablo Torres,Universidade de Chile,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860,7/26/2020,4/26/2021
200710_Santiago_UniversidadDeChile_AllStaff,7/10/2020,Sublocal,Chile,Chile; Santiago; Vitacura,"May 4, 2020","May 19, 2020",Essential non-healthcare workers,Adults (18-64 years),235,16.60%,12.10%,21.90%,Stratified probability,Genrui Biotech,Colloidal gold,"IgG,IgM",91.01%,95.37%,High,Journal Article (Peer-Reviewed),Juan Pablo Torres,Universidade de Chile,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860,7/26/2020,4/26/2021
200602_Wuhan_HuazhongUniversityofScienceandTechnology_HealthCareWorkers,6/2/2020,Local,China,China; Hubei; Wuhan,"February 12, 2020","March 17, 2020",Health care workers and caregivers,Adults (18-64 years),797,4.39%,,,Convenience,Not reported,ELISA,IgG,,,Unclear,Preprint,Shue Xiong,Huazhong University of Science and Technology,https://www.medrxiv.org/content/10.1101/2020.05.28.20110767v1.full.pdf,6/3/2020,4/26/2021
200605_China_NationalClinicalResearchCentre_CommunitySetting,6/5/2020,National,China,"China; Hubei, Sichuan, Guangdong; Wuhan, Guangzhou, Chengdu","March 9, 2020","April 10, 2020",Multiple populations,Adults (18-64 years),10449,0.80%,,,Self-referral,Bioscience,Chemiluminescence Immunoassay,"IgG,IgM",,99.30%,High,Journal Article (Peer-Reviewed),Xin Xu,National Clinical Research Centre for Kidney Disease,https://www.nature.com/articles/s41591-020-0949-6,6/6/2020,4/26/2021
200602_Wuhan_SunYat-senUniversity_HCW_IgG,6/10/2020,Local,China,China; Hubei; Wuhan,"February 7, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),420,0.00%,,,Convenience,YHLO,Chemiluminescence Immunoassay,IgG,97.80%,97.90%,High,Journal Article (Peer-Reviewed),Min Liu,Sun Yat-sen University,https://www.bmj.com/content/369/bmj.m2195,6/12/2020,4/26/2021
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG,11/2/2020,Local,China,China; Hubei; Wuhan,"February 29, 2020","April 29, 2020",Health care workers and caregivers,Multiple groups,3832,4.00%,3.40%,4.70%,Convenience,YHLO,Chemiluminescence Immunoassay,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,6/17/2020,4/26/2021
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG,11/2/2020,Local,China,China; Hubei; Wuhan,"February 29, 2020","April 29, 2020",Household and community samples,Multiple groups,19555,4.60%,4.30%,4.90%,Convenience,YHLO,Chemiluminescence Immunoassay,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,6/17/2020,4/26/2021
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG,11/2/2020,Local,China,China; Hubei; Wuhan,"February 29, 2020","April 29, 2020",Residual sera,Multiple groups,1616,1.00%,0.50%,1.50%,Sequential,YHLO,Chemiluminescence Immunoassay,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,6/17/2020,4/26/2021
200603_WuhantoUSAtravel_CDC_PassengersGenPop,7/3/2020,Sublocal,China,China; Hubei; Wuhan,"January 28, 2020","January 28, 2020",Household and community samples,Multiple groups,186,0.54%,,,Convenience,SeraCare Life Sciences,ELISA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Benjamin Hallowell,US Centers for Disease Control and Prevention,https://wwwnc.cdc.gov/eid/article/26/9/20-1590_article,7/6/2020,4/26/2021
200604_Nanjing_NanjingUniversityMedicalSchool_HCWs/ContactsofCOVID-19patients,6/4/2020,Local,China,China; Jiangsu; Nanjing,"February 19, 2020","February 19, 2020",Health care workers and caregivers,Adults (18-64 years),105,17.14%,,,Convenience,Author-designed,ELISA,"IgG,IgM",93.30%,100.00%,High,Journal Article (Peer-Reviewed),Yuxin Chen,Nanjing University Medical School,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270786/pdf/main.pdf,7/16/2020,4/26/2021
200420_Wuhan_CR&WISCOGeneralHospital_HospitalizedPatients,4/20/2020,Sublocal,China,China; Hubei; Wuhan,"April 3, 2020","April 15, 2020",Residual sera,Not reported,381,10.49%,,,Unclear,Innovita Biological Technology Co. Ltd,Colloidal Gold Immunochromatography Assay (LFIA),"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Xiaodong Wu,Wuhan University,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904,7/19/2020,4/26/2021
200420_Wuhan_CR&WISCOGeneralHospital_PeopleSeekingReturntoWork,4/20/2020,Sublocal,China,China; Hubei; Wuhan,"April 3, 2020","April 15, 2020",Essential non-healthcare workers,Adults (18-64 years),1021,9.60%,,,Unclear,Innovita Biological Technology Co. Ltd,Colloidal Gold Immunochromatography Assay (LFIA),"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Xiaodong Wu,Wuhan University,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904,7/19/2020,4/26/2021
200714_Shijiazhuang_PekingUnionMedicalCollege_BloodDonors,7/14/2020,Local,China,China; Hebei; Shijiazhuang,"January 23, 2020","March 15, 2020",Blood donors,Multiple groups,13540,0.01%,0.00%,0.04%,Sequential,Wantai Biological Pharmacy Enterprise,ELISA,"IgA,IgG,IgM",,,High,Preprint,Le Chang,Beijing Hospital,https://www.medrxiv.org/content/10.1101/2020.07.13.20153106v1.full.pdf,7/19/2020,4/26/2021
200714_Shenzhen_PekingUnionMedicalCollege_BloodDonors,7/14/2020,Local,China,China; Guangdong; Shenzhen,"February 2, 2020","March 15, 2020",Blood donors,Multiple groups,6810,0.03%,0.01%,0.11%,Sequential,Wantai Biological Pharmacy Enterprise,ELISA,"IgA,IgG,IgM",,,High,Preprint,Le Chang,Beijing Hospital,https://www.medrxiv.org/content/10.1101/2020.07.13.20153106v1.full.pdf,7/19/2020,4/26/2021
200714_Wuhan_PekingUnionMedicalCollege_BloodDonors,7/14/2020,Local,China,China; Hubei; Wuhan,"January 15, 2020","April 30, 2020",Blood donors,Multiple groups,17794,2.29%,2.08%,2.52%,Sequential,Wantai Biological Pharmacy Enterprise,ELISA,"IgA,IgG,IgM",,,High,Preprint,Le Chang,Beijing Hospital,https://www.medrxiv.org/content/10.1101/2020.07.13.20153106v1.full.pdf,7/19/2020,4/26/2021
200605_China_NationalClinicalResearchCentre_HospitalSetting,6/5/2020,National,China,"China; Hubei, Sichuan, Guangdong; Wuhan, Guangzhou, Jinzhou, Honghu, Chongqing, Chengdu, Foshan","March 9, 2020","April 10, 2020",Multiple populations,Adults (18-64 years),6919,2.46%,,,Self-referral,Bioscience,Chemiluminescence Immunoassay,"IgG,IgM",,99.30%,High,Journal Article (Peer-Reviewed),Xin Xu,National Clinical Research Centre for Kidney Disease,https://www.nature.com/articles/s41591-020-0949-6,7/24/2020,4/26/2021
200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgG/IgM,7/20/2020,Local,China,China; Guangdong; Guangzhou,"January 20, 2020","April 30, 2020",Multiple populations,Multiple groups,8782,0.59%,,,Convenience,Shenzhen YHLO Biotech Co,Chemiluminescence Immunoassay,"IgG,IgM",,100.00%,High,Journal Article (Peer-Reviewed),Wenhua Liang,The First Affiliated Hospital of Guangzhou Medical University,https://dx.doi.org/10.1038/s41422-020-0371-0,7/31/2020,4/26/2021
200720_Wuhan_GuangzhouMedicalUniversity_OverallIgG/IgM,7/20/2020,Local,China,China; Hubei; Wuhan,"January 19, 2020","April 30, 2020",Multiple populations,Multiple groups,8272,2.14%,,,Convenience,Innovita,Colloidal gold,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Wenhua Liang,The First Affiliated Hospital of Guangzhou Medical University,https://dx.doi.org/10.1038/s41422-020-0371-0,7/31/2020,4/26/2021
200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_IgGandorIgM,7/3/2020,Local,China,China; Hubei; Wuhan,"March 8, 2020","March 21, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1027,4.58%,,,Convenience,"""Tangshan Yingnuote Biotechnology Enterprise Co., Ltd.""",Colloidal Gold Immunochromatography Assay (LFIA),"IgG,IgM",87.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Hui Tang, Tongji Medical College,https://dx.doi.org/10.1053/j.ajkd.2020.06.008,8/2/2020,4/26/2021
200725_Wuhan_WuhanInstituteofVirology_IgG,7/25/2020,Sublocal,China,China; Hubei; Wuhan,"March 19, 2020","March 20, 2020",Health care workers and caregivers,Adults (18-64 years),325,43.08%,,,Stratified probability,"Vazyme, Zhu Hai Livzon Diagnostics Ins, NZK Biotech Co","ELISA,Colloidal gold,Dual-target immuno-fluorescence assay (DTFA)",IgG,,,High,Journal Article (Peer-Reviewed),Danna Tu,Wuhan Institute of Virology,http://dx.doi.org/10.1016/j.jinf.2020.07.023,9/28/2020,4/26/2021
200729_Wuhan_WuhanUniversity_Overall,8/3/2020,Sublocal,China,China; Hubei; Wuhan,"January 14, 2020","February 21, 2020",Health care workers and caregivers,Not reported,1060,8.30%,,,Convenience,Shenzhen YHLO Biotech Co,Chemiluminescence Immunoassay,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Dong Zhao,Renmin Hospital of Wuhan University,https://dx.doi.org/10.1016/j.ijid.2020.07.082,10/1/2020,4/26/2021
200725_Shenzhen_ ShenzhenSecondPeoplesHospital_Builders,7/25/2020,Local,China,China; Guangdong; Shenzhen,"February 29, 2020","March 18, 2020",Non-essential workers and unemployed persons,Multiple groups,1589,0.38%,,,Convenience,Shenzhen Sciarray Biotech Ltd,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Cantong Zhang,Shenzhen Second People's Hospital,http://dx.doi.org/10.1002/jmv.26355,10/3/2020,4/26/2021
200829_Hubei_HuazhongUniversity_HospitalizedChildren,8/29/2020,Local,China,"China; Hubei; Wuhan, Xiangyang","January 23, 2020","April 24, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),299,0.00%,,,Unclear,Not reported,magnetic particle chemiluminescence,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Song-mi Want,Huazhong University of Science and Technology,https://link.springer.com/article/10.1007/s11596-020-2228-7,10/3/2020,4/26/2021
200701_HongKong_QueenMaryHospital_Evacuees_EnzymeImmunoAssay,6/3/2020,Regional,China,China; Hubei,"March 4, 2020","March 17, 2020",Household and community samples,Multiple groups,452,2.88%,,,Convenience,Author-designed,Enzyme immunoassay,IgG,73.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kelvin To,Queen Mary Hospital,https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,10/9/2020,4/26/2021
200701_HongKong_QueenMaryHospital_Jan2020_EnzymeImmunoAssay,6/3/2020,Regional,China,China; Hong Kong,"January 1, 2020","January 31, 2020",Residual sera,Multiple groups,580,2.59%,1.46%,4.23%,Sequential,Author-designed,Enzyme immunoassay,IgG,73.30%,100.00%,High,Journal Article (Peer-Reviewed),Kelvin To,Queen Mary Hospital,https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,10/9/2020,4/26/2021
200701_HongKong_QueenMaryHospital_Feb2020_EnzymeImmunoAssay,6/3/2020,Regional,China,China; Hong Kong,"February 1, 2020","February 13, 2020",Residual sera,Multiple groups,233,0.43%,0.01%,2.37%,Sequential,Author-designed,Enzyme immunoassay,IgG,73.30%,100.00%,High,Journal Article (Peer-Reviewed),Kelvin To,Queen Mary Hospital,https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,10/9/2020,4/26/2021
200811_Wuhan_HuazhongUniversityofScienceandTechnologyIgG,8/11/2020,Sublocal,China,China; Hubei; Wuhan,"January 23, 2020","March 27, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),44,0.00%,,,Sequential,Not reported,Chemiluminescence Immunoassay,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ai Zhang,Huazhong University of Science and Technology,https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.28424,10/9/2020,4/26/2021
200820_Hubei_NanjingUniversity_hcw_IgG,8/20/2020,Local,China,China; Hubei; Wuhan,"May 12, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),191,,,,Convenience,Shenzhen YHLO Biotech Co,Chemiluminescence Immunoassay,IgG,,,High,Journal Article (Peer-Reviewed),Xin Tong,Nanjing University Medical School,https://dx.doi.org/10.1002/iid3.340,10/12/2020,4/26/2021
200819_Guangzhou_InstituteofBloodTransfusion_BloodDonors_TotalAnti,8/19/2020,Local,China,China; Guangdong; Guangzhou,"March 23, 2020","April 2, 2020",Blood donors,Adults (18-64 years),2199,0.32%,,,Simplified probability,"Wantai Biological Pharmacy Enterprise, Lizhu Diagnostics",ELISA,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Ru Xu,Institute of Blood Transfusion,http://dx.doi.org/10.1002/jmv.26445,10/18/2020,4/26/2021
200824_Wuhan_WuhanUniversity_IgG_T2,8/24/2020,Sublocal,China,China; Hubei; Wuhan,"May 13, 2020","June 10, 2020",Health care workers and caregivers,Adults (18-64 years),1059,9.30%,,,Convenience,Livzon Diagnostics,Colloidal Gold Immunochromatography Assay (LFIA),IgG,,,High,Journal Article (Peer-Reviewed),Lu He,Wuhan University,http://dx.doi.org/10.1016/j.jinf.2020.08.027,10/18/2020,4/26/2021
200901_Wuhan_ZhongnanHospitalofWuhanUniversity_IgGTotal,9/14/2020,Sublocal,China,China; Hubei; Wuhan,"March 16, 2020","March 25, 2020",Health care workers and caregivers,Adults (18-64 years),3674,1.70%,,,Convenience,Shenzhen Yahuilong Biotechnology Co.,Chemiluminescence Immunoassay,IgG,,,Moderate,Journal Article (Peer-Reviewed),Fuling Zhou,Zhongnan Hospital of Wuhan University,http://dx.doi.org/10.1016/j.eclinm.2020.100510,10/29/2020,4/26/2021
200923_Wuhan_NationalCenterforMedicalServiceAdministration_Overall,9/23/2020,Sublocal,China,China; Hubei; Wuhan,"February 10, 2020","March 22, 2020",Contacts of COVID patients,Multiple groups,300,47.67%,,,Convenience,Innovita Biological Technology Co. Ltd,Colloidal Gold Immunochromatography Assay (LFIA),"IgG,IgM",97.10%,95.30%,High,Journal Article (Peer-Reviewed),Yaqing Li,National Center for Medical Service Administration,https://dx.doi.org/10.5858/arpa.2020-0310-SA,11/19/2020,4/26/2021
200923_Beijing_PekingUniversity_Overall,9/23/2020,Local,China,China; Hebei; Beijing,"April 15, 2020","April 18, 2020",Household and community samples,Multiple groups,2184,0.17%,,,Stratified probability,"Wondfo Biotech Co., Innovita Biological Technology Co Ltd",Colloidal gold,"IgG,IgM",,,Moderate,Preprint,Xiaoli Wang,Peking University,https://www.medrxiv.org/content/10.1101/2020.09.23.20197756v1,11/22/2020,4/26/2021
200921_Wuhan_TongjiMedicalCollege_Overall,9/21/2020,Local,China,China; Hubei; Wuhan,"February 17, 2020","April 28, 2020",Multiple populations,Multiple groups,11766,0.50%,,,Sequential,YHLO,Chemiluminescence Immunoassay,"IgM,IgG",66.70%,99.50%,High,Journal Article (Peer-Reviewed),Qing Lei, Tongji Medical College,https://dx.doi.org/10.1111/all.14622,11/25/2020,4/26/2021
201119_Shanghai_FudanUniversity_Overall,11/19/2020,Sublocal,China,China; Shanghai Municipality; Shanghai,"May 15, 2020","October 15, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,6414,0.31%,,,Convenience,Bioscience,,"IgG,IgM",,,High,Preprint,Shengjie Li,Fudan University,https://www.medrxiv.org/content/10.1101/2020.09.22.20198465v2,11/30/2020,4/26/2021
200922_Wuhan_WuhanUniversity_IgM/IgG,10/6/2020,Local,China,China; Hubei; Wuhan,"May 15, 2020","May 26, 2020",Household and community samples,Multiple groups,61437,2.39%,2.27%,2.52%,Stratified probability,"Nanjing Vazyme Medical technology Co., Ltd",,"IgG,IgM",91.54%,97.02%,Moderate,Journal Article (Peer-Reviewed),Yunbao Pan,Wuhan University,https://dx.doi.org/10.1016/j.cmi.2020.09.044,12/8/2020,4/26/2021
201023_Wuhan_HuazhongUniversityofScienceandTechnology_Overall_unadj,10/23/2020,Local,China,China; Hubei; Wuhan,"March 27, 2020","May 26, 2020",Household and community samples,Multiple groups,35040,3.90%,3.70%,4.10%,Unclear,"Bioscience, Tianjin, China",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anding Liu,Huazhong University of Science and Technology,https://dx.doi.org/10.1001/jamanetworkopen.2020.25717,1/22/2021,4/26/2021
201225_Wuhan_RenminHospitalofWuhanUniversity_Community,12/25/2020,Local,China,China; Hubei; Wuhan,"May 15, 2020","May 29, 2020",Household and community samples,Multiple groups,4454,2.90%,,,Unclear,Livzon Diagnostics Inc. ,,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lu He,Renmin Hospital of Wuhan University,https://dx.doi.org/10.7883/yoken.JJID.2020.691,1/28/2021,4/26/2021
201225_Wuhan_RenminHopsitalofWuhanUniversity_HCW,12/25/2020,Sublocal,China,China; Hubei; Wuhan,"May 15, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),4614,3.30%,,,Convenience,Livzon Diagnostics Inc. ,,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lu He,Renmin Hospital of Wuhan University,https://dx.doi.org/10.7883/yoken.JJID.2020.691,1/28/2021,4/26/2021
201228_Beijing_CapitalMedicalUniversity_IgG,12/28/2020,Sublocal,China,China,"January 1, 2020","August 31, 2020",Residual sera,Children and Youth (0-17 years),19797,0.06%,,,Sequential,Beijing Innovita Biological Technology,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Ran Wang,Capital Medical University ,https://dx.doi.org/10.1002/ped4.12231,1/31/2021,4/26/2021
210107_China_WuhanUniversity,1/7/2021,Regional,China,China; Hubei,"March 6, 2020","May 3, 2020",,Multiple groups,63107,0.74%,,,Unclear,"Innovita, Tangshan, China",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shuhui Duan,Wuhan University,https://dx.doi.org/10.1371/journal.pntd.0008975,2/6/2021,3/31/2021
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_contacts_TotalAb_TestAdj,1/19/2021,Local,China,China,"April 12, 2020","May 4, 2020",Contacts of COVID patients,Multiple groups,880,4.10%,2.90%,5.70%,Convenience,Beijing Wantai Biological Pharmacy Enterprise,,Total Antibody,98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/24/2021,4/9/2021
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodNoCases_TotalAb_TestAdj,1/19/2021,Local,China,China,"April 17, 2020","April 23, 2020",,Not reported,350,0.00%,0.00%,1.10%,Convenience,Beijing Wantai Biological Pharmacy Enterprise,,Total Antibody,98.00%,99.00%,High,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/24/2021,4/9/2021
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodReportedCases_TotalAb_TestAdj,1/19/2021,Local,China,China,"April 17, 2020","April 23, 2020",,Not reported,50,0.00%,0.00%,6.80%,Convenience,Beijing Wantai Biological Pharmacy Enterprise,,Total Antibody,98.00%,99.00%,High,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/24/2021,4/9/2021
210109_Taiwan_NationalTaiwanUniversityHospital_HCW_Overall,1/9/2021,Sublocal,China,China; Taiwan; Taipei,"July 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),194,0.00%,,,Convenience,Abbott; Roche; Mikrogen Diagnostik,,IgG,,,High,Journal Article (Peer-Reviewed),Sung-Ching Pan,National Taiwan University Hospital,https://dx.doi.org/10.1016/j.jfma.2021.01.002,3/14/2021,3/28/2021
210206_China_ChineseCenterforDiseaseControlandPrevention_Overall,2/6/2021,National,China,China,"April 10, 2020","April 18, 2020",Household and community samples,Multiple groups,34857,1.23%,,,Stratified probability,"Wondfo, Innovita, Bioscience, In-House (China CDC)",,"IgM,IgG,Neutralizing ,Total Antibody",76.00%,100.00%,Low,Journal Article (Peer-Reviewed),Zhongjie Li ,Chinese Center for Disease Control and Prevention,https://dx.doi.org/10.1016/j.lanwpc.2021.100094,3/23/2021,3/28/2021
210320_Wuhan_ChineseAcademyOfMedicalSciences_overall_Roche,3/20/2021,Regional,China,China; Wuhan,"April 14, 2020","April 15, 2020",Household and community samples,Multiple groups,9542,6.92%,6.41%,7.43%,Stratified non-probability,Roche,,Total Antibody,100.00%,100.00%,Low,Journal Article (Peer-Reviewed),Zhenyu He,Chinese Academy of Medical Sciences & Peking Union Medical College,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00238-5/fulltext?dgcid=raven_jbs_etoc_email,3/24/2021,4/1/2021
200825_Wuhan_ChineseCenterforDiseaseControlandPrevention_primary,8/25/2020,Local,China,China; Hubei; Wuhan,"March 25, 2020","April 28, 2020",Household and community samples,Multiple groups,18712,3.27%,3.02%,3.52%,Self-referral,Innovita,,"IgG,IgM",89.50%,99.00%,Moderate,Preprint,Ruijie Ling,Chinese Center for Disease Control and Prevention,https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v3,4/8/2021,4/26/2021
210302_Wuhan_ChineseAcademyofMedicalSciences1_overall_adj,,Local,China,China,"January 15, 2020","April 15, 2020",Blood donors,Adults (18-64 years),17794,2.66%,2.24%,3.07%,Convenience,Not reported,,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,4/11/2021,4/11/2021
210302_Shenzhen_ChineseAcademyofMedicalSciences2_overall_adj,,Local,China,China,"January 15, 2020","April 15, 2020",Blood donors,Multiple groups,6810,0.03%,0.00%,0.27%,Convenience,Not reported,,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,4/11/2021,4/11/2021
210302_Shijiazhuang_ChineseAcademyofMedicalSciences3_overall_adj,,Local,China,China,"January 15, 2020","April 15, 2020",Blood donors,Adults (18-64 years),13540,0.00%,0.00%,0.16%,Convenience,Not reported,,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,4/11/2021,4/11/2021
210308_ZhongnanHospital_Wuhan,3/8/2021,Sublocal,China,China; Hubei; Wuhan,"January 1, 2020","April 8, 2020",Health care workers and caregivers,Adults (18-64 years),112,0.00%,,,Unclear,NR,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yin‐xian Wen,Zhongnan Hospital of Wuhan University,https://dx.doi.org/10.1111/os.12898,4/18/2021,4/18/2021
200918_Bogota_PontificiaUniversidadJaveriana_HCW_FinalEndpoint_UnAdj,1/3/2021,Sublocal,Colombia,Colombia; Capital District Cundinamarca; Bogotá,"June 25, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),351,8.26%,5.81%,11.61%,Self-referral,"Abbott, Columbia
SD Biosensor",Not reported,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Beatriz Ariza,Pontificia Universidad Javeriana,http://www.revistainfectio.org/index.php/infectio/article/view/938,10/5/2020,4/26/2021
201030_Colombia_UniversidadIndustrialdeSantander_primary,10/30/2020,National,Colombia,Colombia,"April 17, 2020","July 14, 2020",Non-essential workers and unemployed persons,Multiple groups,4234,4.00%,,,Unclear,NR,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alvaro J Idrovo,Universidad Industrial de Santander,https://dx.doi.org/10.7705/biomedica.5829,1/23/2021,4/26/2021
201112_Monteria_UniversidaddeCórdoba_GenPopAdj,11/12/2020,Local,Colombia,Colombia; Caribbean Region; Monteria,"August 4, 2020","September 1, 2020",Household and community samples,Multiple groups,1368,55.30%,52.50%,57.80%,Stratified probability,Ingenasa,,"IgG,IgM,IgA",92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Salim Mattar,Universidad de Córdoba,https://dx.doi.org/10.1093/ofid/ofaa550,2/4/2021,4/26/2021
210122_Bogota_InstitutoNacionaldeSalud_OverallTestAdj,1/22/2021,Sublocal,Colombia,Colombia; Capital District; Bogota,"June 1, 2020","September 30, 2020",Essential non-healthcare workers,Adults (18-64 years),212,16.03%,10.43%,21.62%,Convenience,Abbott Laboratories,,Total Antibody,85.50%,97.30%,High,Journal Article (Peer-Reviewed),Jeadran Malagón-Rojas,Instituto Nacional de Salud,https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab006/6106252?searchresult=1,3/12/2021,4/7/2021
210317_UniversidadDeLosAndes_UniversidadDeLosAndes_overall,3/17/2021,Sublocal,Colombia,Colombia,"November 23, 2020","December 6, 2020",Essential non-healthcare workers,Adults (18-64 years),237,13.50%,,,Convenience,Abbott,,IgG,,,High,Preprint,John M. Gonzalez,Universidad de Los Andes,https://www.medrxiv.org/content/10.1101/2021.03.15.21253609v1,3/29/2021,4/1/2021
210325_Bucaramanga_FundaciónCardiovascularDeColombia_overall_popadj_testadj,3/25/2021,Local,Colombia,Colombia,"September 28, 2020","December 24, 2020",Multiple populations,Adults (18-64 years),7045,19.50%,18.60%,20.40%,Stratified probability,Abbot,,"IgG,IgM",,,Moderate,Preprint,Claudia C. Colmenares-Mejía,Fundación Cardiovascular de Colombia,https://www.preprints.org/manuscript/202103.0631/v1,3/29/2021,4/1/2021
201222_Brazzaville_FondationCongolaisePourLaRechercheMédicale_GenPop_Overall,12/22/2020,Local,Congo,Congo,"April 1, 2020","July 31, 2020",Household and community samples,Adults (18-64 years),754,19.70%,,,Self-referral,"Wuhan UNniscience Biotechnology, Salofa Oy manufacturer, Finland",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), Armel Batchi-Bouyou,Fondation Congolaise pour la Recherche Médicale,https://dx.doi.org/10.1016/j.ijid.2020.12.065,1/30/2021,4/26/2021
210129_IvoryCoast_ CentreHospitalierRegionald’Orleans_primary,1/29/2021,Sublocal,Côte d'Ivoire,Côte d'Ivoire,"July 15, 2020","October 13, 2020",,Adults (18-64 years),1687,25.10%,,,Convenience,AAZ LMB,,"IgM,IgG",,,High,Preprint,Jean Marie Milleliri, Centre Hospitalier Regional d’Orleans,https://www.medrxiv.org/content/10.1101/2021.01.27.21249186v1,2/16/2021,3/31/2021
210318_IvoryCoast_CentreHospitalierRegionald’Orleans_Overall,3/18/2021,National,Côte d'Ivoire,Côte d'Ivoire; NR; NR,"July 15, 2020","October 13, 2020",Essential non-healthcare workers,Adults (18-64 years),1687,25.10%,,,Convenience,"AAZ LMB, Boulogne Billanco",,"IgG,IgM",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jean Milleliri,Centre Hospitalier Regional d’Orleans,https://dx.doi.org/10.4269/ajtmh.21-0081,4/15/2021,4/15/2021
200515_Croatia_UniversityofSplit_IndustryWorkers_Overall,5/15/2020,Local,Croatia,Croatia,"April 23, 2020","April 28, 2020",Essential non-healthcare workers,Multiple groups,1494,1.27%,0.77%,1.98%,Convenience,AMP Diagnostics,Rapid immunochromatographic test,"IgM,IgG",91.80%,96.40%,High,Journal Article (Peer-Reviewed),Ivan Jerkovic,University of Split,https://journals.lww.com/joem/Abstract/9000/SARS_CoV_2_Antibody_Seroprevalence_in_Industry.98091.aspx,7/16/2020,4/26/2021
200826_Croatia_UniversityofZagreb_HCWsIgG,8/26/2020,National,Croatia,Croatia,"April 25, 2020","May 24, 2020",Health care workers and caregivers,Adults (18-64 years),592,2.70%,,,Convenience,Vircell Spain S.L.U,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Tatjana Vilibic-Cavlek,University of Zagreb,https://dx.doi.org/10.1590/0037-8682-0458-2020,10/17/2020,4/26/2021
201231_Zagreb_ZagrebUniversity_overall,12/31/2020,Sublocal,Croatia,Croatia,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1678,0.60%,,,Convenience,Abbott Laboratories,,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Ivana Lapić,Zagreb University,https://pubmed.ncbi.nlm.nih.gov/33410294/,2/1/2021,4/26/2021
201104_Croatia_CroatianFootballFederation_FootballPlayers&ClubStaff,11/4/2020,Sublocal,Croatia,Croatia,"May 29, 2020","July 31, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),305,20.00%,,,Convenience,Euroimmun Medizinische Labordiagnostika AG,,"IgA,IgG",,,Moderate,Preprint,Adriana Vince,Croatian Football Federation,https://www.medrxiv.org/content/10.1101/2020.10.30.20223230v1,2/6/2021,4/26/2021
200802_AguadadePasajeros_UniversityofMedicalSciencesofCienfuegos,8/23/2020,Local,Cuba,Cuba; Cienfuegos; Aguada de Pasajeros,"March 23, 2020","April 6, 2020",Contacts of COVID patients,Multiple groups,200,0.00%,,,Convenience,NR,,"IgM,IgG",,,Unclear,Journal Article (Peer-Reviewed),Alain Morejón Giraldoni,University of Medical Sciences of Cienfuegos,http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2020000400721,1/7/2021,4/26/2021
200714_CzechRepublic_ResearchCenterIBD_HCW,7/14/2020,Sublocal,Czechia,Czechia; Central Bohemian; Prague,,"April 15, 2020",Health care workers and caregivers,Adults (18-64 years),92,2.17%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed), Karin Malickova,Clinical and Research Center for Inflammatory Bowel Disease,https://dx.doi.org/10.1080/00365521.2020.1791244,8/2/2020,4/26/2021
201112_Prague_CharlesUniversityandThomayer'sHospital_Roche,11/12/2020,Sublocal,Czechia,Czechia; Prague; Prague,"July 3, 2020","August 19, 2020",Residual sera,Children and Youth (0-17 years),200,0.00%,0.00%,0.50%,Sequential,Roche Diagnostics,,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Marketa Bloomfield,Charles University and Thomayer’s Hospital,http://dx.doi.org/10.3389/fped.2020.597736,1/23/2021,4/26/2021
210216_Bukavu_UniversitéLibredeBruxelles_OverallELISA,,Sublocal,Democratic Republic of the Congo,Democratic Republic of the Congo; South-Kivu; Bukavu,"July 2, 2020","August 19, 2020",Health care workers and caregivers,Adults (18-64 years),359,41.20%,,,Convenience,Euroimmun,,IgG,61.70%,98.60%,High,Journal Article (Peer-Reviewed),Denis Mukwege ,Université Libre de Bruxelles (ULB),https://dx.doi.org/10.4269/ajtmh.20-1526,3/13/2021,3/29/2021
210217_Kinhasa_InstitutNationaldeRechercheBiomedicale_EUROIMMUN,2/17/2021,Local,Democratic Republic of the Congo,Democratic Republic of the Congo; Kinhasa; Kinhasa,"July 17, 2020","August 13, 2020",Health care workers and caregivers,Adults (18-64 years),562,36.00%,,,Stratified probability,"EUROIMMUN, Lübeck, Germany",,IgG,94.60%,99.80%,Moderate,Journal Article (Peer-Reviewed),Antoine Nkuba Ndaye,Institut National de Recherche Biomedicale,https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00060-7/fulltext,3/20/2021,3/29/2021
210127_Bukavu_CliniqueSaint-LucDeBukavu_Overall,1/27/2021,Sublocal,Democratic Republic of the Congo,Democratic Republic of the Congo,"May 15, 2020","August 30, 2020",Multiple populations,Multiple groups,684,40.79%,,,Self-referral,Cellex,,"IgG,IgM",93.80%,96.00%,High,Journal Article (Peer-Reviewed),Philippe Bianga Katchunga,Clinique Saint-Luc de Bukavu,https://www.panafrican-med-journal.com/content/article/38/93/full/,4/15/2021,4/20/2021
200625_Denmark_GeneralPopTestAdj,6/25/2020,National,Denmark,Denmark,"April 6, 2020","May 3, 2020",Blood donors,Adults (18-64 years),20640,1.90%,0.80%,2.30%,Entire sample,Livzon Diagnostics,LFIA: Lateral flow immunoassay,"IgG,IgM",82.58%,99.54%,Moderate,Journal Article (Peer-Reviewed),Christian Erikstrup,Copenhagen University Hospital,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa849/5862661,6/26/2020,4/26/2021
200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_IgG_ANDOR_IgM_adj,8/3/2020,Regional,Denmark,Denmark; Capital Region of Denmark,"April 15, 2020","April 22, 2020",Health care workers and caregivers,Adults (18-64 years),28792,4.36%,4.09%,4.65%,Entire sample,Livzon Diagnostics,LFIA: Lateral flow immunoassay,"IgM,IgG",73.40%,99.90%,Low,Journal Article (Peer-Reviewed),Kasper Iversen,University of Copenhagen,https://dx.doi.org/10.1016/S1473-3099(20)30589-2,9/29/2020,4/26/2021
200803_CapitalRegionDenmark_UniversityofCopenhagen_blooddonors_IgG_ANDOR_IgM,8/3/2020,Regional,Denmark,Denmark; Capital Region of Denmark,"April 15, 2020","April 22, 2020",Blood donors,Adults (18-64 years),4672,3.04%,2.58%,3.57%,Sequential,Livzon Diagnostics,LFIA: Lateral flow immunoassay,"IgM,IgG",73.40%,99.90%,High,Journal Article (Peer-Reviewed),Kasper Iversen,University of Copenhagen,https://dx.doi.org/10.1016/S1473-3099(20)30589-2,10/1/2020,4/26/2021
201003_Denmark_AarhusUniversity_HCW_testadj,10/3/2020,Regional,Denmark,Denmark; Central Denmark Region,"May 18, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),17948,3.36%,2.38%,3.82%,Convenience,"Wantai Biological Pharmacy Enterprise Co, Ltd, Beijing,
China",,"IgG,IgM,IgA",96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Senne Jespersen,Aarhus University Hospital,https://dx.doi.org/10.1093/cid/ciaa1471,12/19/2020,4/26/2021
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_ParturientWomen_TestAdj,10/27/2020,Sublocal,Denmark,Denmark; Capital Region of Denmark; Copenhagen,"April 4, 2020","July 3, 2020",Pregnant or parturient women,Adults (18-64 years),1313,2.60%,1.70%,4.00%,Sequential,Shenzhen Yhlo Biotech,,"IgG,IgM",94.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,1/8/2021,4/26/2021
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_PartnersofParturientWomen_TestAdj,10/27/2020,Sublocal,Denmark,Denmark; Capital Region of Denmark; Copenhagen ,"April 4, 2020","July 3, 2020",Hospital visitors,Adults (18-64 years),1188,3.50%,2.30%,5.10%,Sequential,"Shenzhen Yhlo Biotech
",,"IgG,IgM",94.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,1/9/2021,4/26/2021
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_Newborns,10/27/2020,Sublocal,Denmark,Denmark; Capital Region of Denmark; Copenhagen ,"April 4, 2020","July 3, 2020",Perinatal,Children and Youth (0-17 years),1206,1.40%,,,Sequential,Shenzhen Yhlo Biotech,,"IgG,IgM",94.00%,99.30%,High,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,1/9/2021,4/26/2021
201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_retired_adj,10/26/2020,National,Denmark,Denmark,"June 2, 2020","June 19, 2020",Blood donors,Seniors (65+ years),1200,1.40%,0.30%,2.50%,Simplified probability,Beijing Wantai Biological Pharmacy Enterprise,,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Ole Birger Pedersen,Copenhagen University Hospital Rigshospitalet,https://dx.doi.org/10.1093/cid/ciaa1627,1/10/2021,4/26/2021
201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_Active_adj,10/26/2020,National,Denmark,Denmark,"June 1, 2020","June 26, 2020",Blood donors,Adults (18-64 years),1110,2.50%,1.30%,3.80%,Sequential,Beijing Wantai Biological Pharmacy Enterprise,,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Ole Birger Pedersen,Copenhagen University Hospital Rigshospitalet,https://dx.doi.org/10.1093/cid/ciaa1627,1/11/2021,4/26/2021
201227_Denmark_CopenhagenUniversityHospital_PregnancyLoss2_Overall,12/27/2020,Sublocal,Denmark,Denmark; Copenhagen; Copenhagen,"April 14, 2020","May 21, 2020",Pregnant or parturient women,Adults (18-64 years),36,0.00%,,,Self-referral,YHLO Biotechnology,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), ‪Nina Freiesleben,Copenhagen University Hospital,https://dx.doi.org/10.1093/humrep/deaa311,1/15/2021,4/26/2021
201027_Aarhus_AarhusDepartmentofPublicHealth_IgGorIgM,11/20/2020,Local,Denmark,Denmark; Central Denmark Region; Aarhus,"June 1, 2020","June 4, 2020",Persons experiencing homelessness,Adults (18-64 years),129,4.70%,2.10%,9.80%,Convenience,NR,,"IgG,IgM",98.90%,97.60%,High,Journal Article (Peer-Reviewed),Signe Storgaard,Aarhus Department of Public Health ,"https://pubmed.ncbi.nlm.nih.gov/33269697/#:~:text=Conclusions%3A%20Despite%20their%20vulnerable%20profile,funded%20by%20Aarhus%20University%20Hospital.",1/23/2021,4/26/2021
201227_Denmark_CopenhagenUniversityHospital_Pregnant1_Overall,12/27/2020,Sublocal,Denmark,Denmark; Copenhagen; Copenhagen,"February 17, 2020","April 17, 2020",Pregnant or parturient women,Adults (18-64 years),1019,1.80%,,,Convenience,YHLO Biotechnology,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), ‪Nina Freiesleben,Copenhagen University Hospital,https://dx.doi.org/10.1093/humrep/deaa311,2/13/2021,4/26/2021
210121_Denmark_CopenhagenUniversityHospital_Denmark,1/21/2021,National,Denmark,Denmark,"June 22, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),2024,2.80%,,,Convenience,"Livson Diagnostics, Zhuhai, Gunangdong, China; Guangzhou Wondfo Biotech",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jannie Laursen,Copenhagen University Hospital,https://dx.doi.org/10.3390/ijerph18030923,2/25/2021,4/26/2021
210212_Copenhagen_Herlev-GentofteHospital_Overall,2/12/2021,Sublocal,Denmark,Denmark; Capital Region; Copenhagen,"October 19, 2020","October 26, 2020",Health care workers and caregivers,Adults (18-64 years),1096,34.58%,31.82%,37.45%,Convenience,Beijing Wantai Biological Pharmacy Enterprise,,"IgG,IgA,IgM",97.00%,99.50%,Moderate,Preprint,Johannes R. Madsen,Herlev-Gentofte Hospital,https://www.medrxiv.org/content/10.1101/2021.02.09.21251421v1,3/18/2021,3/31/2021
201202_DominicanRepublic_UniversidadIberoamericana_genpop_IgG,12/2/2020,National,Dominican Republic,Dominican Republic,"April 15, 2020","June 15, 2020",Household and community samples,Multiple groups,12897,5.50%,,,Simplified probability,GenBody Inc.,,IgG,56.70%,100.00%,High,Journal Article (Peer-Reviewed),Robert Paulino-Ramirez,Universidad Iberoamericana,https://dx.doi.org/10.4269/ajtmh.20-0907,1/12/2021,4/26/2021
200727_Atahualpa_UniversidadPeruanaCayetanoHeredia_RuralOver40_Overall,7/27/2020,Local,Ecuador,Ecuador; El Oro,"May 1, 2020","May 25, 2020",Household and community samples,Multiple groups,673,45.00%,,,Entire sample,Biohit Health Care Ltd,LFIA: Lateral flow immunoassay,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Oscar Del Brutto,Universidad Peruana Cayetano Heredia,http://dx.doi.org/10.1093/cid/ciaa1055,10/2/2020,4/26/2021
200929_Atahualpa_UniversidadPeruanaCayetanoHeredia_overall,9/29/2020,Local,Ecuador,Ecuador,"June 25, 2020","June 30, 2020",Household and community samples,Adults (18-64 years),362,7.70%,,,Simplified probability,BIOHIT Health Care,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Oscar H. Del Brutto,Universidad Peruana Cayetano Heredia,https://www.tandfonline.com/doi/full/10.1080/20477724.2020.1826152,4/26/2021,4/27/2021
200721_Egypt_CairoUniversity_TotalHCW_Overall,7/21/2020,Local,Egypt,Egypt,"June 1, 2020","June 14, 2020",Health care workers and caregivers,Adults (18-64 years),74,12.20%,,,Convenience,Artron Laboratories,LFIA: Lateral flow immunoassay,"IgG,IgM",93.40%,97.70%,High,Journal Article (Peer-Reviewed),Abdel Meguid Kassem,Cairo University,https://dx.doi.org/10.1016/j.ajg.2020.07.005,9/29/2020,4/26/2021
210115_Cairo_CairoUniversity,1/15/2021,Sublocal,Egypt,Egypt,"June 1, 2020","June 14, 2020",Health care workers and caregivers,Adults (18-64 years),203,18.20%,,,Convenience,"Artron Laboratories, Burnaby, Canada",,"IgG,IgM",93.40%,97.70%,High,Journal Article (Peer-Reviewed),Reham Abdelmoniem,Cairo University ,https://dx.doi.org/10.1016/j.jcv.2020.104710,1/23/2021,3/31/2021
201023_Egypt_AinShamsUniversity_Overall,10/23/2020,Local,Egypt,Egypt; Cairo Governorate; Cairo,"April 22, 2020","May 14, 2020",Health care workers and caregivers,Multiple groups,4040,1.31%,,,Convenience,Artron Laboratories,,"IgG,IgM",83.30%,100.00%,High,Journal Article (Peer-Reviewed),Aya Mostafa,Ain Shams University,https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyaa173/5936053,1/23/2021,4/26/2021
210402_Cairo_CairoUniversity_HCW,4/2/2021,Sublocal,Egypt,Egypt,"May 5, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),455,7.90%,5.80%,10.80%,Convenience,"SD-Biosensor

YHLO Biotech",,IgG,,,High,Journal Article (Peer-Reviewed),Ahmed Mukhtar,Cairo University,https://dx.doi.org/10.4081/jphr.2021.2102,4/18/2021,4/25/2021
201023_Tallinn_UniversityofTartu_Overall,10/23/2020,Local,Estonia,Estonia,"May 8, 2020","July 31, 2020",Household and community samples,Multiple groups,1006,1.50%,0.90%,2.50%,Stratified probability,"Abbott, DiaSorin, SD Biosensor",,"IgG,IgM",,,Moderate,Preprint,Piia Jogi,University of Tartu,https://www.medrxiv.org/content/10.1101/2020.10.21.20216820v1,1/8/2021,4/26/2021
201023_Saaremaa_UniversityofTartu_Overall,10/23/2020,Local,Estonia,Estonia,"May 8, 2020","July 31, 2020",Household and community samples,Multiple groups,954,6.30%,5.00%,7.90%,Stratified probability,"Abbott, DiaSorin, SD Biosensor",,"IgG,IgM",,,Moderate,Preprint,Piia Jogi,University of Tartu,https://www.medrxiv.org/content/10.1101/2020.10.21.20216820v1,1/8/2021,4/26/2021
210226_Estonia_UniversityofTartu_primary,4/20/2021,National,Estonia,Estonia,"February 11, 2021","February 22, 2021",Household and community samples,Multiple groups,2626,11.49%,10.29%,12.77%,Stratified probability,Synlab,,IgG,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire,2/26/2021,3/31/2021
210107_Estonia_UniversityCollegeLondon_PaediatricHCW,1/27/2021,Sublocal,Estonia,Estonia; NR; NR,"June 10, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),130,0.00%,0.00%,2.87%,Convenience,"Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)",,IgG,,,High,Journal Article (Peer-Reviewed),D. Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,4/9/2021
200924_Estonia_UniversityofTartu_overall,9/24/2020,National,Estonia,Estonia,"May 4, 2020","June 10, 2020",Pregnant or parturient women,Adults (18-64 years),433,0.46%,,,Convenience,Abbott,,IgG,,,High,Journal Article (Peer-Reviewed),Piret Veerus,University of Tartu,https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/aogs.13995,3/19/2021,4/26/2021
210323_Estonia_UniversityOfTartu_overall,4/20/2021,National,Estonia,Estonia,"March 11, 2021","March 22, 2021",Household and community samples,Multiple groups,2382,21.41%,19.78%,23.11%,Stratified probability,Synlab,,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire,3/25/2021,3/31/2021
210420_Estonia_UniversityOfTartu_overall,4/20/2021,National,Estonia,Estonia,"April 8, 2021","April 19, 2021",Household and community samples,Multiple groups,2491,35.87%,33.97%,37.79%,Stratified probability,Synlab,,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire,4/20/2021,4/20/2021
200922_AddisAbaba_KuwaitUniversity_GenPop,9/22/2020,Local,Ethiopia,Ethiopia,"May 18, 2020","May 21, 2020",Residual sera,Multiple groups,99,3.00%,0.60%,8.60%,Convenience,Abbott,,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),John Kempen,Kuwait University,https://dx.doi.org/10.4269/ajtmh.20-0816,12/6/2020,4/26/2021
201013_AddisAbaba_MinistryOfHealthEthiopia_TestAdj_PopUnAdj,10/13/2020,Local,Ethiopia,Ethiopia,"April 23, 2020","April 28, 2020",Household and community samples,Adults (18-64 years),301,8.80%,5.50%,11.60%,Simplified probability,"Zhejiang Orient Gene Biotech Co Ltd, Huzhou, Zhejiang, China",,"IgG,IgM",87.90%,100.00%,Moderate,Preprint,Berhanu Alemu,"Ministry of Health, Ethiopia",https://www.biorxiv.org/content/10.1101/2020.10.13.337287v1,12/10/2020,4/26/2021
210302_Diredawa_TheUniversityofSheffield_Overall,3/2/2021,Regional,Ethiopia,Ethiopia; Diredawa,"June 15, 2020","July 30, 2020",Household and community samples,Multiple groups,684,3.20%,1.00%,4.80%,Stratified probability,Abbott Laboratories,,IgG,100.00%,99.60%,Moderate,Preprint,Tamrat Shaweno,University of Sheffield,https://www.researchsquare.com/article/rs-266413/v1,3/31/2021,3/31/2021
200727_ FaroeIslands_TheFaroeseHospitalSystem_GenPop_TestAdj,7/27/2020,Regional,Faroe Islands,Faroe Islands; Faroe Islands,"April 27, 2020","May 1, 2020",Household and community samples,Adults (18-64 years),1075,0.70%,,,Simplified probability,Beijing Wantai Biological Pharmacy Enterprise ,ELISA,"IgG,IgM",94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Maria Skaalum Petersen,University of the Faroe Islands,http://dx.doi.org/10.3201/eid2611.202736,9/26/2020,4/26/2021
201213_Helsinki_UniversityofHelsinki_HCW_unadj,12/13/2020,Sublocal,Finland,Finland; Uusimaa; Helsinki,"April 22, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),1095,3.00%,,,Convenience,"Euroimmun, Abbott Laboratories, University of Helsinki (In-House)",,IgG,,,High,Journal Article (Peer-Reviewed),Anu Kantele,University of Helsinki,https://dx.doi.org/10.1016/j.tmaid.2020.101949,2/1/2021,4/26/2021
200902_Lille_InstitutPasteur_BloodDonors_ELISA-N,9/2/2020,Local,France,"France; Hauts-de-France; Clermont, Noyon, Lille","March 20, 2020","March 24, 2020",Blood donors,Not reported,200,0.00%,,,Sequential,Author-designed,ELISA-N,"IgA,IgE,IgD,IgM,IgG,Total Antibody",,95.00%,High,Journal Article (Peer-Reviewed),Ludivine Grzelak,Institut Pasteur,https://stm.sciencemag.org/content/12/559/eabc3103,4/28/2020,4/26/2021
200629_Crepy-en-Valois_PasteurInstitute_Overall,6/29/2020,Local,France,France; Hauts-de-France; Crepy-en-Valois,"April 28, 2020","April 30, 2020",Household and community samples,Multiple groups,1340,10.40%,,,Convenience,Institut Pasteur,Flow cytometry assay,Not reported,99.40%,100.00%,Moderate,Preprint,Arnaud Fontanet,Institut Pasteur,https://www.medrxiv.org/content/10.1101/2020.06.25.20140178v2,7/15/2020,4/26/2021
200501_France_ CentreLeonBerard_HCW,5/1/2020,Sublocal,France,France; Auvergne-Rhône-Alpes; Lyon,"March 1, 2020","April 16, 2020",Health care workers and caregivers,Adults (18-64 years),85,5.88%,,,Self-referral,TODA Pharma,LFIA: Lateral flow immunoassay,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),M Solodky,Centre Leon Berard,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/,7/18/2020,4/26/2021
200501_France_ CentreLeonBerard_CancerPatient,5/1/2020,Sublocal,France,France; Auvergne-Rhône-Alpes; Lyon,"March 1, 2020","April 16, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,244,5.33%,,,Sequential,TODA Pharma,LFIA: Lateral flow immunoassay,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),M Solodky,Centre Leon Berard,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/,7/18/2020,4/26/2021
200715_France_UnitedesVirusEmergents_BloodDonors,7/15/2020,National,France,"France; Provence-Alpes-Côte d'Azur, Grand-Est, Hauts-de-France, Île-de-France","March 25, 2020","April 7, 2020",Blood donors,Adults (18-64 years),998,2.71%,,,Sequential,Author-designed,Neutralization assay,Not reported,,100.00%,High,Journal Article (Peer-Reviewed),Pierre Gallian,Unite des Virus Emergents,https://reader.elsevier.com/reader/sd/pii/S0166354220302941?token=72010A825B9F560E0F15AF8D56563D596F45421D41A05764732590DB465F0C2C839E77D689CCDEDEFB85BA331FE13C72,8/1/2020,4/26/2021
200722_France_PicardieUniversity_IBDPatients_Overall,7/22/2020,Sublocal,France,France; Somme; Amiens,"March 25, 2020","May 11, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,146,4.80%,,,Convenience,DiaSorin,Chemiluminescence Immunoassay,IgG,97.40%,98.50%,High,Journal Article (Peer-Reviewed),Mathurin Fumery,Picardie University,https://dx.doi.org/10.1093/ecco-jcc/jjaa154,8/1/2020,4/26/2021
200827_Paris_RothschildFoundationHospital_HealthcareProfessionals,8/27/2020,Sublocal,France,France; Paris; Paris,"June 8, 2020","June 22, 2020",Health care workers and caregivers,Adults (18-64 years),646,12.00%,,,Convenience,Roche,ELISA,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Malcie Mesnil,Rothschild Foundation Hospital,http://dx.doi.org/10.1016/j.accpm.2020.08.003,10/21/2020,4/26/2021
200903_Paris_HopitalEuropeenGeorgesPompidou_Overall,9/3/2020,Sublocal,France,France;  Île-de-France; Paris,"May 2, 2020","June 26, 2020",Health care workers and caregivers,Adults (18-64 years),3569,11.90%,,,Convenience,Abbott,Chemiluminescence Immunoassay,IgG,,,High,Journal Article (Peer-Reviewed),Helene Pere,Hopital Europeen Georges Pompidou,https://dx.doi.org/10.1016/j.jcv.2020.104617,11/9/2020,4/26/2021
200918_France_ParisUniversity_Overall,9/18/2020,National,France,France,"May 4, 2020","June 23, 2020",Household and community samples,Multiple groups,14628,6.72%,,,Simplified probability,Euroimmun,,IgG,97.90%,97.70%,Moderate,Preprint,Fabrice Carrat,Paris University,https://www.medrxiv.org/content/10.1101/2020.09.16.20195693v1,1/13/2021,4/26/2021
201015_Paris_ParisSaclayUniversity_unadj,10/15/2020,Sublocal,France,France; Paris; Paris,"May 4, 2020","May 31, 2020",Pregnant or parturient women,Adults (18-64 years),249,8.00%,,,Sequential,"Abbott, Ortho-Clinical Diagnostics",,IgG,,,High,Journal Article (Peer-Reviewed),Jérémie Mattern,Paris Saclay University,http://dx.doi.org/10.1371/journal.pone.0240782,1/15/2021,4/26/2021
201106_Lyon_UniversitéClaudeBernardLyon_Overall,11/6/2020,Sublocal,France,France; Auvergne-Rhône-Alpes; Lyon,"April 10, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),190,3.68%,,,Unclear,"Wantai, Beijing, China
bioMérieux, Lyon, France",,"Total Antibody,IgG",,,High,Preprint,Antonin Bal,Université Claude Bernard Lyon,https://www.medrxiv.org/content/10.1101/2020.11.04.20225862v1,1/17/2021,4/26/2021
201105_Corsica_UniversitédeCorse_Totaladj,11/5/2020,Regional,France,"France; Corsica; Ajaccio
Corte","April 16, 2020","June 15, 2020",Residual sera,Multiple groups,1973,5.46%,4.51%,6.57%,Sequential,"EUROIMMUN, Bussy-Saint Martin, France",,IgG,86.40%,96.20%,Moderate,Journal Article (Peer-Reviewed),Lisandru Capai,Université de Corse,https://www.mdpi.com/2077-0383/9/11/3569,1/17/2021,4/26/2021
201021_France_SantePubliqueFrance_March1_Overall_PopTestAdj,10/21/2020,National,France,"France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","March 9, 2020","March 15, 2020",Residual sera,Multiple groups,3834,0.40%,0.10%,0.90%,Convenience,N/A - Author Designed,,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Preprint,Stéphane Le Vu,Santé publique France,https://www.medrxiv.org/content/10.1101/2020.10.20.20213116v1,1/18/2021,4/26/2021
201021_France_SantePubliqueFrance_April2_Overall_PopTestAdj,10/21/2020,National,France,"France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","April 6, 2020","April 12, 2020",Residual sera,Multiple groups,3595,4.10%,3.30%,5.00%,Convenience,N/A - Author Designed,,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Preprint,Stéphane Le Vu,Santé publique France,https://www.medrxiv.org/content/10.1101/2020.10.20.20213116v1,1/19/2021,4/26/2021
201021_France_SantePubliqueFrance_May3_Overall_PopTestAdj,10/21/2020,National,France,"France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","May 11, 2020","May 17, 2020",Residual sera,Multiple groups,3592,4.90%,4.00%,5.90%,Convenience,N/A - Author Designed,,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Preprint,Stéphane Le Vu,Santé publique France,https://www.medrxiv.org/content/10.1101/2020.10.20.20213116v1,1/19/2021,4/26/2021
210205_IledeFrance_Epicentre_Shelters,2/5/2021,Local,France,France; Ile de France; Paris,"June 23, 2020","July 2, 2020",Persons experiencing homelessness,Multiple groups,818,52.00%,,,Convenience,N/A - Author Designed,,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Thomas Roederer,Médecins sans Frontières (Epicentre) ,https://www.thelancet.com/action/showPdf?pii=S2468-2667%2821%2900001-3,1/23/2021,4/26/2021
201104_Paris_CochinAPHP_HCW,11/4/2020,Sublocal,France,France; Île-de-France; Paris,"May 14, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),4607,11.50%,10.60%,12.40%,Convenience,Abbott Laboratories,,IgG,,,High,Journal Article (Peer-Reviewed),Chantal Delmas,Cochin APHP,https://dx.doi.org/10.1017/ice.2020.1309,1/23/2021,4/26/2021
201130_Strasbourg_StrasbourgUniversityHospital_Abbott,11/30/2020,Local,France,France; Grand-Est ; Strasbourg,"May 7, 2020","June 26, 2020",Contacts of COVID patients,Adults (18-64 years),11,0.00%,,,Unclear,Abbott Laboratories,,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Floriane Gallais,Strasbourg University Hospital,https://dx.doi.org/10.3201/eid2701.203611,1/23/2021,4/26/2021
201210_ Paris_UniversitéParis-Saclay,12/10/2020,Sublocal,France,France; Île-de-France; Paris ,"April 29, 2020","June 26, 2020",Pregnant or parturient women,Adults (18-64 years),529,4.70%,3.00%,6.70%,Sequential,Abbott,,IgG,92.70%,99.00%,High,Journal Article (Peer-Reviewed),Vassilis Tsatsarisa,Université Paris-Saclay,https://dx.doi.org/10.1016/j.jogoh.2020.102041,1/23/2021,4/26/2021
210208_Paris_JeanVerdierHospital_DaycareChildren1_Overall_TestAdj,2/8/2021,Local,France,France,,,Household and community samples,Children and Youth (0-17 years),,,,,Convenience,"Biosynex, Illkirch-
Graffenstaden, France)",,"IgM,IgG",91.80%,99.20%,,Journal Article (Peer-Reviewed),Eric Lachassinne,Jean Verdier Hospital,https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,2/19/2021,4/2/2021
200930_Toulouse_CentreHospitalierUniversitaireDeToulouse_HCW&Staff,9/30/2020,Sublocal,France,France,"June 10, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),8758,3.20%,2.80%,3.50%,Convenience,Beijing Wantai Biological Pharmacy Enterprise Co.,,Total Antibody,,,High,Journal Article (Peer-Reviewed),Chloe Dimeglio,Centre Hospitalier Universitaire (CHU) de Toulouse,http://dx.doi.org/10.1016/j.jinf.2020.09.035,2/20/2021,4/26/2021
210118_France_SorbonneUniversité_primary,1/18/2021,National,France,France; Île-de-France and Grand Est ,"May 15, 2020","June 15, 2020",Household and community samples,Multiple groups,9782,3.46%,,,Simplified probability,"1) EuroImmun

2) EuroImmun

3) N/A - author desgined",,IgG,85.00%,95.00%,Moderate,Journal Article (Peer-Reviewed),Nathanael Lapidus,Sorbonne Université,https://dx.doi.org/10.1016/j.idnow.2020.12.007,2/25/2021,3/28/2021
201119_Paris_CentreHospitalierIntercommunalDeCréteil_Children,11/19/2020,Local,France,France; Île-de-France; Paris,"April 14, 2020","May 12, 2020",Residual sera,Children and Youth (0-17 years),605,10.70%,8.40%,13.50%,Sequential,Biosynex,,"IgG,IgM",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Robert Cohen,Centre Hospitalier Intercommunal de Créteil,http://dx.doi.org/10.1136/bmjpo-2020-000887,2/28/2021,4/26/2021
210115_France_InstitutNationaldelaStatistiqueetdesÉtudesÉconomiques_Overall,1/15/2021,National,France,France,"May 2, 2020","June 2, 2020",Household and community samples,Multiple groups,12114,4.50%,3.90%,5.00%,Stratified probability,EUROIMMUN,,IgG,94.40%,100.00%,Low,Institutional Report,Josiane Warszawski,l’Institut national de la santé et de la recherche médicale (Inserm) ,https://drees.solidarites-sante.gouv.fr/sites/default/files/2021-01/er1167-en.pdf,3/10/2021,3/29/2021
210201_France_TissueBankofLille_overall_unadj,2/1/2021,Local,France,France,"November 1, 2019","March 16, 2020",Tissue donor,Multiple groups,235,1.70%,,,Sequential,"1) Abbott 

2)Wantai",,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Nicolas Germain,CHU Lille,https://dx.doi.org/10.1007/s10561-021-09901-3,3/13/2021,4/26/2021
201223_Paris_InstitutCurie_overall,12/23/2020,Local,France,France;  Île-de-France; Paris,"April 28, 2020","July 31, 2020",Health care workers and caregivers,Multiple groups,1847,11.60%,10.20%,13.20%,Convenience,Institut Curie - author designed,,"IgG,Total Antibody",,99.00%,Moderate,Journal Article (Peer-Reviewed),François Anna, Institut Curie,https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202049058,3/19/2021,4/26/2021
210127_Nice_UniversitéCôted'Azur,1/27/2021,Sublocal,France,France; Provence-Alpes-Côte d'Azur; Nice,"April 15, 2020","May 26, 2020",Health care workers and caregivers,Adults (18-64 years),196,15.00%,,,Convenience,EUROIMMUN,,"IgA,IgG",100.00%,,High,Journal Article (Peer-Reviewed),Marion Cremoni,Université Côte d'Azur,https://dx.doi.org/10.3389/fmed.2020.608804,3/27/2021,4/16/2021
210304_Rennes_UniversitéRennes,3/4/2021,Sublocal,France,France; Brittany; Rennes,"May 29, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),3234,3.80%,,,Convenience,"NG BioTech;
WANTAI",,IgG,82.50%,98.00%,High,Preprint,Christophe Paris,Université Rennes,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3795306,3/27/2021,4/2/2021
210312_Strasbourg_UniversityHospitalStrasbourg_overall,3/12/2021,Sublocal,France,France,"February 18, 2021","February 25, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,241,10.80%,,,Unclear,Abbott,,IgG,,,High,Preprint,Ilies Benotmane,"University Hospital, Strasbourg",10.1101/2021.03.08.21252741,3/31/2021,4/10/2021
210212_Nancy_UniversitéDeLorraine_overall,2/12/2021,Local,France,France,"June 26, 2020","July 24, 2020",Household and community samples,Multiple groups,2006,2.50%,1.80%,3.30%,Stratified probability,"1) BioRad
2) Biosynex
3)Euroimmun",,"Total Antibody,IgM,IgG,IgA",100.00%,99.50%,Low,Preprint,Anne Gégout petit,Université de Lorraine,10.1101/2021.02.10.21250862,3/31/2021,3/31/2021
210312_Paris_SorbonneUniversite_M3,3/12/2021,Sublocal,France,France,"June 24, 2020","July 25, 2020",Health care workers and caregivers,Adults (18-64 years),938,13.00%,11.10%,15.20%,Convenience,Abbott,,IgG,,,High,Preprint,Pierre Hausfater,Sorbonne Universite ,10.1101/2021.03.09.21253200,4/1/2021,4/1/2021
210308_Perpignan_CentreHospitalierDePerpignan_Overall_PopAdj,3/8/2021,Local,France,France; Occitanie; Perpignan,"June 19, 2020","July 17, 2020",Household and community samples,Multiple groups,700,35.40%,30.20%,41.00%,Stratified probability,Roche Diagnostics,,"IgG,IgM",99.50%,99.80%,Low,Preprint,Adeline Beaumont,Centre Hospitalier de Perpignan,https://www.medrxiv.org/content/10.1101/2021.03.05.21252835v1.full-text,4/2/2021,4/17/2021
210206_France_ParisUniversity_ELISA,2/6/2021,National,France,France,"November 4, 2019","March 16, 2020",Residual sera,Multiple groups,9144,3.90%,,,Simplified probability,EUROIMMUN,,IgG,,100.00%,Moderate,Journal Article (Peer-Reviewed),Fabrice Carrat,Paris University,http://dx.doi.org/10.1007/s10654-020-00716-2,4/5/2021,4/5/2021
210223_France_MontpellierUniversity_NursingHomeResidents,2/23/2021,Regional,France,France; Occitanie,"April 21, 2020","July 29, 2020",Assisted living and long-term care facilities,Seniors (65+ years),456,30.70%,,,Entire sample,NR,,IgG,,,High,Journal Article (Peer-Reviewed),Hubert Blain, Montpellier University,https://dx.doi.org/10.1093/ageing/afab050,4/9/2021,4/9/2021
210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Staff_Overall,2/27/2021,Sublocal,France,France,"May 11, 2020","May 25, 2020",Health care workers and caregivers,Adults (18-64 years),663,1.80%,,,Convenience,Roche Diagnostics,,"IgG,IgM,IgA",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Francois Leclerc,https://dx.doi.org/10.1016/j.ejca.2021.02.027,4/18/2021,4/18/2021
210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Patients_Overall,2/27/2021,Sublocal,France,France,"May 25, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1011,1.70%,,,Convenience,Roche Diagnostics,,"IgG,IgM,IgA",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Francois Leclerc,https://dx.doi.org/10.1016/j.ejca.2021.02.027,4/18/2021,4/18/2021
210322_GrandEst_StrasbourgUniversityHospital_KidneyTransplantPatients,3/22/2021,Sublocal,France,France; Grand Est,,"September 15, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,780,6.20%,,,Convenience,,,,,,High,Journal Article (Peer-Reviewed),Sophie Caillard,Strasbourg University Hospital,https://dx.doi.org/10.1097/TP.0000000000003766,4/18/2021,4/18/2021
200928_FrenchGuiana_InstitutPasteur_OverallPopAdj,9/28/2020,National,French Guiana,French Guiana,"July 15, 2020","July 23, 2020",Residual sera,Multiple groups,480,15.40%,9.30%,24.40%,Sequential,Euroimmun,,IgG,93.80%,97.90%,Moderate,Preprint,Claude Flamand,Institut Pasteur ,https://www.medrxiv.org/content/10.1101/2020.09.27.20202465v1,1/19/2021,4/26/2021
200918_Tbilisi_InfectiousDiseaseResearchCenter_Total_PopTestAdj,9/18/2020,Local,Georgia,Georgia; Tbilisi; Tbilisi,"May 18, 2020","May 27, 2020",Household and community samples,Multiple groups,1086,1.02%,0.38%,2.18%,Convenience,Zhejiang Orient Gene Biotech Co Ltd,LFIA: Lateral flow immunoassay,IgG,93.10%,99.20%,Moderate,Preprint,Tengiz Tsertsvadze,"Infectious Diseases, AIDS and Clinical Immunology Research Center",https://www.medrxiv.org/content/10.1101/2020.09.18.20195024v1,11/21/2020,4/26/2021
200513_Germany_UniversityHospitalEssen_HCW,5/13/2020,Sublocal,Germany,Germany; North Rhine-Westphalia; Essen,"March 25, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),316,1.60%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Johannes Korth,University Hospital Essen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219425/,5/19/2020,4/26/2021
200525_Frankfurt_Goethe-UniversityFrankfurt_Employees,5/25/2020,Local,Germany,Germany; Hesse; Frankfurt,"April 6, 2020","April 14, 2020",Essential non-healthcare workers,Adults (18-64 years),998,0.40%,0.16%,1.02%,Self-referral,Author-designed,ELISA,IgG,,99.20%,High,Preprint,Verena Kraehling, Goethe-University Frankfurt,https://www.medrxiv.org/content/10.1101/2020.05.20.20107730v1,5/26/2020,4/26/2021
200514_Saalfeld_Thuringia_IgG,5/14/2020,Sublocal,Germany,Germany; Thuringia; Saalfeld,"April 16, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),18,0.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Igor Harsch,Thuringia Clinic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273321/pdf/HIC-15-09.pdf,6/18/2020,4/26/2021
200615_Germany_UniversityofHannover_hcw,6/15/2020,Sublocal,Germany,Germany; Lower Saxony; Hannover,"April 20, 2020","April 30, 2020",Health care workers and caregivers,Multiple groups,385,2.86%,,,Convenience,EUROIMMUN,ELISA,IgG,94.60%,99.80%,High,Journal Article (Peer-Reviewed),Simone Schmidt,University of Hannover,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235417,6/26/2020,4/26/2021
200717_Ilm-Kreis_JenaUniversityHospital_Overall,7/17/2020,Local,Germany,Germany; Thuringia,"May 12, 2020","May 22, 2020",Household and community samples,Multiple groups,620,8.39%,,,Entire sample,"Epitope Diagnostics, EUROIMMUN, DiaSorin, Snibe Diagnostic, Abbott, Roche","ELISA,Chemiluminescence Immunoassay",IgG,,,Moderate,Preprint,Sebastian Weis ,Jena University Hospital,https://www.medrxiv.org/content/10.1101/2020.07.15.20154112v1,7/18/2020,4/26/2021
200622_Rostock_UniversitätsmedizinRostock_Mothers_IgGorIgA,6/22/2020,Sublocal,Germany,Germany; Mecklenburg-Westpomerania; Rostock,"April 20, 2020","April 22, 2020",Household and community samples,Adults (18-64 years),401,2.99%,,,Self-referral,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Emil Reisinger ,Universitätsmedizin Rostock,https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1197-4293,8/4/2020,4/26/2021
200807_Bavaria_UniversityHospitalMunich,8/7/2020,Regional,Germany,Germany; Bavaria; Dachau,"April 2, 2020","April 6, 2020",Health care workers and caregivers,Adults (18-64 years),151,2.60%,0.80%,7.10%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Korbinian Lackermair,University Hospital Munich,http://dx.doi.org/10.1093/fampra/cmaa078,9/24/2020,4/26/2021
200904_Hannover_HannoverMedicalSchool_HCWs_S1IgG,"9/4/2020, 6/10/2020",Local,Germany,Germany; Lower Saxony; Hannover,"March 23, 2020","April 17, 2020",Health care workers and caregivers,Adults (18-64 years),217,1.38%,,,Self-referral,EUROIMMUN,ELISA,IgG,87.20%,99.30%,High,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Georg Behrens, Georg Behrens", Hannover Medical School,"https://link.springer.com/article/10.1007/s40121-020-00334-1, https://link.springer.com/article/10.1007%2Fs15010-020-01461-0",9/28/2020,4/26/2021
200824_Jena_UniversitätsklinikumJena_Pregnantwomen_Overall,8/24/2020,Local,Germany,Germany; Thuringia; Jena,"April 6, 2020","May 13, 2020",Pregnant or parturient women,Not reported,180,0.60%,0.00%,1.70%,Unclear,Epitope Diagnostics,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Janine Zöllkau,Universitätsklinikum Jena,https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1206-1033,9/28/2020,4/26/2021
200717_Germany_NorthRhineWestphaliaLowerSaxonyHesse_BloodDonors_PrimaryEstimate,7/16/2020,Regional,Germany,"Germany; North Rhine-Westphalia, Lower Saxony, Hesse","March 9, 2020","June 3, 2020",Residual sera,Not reported,3186,0.91%,0.58%,1.24%,Sequential,"Abbott, EUROIMMUN, DiaSorin",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Bastian Fischer,Heart and Diabetes Center NRW,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,10/1/2020,4/26/2021
200723_Germany_ThuringiaClinicSaalfeld_CleaningStaffIgG,7/23/2020,Sublocal,Germany,Germany; Thuringia; Saalfeld,"June 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),45,0.00%,,,Convenience,PerkinElmer Inc,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jörg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000353,10/1/2020,4/26/2021
200723_Germany_ThuringiaClinicSaalfeld_OncologyStaffIgG,7/23/2020,Sublocal,Germany,Germany; Thuringia; Saalfeld,"June 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),20,5.00%,,,Convenience,PerkinElmer Inc,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jörg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000353,10/1/2020,4/26/2021
200629_Fulda_UniversitätsmedizinMarburg_Entirecohort_IgG,6/29/2020,Sublocal,Germany,Germany,"April 9, 2020","April 16, 2020",Multiple populations,Multiple groups,1780,0.96%,0.56%,1.53%,Unclear,EUROIMMUN,ELISA,IgG,93.80%,99.00%,High,Journal Article (Peer-Reviewed),Peter Kern,Universitätsmedizin Marburg,http://dx.doi.org/10.1055/a-1198-1243,10/11/2020,4/26/2021
200929_Jena_JenaUniversityHospital_Overall,9/29/2020,Sublocal,Germany,Germany; Thuringia; Jena,"May 19, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),660,2.70%,,,Convenience,"Epitope Diagnostics, Roche","ELISA,Chemiluminescence Immunoassay",IgG,,,High,Preprint,Christina Bahrs,Jena University Hospital,https://www.medrxiv.org/content/10.1101/2020.09.29.20203737v1,11/27/2020,4/26/2021
200929_Oberspreewald-Lausitz_BrandenburgUniversityofTechnologyCottbus-Senftenberg_HCW,9/29/2020,Sublocal,Germany,Germany; Brandenburg; Oberspreewald-Lausitz,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),156,1.30%,,,Convenience,Author-designed,chemiluminescent microparticle immunoassay,Total Antibody,99.50%,99.80%,High,Preprint,Stephanie Hoffmann,Brandenburg University of Technology Cottbus-Senftenberg,https://doi.org/10.21203/rs.3.rs-84703/v1,11/27/2020,4/26/2021
200806_Regensburg_UniversityofRegensburg_12Wks,8/6/2020,Sublocal,Germany,Germany; Bavaria; Regensburg,"March 15, 2020","June 7, 2020",Health care workers and caregivers,Adults (18-64 years),139,0.00%,,,Convenience,"EUROIMMUN AG, Roche Diagnostics",,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Sara Malfertheiner,University of Regensburg,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406471/pdf/main.pdf,12/2/2020,4/26/2021
200813_Northrhine-Westfalia_SpecialistPracticeAndLaboratory_IgGandOverall,8/13/2020,Regional,Germany,Germany; North Rhine-Westphalia,"March 26, 2020","June 4, 2020",Residual sera,Multiple groups,415,1.20%,,,Convenience,Euroimmun,,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),Burkhard Herrmann,Internal medicine and laboratory medicine specialist practice and laboratory,http://dx.doi.org/10.1007/s15006-020-0750-y,1/5/2021,4/26/2021
201103_Germany_UniversityofWitten,11/3/2020,National,Germany,Germany,"June 15, 2020","September 1, 2020",Residual sera,Children and Youth (0-17 years),731,11.20%,,,Convenience,"Euroimmun IgG, Diasorin IgG, Microgen IgG, Roche IgM, Cleartest IgM, Nadal IgM, Euroimmun IgA",,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Silke Schwarz,University of Witten,https://dx.doi.org/10.1007/s00112-020-01050-3,1/6/2021,4/26/2021
200610_Munich_TechnicalUniversityofMunich_hcw,10/6/2020,Sublocal,Germany,Germany; Bavaria; Munich,"April 14, 2020","May 29, 2020",Health care workers and caregivers,Multiple groups,4554,2.40%,1.90%,2.90%,Convenience,Unclear,,IgG,,,High,Preprint,Johanna Erber,Technical University of Munich,https://www.medrxiv.org/content/10.1101/2020.10.04.20206136v1,1/7/2021,4/26/2021
201023_Berlin_CharitéUniversity_primary,10/23/2020,Sublocal,Germany,Germany; Berlin; Berlin,"March 19, 2020","May 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,223,7.10%,,,Unclear,Euroimmun Medizinische Labordiagnostika AG,,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Mira Choi,Charité University,https://pubmed.ncbi.nlm.nih.gov/33114149/,1/13/2021,4/26/2021
201126_Germany_RobertKochInstitute_BloodDonors_TestAdj,11/26/2020,National,Germany,Germany,"April 15, 2020","November 5, 2020",Blood donors,Multiple groups,48976,1.35%,,,Simplified probability,NR,,IgG,,,Moderate,Institutional Report,Robert Koch Institute,Robert Koch Institute,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html;jsessionid=0C30892A66A0F7CDD897F3809AA3F10F.internet102,1/14/2021,4/26/2021
201130_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_S3,11/30/2020,Sublocal,Germany,Germany; Hamburg; Hamburg,"June 22, 2020","July 17, 2020",Health care workers and caregivers,Adults (18-64 years),1253,1.80%,1.00%,2.50%,Convenience,Euroimmun,,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Thomas Brehm,University Medical Center Hamburg-Eppendorf,https://dx.doi.org/10.1016/j.ijheh.2020.113671,1/21/2021,4/26/2021
210103_Munich_LudwigMaximillianUniversityofMunich_Overall,1/3/2021,Sublocal,Germany,Germany,"March 24, 2020","July 7, 2020",Health care workers and caregivers,Adults (18-64 years),300,4.67%,,,Convenience,"1. EuroImmun
2. Roche
3.DiaSorin
4.Abbott",,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Tobias Weinberger,Ludwig Maximillian University of Munich,https://dx.doi.org/10.1093/cid/ciaa1935,1/23/2021,3/30/2021
201212_Bavaria_UniversityofRegensburg_overall,12/12/2020,Regional,Germany,Germany; Bavaria,"May 22, 2020","July 22, 2020",Household and community samples,Children and Youth (0-17 years),2832,5.70%,,,Convenience,1. Roche Diagnostics,,"IgA,IgG,IgM",,,Moderate,Preprint,Otto Laub,University of Regensburg,https://www.authorea.com/users/382535/articles/498454-coronavirus-antibody-screening-identifies-children-with-mild-to-moderate-courses-of-pmis,1/25/2021,4/26/2021
201111_NeustadtAmRennsteig_FriedrichSchillerUniversity_Overall,11/19/2020,Sublocal,Germany,Germany; Thuringia,"May 13, 2020","May 16, 2020",Household and community samples,Multiple groups,620,8.40%,,,Self-referral,"Epitope Diagnostics Inc., San Diego, USA
Euroimmun, Lübeck, Germany
DiaSorin, Saluggia, Italy
Snibe Co., Ltd., Shenzhen, China
Abbott, Chicago, USA
Roche, Basel Switzerland",,IgG,,,Moderate,Journal Article (Peer-Reviewed),Sebastian Weis,Friedrich Schiller University,https://dx.doi.org/10.1016/j.cmi.2020.11.009,1/27/2021,4/26/2021
201203_Tirschenreuth_MunichClinic_HCW_Overall,12/3/2020,Sublocal,Germany,"Germany; Bavaria; Tirschenreuth, Wieden","June 29, 2020","July 29, 2020",Health care workers and caregivers,Adults (18-64 years),1838,15.10%,,,Convenience,Roche Diagnostics,,"IgM,IgG",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),T Finkenzeller,Munich Clinic,https://dx.doi.org/10.1007/s00063-020-00761-5,1/27/2021,4/26/2021
201203_Tirschenreuth_MunichClinic_NMU_Overall,12/3/2020,Sublocal,Germany,"Germany; Bavaria; Tirschenreuth, Wieden","June 29, 2020","July 29, 2020",Essential non-healthcare workers,Adults (18-64 years),986,3.70%,,,Convenience,Roche DIagnostics,,"IgM,IgG",99.50%,99.80%,High,Journal Article (Peer-Reviewed),T Finkenzeller,Munich Clinic,https://dx.doi.org/10.1007/s00063-020-00761-5,1/27/2021,4/26/2021
200101_Hamburg_UniversityHospitalsoftheRuhr-UniversityofBochum_Overall,10/16/2020,Sublocal,Germany,Germany; Schleswig-Holstein; Hamburg,"April 14, 2020","June 16, 2020",Health care workers and caregivers,Multiple groups,871,2.64%,,,Convenience,"Mikrogen Diagnostik, Euroimmun",,IgG,,,High,Journal Article (Peer-Reviewed),Jonas Herzberg,University Hospitals of the Ruhr‑University of Bochum,http://dx.doi.org/10.1016/j.ijid.2020.10.026,1/29/2021,4/26/2021
201204_Germany_SaarlandUniversity_overall,12/4/2020,National,Germany,Germany,"June 16, 2020","June 30, 2020",Non-essential workers and unemployed persons,Multiple groups,1007,2.09%,1.37%,3.17%,Self-referral,"EUROimmun, Roche, NR",,"IgG,Not reported",,,High,Journal Article (Peer-Reviewed),Dietrich Mack,Saarland University,https://dx.doi.org/10.1016/j.cmi.2020.11.033,1/30/2021,4/26/2021
201126_Kupferzell_RobertKochInstitute_OverallAdj,11/26/2020,Local,Germany,Germany; Baden-Württemberg; Kupferzell,"May 20, 2020","June 9, 2020",Household and community samples,Multiple groups,2203,12.00%,10.40%,14.00%,Simplified probability,Euroimmun,,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Claudia Santos-Hovener,Robert Koch Institute,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.47.2001752,2/4/2021,4/26/2021
201209_Berlin_BerlinInstituteofHealth_overall_unadj,12/9/2020,Local,Germany,Germany; City State of Berlin; Berlin,"September 28, 2020","October 2, 2020",Multiple populations,Multiple groups,672,0.15%,,,Stratified probability,"Euroimmun AG, Germany",,IgG,,,Moderate,Preprint,Marlene Thielecke,Berlin Institute of Health,https://www.medrxiv.org/content/10.1101/2020.12.08.20245910v1,2/4/2021,4/26/2021
201216_Germany_Ruhr-UniversityBochum_overall,12/16/2020,Local,Germany,Germany,"April 1, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,99,3.03%,,,Sequential,"Euroimmun
",,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Constantin J. Thieme,Ruhr-University Bochum,https://dx.doi.org/10.1016/j.transproceed.2020.12.001,2/6/2021,4/26/2021
200829_Bonn_UniversityOfBonn_RhinelandStudy1_ELISAPositive,8/29/2020,Local,Germany,Germany; North Rhine-Westphalia; Bonn,"April 24, 2020","June 30, 2020",Household and community samples,Multiple groups,4771,0.97%,0.72%,1.30%,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Preprint,Ahmad Aziz,University of Bonn,https://www.medrxiv.org/content/10.1101/2020.08.24.20181206v1,2/13/2021,4/26/2021
200829_Bonn_UniversityOfBonn_Voluntary2,8/29/2020,Local,Germany,Germany; North Rhine-Westphalia; Bonn,"April 24, 2020","June 30, 2020",Household and community samples,Multiple groups,360,1.94%,0.84%,4.42%,Self-referral,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Preprint,Ahmad Aziz,University of Bonn,https://www.medrxiv.org/content/10.1101/2020.08.24.20181206v1,2/13/2021,4/26/2021
210129_Eschweiler_St.AntoniusHospitalEschweiler_IgG,1/29/2021,Sublocal,Germany,Germany; North Rhine-Westphalia; Eschweiler,"April 27, 2020","May 20, 2020",Health care workers and caregivers,Multiple groups,1212,3.30%,,,Convenience,EUROIMMUN,,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler,https://dx.doi.org/10.1055/a-1322-5355,2/13/2021,4/1/2021
210122_Germany_HeidelbergUniversity_Parents_Overall_unadj,1/22/2021,Regional,Germany,"Germany; Baden-Württemberg; Freiburg, Heidelberg, Tübingen, Ulm","April 22, 2020","May 15, 2020",,Adults (18-64 years),2482,1.90%,,,Convenience,Euroimmun; Roche Elecsys' Mikrogen in-house,,IgG,,99.60%,Moderate,Journal Article (Peer-Reviewed),Burkhard Tonshoff,Heidelberg University,https://dx.doi.org/10.1001/jamapediatrics.2021.0001,2/18/2021,3/28/2021
210122_Germany_HeidelbergUniversity_Children_Overall_unadj,1/22/2021,Regional,Germany,"Germany; Baden-Württemberg; Freiburg, Heidelberg, Tübingen, Ulm","April 22, 2020","May 15, 2020",,Children and Youth (0-17 years),2482,1.40%,,,Convenience,Euroimmun; Roche Elecsys' Mikrogen in-house,,IgG,,99.60%,Moderate,Journal Article (Peer-Reviewed),Burkhard Tonshoff,Heidelberg University,https://dx.doi.org/10.1001/jamapediatrics.2021.0001,2/18/2021,3/29/2021
210129_Berlin_UniversitätsmedizinBerlin_Students_Overall,1/29/2021,Local,Germany,Germany,"November 2, 2020","November 16, 2020",Students and Daycares,Children and Youth (0-17 years),347,2.00%,0.80%,4.10%,Stratified probability,NR,,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,10.1101/2021.01.27.21250517,2/21/2021,4/22/2021
210129_Berlin_UniversitätsmedizinBerlin_Staff_Overall ,1/29/2021,Local,Germany,Germany,"November 2, 2020","November 16, 2020",Essential non-healthcare workers,Adults (18-64 years),141,1.40%,0.20%,5.00%,Stratified probability,NR,,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,10.1101/2021.01.27.21250517,2/21/2021,4/22/2021
210129_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Overall,1/29/2021,Local,Germany,Germany,"November 2, 2020","November 16, 2020",Household and community samples,Multiple groups,576,1.40%,0.60%,2.70%,Stratified probability,NR,,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,10.1101/2021.01.27.21250517,2/21/2021,4/22/2021
210203_Dusseldorf_InstituteOfMedicalSociology_overall_TestAdj,2/3/2021,Local,Germany,Germany,"November 2, 2020","November 23, 2020",Household and community samples,Adults (18-64 years),2186,3.10%,2.40%,4.00%,Simplified probability,Roche,,"IgG,IgA,IgM",90.00%,99.80%,Low,Institutional Report,Insa Backhaus,Institute Of Medical Sociology,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,3/9/2021,3/31/2021
210203_Dusseldorf_InstituteOfMedicalSociology_SERODUSII_overall_TestAdj,2/3/2021,Local,Germany,Germany,"November 23, 2020","November 27, 2020",Essential non-healthcare workers,Adults (18-64 years),745,4.40%,3.10%,6.20%,Convenience,Roche,,"IgG,IgM,IgA",90.00%,99.80%,High,Institutional Report,Insa Backhaus,Institute Of Medical Sociology,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,3/9/2021,3/31/2021
200731_Bremen_UniversityOfBremen_IgG/IgA,7/31/2020,Local,Germany,Germany,"March 31, 2020","May 16, 2020",Multiple populations,Adults (18-64 years),281,2.13%,,,Unclear,Euroimmun,,"IgG,IgA",93.80%,99.60%,High,Journal Article (Peer-Reviewed),Jan Neumann,University of Bremen,https://www.asu-arbeitsmedizin.com/node/153868/print,3/11/2021,4/26/2021
210106_Munich_LudwigMaximilianUniversityOfMunich_Overall_TestAdj,1/6/2021,Local,Germany,Germany; Bavaria; Munich,"April 5, 2020","June 12, 2020",Household and community samples,Multiple groups,5313,1.82%,1.28%,2.37%,Stratified probability,Roche,,Total Antibody,88.60%,99.72%,Low,Preprint,Michael Pritsch,Ludwig Maximilian Unviersity of Munich,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3745128,3/11/2021,3/31/2021
210219_Jena_JenaUniversityHospital_Overall,2/19/2021,Sublocal,Germany,Germany; Urban district; Jena,"May 19, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),660,2.70%,1.60%,4.30%,Convenience,Epitope Diagnostics Inc.; Roche Diagnostics,,IgG,98.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Christina Bahrs,Jena University Hospital,https://dx.doi.org/10.1111/tbed.14041,3/13/2021,3/28/2021
201001_SouthwesternGermany_UniversityMedicalCenterofTheJohannesGutenbergUniversityMainz_BloodDonors_Overall,10/1/2020,Regional,Germany,Germany; Southwest,"March 15, 2020","June 15, 2020",Blood donors,Multiple groups,3880,0.90%,,,Unclear,Abbott Laboratories ,,IgG,,99.60%,High,Journal Article (Peer-Reviewed),Stefan Runkel,University Medical Center of The Johannes Gutenberg-University Mainz,https://pubmed.ncbi.nlm.nih.gov/33073955/,3/14/2021,4/26/2021
210212_Bavaria_ GermanResearchCenterForEnvironmentalHealth_Children_overall,2/12/2021,Regional,Germany,Germany; Bavaria,"January 1, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),11884,0.69%,,,Convenience,N/A - author desgined,,Total Antibody,97.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Markus Hippich, German Research Center for Environmental Health,https://www.cell.com/med/fulltext/S2666-6340(20)30020-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666634020300209%3Fshowall%3Dtrue,3/18/2021,3/31/2021
210212_Bavaria_ GermanResearchCenterForEnvironmentalHealth_Newborns_overall,2/12/2021,Regional,Germany,Germany; Bavaria,"April 1, 2020","June 30, 2020",Pregnant or parturient women,Adults (18-64 years),1916,0.47%,,,Convenience,N/A - author desgined,,Total Antibody,97.30%,100.00%,High,Journal Article (Peer-Reviewed),Markus Hippich, German Research Center for Environmental Health,https://www.cell.com/med/fulltext/S2666-6340(20)30020-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666634020300209%3Fshowall%3Dtrue,3/18/2021,3/31/2021
201127_Germany_IfoInstitue_overall_PopAdj,11/27/2020,National,Germany,Germany,"October 26, 2020","November 18, 2020",Household and community samples,Multiple groups,9929,1.10%,0.92%,1.33%,Unclear,Roche,,Total Antibody,,99.80%,Unclear,Institutional Report,Clemens Fuest,ifo Institute,https://www.ifo.de/en/publikationen/2020/monograph-authorship/die-deutschen-und-corona,3/21/2021,4/26/2021
201129_Saxony_TechnischeUniversitätDresden_Overall,11/29/2020,Regional,Germany,Germany; Saxony,"September 15, 2020","October 13, 2020",Multiple populations,Multiple groups,1779,0.70%,,,Unclear,"1) DiaSorin LIAISON, 2) Abbott, 3) EUROIMMUN",,IgG,,,Moderate,Preprint,Jakob Armann,Technische Universität Dresden,https://www.medrxiv.org/content/10.1101/2020.07.16.20155143v4,4/7/2021,4/26/2021
201216_Heidelberg_UniversityHospitalHeidelberg_Overall,12/16/2020,Sublocal,Germany,Germany; Baden-Württemberg; Heidelberg,"May 5, 2020","August 6, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,219,3.20%,,,Sequential,EUROIMMUN™,,IgG,94.60%,99.80%,High,Journal Article (Peer-Reviewed),Conrad Rauber,University Hospital Heidelberg,https://www.sciencedirect.com/science/article/abs/pii/S0041134520329043?via%3Dihub,4/8/2021,4/26/2021
210203_HeinsbergDistrict_UniversityHospitalDusseldorf_NeutralizationAssay,2/3/2021,Local,Germany,Germany,"April 9, 2021","April 9, 2021",Contacts of COVID patients,Multiple groups,42,62.00%,,,Convenience,,,Not reported,,,High,Journal Article (Peer-Reviewed),Lisa Muller,University Hospital Dusseldorf,https://dx.doi.org/10.1007/s10096-021-04169-7,4/9/2021,4/9/2021
210310_Bavaria_BrandenburgMedicalSchoolTheodorFontane,3/10/2021,Sublocal,Germany,Germany; Bavaria; Wieden,"July 17, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1838,15.10%,13.40%,16.70%,Convenience,Roche Diagnostics,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),,Brandenburg Medical School Theodor Fontane,https://dx.doi.org/10.1055/a-1393-6668,4/15/2021,4/15/2021
210310_Brandenburg_BrandenburgMedicalSchoolTheodorFontane,3/10/2021,Sublocal,Germany,Germany; Brandenburg; NR,"July 17, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),585,2.10%,1.20%,3.80%,Convenience,EUROIMMUN,,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),,Brandenburg Medical School Theodor Fontane,https://dx.doi.org/10.1055/a-1393-6668,4/15/2021,4/15/2021
210223_Regensberg_HospitalStHedwigOfTheOrderOfStJohn_IgG+,2/23/2021,Sublocal,Germany,Germany; Bavaria; Regensberg,"April 9, 2020","April 30, 2020",Pregnant or parturient women,Adults (18-64 years),151,2.00%,,,Sequential,"EUROIMMUN AG, Lübeck,
Germany",,IgG,,,High,Journal Article (Peer-Reviewed),Sebastian Hausler,Hospital St Hedwig of the Order of St John,https://dx.doi.org/10.1515/jpm-2021-0001,4/18/2021,4/18/2021
201117_Gangelt_UniversityofBonn_ v3_overall_TestAdj_IgG,11/17/2020,Local,Germany,Germany; Heinsberg; Gangelt,"March 31, 2021","April 6, 2020",Household and community samples,Multiple groups,919,14.11%,11.15%,17.27%,Simplified probability,EUROIMMUN,ELISA,IgG,90.90%,99.10%,"Low, Low",Journal Article (Peer-Reviewed),Hendrik Streeck,University of Bonn,https://www.nature.com/articles/s41467-020-19509-y,4/26/2021,4/26/2021
200806_Greece_UniversityofThessaly_Overall,8/6/2020,National,Greece,"Greece; Central Macedonia, Attica, Peloponnese, Thessaly, Western Macedonia, Central Greece, Western Greece, Epirus","March 1, 2020","April 30, 2020",Residual sera,Multiple groups,6586,0.36%,,,Convenience,Abbott,Chemiluminescence Immunoassay,IgG,84.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Zacharoula Bogogiannidou,University of Thessaly,https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.31.2001369,10/2/2020,4/26/2021
200921_Athens_NationalandKapodistrianUniversityofAthens_OverallAdj,9/21/2020,Sublocal,Greece,Greece,"June 15, 2020","July 15, 2020",Non-essential workers and unemployed persons,Multiple groups,2500,0.93%,0.27%,2.09%,Convenience,Roche Diagnostics,Electro chemiluminescence immunoassay,Total Antibody,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Ourania Tsitsilonis ,National and Kapodistrian University of Athens,https://dx.doi.org/10.3390/life10090214,11/9/2020,4/26/2021
201027_Athens_NationalandKapodistrianUniversityofAthens_Overall,10/27/2020,Sublocal,Greece,Greece; Attica; Athens,"April 25, 2020","May 10, 2020",Health care workers and caregivers,Adults (18-64 years),321,2.18%,,,Unclear,"EUROIMMUN, Germany",,IgG,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Panayiotis Vlachoyiannopoulosa,National and Kapodistrian University of Athens/Laiko University Hospital,http://dx.doi.org/10.1016/j.clim.2020.108619,1/11/2021,4/26/2021
201203_Athens_UniversityOfAthens_Overall_BothAdj,12/3/2020,Sublocal,Greece,Greece; Attica; Athens,"April 13, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,1495,1.26%,0.43%,3.26%,Convenience,Genebody Inc,,"IgG,IgM",74.10%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mina Psichogiou,University of Athens,https://dx.doi.org/10.1371/journal.pone.0243025,2/7/2021,4/26/2021
210107_Greece_UniversityCollegeLondon_PaediatricHCW,1/27/2021,Sublocal,Greece,Greece; NR; NR,"June 19, 2020","July 16, 2020",Health care workers and caregivers,Adults (18-64 years),77,1.30%,0.23%,7.00%,Convenience,"Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)",,IgG,,,High,Journal Article (Peer-Reviewed),D. Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,4/9/2021
210308_Bissau_UniversityofSouthernDenmark_Overall,3/8/2021,Sublocal,Guinea,Guinea,"November 9, 2020","November 24, 2020",Health care workers and caregivers,Adults (18-64 years),140,18.00%,,,Convenience,CTK Biotech,,IgG,,,High,Preprint,Christine Benn,University of Southern Denmark,10.1101/2021.03.06.21253046,4/18/2021,4/18/2021
201217_Honduras_ColegioMédico_OverallGenpop,12/17/2020,National,Honduras,Honduras; NR; NR,"June 16, 2020","June 23, 2020",Household and community samples,Multiple groups,792,6.20%,,,Stratified probability,NR,,"IgG,IgM",93.40%,97.70%,Moderate,Journal Article (Peer-Reviewed),Mario Rene Mejía Núñez ,Colegio Médico,https://revistas.ucr.ac.cr/index.php/psm/article/view/43261/46175,4/16/2021,4/22/2021
200717_Hungary_SemmelweisUniversity__GenPop_PopAdj,7/17/2020,National,Hungary,Hungary,"May 1, 2020","May 16, 2020",Household and community samples,Multiple groups,10474,0.68%,0.50%,0.86%,Stratified probability,Abbott,Chemiluminescence Immunoassay,IgG,,,Moderate,Journal Article (Peer-Reviewed),Béla Merkely,Semmelweis University,https://dx.doi.org/10.1007/s11357-020-00226-9,8/1/2020,4/26/2021
200901_Iceland_deCODEGenetics_OverallPopAdj,9/1/2020,National,Iceland,Iceland,"April 27, 2020","June 12, 2020",Household and community samples,Multiple groups,23452,0.30%,,,Convenience,"Roche International, Wantai/Nordic BioSite",Chemiluminescence Immunoassay,"IgG,IgM,IgA",91.10%,99.80%,Moderate,Journal Article (Peer-Reviewed),Daniel Gudbjartsson,deCODE Genetics,http://dx.doi.org/10.1056/NEJMoa2026116,10/13/2020,4/26/2021
200622_India_IndianCouncilofMedicalResearch_GenPop,"6/22/2020, 5/25/2020, 6/8/2020, 6/16/2020",National,India,"India; Andhra Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Jharkhand, Karnataka, Kerala, Madhya Pradesh, Maharashtra, Odisha, Punjab, Haryana, Rajasthan, Tamil Nadu, Telangana, Uttar Pradesh, Uttarakhand, Himachal Pradesh, West Bengal, Jammu, Kashmir","May 11, 2020","May 25, 2020",Household and community samples,Not reported,26400,0.73%,,,Stratified probability,ICMR-National Institute of Virology,ELISA,IgG,,,Moderate,"News and Media, News and Media, News and Media, News and Media","Swatee Kher, Rhythma Kaul, Sumi Dutta, Jacob Koshy",Indian Council of Medical Research,"https://timesofindia.indiatimes.com/city/pune/6-maha-districts-have-higher-ncov-prevalence-than-nations-finding/articleshow/76500273.cms, https://www.google.com/url?rct=j&sa=t&url=https://www.hindustantimes.com/india-news/over-24k-samples-collected-for-random-antibody-tests/story-Pec8jZE03DMQ0zOQwr4KEN.html&ct=ga&cd=CAAYDTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGcW3JvLyfXSvgW5ufbrsvCZIK5Cg, https://www.google.com/url?rct=j&sa=t&url=https://www.newindianexpress.com/nation/2020/jun/08/15-30-people-in-containment-areas-exposed-to-covid-19-icmrs-serosurvey-2153893.html&ct=ga&cd=CAAYHDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG7hdULnqHWatDy0FOZfa_fab9k9g, https://www.google.com/url?rct=j&sa=t&url=https://www.thehindu.com/news/national/news-analysis-india-may-have-undercounted-cases/article31822079.ece&ct=ga&cd=CAAYFDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNH2njMg_YAc93gwu8ZxyGEMwYvnnQ",6/24/2020,4/26/2021
200606_Bengaluru_SJICSR_Staff,6/6/2020,Sublocal,India,India; Karnataka; Bengaluru,"May 23, 2020","June 6, 2020",Health care workers and caregivers,Adults (18-64 years),1000,1.00%,,,Convenience,New Life Healthcare,Not reported,IgG,,,Unclear,News and Media,Sunitha Rao,Sri Jayadeva Institute of Cardiovascular Sciences and Research,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/bengaluru/covid-19-jayadeva-says-its-survey-hints-at-herd-immunity/articleshow/76228490.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrh7Scfh82driNisE_8HVxMcpd8Q,6/27/2020,4/26/2021
200614_Thiruvananthapuram_HealthDepartment_GenPop,6/14/2020,Local,India,India; Kerala; Thiruvananthapuram,"June 9, 2020","June 12, 2020",Household and community samples,Multiple groups,450,2.67%,,,Unclear,Not reported,Not reported,"IgM,IgG",,,Unclear,News and Media,Aswin Kumar,Thiruvanathapuram Health Department,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/thiruvananthapuram/initial-trend-positivity-rate-low-in-antibody-testing/articleshow/76363847.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHcN3WpGsIDw6iptLnm7KkY9Nl-tg,7/5/2020,4/26/2021
200721_Haryana_IntegratedDiseaseSurveillanceProgramme_GenPop,7/21/2020,Regional,India,"India; Haryana; Gurugram, Faridabad, Ambala, Panchkula, Sonipat","June 21, 2020","July 15, 2020",Household and community samples,Adults (18-64 years),1544,12.00%,,,Stratified probability,Not reported,ELISA,IgG,,,High,News and Media,Archana Mishra,Haryana Health Department,https://www.google.com/url?rct=j&sa=t&url=https://www.hindustantimes.com/gurugram/sero-survey-1-544-tested-180-found-with-covid-19-antibodies-in-haryana/story-k7DUZ8WH4jYqAzCsUmXkEJ.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHS65YBS1xHpw-8TGWw9ZqDMQDIog,7/31/2020,4/26/2021
200719_Lucknow_India_KingGeorgeMedicalUniversity_BloodDonors,7/19/2020,Local,India,India; Uttar Pradesh; Lucknow,"July 5, 2020","July 19, 2020",Blood donors,Not reported,1235,3.70%,,,Convenience,Not reported,Not reported,IgG,,,High,News and Media,Yusra Husain,King George's Medical University,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/lucknow/4-healthy-blood-donors-in-city-found-with-covid-antibodies/articleshow/77044828.cms&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrdF6GLOiOPUVeEg19jMKbusa8DA,8/1/2020,4/26/2021
200723_Delhi_IndianCentreforDiseaseControl_GenPop,"7/23/2020, 7/21/2020",Regional,India,India; NCT Delhi,"June 27, 2020","July 10, 2020",Household and community samples,Multiple groups,21387,23.48%,,,Stratified probability,Zydus Cadila Healthcare ,ELISA,IgG,98.70%,100.00%,Moderate,"News and Media, Institutional Report","Astha Saxena , Ministry of Health and Family Welfare",Indian Center for Disease Control,"https://www.google.com/url?rct=j&sa=t&url=https://indianexpress.com/article/cities/delhi/delhi-coronavirus-latest-updates-sero-surveys-6518032/&ct=ga&cd=CAAYJjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGCf7pxljsAyKyKKRtaj_xafKiFPw, https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1640137",8/1/2020,4/26/2021
200723_India_Thyrocare_GenPop,"7/23/2020, 7/22/2020",National,India,India,"June 28, 2020","July 19, 2020",Household and community samples,Not reported,53000,15.00%,,,Simplified probability,Not reported,"ELISA,Chemiluminescence Immunoassay",Not reported,,,High,"News and Media, News and Media","India.com News Desk, HT Correspondent",Thyrocare,"https://www.google.com/url?rct=j&sa=t&url=https://www.india.com/news/india/covid-19-people-from-bhiwandi-anand-vihar-have-antibodies-against-corona-check-report-4092355/&ct=ga&cd=CAAYBTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGDZBY0JyrN9eer5kq9FJfLncpL8Q, https://www.google.com/url?rct=j&sa=t&url=https://www.hindustantimes.com/india-news/15-per-cent-population-may-have-virus-antibodies-says-private-lab-data/story-mUddIj9kxI4vRzYu4KMUiI.html&ct=ga&cd=CAAYBDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEuq1rkJ7vFZU1Rp4WmYN2Cr32JNA",8/4/2020,4/26/2021
200819_Delhi_DelhiGovernment_BloodDonors,8/19/2020,Regional,India,India; NCT Delhi,"August 1, 2020","August 7, 2020",Blood donors,Not reported,15289,28.30%,,,Unclear,Not reported,Not reported,Not reported,,,Unclear,News and Media,Aneesha Bedi,National Centre for Disease Control,https://theprint.in/health/28-3-of-delhis-population-now-exposed-to-covid-shows-second-sero-survey-up-from-23-4/484455/,10/2/2020,4/26/2021
200724_Ahmedabad_AhmedabadMunicipalCorporation_Overall,7/24/2020,Local,India,India; Gujarat; Ahmedabad,"June 16, 2020","July 11, 2020",Multiple populations,Not reported,30054,17.60%,,,Unclear,Not reported,Not reported,Not reported,,,Unclear,News and Media,Unclear,Ahmedabad Municipal Corporation,https://timesofindia.indiatimes.com/city/ahmedabad/ahmedabad-has-no-herd-immunity-only-17-6-have-antibodies/articleshow/77137851.cms,10/6/2020,4/26/2021
200826_India_AllIndiaInstituteofMedicalSciences_HospitalPatients_UnAdj,8/26/2020,Local,India,India; Punjab; New Delhi,"June 8, 2020","August 8, 2020",Residual sera,Multiple groups,212,19.80%,14.70%,25.80%,Convenience,"""Translational Health Science and Technology Institute (THSTI), Faridabad""",ELISA,IgG,88.24%,99.79%,High,Preprint,Animesh Ray,All India Institute of Medical Sciences,https://www.medrxiv.org/content/10.1101/2020.08.22.20179937v2,10/13/2020,4/26/2021
200914_PaschimMedinipur_MedicalCollegeKolkata_Overall,9/14/2020,Regional,India,India; West Bengal,"July 26, 2020","August 8, 2020",Household and community samples,Multiple groups,458,4.15%,2.52%,6.40%,Stratified probability,Calbiotech Inc.,ELISA,IgG,98.30%,98.10%,Moderate,Preprint,Parthasarathi Satpati,Medical College Kolkata,https://www.medrxiv.org/content/10.1101/2020.09.12.20193219v1,11/5/2020,4/26/2021
200903_NewDelhi_MaxSuperSpecialtyHospital_Overall,9/3/2020,Local,India,India; NCT Delhi; New Delhi,"April 15, 2020","August 15, 2020",Multiple populations,Multiple groups,780,19.50%,,,Convenience,Roche Diagnostics,Electrochemiluminescence,Total Antibody,94.50%,99.40%,High,Preprint,Samreen Siddiqui,Max Super Specialty Hospital,https://www.medrxiv.org/content/10.1101/2020.09.02.20186486v1,11/6/2020,4/26/2021
200922_Delhi_NationalCenterforDiseaseControlIndia_Survey1_PopAdj,9/22/2020,Local,India,India; NCT Delhi; New Delhi,"June 26, 2020","July 10, 2020",Household and community samples,Not reported,21387,23.48%,22.96%,24.01%,Unclear,ICMR-National Institute of Virology,ELISA,IgG,92.37%,97.90%,Unclear,Preprint,Smarajit Dey,National Centre for Disease Control,https://www.researchsquare.com/article/rs-80259/v1,11/18/2020,4/26/2021
200922_Delhi_NationalCenterforDiseaseControlIndia_Survey2_PopAdj,9/22/2020,Local,India,India; NCT Delhi; New Delhi,"August 1, 2020","August 7, 2020",Household and community samples,Not reported,15311,29.10%,28.51%,29.95%,Unclear,ICMR-National Institute of Virology,ELISA,IgG,92.37%,97.90%,Unclear,Preprint,Smarajit Dey,National Centre for Disease Control,https://www.researchsquare.com/article/rs-80259/v1,11/18/2020,4/26/2021
200917_India_MinistryofHealth&FamilyWelfare_OverallPopTestAdj,9/17/2020,National,India,India,"May 11, 2020","June 4, 2020",Household and community samples,Multiple groups,28000,0.73%,0.34%,1.13%,Stratified probability,"Cadila Healthcare Limited, EUROIMMUN",ELISA,IgG,,,Low,Journal Article (Peer-Reviewed),Manoj Murhekar,Indian Council of Medical Research,http://dx.doi.org/10.4103/ijmr.IJMR_3290_20,11/26/2020,4/26/2021
201207_Mumbai_KokilabenDhirubhaiAmbaniHospital_hcw_primaryest,12/7/2020,Sublocal,India,India; Maharashtra; Mumbai,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),208,12.50%,,,Convenience,1) Abbott 2) Roche,,Not reported,,,High,Journal Article (Peer-Reviewed),Tanu Singhal,Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute,https://dx.doi.org/10.4103/ijmm.IJMM_20_308,1/12/2021,4/26/2021
201109_Kokalta_ApolloGleneaglesHospitals_HCW_Overall,11/9/2020,Sublocal,India,India; West Bengal; Kolkata,"July 12, 2020","August 23, 2020",Health care workers and caregivers,Adults (18-64 years),1122,11.94%,,,Stratified probability,Ortho Clinical Diagnostics,,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mahesh Goenka,Apollo Gleneagles Hospitals,https://www.japi.org/x264a444/seroprevalence-of-covid-19-amongst-health-care-workers-in-a-tertiary-care-hospital-of-a-metropolitan-city-from-india,1/18/2021,4/26/2021
201104_India_HindujaHospital_GenPop,11/4/2020,Local,India,India; Maharashtra; Mumbai,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,801,11.10%,9.10%,13.50%,Unclear,Roche Diagnostics,,Total Antibody,99.80%,100.00%,High,Journal Article (Peer-Reviewed),Nishant Kumar,Postgraduate Institute of Medical Education and Research,https://dx.doi.org/10.1016/j.vaccine.2020.10.094,1/18/2021,4/26/2021
201013_Odisha_ICMR-RMRC_genpop,10/13/2020,Local,India,"India; Odisha; Bhubaneswar, Berhampur, Rourkela","August 1, 2020","August 31, 2020",Household and community samples,Multiple groups,4146,20.78%,19.56%,22.05%,Stratified probability,NR,,Total Antibody,,,High,Preprint,Jaya Singh Kshatri,Indian Council of Medical Research-Regional Medical Research Centre in Bhubaneswar (ICMR-RMRC) Serosurvey group,https://www.medrxiv.org/node/100529.external-links.html,1/23/2021,4/26/2021
201130_DrDYPatilMedicalCollege_Pimpri-Chinchwad_DashboardPrimary,11/30/2020,Local,India,India; Maharashtra; Pune ,"October 7, 2020","October 17, 2020",Household and community samples,Multiple groups,5000,34.04%,31.30%,36.80%,Stratified probability,"Abbott Chicago, IL, USA.",,IgG,92.70%,99.90%,Moderate,Preprint,Amitav Banerjee,Dr DY Patil Medical College ,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3729394,1/23/2021,4/26/2021
201211_Karnatka_IndianInstituteofPublicHealth_primary_adj,12/11/2020,Regional,India,India; Karnatka,"September 3, 2020","September 16, 2020",Household and community samples,Multiple groups,15624,16.40%,15.10%,17.70%,Stratified non-probability,"Zydus Cadila, India",,IgG,92.10%,99.77%,Moderate,Preprint,Giridhara R Babu,Indian Institute of Public Health,https://www.medrxiv.org/content/10.1101/2020.12.04.20243949v1.full,1/29/2021,4/26/2021
201109_Kolkata_ApolloGleneaglesHospitalsGastroDept_Overall,11/9/2020,Sublocal,India,India; West Bengal; Kolkata,"August 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),117,32.48%,,,Convenience,Ortho Clinical Diagnostics,,IgG,,,High,Journal Article (Peer-Reviewed),Mahesh Goenka,Apollo Gleneagles Hospitals,http://dx.doi.org/10.1002/jgh3.12447,1/30/2021,4/26/2021
201214_Ahmedabad_ MunicipalMedicalCollege_genpop_primary,12/14/2020,Local,India,India; Gujarat; Ahmedabad,"June 16, 2020","July 7, 2020",Residual sera,Multiple groups,29891,17.61%,17.18%,18.04%,Convenience,Zydus Diagnostics,,IgG,92.37%,97.90%,High,Journal Article (Peer-Reviewed),Om Prakash, Municipal Medical College ,https://dx.doi.org/10.1136/bmjopen-2020-044101,2/2/2021,4/26/2021
210104_Chennai_KanchiKamakotiCHILDSTrustHospital_overall,1/4/2021,Sublocal,India,India; Tamil Nadu; Chennai,"July 30, 2020","August 7, 2020",Health care workers and caregivers,Adults (18-64 years),95,16.80%,,,Convenience,Shenzhen YHLO Biotech Co,,IgG,,,High,Preprint,Manoj Madhusudan,"Kanchi Kamakoti CHILDS Trust Hospital,",https://pubmed.ncbi.nlm.nih.gov/33408287/,2/4/2021,3/31/2021
200916_Kerala_AmritaInstituteofMedicalSciencesandResearchCentre,9/16/2020,Sublocal,India,India; Kerala,"July 11, 2020","July 24, 2020",Health care workers and caregivers,Multiple groups,635,0.00%,,,Convenience,"Abbott, Roche Diagnostics, Ortho-Clinical Diagnostics",Not reported,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Anil Kumar,Amrita Institute of Medical Sciences & Research Centre,http://dx.doi.org/10.1016/j.cmi.2020.09.013,2/6/2021,4/26/2021
201214_Delhi_MaulanaAzadMedicalCollege_Oct_PopTestAdj,12/14/2020,Regional,India,India; NCT Delhi,"October 15, 2020","October 21, 2020",Household and community samples,Multiple groups,15015,24.71%,24.01%,25.42%,Stratified probability,NR,,IgG,99.12%,99.33%,Low,Preprint,Nandini Sharma,Government of National Capital Territory of Delhi,https://www.medrxiv.org/content/10.1101/2020.12.13.20248123v1,2/6/2021,4/26/2021
201214_Delhi_MaulanaAzadMedicalCollege_Sept_PopTestAdj,12/14/2020,Regional,India,India; NCT Delhi,"September 1, 2020","September 7, 2020",Household and community samples,Multiple groups,17409,24.08%,23.43%,24.74%,Stratified probability,NR,,IgG,99.12%,99.33%,Low,Preprint,Nandini Sharma,Government of National Capital Territory of Delhi,https://www.medrxiv.org/content/10.1101/2020.12.13.20248123v1,2/6/2021,4/26/2021
201214_Delhi_GovernmentofNationalCapitalTerritory_Aug1_PopTestAdj,12/14/2020,Regional,India,India; NCT Delhi,"August 1, 2020","August 7, 2020",Household and community samples,Multiple groups,15046,28.39%,27.65%,29.14%,Stratified non-probability,NR,,IgG,92.10%,97.70%,Low,Preprint,Nandini Sharma,Government of National Capital Territory of Delhi,https://www.medrxiv.org/content/10.1101/2020.12.13.20248123v1,2/6/2021,4/26/2021
211104_Karnataka_Mapmygenome_primary_adj,2/4/2021,Regional,India,India; Karnataka,"June 15, 2020","August 29, 2020",Household and community samples,Multiple groups,1197,46.70%,43.30%,50.00%,Stratified probability,"Translational Health Science and Technology Institute, India",,IgG,84.70%,100.00%,Moderate,Journal Article (Peer-Reviewed),Manoj Mohanan,Mapmygenome,https://dx.doi.org/10.1001/jama.2021.0332,2/8/2021,4/26/2021
201130_PuneCity_IndianInstituteOfScienceEducationAndResearch_OverallAdj,11/30/2020,Local,India,India; Maharashtra; Pune,"July 20, 2020","August 5, 2020",Household and community samples,Multiple groups,1659,51.30%,39.90%,62.40%,Stratified probability,In-house developed.,,IgG,,,Moderate,Preprint,Aurnab Ghose,Indian Institute of Science Education and Research,https://www.medrxiv.org/content/10.1101/2020.11.17.20228155v2.full-text,2/11/2021,4/26/2021
210114_Puducherry_JawaharlalInstitute_August_primary,1/14/2021,Regional,India,India; Puducherry,"August 11, 2020","August 16, 2020",,Multiple groups,869,4.90%,3.50%,6.40%,Stratified probability,Roche,,Total Antibody,99.50%,99.80%,Low,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,2/16/2021,3/31/2021
210114_Puducherry_JawaharlalInstitute_Sep_primary,1/14/2021,Regional,India,India; Puducherry,"September 10, 2020","September 16, 2020",,Multiple groups,898,20.70%,18.00%,23.30%,Stratified probability,Roche,,Total Antibody,99.50%,99.80%,Low,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,2/16/2021,3/31/2021
210114_Puducherry_JawaharlalInstitute_Oct_primary,1/14/2021,Regional,India,India; Puducherry,"October 12, 2020","October 16, 2020",,Multiple groups,900,34.50%,31.50%,37.70%,Stratified probability,Roche,,Total Antibody,99.50%,99.80%,Low,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,2/16/2021,3/31/2021
210120_Chennai_NationalInstituteOfEpidemiology_primary_adj,1/20/2021,Local,India,India,"July 1, 2020","July 31, 2020",Household and community samples,Multiple groups,12405,18.40%,14.80%,22.60%,Stratified probability,Abbott,,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Sriram Selvaraju,National Institute of Epidemiology,https://dx.doi.org/10.3201/eid2702.203938,2/20/2021,4/14/2021
201113_Mumbai_TataInstituteforFundamentalResearch_slums_testpopadj,11/13/2020,Local,India,India,"June 29, 2020","July 19, 2020",Persons living in slums,Multiple groups,4202,58.30%,56.80%,59.90%,Stratified probability,Abbott Laboratories,,IgG,90.00%,99.00%,Low,Journal Article (Peer-Reviewed),Anup Malani,Tata Institute for Fundamental Research,http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8,2/21/2021,4/26/2021
201113_Mumbai_TataInstituteforFundamentalResearch_nonslums_adj,11/13/2020,Local,India,India,"June 29, 2020","July 19, 2020",Household and community samples,Multiple groups,2702,17.10%,15.80%,18.40%,Stratified probability,Abbott Laboratories,,IgG,90.00%,99.00%,Low,Journal Article (Peer-Reviewed),Anup Malani,Tata Institute for Fundamental Research,http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8,2/21/2021,4/26/2021
210131_Thissur_JubileeMissionHospital_primary,1/31/2021,Sublocal,India,India; Kerala; Thrissur,"September 5, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),423,8.75%,6.23%,11.86%,Convenience,Vitros,,IgG,90.00%,100.00%,High,Preprint,Aboobacker Mohamed Rafi,Jubilee Mission Hospital,10.1101/2021.01.27.21250502,2/28/2021,3/29/2021
210201_Chennai_KanchiKamakotiCHILDSTrustHospital_overall_IgG,2/1/2021,Sublocal,India,India; Tamil Nadu; Chennai,"June 1, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),463,19.60%,15.40%,22.50%,Convenience,YHLO Biotechnology Corporation,,IgG,,,High,Preprint,Aishwarya Venkataraman,Bristol Royal Hospital for Children,10.1101/2021.01.29.21250660,3/3/2021,4/8/2021
201031_Bhubaneswar_RegionalMedicalResearchCentre_overall,10/31/2020,Local,India,India,"October 16, 2020","October 18, 2020",Household and community samples,Not reported,1403,50.00%,,,Simplified probability,NR,,Not reported,,,Unclear,News and Media,Riyan Ramanath,The Regional Medical Research Centre in Bhubaneswar,https://timesofindia.indiatimes.com/city/bhubaneswar/survey-50-of-bhubaneswar-residents-have-antibodies/articleshow/78966615.cms,3/7/2021,4/26/2021
201027_DistrictSrinagar_GovernmentMedicalCollege_Overall,10/27/2020,Local,India,India; Kashmir,"June 15, 2020","June 29, 2020",Health care workers and caregivers,Adults (18-64 years),2905,2.50%,2.00%,3.10%,Convenience,Abbott Laboratories,,IgG,100.00%,,Moderate,Preprint,Muhammad Salim Khan,Government Medical College,https://www.medrxiv.org/content/10.1101/2020.10.23.20218164v1.full-text,3/16/2021,4/26/2021
210127_India_ICRM_overall_adj,1/27/2021,National,India,India,"August 18, 2020","September 20, 2020",Household and community samples,Multiple groups,29082,6.60%,5.80%,7.40%,Stratified probability,Abbott,,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Manoj V Murhekar,The Indian Council of Medical Research (ICMR),https://dx.doi.org/10.1016/S2214-109X(20)30544-1,3/17/2021,4/20/2021
210205_India_ICRM_overall,2/5/2021,National,India,India,"December 17, 2020","January 8, 2021",Household and community samples,Multiple groups,28589,21.50%,,,Stratified probability,NR,,Not reported,,,Unclear,News and Media,BBC News,The Indian Council of Medical Research (ICMR),https://www.bbc.com/news/world-asia-india-55945382,3/17/2021,4/18/2021
210208_TamilNadu_GovernmentofTamilNadu_Overall,2/8/2021,Regional,India,India; Tamil Nadu,"October 19, 2020","November 30, 2020",Household and community samples,Multiple groups,26135,31.60%,20.40%,32.80%,Stratified probability,Shenzhen YHLO Biotech; Ortho-Clinical Diagnostics,,IgG,90.00%,100.00%,Low,Preprint,Anup Malani,Government of Tamil Nadu,https://www.medrxiv.org/content/10.1101/2021.02.03.21250949v1,3/18/2021,3/28/2021
210301_NewDelhi_AllIndiaInstituteofMedicalSciences_Overall,3/1/2021,Sublocal,India,India; NCT Delhi; New Delhi,"June 22, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),3739,13.02%,,,Convenience,"Siemens AG, Munich, Germany",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ritu Gupta,All India Institute of Medical Sciences,https://pubmed.ncbi.nlm.nih.gov/33642348/,3/23/2021,4/19/2021
210311_Vellore_UniversityOfEdinburgh_CommunitySurvey1_overall,3/11/2021,Local,India,India; Tamil Nadu,"July 6, 2020","August 20, 2020",Household and community samples,Multiple groups,501,2.20%,0.80%,3.40%,Simplified probability,"1) Roche
2) Siemens ",,IgG,,,Moderate,Preprint,Rita Isaac,University of Edinburgh,https://www.researchsquare.com/article/rs-289385/v1,3/30/2021,3/31/2021
210311_Vellore_UniversityOfEdinburgh_CommunitySurvey2_overall ,3/11/2021,Local,India,India; Tamil Nadu,"November 6, 2020","November 20, 2020",Household and community samples,Multiple groups,200,22.00%,16.30%,27.70%,Simplified probability,"1) Roche
2) Siemens ",,IgG,,,Moderate,Preprint,Rita Isaac,University of Edinburgh,https://www.researchsquare.com/article/rs-289385/v1,3/30/2021,3/31/2021
210212_Gurugram_Medanta-TheMedicity,2/12/2021,Sublocal,India,India; Haryana; Gurugram,"January 12, 2021","February 13, 2021",Health care workers and caregivers,Adults (18-64 years),3258,46.20%,44.40%,47.90%,Convenience,DiaSorin,,IgG,,,Moderate,Preprint,Sushila Kataria,Madanta- The Medicity,https://www.medrxiv.org/content/10.1101/2021.02.10.21251543v1,3/30/2021,3/31/2021
201111_Srinagar_GovernmentMedicalCollegeSrinagar,11/11/2020,Regional,India,India; Srinagar; District Srinagar,"July 1, 2020","July 15, 2020",Residual sera,Multiple groups,2906,3.60%,2.90%,4.30%,Convenience,Abbott,,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),S. Muhammad Salim Khan,Government Medical College Srinagar,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239303,4/8/2021,4/26/2021
210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_September_AnaesthesiaHCW,3/26/2021,Local,India,India,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),128,12.50%,7.30%,19.50%,Unclear,Abbott Laboratories,,IgG,100.00%,99.63%,High,Preprint,Debaprasad Parai,ICMR-Regional Medical Research Centre (Government of India),https://doi.org/10.1101/2021.03.20.21253819,4/9/2021,4/9/2021
210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_December_AnaesthesiaHCW,3/26/2021,Local,India,India,"December 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),164,38.40%,30.90%,46.30%,Unclear,Abbott Laboratories,,IgG,100.00%,99.63%,Unclear,Preprint,Debaprasad Parai,ICMR-Regional Medical Research Centre (Government of India),https://doi.org/10.1101/2021.03.20.21253819,4/9/2021,4/9/2021
210411_India_BanarasHinduUniversity_Overall,4/11/2021,National,India,India; NR; NR,"September 15, 2020","December 15, 2020",Household and community samples,Adults (18-64 years),2301,30.55%,28.70%,32.50%,Simplified probability,Biosense Technologies,,"IgM,IgA,IgG,Total Antibody",100.00%,99.00%,Moderate,Preprint,Prajjval Singh,Banaras Hindu University,https://www.medrxiv.org/content/10.1101/2021.02.05.21251118v2,4/14/2021,4/14/2021
210202_Delhi_DelhiGovernment,2/2/2021,Regional,India,India,"January 15, 2021","January 23, 2021",Household and community samples,Not reported,28000,56.13%,,,Unclear,NR,,Not reported,,,Unclear,News and Media,Mallika Soni,Delhi Government,https://www.hindustantimes.com/india-news/after-5th-serosurvey-health-minister-jain-says-don-t-let-your-guard-down-101612264692531.html,4/14/2021,4/18/2021
210215_Patna_AllIndiaInstituteOfMedicalSciences_Overall,2/15/2021,Sublocal,India,India; Bihar; Patna,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),919,13.30%,11.20%,15.60%,Convenience,ADVIA Centaur,,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Mala Mahto,All India Institute of Medical Sciences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010601/,4/15/2021,4/15/2021
210301_Ahmedabad_SmtNHLMunicipalMedicalCollege_Overall,3/1/2021,Sublocal,India,India,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1333,27.76%,,,Unclear,Siemens,,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Jemil S Makadia,Smt NHL Municipal Medical College,http://dx.doi.org/10.7860/JCDR/2021/46817.14599,4/17/2021,4/17/2021
210311_NewDelhi_AllIndiaInstituteOfMedicalSciences_Overall,3/11/2021,Sublocal,India,India,"April 15, 2020","July 15, 2020",Blood donors,Multiple groups,1191,9.50%,,,Convenience,Abbott,,IgG,,,High,Journal Article (Peer-Reviewed),Hem Chandra Pandey,All India Institute of Medical Sciences ,https://dx.doi.org/10.1016/j.transci.2021.103118,4/17/2021,4/17/2021
201103_Haryan_TheHindu_primary,11/3/2020,Regional,India,India; Haryan,"October 18, 2020","October 24, 2020",Household and community samples,Multiple groups,16477,14.76%,,,Stratified probability,NR,,Not reported,,,Unclear,News and Media,Ashok Kumar,Unclear,https://www.thehindu.com/news/cities/Delhi/6-rise-in-seropositivity-among-delhis-neighbours/article33006634.ece,4/22/2021,4/25/2021
201017_Ujjain_TheTimesOfIndia_primary,9/17/2020,Regional,India,India; Madhya Pradesh,"August 27, 2020","August 30, 2020",Household and community samples,Multiple groups,3000,11.90%,,,Unclear,NR,,Not reported,,,Unclear,News and Media,Amarjeet Singh,The Times of India,https://timesofindia.indiatimes.com/city/bhopal/11-9-seroprevalence-in-ujjain-finds-survey/articleshow/78159395.cms,4/22/2021,4/25/2021
200820_PunjabSeroSurvey_India_genpop,8/20/2020,Regional,India,India,"August 1, 2020","August 17, 2020",Household and community samples,Multiple groups,1250,27.70%,,,Simplified probability,NR,,"IgM,IgG",,,Unclear,News and Media,Express News Service,Punjab Sero-survey,https://indianexpress.com/article/india/punjab-sero-survey-report-27-7-people-in-containment-zones-have-antibodies-against-covid-6563226/,4/25/2021,4/25/2021
200901_Aurangabad_GovernmentMedicalSchool_overall,9/1/2020,Local,India,India; Maharashtra,"August 10, 2020","August 19, 2020",Household and community samples,Multiple groups,6571,5.80%,,,Stratified probability,NR,,IgG,,,Moderate,Journal Article (Peer-Reviewed),J.V. Dixit,"Government Medical School, Aurangabad",https://ijcrt.org/papers/IJCRT2009467.pdf,4/26/2021,4/27/2021
20210406_Kashmir_GovernmentMedicalCollegeSringar_PopTestAdj,4/6/2021,Regional,India,India,"October 17, 2020","November 4, 2020",Household and community samples,Adults (18-64 years),6230,36.70%,34.30%,39.20%,Stratified probability,Abbott,,IgG,100.00%,99.63%,Low,Journal Article (Peer-Reviewed),Muhammad Khan,Government Medical College Sringar,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3820632,4/26/2021,4/27/2021
210303_Jabalpur_NationalCentreForDiseaseControl_TestPopAdj,3/31/2021,Local,India,India; Madya Pradesh; Jabalpur,"December 11, 2020","December 21, 2020",Household and community samples,Multiple groups,9279,29.42%,28.41%,30.42%,Stratified probability,ICMR,,IgG,92.37%,97.90%,Low,Journal Article (Peer-Reviewed),Sudarshan Ramaswamy,National Centre for Disease Control,https://web.archive.org/web/20210410213821/http://medical.advancedresearchpublications.com/index.php/Journal-CommunicableDiseases/article/view/536,4/27/2021,4/27/2021
200915_Tehran_IranUniversityOfMedicalSciences_Patients_Overall,9/1/2020,Sublocal,Iran (Islamic Republic of),Iran (Islamic Republic of); Tehran; Tehran,"February 20, 2020","March 20, 2020",Multiple populations,Multiple groups,178,17.98%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shahrzad Ossareh,Iran University of Medical Sciences,http://www.ijkd.org/index.php/ijkd/article/view/5832/1205,10/30/2020,4/26/2021
201221_Guilan_TehranUniversityofMedicalSciences_overall,12/21/2020,Regional,Iran (Islamic Republic of),Iran (Islamic Republic of); Guilan,"April 11, 2020","April 19, 2020",Household and community samples,Multiple groups,528,22.20%,16.40%,28.50%,Stratified probability,VivaChek,,"IgG,IgM",83.30%,99.00%,Moderate,Journal Article (Peer-Reviewed),Maryam Shakiba,Tehran University of Medical Sciences,https://dx.doi.org/10.3201/eid2702.201960,1/23/2021,4/26/2021
201110_Tehran_TehranUniversityofMedicalSciences_unadj,11/10/2020,Sublocal,Iran (Islamic Republic of),Iran (Islamic Republic of); Tehran; Tehran,"March 20, 2020","May 20, 2020",Essential non-healthcare workers,Adults (18-64 years),243,41.56%,,,Convenience,KarmaAzmaAndish Co.,,"IgM,IgG",71.10%,58.70%,High,Journal Article (Peer-Reviewed),Peyman Saberian,Tehran University of Medical Sciences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720855/,1/23/2021,4/26/2021
201206_Tehran_HighInstituteforResearchandEducationinTransfusionMedicine,12/6/2020,Sublocal,Iran (Islamic Republic of),Iran (Islamic Republic of); Tehran; Tehran,"April 20, 2020","May 5, 2020",Health care workers and caregivers,Adults (18-64 years),475,29.40%,,,Convenience,Hangzhou AllTest Biotech Co.,,"IgG,IgM",99.90%,98.00%,High,Journal Article (Peer-Reviewed),Shahnaz Armin,High Institute for Research and Education in Transfusion Medicine,https://sites.kowsarpub.com/jjm/articles/108592.html,1/26/2021,4/26/2021
201223_RafsanjanCounty_UniversityofPecs,12/23/2020,Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Kerman,"March 1, 2020","April 30, 2020",Contacts of COVID patients,Multiple groups,238,15.55%,,,Sequential,NR,,"IgG,IgM",,,High,Preprint,Reza Vazirinejad,University of Pecs,https://europepmc.org/article/ppr/ppr257302#fulltext--permissions-,2/2/2021,4/26/2021
201215_Iran_TehranUniversityofMedicalSciences_GenPop1_overall_PopTestAdj,12/15/2020,National,Iran (Islamic Republic of),Iran (Islamic Republic of),"April 17, 2020","June 2, 2020",Household and community samples,Multiple groups,3530,17.10%,14.60%,19.50%,Stratified probability,Pishtaz Teb,,"IgG,IgM",66.90%,98.20%,Low,Journal Article (Peer-Reviewed),Hossein Poustchi,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6,2/5/2021,4/26/2021
210120_Tehran_TehranUniversityofMedicalSciences_InPatients,1/20/2021,Sublocal,Iran (Islamic Republic of),Iran (Islamic Republic of),"April 15, 2020","October 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1375,21.20%,,,Convenience,IDEAL TASHKHIS Co,,"IgG,IgM",82.00%,,High,Preprint,Zeinab Tabanejad,Tehran University of Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.01.18.20248911v1.full-text,2/6/2021,3/31/2021
201215_Iran_TehranUniversityofMedicalSciences_HighRisk2_overall_PopTestAdj ,12/15/2020,National,Iran (Islamic Republic of),Iran (Islamic Republic of),"April 17, 2020","June 2, 2020",Multiple populations,Multiple groups,5372,20.00%,18.50%,21.70%,Stratified probability,Pishtaz Teb,,"IgG,IgM",66.90%,98.20%,Moderate,Journal Article (Peer-Reviewed),Hossein Poustchi,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6,2/6/2021,4/26/2021
2101_Zahedan_TehranUniversityofMedicalSciences,1/1/2021,Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Sistan and Balouchestan; Zahedan,"July 1, 2020","July 31, 2020",,Adults (18-64 years),167,9.70%,,,Convenience,"Pishtaz Teb, Tehran, Iran",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Zahra Mohammadi,Tehran University of Medical Sciences,http://dx.doi.org/10.34172/mejdd.2021.206,3/14/2021,3/28/2021
2101_Zahedan_TehranUniversityofMedicalSciences_NonDrugUsers,1/1/2021,Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Sistan and Balouchestan; Zahedan,"July 1, 2020","July 31, 2020",Household and community samples,Adults (18-64 years),134,4.80%,,,Simplified probability,"Pishtaz Teb Tehran, Iran",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Zahra Mohammadi,Tehran University of Medical Sciences,http://dx.doi.org/10.34172/mejdd.2021.206,3/14/2021,3/28/2021
210105_Mazandaran_MazandaranUniversityofMedicalSciences_OverallPopAdj,1/5/2021,Regional,Iran (Islamic Republic of),Iran (Islamic Republic of); Mazandaran,"March 15, 2020","May 15, 2020",Household and community samples,Multiple groups,1588,17.29%,14.84%,17.79%,Stratified probability,Danesh Bonyan Pishtaz Teb Company,,"IgG,IgM",59.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Seyed Abbas Mousavi,Mazandaran University of Medical Sciences,https://www.apjtm.org/article.asp?issn=1995-7645;year=2021;volume=14;issue=1;spage=10;epage=16;aulast=Mousavi,3/17/2021,3/31/2021
210314_Iran_TehranUniversityofMedicalSciences_overall_adj,,National,Iran (Islamic Republic of),Iran (Islamic Republic of),"August 3, 2020","October 31, 2020",Household and community samples,Multiple groups,11256,14.20%,13.30%,15.20%,Stratified probability,"Pishtaz Teb, Tehran, Iran; catalogue number PT-SARS-CoV-2.IgG-96",,IgG,74.00%,0.98%,Low,Preprint,Kazem Khalagi,Tehran University of Medical Sciences,10.1101/2021.03.12.21253442,4/7/2021,4/7/2021
210217_Shiraz_ShirazUniversityOfMedicalSciences_Overall,2/17/2021,Local,Iran (Islamic Republic of),Iran (Islamic Republic of),"July 13, 2020","August 5, 2020",Health care workers and caregivers,Multiple groups,494,5.90%,,,Convenience,Pishtaz Co,,IgG,,,High,Journal Article (Peer-Reviewed),Kamran Bagheri Lankarani,Shiraz University of Medical Sciences,http://dx.doi.org/10.5812/semj.112681,4/15/2021,4/15/2021
210301_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_IgG,3/1/2021,Local,Iran (Islamic Republic of),Iran (Islamic Republic of); Tehran Province; Tehran,"April 4, 2020","April 6, 2020",Multiple populations,Not reported,2021,14.40%,,,Unclear,NR,,IgG,,,Unclear,Journal Article (Peer-Reviewed),Sahar Mortezagholi,,https://dx.doi.org/10.22034/iji.2021.88168.1851,4/27/2021,4/27/2021
210326_Duhok_UniversityOfDuhok_Overall,3/26/2021,Local,Iraq,Iraq,"January 10, 2021","January 30, 2021",Multiple populations,Multiple groups,743,62.58%,,,Stratified probability,Roche,,IgG,,,Moderate,Preprint,Nawfal Hussein,University of Duhok,10.1101/2021.03.23.21254169,4/9/2021,4/9/2021
200817_Ireland_HPSC_genpop_popadj,8/17/2020,National,Ireland,"Ireland; Connaught, Leinster; Dublin, Sligo","June 22, 2020","July 16, 2020",Household and community samples,Adults (18-64 years),1733,1.70%,1.10%,2.40%,Stratified probability,"Abbott, FORTRESS ",Chemiluminescence Immunoassay,IgG,,,Moderate,Institutional Report,Derval Igoe ,HSE Health Protection Surveillance Centre (HPSC) ,https://www.hpsc.ie/a-z/respiratory/coronavirus/novelcoronavirus/scopi/SCOPI%20report%20preliminary%20results%20final%20version.pdf,10/18/2020,4/26/2021
210212_Dublin_RotundaHospital,2/12/2021,Sublocal,Ireland,Ireland; Leinster; Dublin,"May 12, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),51,4.00%,,,Convenience,Trinity Biotech,,IgG,95.92%,100.00%,High,Preprint,Joanna Griffin,Rotunda Hospital,https://www.medrxiv.org/content/10.1101/2021.02.10.20248323v1.full-text,3/25/2021,4/18/2021
200601_Israel_PandemicTaskForce_GenPop,"6/2/2020, 6/2/2020",National,Israel,Israel; Israel,,"June 2, 2020",Household and community samples,Multiple groups,1700,2.50%,,,Stratified probability,Not reported,Not reported,IgG,,,Moderate,"News and Media, News and Media","Ido Efrati, Michael Bachner",Israeli Pandemic Task Force,"https://www.google.com/url?rct=j&sa=t&url=https://www.haaretz.com/israel-news/.premium-up-to-270-000-israelis-had-coronavirus-new-study-concludes-1.8888435&ct=ga&cd=CAAYETIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNExqw1wlJNVBFrKKUd7hGTplMnR5A, https://www.google.com/url?rct=j&sa=t&url=https://www.timesofisrael.com/initial-antibody-tests-indicate-200000-israelis-have-had-covid-19-report/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHYeXqD2hIEiNnZoH5qLiVlZKxQjg",6/2/2020,4/26/2021
201008_BneiBrak_CentralBureauofStatistics_primary,10/8/2020,Local,Israel,Israel,"June 15, 2020","August 15, 2020",Household and community samples,Multiple groups,3500,14.60%,,,Stratified probability,NR,,Not reported,,,Moderate,News and Media,Aaron Rabinowitz,The Central Bureau of Statistics ,https://www.haaretz.com/israel-news/.premium-antibody-tests-30-percent-of-bnei-brak-residents-have-been-infected-with-covid-1.9217689,4/23/2021,4/25/2021
200508_Bari_IstitutoTumoriGPaolo_HCW_IgG,5/8/2020,Sublocal,Italy,Italy; Puglia; Bari,"March 26, 2020","April 17, 2020",Health care workers and caregivers,Adults (18-64 years),606,0.33%,,,Convenience,Snibe Diagnostic,Chemiluminescence Immunoassay,IgG,,,High,Preprint,Angelo Virgilio Paradiso,Istituto Tumori G. Paolo II,https://www.medrxiv.org/content/10.1101/2020.05.05.20086017v1,5/13/2020,4/26/2021
210203_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_GenPop_UnAdj,2/3/2021,Local,Italy,Italy; Lombardy; Milan,"February 24, 2020","April 8, 2020",Blood donors,Adults (18-64 years),789,5.10%,,,Convenience,Prima Lab,LFIA: Lateral flow immunoassay,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luca Valenti, Fondazione IRCCS Ca' Granda Ospedale Maggiore ,https://dx.doi.org/10.2450/2021.0324-20,5/20/2020,4/26/2021
200430_Bergamo_ATSBergamo_GeneralPopulation_AnalyzedLab1,4/30/2020,Local,Italy,"Italy; Lombardy; Alzano, Nembro","April 23, 2020","April 28, 2020",Household and community samples,Not reported,750,61.00%,,,Unclear,Not reported,Not reported,Not reported,,,Unclear,News and Media,Armando Di Landro,ATS Bergamo,https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp,6/1/2020,4/26/2021
200430_Bergamo_HospitalofBergamo_HCW,4/30/2020,Sublocal,Italy,Italy; Lombardy; Bergamo,,"April 24, 2020",Health care workers and caregivers,Adults (18-64 years),3000,13.00%,,,Unclear,Not reported,Not reported,Not reported,,,Unclear,News and Media,Armando Di Landro,Hospital of Bergamo,https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp,6/1/2020,4/26/2021
200609_Milan_UniMilan_OverallAb,6/9/2020,Local,Italy,Italy; Lombardy; Milan,"March 30, 2020","March 31, 2020",Household and community samples,Adults (18-64 years),197,10.15%,,,Self-referral,"Beijing Wantai Biological Pharmacy Enterprise , EUROIMMUN",ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Gregorio Milani,University of Milan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280100/pdf/main.pdf,6/23/2020,4/26/2021
200618_Italy_IRCCSPoliclinicoSanMatteo_BloodDonors,6/18/2020,Local,Italy,Italy; Lombardy; Lodi,"March 18, 2020","April 6, 2020",Blood donors,Multiple groups,390,23.33%,,,Sequential,Author-designed,Neutralization assay,Not reported,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Elena Percivalle,IRCCS Policlinico San Matteo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315724/,6/26/2020,4/26/2021
200609_Bergamo_HealthAgency_GenPop,6/9/2020,Regional,Italy,Italy; Lombardy,"April 23, 2020","June 3, 2020",Household and community samples,Not reported,9965,57.00%,,,Simplified probability,Not reported,Not reported,Not reported,,,Moderate,News and Media,Angelo Amante,Bergamo Health Agency,https://www.google.com/url?rct=j&sa=t&url=https://www.thejakartapost.com/news/2020/06/09/over-half-of-people-tested-in-italys-bergamo-have-covid-19-antibodies.html&ct=ga&cd=CAAYAjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEF-NEDdVnSHZTUUTQEQL5px8dXmw,7/5/2020,4/26/2021
200617_Italy_D.CotugnoHospital_HCW_IgG,6/17/2020,Sublocal,Italy,Italy; Campania; Naples,"March 23, 2020","April 2, 2020",Health care workers and caregivers,Adults (18-64 years),115,1.74%,,,Convenience,Snibe Diagnostic,Chemiluminescence Immunoassay,IgG,,,High,Journal Article (Peer-Reviewed),Francesco Fusco,D. Cotugno’ Hospital,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30306-6/fulltext,7/18/2020,4/26/2021
200619_Rome_UniversityofRome_IgG,6/19/2020,Sublocal,Italy,Italy; Lazio; Rome,"April 7, 2020","April 27, 2020",Health care workers and caregivers,Adults (18-64 years),1084,0.70%,,,Convenience,Medical Systems,Chemiluminescence Immunoassay,IgG,50.00%,99.10%,High,Journal Article (Peer-Reviewed),Edith Lahner,University of Rome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345358/,7/21/2020,4/26/2021
200704_Milan_SantagostinoMedicalCenter_HCWs+Family,7/4/2020,Local,Italy,Italy; Lombardy; Milan,"May 2, 2020","May 31, 2020",Family of essential workers,Multiple groups,119,23.53%,,,Convenience,Prima Lab,Serological rapid test,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Dioscoridi Lorenzo,Santagostino Medical Center,https://dx.doi.org/10.1016/j.ijid.2020.06.106,7/29/2020,4/26/2021
200707_Turin_University of Turin_PregnantWomen_IgGonly,7/7/2020,Local,Italy,Italy; Piedmont; Turin,"April 16, 2020","June 4, 2020",Pregnant or parturient women,Adults (18-64 years),138,5.80%,,,Sequential,Boditech,LFIA: Lateral flow immunoassay,IgG,,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26267,8/1/2020,4/26/2021
200808_Italy_UniversityofTurin_CLLPatients_Overall,8/8/2020,Local,Italy,"Italy; Piedmont; Turin, Novara, Alessandria, Verbania","March 8, 2020","April 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),24,12.50%,,,Convenience,"DiaSorin, In3diagnostic, Medical Systems","Chemiluminescence Immunoassay,ELISA",IgG,,,High,Journal Article (Peer-Reviewed),Marco Denina ,University of Turin,http://dx.doi.org/10.1016/j.jaad.2020.08.021,9/25/2020,4/26/2021
200813_Foggia_UniversityofFoggia_OverallIgG/IgM,8/13/2020,Local,Italy,Italy;  Apulia; Foggia,"May 1, 2020","May 31, 2020",Blood donors,Adults (18-64 years),904,0.99%,,,Convenience,"""New Industries Biomedical Engineering Co., Ltd""",Chemiluminescence Immunoassay,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Josè Ramòn Fiore,University of Foggia,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26425,9/26/2020,4/26/2021
200804_Tuscany_ArezzoHospital_HealthcareWorkers_Overall,8/4/2020,Regional,Italy,Italy; Tuscany,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),17098,3.10%,,,Convenience,"Screen Italia S.R.L, ""Zhejiang Orient Gene Biotech Co., LTD""",LFIA: Lateral flow immunoassay,"IgG,IgM",,,High,Preprint,Francesca Carozzi,Arezzo Hospital,https://www.medrxiv.org/content/10.1101/2020.07.30.20149567v1,9/27/2020,4/26/2021
200721_Arezzo_OspedaleSanDonato_Total,7/21/2020,Local,Italy,Italy; Tuscany; Arezzo,"March 17, 2020","March 21, 2020",Residual sera,Adults (18-64 years),516,13.00%,,,Sequential,Acro Biotech Inc.,Rapid immunochromatographic test,"IgG,IgM",37.00%,94.00%,High,Journal Article (Peer-Reviewed),Alessandro Pancrazzi,Ospedale San Donato,http://dx.doi.org/10.1016/j.clinbiochem.2020.07.002,9/27/2020,4/26/2021
200728_Prato_SantoStefanoHospital_Overall,7/28/2020,Local,Italy,Italy; Tuscany; Prato,"April 4, 2020","May 16, 2020",Pregnant or parturient women,Adults (18-64 years),134,4.48%,,,Sequential,Acro Biotech Inc.,Rapid point-of care,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anna Cavaliere,Santo Stefano Hospital,http://dx.doi.org/10.1080/14767058.2020.1793317,9/29/2020,4/26/2021
200729_Milan_UniversitadegliStudidiMilano_Overall_IgG,7/29/2020,Local,Italy,Italy; Lombardy; Milan,"April 2, 2020","April 16, 2020",Health care workers and caregivers,Adults (18-64 years),202,7.40%,3.80%,11.00%,Convenience,BioMedomics,LFIA: Lateral flow immunoassay,IgG,88.70%,90.60%,High,Journal Article (Peer-Reviewed),Giovanni Sotgiu,Università degli Studi di Milano ,https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-01237-0,9/29/2020,4/26/2021
200803_Italy_ItalianMinistryOfHealth_Overall,8/3/2020,National,Italy,"Italy; Abruzzo, Basilicata, Calabria, Campania, Emilia Romagna, Friuli-Venezia Giulia, Lazio, Liguria, Lombardy, Marche, Molise, Piemonte, Trentino-Alto Adige, Puglia, Sardegna, Sicily, Tuscany, Umbria, Valle D'Aosta, Veneto","May 25, 2020","July 15, 2020",Household and community samples,Multiple groups,64660,2.50%,,,Stratified non-probability,Abbott,Chemiluminescence Immunoassay,IgG,,,Unclear,News and Media,Italian Ministry of Health,Italian Ministry of Health,http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&menu=notizie&p=dalministero&id=4998,10/4/2020,4/26/2021
200907_Bari_PoliclinicoHospital_Overall,9/7/2020,Local,Italy,Italy;  Apulia; Bari,"March 23, 2020","April 21, 2020",Residual sera,Multiple groups,819,8.55%,,,Sequential,VivaChek Biotech,Colloidal gold,"IgG,IgM",35.10%,97.30%,High,Journal Article (Peer-Reviewed),Daniela Loconsole,Policlinico Hospital,https://dx.doi.org/10.3390/ijerph17186493,10/14/2020,4/26/2021
200823_Bergamo_HospitalPapaGiovanniXXIII_Overall,8/26/2020,Sublocal,Italy,Italy; Lombardy; Bergamo,"March 4, 2020","July 10, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,90,21.10%,,,Convenience,VivaChek,LFIA: Lateral flow immunoassay,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Lorenzo Norsa,Papa Giovani XXII,http://dx.doi.org/10.1053/j.gastro.2020.08.046,10/14/2020,4/26/2021
200827_LiguriaLombardia_UniversityofGenoa_Overall,8/27/2020,Regional,Italy,"Italy; Lombardy, Liguria","March 1, 2020","April 30, 2020",Residual sera,Adults (18-64 years),3609,11.00%,10.00%,12.10%,Convenience,"Maglumi, Realy-Tech, Biosynex","Chemiluminescence Immunoassay,Rapid immunochromatographic test,LFIA: Lateral flow immunoassay","IgG,IgM",,,High,Journal Article (Peer-Reviewed),Antonio Vena,University of Genoa,https://dx.doi.org/10.3390/jcm9092780,10/15/2020,4/26/2021
200818_Brescia_UniversityofBrescia_Overall,8/18/2020,Sublocal,Italy,Italy; Lombardy; Brescia,"April 27, 2020","April 27, 2020",Health care workers and caregivers,Adults (18-64 years),76,11.80%,,,Convenience,DiaSorin,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Alberto Dalla Volta,University of Brescia,http://dx.doi.org/10.3389/fonc.2020.01574,10/15/2020,4/26/2021
200806_Milan_UniversityofMilan_Overall,8/6/2020,Sublocal,Italy,Italy; Lombardy; Milan,"April 15, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),663,5.13%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Antonella Amendola,University of Milan,http://dx.doi.org/10.1017/ice.2020.401,10/25/2020,4/26/2021
200919_Castiglioned'Adda_UniversityofMilan_Overall,9/19/2020,Local,Italy,Italy; Lombardy; Castiglione D’Adda,"May 18, 2020","June 7, 2020",Household and community samples,Multiple groups,509,22.60%,17.20%,29.10%,Stratified probability,Abbott,Chemiluminescence Immunoassay,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gabriele Pagani,University of Milan,https://dx.doi.org/10.1016/j.jinf.2020.09.021,11/9/2020,4/26/2021
201006_Turin_UniversityofTorino_TotalHCWs,10/6/2020,Local,Italy,Italy; Piemonte; Torino (Turin),"April 17, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),5444,6.90%,,,Convenience,DiaSorin ,,IgG,97.90%,98.50%,Moderate,Journal Article (Peer-Reviewed),Andrea Calcagno,University of Torino,https://dx.doi.org/10.3201/eid2701.203027,12/9/2020,4/26/2021
200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_Patients&Caregivers,9/15/2020,Sublocal,Italy,Italy; Campania; Naples,"April 3, 2020","May 29, 2020",Multiple populations,Not reported,1397,0.43%,,,Convenience,"VivaDiag, N/A, N/A",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pio Stellato,Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon,http://dx.doi.org/10.1136/bmjpo-2020-000818,12/15/2020,4/26/2021
200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_HCW,9/15/2020,Sublocal,Italy,Italy; Campania; Naples,"April 3, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),249,2.01%,,,Convenience,"VivaDiag, N/A, N/A",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pio Stellato,Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon,http://dx.doi.org/10.1136/bmjpo-2020-000818,12/15/2020,4/26/2021
200901_Bergamo_ASSTPapaGiovanniXXIII,9/1/2020,Sublocal,Italy,Italy; Lombardy; Bergamo,"April 1, 2020","April 30, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,560,31.00%,,,Sequential,"NADAL (Moers, Germany)",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alberto Zambelli,ASST Papa Giovanni XXIII,http://dx.doi.org/10.1016/j.annonc.2020.08.1741,1/8/2021,4/26/2021
201103_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM,11/3/2020,Sublocal,Italy,Italy; Sardinia; Cagliari,"March 31, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),86,5.80%,,,Convenience,Snibe,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Fabio Medas, University of Cagliari,https://dx.doi.org/10.1016/j.amsu.2020.11.006,1/9/2021,4/26/2021
201027_Perugia_UniversityofPerugia_HIVPositive1_PLWHIgG,10/27/2020,Sublocal,Italy,Italy; Umbria; Perugia,"May 4, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,270,3.70%,,,Sequential,Screen Italia,,IgG,,,High,Journal Article (Peer-Reviewed),Chiara Papalini,University of Perugia,https://dx.doi.org/10.4084/MJHID.2020.080,1/9/2021,4/26/2021
201031_Milan_SanRaffaeleScientificInstitute_HCW_IgG,10/31/2020,Sublocal,Italy,Italy; Lombardy; Milan,"March 15, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),40,5.00%,,,Convenience,"Prima lab SA, Diasorin",,IgG,,,High,Journal Article (Peer-Reviewed),Diana Canetti,San Raffaele Scientific Institute,https://pubmed.ncbi.nlm.nih.gov/33135083/,1/12/2021,4/26/2021
201021_Italy_IRCCS_Overall_IgG_unadj,10/21/2020,Regional,Italy,Italy; Lombardy,"March 30, 2020","May 11, 2020",Multiple populations,Multiple groups,166,41.57%,,,Convenience,PRIMA Lab SA,,IgG,,,High,Journal Article (Peer-Reviewed),Antonio Marra,Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS),https://dx.doi.org/10.1016/j.annonc.2020.10.473,1/15/2021,4/26/2021
201008_Udine_UniversityofUdine_SCTrecipients,10/8/2020,Sublocal,Italy,Italy; Udine; Udine,"April 1, 2020","May 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,70,1.43%,,,Sequential,Cellex,,"IgG,IgM",93.75%,96.40%,High,Journal Article (Peer-Reviewed),Alessandra Sperotto,The University of Udine,https://dx.doi.org/10.1002/jmv.26586,1/17/2021,4/26/2021
201111_Italy_IstitutoNazionaleTumori_primaryest,11/11/2020,National,Italy,Italy,"September 1, 2019","March 10, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,959,11.60%,,,Sequential,Mazzini et al,,"IgM,IgG",85.70%,98.10%,High,Journal Article (Peer-Reviewed),Giovanni Apolone,Istituto Nazionale Tumori ,https://dx.doi.org/10.1177/0300891620974755,1/21/2021,4/26/2021
200806_Lombardy_BrunoKesslerFoundation,8/6/2020,Regional,Italy,Italy; Lombardy,"April 16, 2020","May 25, 2020",Contacts of COVID patients,Multiple groups,4120,53.10%,,,Stratified non-probability, LIAISON® ,,IgG,94.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Piero Poletti,Bruno Kessler Foundation,http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001383,1/21/2021,4/26/2021
201031_VillaCaldari_IstitutoZooprofilatticoSperimentaleDell’AbruzzoEdelMoliseG.Caporale_Overall,10/31/2020,Local,Italy,Italy; Abruzzo; Villa Caldari,"April 18, 2020","April 19, 2020",Household and community samples,Multiple groups,667,10.90%,8.80%,13.50%,Entire sample,"Beijing Wantai Biological Pharmacy Enterprise Co., Beijing, China",,Total Antibody,93.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Francesa Cito,Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise G. Caporale ,https://dx.doi.org/10.3390/microorganisms8111711,1/21/2021,4/26/2021
201222_Rome_EleemosynariaApostolica_overall,12/22/2020,Local,Italy,Italy; Lazio; Rome,"April 14, 2020","July 31, 2020",Multiple populations,Multiple groups,173,1.80%,,,Convenience,Inzek B.V,,"IgG,IgM",96.00%,96.00%,High,Journal Article (Peer-Reviewed),Massimo Ralli,Eleemosynaria Apostolica,https://dx.doi.org/10.4081/jphr.2020.1986,1/23/2021,4/26/2021
201219_Tuscany_UniversityOfFlorence_Overall,12/19/2020,Regional,Italy,Italy; Prato,"May 1, 2020","May 31, 2020",Multiple populations,Multiple groups,4656,3.00%,2.50%,3.50%,Convenience,"Hangzhou Laihe Biotech Co., Ltd, Hangzhou China",,"IgG,IgM",100.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Vieri Lastrucci,University of Florence,https://dx.doi.org/10.3390/vaccines8040778,1/23/2021,4/26/2021
201119_Italy_UniversityofCagliari_Milano1_IBDPatients,11/19/2020,Local,Italy,Italy,"April 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,354,2.30%,0.80%,3.80%,Convenience,University of Cagliari,,"IgG,IgA",97.64%,95.20%,High,Journal Article (Peer-Reviewed),Roberto Berte,University of Cagliari,https://dx.doi.org/10.1093/ecco-jcc/jjaa237,1/23/2021,4/26/2021
201119_Italy_UniversityofCagliari_MilanoGenPop3_GenPop,11/19/2020,Local,Italy,Italy; Lombardy; Milan,"April 15, 2020","June 15, 2020",Household and community samples,Multiple groups,129,7.00%,4.40%,9.60%,Sequential,University of Cagliari,,"IgG,IgA",97.64%,95.20%,High,Journal Article (Peer-Reviewed),Roberto Berte,University of Cagliari,https://dx.doi.org/10.1093/ecco-jcc/jjaa237,1/23/2021,4/26/2021
201127_Trento_AziendaProvincialeperiServiziSanitari_OverallAdj,11/27/2020,Regional,Italy,Italy; Trento,"May 5, 2020","May 15, 2020",Household and community samples,Multiple groups,6075,25.70%,,,Entire sample,Abbott Laboratories,,IgG,90.00%,100.00%,Low,Journal Article (Peer-Reviewed),Paola Stefanelli,Azienda Provinciale per i Servizi Sanitari,https://dx.doi.org/10.1016/j.cmi.2020.11.013,1/23/2021,4/26/2021
201109_Milan_UniversitadegliStudidiMilano_patients_antiN_S,11/20/2020,Sublocal,Italy,Italy; Lombardy ; Milan,"May 11, 2020","July 5, 2020",Residual sera,Multiple groups,2753,3.34%,,,Sequential,"Abbott, Abbott Park, Illinois, US; DiaSorin S.p.A., Saluggia, Italy",,IgG,,,Moderate,Journal Article (Peer-Reviewed),Valeria Cento,Universita degli Studi di Milano,http://dx.doi.org/10.1371/journal.pone.0242765,1/23/2021,4/26/2021
201201_Verona_InstitutoDiRicoveroECuraACaratterre_Overall,12/1/2020,Local,Italy,Italy; Veneto; Verona,"April 25, 2020","May 8, 2020",Household and community samples,Multiple groups,1515,2.70%,,,Simplified probability,Abbott Laboratories,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Massimo Guerriero,Instituto di Ricovero e Cura A Caratterre,https://dx.doi.org/10.3201/eid2701.202740,1/30/2021,4/26/2021
201126_Naples_UniversityofNaples_MS,11/26/2020,Sublocal,Italy,Italy; Campania; Naples,"May 11, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),310,2.90%,,,Sequential,"Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China",,"IgG,IgM",66.00%,96.60%,Moderate,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,1/30/2021,4/26/2021
201126_Naples_UniversityofNaples_LowRisk,11/26/2020,Sublocal,Italy,Italy; Campania;  Naples,"May 11, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),862,1.30%,,,Convenience,"Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China",,"IgG,IgM",66.00%,96.60%,Moderate,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,1/30/2021,4/26/2021
201126_Naples_UniversityofNaples_HighRisk,11/26/2020,Sublocal,Italy,Italy; Campania; Naples,"May 11, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),235,10.60%,,,Convenience,"Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China",,"IgG,IgM",66.00%,96.60%,High,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,1/30/2021,4/26/2021
210109_GiglioIsland_UniversitàdegliStudidiMilano,1/9/2021,Local,Italy,Italy; Tuscany; Giglio Island,"April 29, 2020","May 3, 2020",Household and community samples,Adults (18-64 years),723,0.41%,,,Self-referral,"Zhejiang Orient Gene Biotech Co Ltd, Huzhou, Zhejiang, China",,"IgG,IgM",87.90%,100.00%,High,Preprint,Antonio Bognanni,Università degli Studi di Milano,https://www.medrxiv.org/content/10.1101/2021.01.08.20248948v1,1/31/2021,3/31/2021
201217_Naples_UniversityofCampania_ELISA,12/17/2020,Sublocal,Italy,Italy; Campania; Naples,"March 27, 2020","August 30, 2020",Health care workers and caregivers,Adults (18-64 years),65,0.00%,,,Convenience,Xiamen,,Total Antibody,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Antonio Russo,University of Campania,https://dx.doi.org/10.2147/IDR.S282652,2/1/2021,4/26/2021
201223_Bergamo_OspedalePapaGiovanniXXIII_overall,12/23/2020,Sublocal,Italy,Italy; Lombardy; Bergamo,"April 1, 2020","April 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,560,31.00%,,,Sequential,"Moers, Germany",,"IgG,IgM",92.10%,99.20%,High,Journal Article (Peer-Reviewed),Alberto Zambelli,Ospedale Papa Giovanni XXIII,https://dx.doi.org/10.1002/onco.13654,2/2/2021,4/26/2021
210111_Pavia_University of Pavia_overall,1/13/2021,Sublocal,Italy,Italy,"May 4, 2020","June 3, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),104,13.46%,,,Convenience,Roche,,IgG,,,High,Journal Article (Peer-Reviewed),Giulia Mallucci,University of Pavia,https://doi.org/10.1016/j.msard.2021.102754,2/3/2021,4/9/2021
201213_Foggia_AziendaOspedalieraUniversitariaPoliclinicoRiunitiDiFoggia_HCW,12/13/2020,Sublocal,Italy,"Italy; Apulia, Province of Foggia; Foggia","March 17, 2020","May 18, 2020",Health care workers and caregivers,Adults (18-64 years),3242,1.90%,1.40%,2.30%,Convenience,Shenzhen YHLO Biotech,,"IgG,IgM",97.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Armando De Carlo,Azienda Ospedaliera-Universitaria Policlinico Riuniti di Foggia,https://dx.doi.org/10.3390/ijerph17249324,2/5/2021,4/26/2021
201101_ Borgosesia_ASLVercelli_overall,11/1/2020,Local,Italy,Italy; Piedmont; Borgosesia,"May 23, 2020","May 24, 2020",Household and community samples,Multiple groups,4987,4.90%,4.33%,5.55%,Self-referral,Prima Lab SA,,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Daniela Alessi,ASL Vercelli,https://dx.doi.org/10.19191/EP20.5-6.S2.119,2/7/2021,4/26/2021
210306_Rome_UniversitaCattolicadelSacroCuore_VenousBloodTest_overall,3/6/2021,Sublocal,Italy,Italy,"June 4, 2020","July 3, 2020",Health care workers and caregivers,Multiple groups,4694,1.19%,,,Convenience,Euroimmun,,IgG,78.79%,99.36%,High,Journal Article (Peer-Reviewed),Giuseppe Vetrugno,Università Cattolica del Sacro Cuore,http://dx.doi.org/10.3390/ijerph18052650,2/8/2021,4/26/2021
210204_Milan_ASSTFatebenefratelliSacco_PhaseI_overall,2/4/2021,Sublocal,Italy,Italy,"March 4, 2020","March 12, 2020",Health care workers and caregivers,Adults (18-64 years),679,0.40%,,,Convenience,Beijing Wantai Biolog- ical Pharmacy Enterprise,,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,2/11/2021,3/31/2021
210204_Milan_ASSTFatebenefratelliSacco_PhaseIII,2/4/2021,Sublocal,Italy,Italy,"May 20, 2020","May 27, 2020",Health care workers and caregivers,Adults (18-64 years),629,4.60%,,,Convenience,Beijing Wantai Biolog- ical Pharmacy Enterprise,,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,2/11/2021,3/31/2021
210204_Milan_ASSTFatebenefratelliSacco_PhaseII,2/4/2021,Sublocal,Italy,Italy,"April 4, 2020","April 22, 2020",Health care workers and caregivers,Adults (18-64 years),608,4.20%,,,Convenience,Beijing Wantai Biolog- ical Pharmacy Enterprise,,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,2/11/2021,3/31/2021
_Modena_OspedaleCivileS.AgostinoEstense_overall,,Sublocal,Italy,Italy; Emilia-Romagna Region; Modena,"March 30, 2020","May 31, 2020",,Adults (18-64 years),7711,5.00%,,,,,,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Valentina Pecoraro,Ospedale Civile S.Agostino Estense,https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-984696,2/12/2021,3/31/2021
210105_SanGiovaniRotondo_FondazioneCasaSollievoDellaSofferenza_overall,1/5/2021,Sublocal,Italy,Italy,"May 1, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,245,2.90%,,,Convenience,"1) Kehua Bio- engineering
2) Tecan",,"IgG,IgM",90.00%,96.30%,High,Journal Article (Peer-Reviewed),Fabrizio Bossa,Fondazione Casa Sollievo della Sofferenza,http://dx.doi.org/10.1016/j.dld.2020.12.120,2/13/2021,3/28/2021
210127_Merano_FranzTappeinerHospital_patients_primary,1/27/2021,Sublocal,Italy,Italy,"June 22, 2020","July 17, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,250,0.80%,,,Sequential,Abbott,,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Dominic Fong,Franz Tappeiner Hospital,https://dx.doi.org/10.1007/s00508-020-01807-6,2/23/2021,4/9/2021
210127_Merano_FranzTappeinerHospital_HCW_primary,1/27/2021,Sublocal,Italy,Italy,"June 22, 2020","July 17, 2020",Health care workers and caregivers,Adults (18-64 years),36,5.50%,,,Convenience,Abbott,,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Dominic Fong,Franz Tappeiner Hospital,https://dx.doi.org/10.1007/s00508-020-01807-6,2/23/2021,3/29/2021
201027_Perugia_UniversityofPerugia_HIVNegative2_Overall,10/27/2020,Local,Italy,Italy; Umbria; Perugia,"May 4, 2020","May 31, 2020",Multiple populations,Multiple groups,2843,5.40%,,,Unclear,Screen Italia,,IgG,,,Unclear,Journal Article (Peer-Reviewed),Chiara Papalini,University of Perugia,https://dx.doi.org/10.4084/MJHID.2020.080,2/26/2021,4/26/2021
210112_ArianoIrpino_Zoo-ProphylacticInstituteOfSouthernItaly_overall,1/12/2021,Local,Italy,Italy; Province of Avellino in the Campania region; Ariano Irpino,"May 16, 2020","May 19, 2020",Household and community samples,Multiple groups,13218,5.60%,5.20%,6.00%,Convenience,Roche,,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Pellegrino Cerino,The Zoo-Prophylactic Institute of Southern Italy,10.2144/fsoa-2020-0203,3/4/2021,4/9/2021
210127_UniversityHospitalofBari_UniversityofBari_overall_IgG_unadj,1/27/2021,Sublocal,Italy,Italy; Puglia; Bari,"April 8, 2020","June 7, 2020",Health care workers and caregivers,Adults (18-64 years),2407,2.37%,,,Convenience,Abbott,,IgG,50.00%,97.99%,High,Journal Article (Peer-Reviewed),Luigi Vimercati,University of Bari,https://dx.doi.org/10.1016/j.envres.2021.110793,3/10/2021,3/29/2021
210209_Catania_UniversityofCatania,2/9/2021,Local,Italy,Italy; Sicily; Catania,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),133,3.00%,,,Convenience,"NovaTec Immundiagnostics GmbH, Dietzenbach, Germany",,IgG,,,High,Journal Article (Peer-Reviewed),Caterina Ledda ,University of Catania,https://dx.doi.org/10.3390/tropicalmed6010021,3/14/2021,3/31/2021
201031_Veneto_NationalAssociationofCompanyandCompetentDoctors,10/31/2020,Local,Italy,Italy; Veneto,"April 11, 2020","April 29, 2020",Essential non-healthcare workers,Adults (18-64 years),1267,1.58%,,,Convenience,"NR, MAGLUMI, NR",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Danilo Bontadi,National Association of Company and Competent Doctors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809981/,3/16/2021,4/26/2021
210204_Milan_UniversityOfMilan_Overall,2/4/2021,Local,Italy,Italy; Lombardy; Milan,"June 13, 2020","August 6, 2020",Contacts of COVID patients,Children and Youth (0-17 years),49,16.30%,,,Convenience,Livzon ,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Marco Farronato ,University of Milan,https://dx.doi.org/10.3390/ijerph18041488,3/19/2021,3/31/2021
210302_Milan_FondazioneIRCCSIstitutoNazionaleDeiTumori_HCW_overall,3/2/2021,Sublocal,Italy,Italy,"April 9, 2020","September 9, 2020",Health care workers and caregivers,Adults (18-64 years),110,20.00%,,,Simplified probability,"Diagnostic Bioprobes, Dia.Pro, Sesto San Giovanni, Milan, Italy; PRIMA LAB SA, Switzerland), DiaSorin, Saluggia, Italy; FDA-EUA)",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Chiara Maura Ciniselli,Fondazione IRCCS Istituto Nazionale dei Tumori (INT),http://dx.doi.org/10.3390/cancers13051035,3/23/2021,3/28/2021
210224_NortheastItaly_PaduaUniversityHospital_HCW,2/24/2021,Sublocal,Italy,Italy; Veneto Region; Padua,"April 8, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),344,7.85%,,,Convenience,Snibe Diagnostic,,"IgG,IgM",91.21%,97.30%,High,Preprint,F Barbaro,Padua University Hospital ,https://doi.org/10.1101/2021.02.23.21249481,3/25/2021,4/1/2021
210301_SouthernItaly_GragnanoHospital_Patients,3/1/2021,Local,Italy,Italy; Naples,"June 25, 2020","July 12, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,2740,1.40%,,,Unclear,NR,,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),C. Coppola,Gragnano Hospital,http://dx.doi.org/10.1016/j.dld.2020.12.018,3/26/2021,3/29/2021
201020_DipartimentoOncologicoAziendaUslToscanaCentroFirenze_Florence,10/20/2020,Sublocal,Italy,Italy; Tuscany; Florence,"May 11, 2020","May 17, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1145,2.30%,,,Sequential,NR,,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Francesca Martella ,Azienda Usl Toscana Centro Oncology,http://dx.doi.org/10.1177/0300891620953388,3/26/2021,4/26/2021
201020_Milan_UniversitàdegliStudidiMilano_Patients1_Overall,10/20/2020,Sublocal,Italy,Italy; Lombardy; Milan,"April 15, 2020","May 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,42,9.50%,,,Unclear,"Abbott Laboratories, Diasorin",,IgG,,,Unclear,Journal Article (Peer-Reviewed),Andrea Sartore Bianchi,Università degli Studi di Milano,http://dx.doi.org/10.1177/0300891620953388,3/27/2021,4/26/2021
210220_Lazio_ UniversitàCattolicadelSacroCuore_Overall,2/20/2021,Sublocal,Italy,Italy; Lazio; Rome,"May 25, 2020","August 10, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),202,1.50%,,,Convenience,NR,,Not reported,,,High,Journal Article (Peer-Reviewed),Fabio Del Zompo,Università Cattolica del Sacro Cuore,https://dx.doi.org/10.1016/j.dld.2021.02.015,3/27/2021,3/27/2021
210303_Lodi_IRCCSPoliclinico_overall_CLIA,3/3/2021,Local,Italy,Italy; Lombardy region; Lodi,"March 18, 2020","June 24, 2020",Blood donors,Not reported,1922,19.70%,,,Convenience,DiaSorin,,IgG,,,High,Journal Article (Peer-Reviewed),Irene Cassaniti,IRCCS Policlinico,https://dx.doi.org/10.1016/j.cmi.2021.01.030,3/31/2021,3/31/2021
210204_Milan_ FoundationIRCCS Ca'GrandaOspedaleMaggiorePoliclinico_overall_adj,,Sublocal,Italy,Italy; Lombardy; Milan,"April 27, 2020","June 12, 2020",Health care workers and caregivers,Multiple groups,4055,6.40%,,,Convenience,"DiaSorin, Saluggia, Italy",,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Andrea Lombardi,Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico,https://dx.doi.org/10.1136/bmjopen-2020-047216,4/2/2021,4/2/2021
201020_Sondrio_AltoLario-OncologiaMedicaSondrio_Overall,10/20/2020,Sublocal,Italy,Italy; Lombardy; Sondrio,"March 1, 2020","October 19, 2020",Health care workers and caregivers,Adults (18-64 years),220,11.36%,,,Convenience,Nal Von Minden GmbH (Germany),,"IgG,IgM",94.10%,99.20%,Unclear,Journal Article (Peer-Reviewed),G. Caponigro ,ASST della Valtellina  Alto Lario-Oncologia Medica Sondrio,http://dx.doi.org/10.1177/0300891620953388,4/4/2021,4/25/2021
210202_Turin_UniversityofTurin_Overall,2/2/2021,Sublocal,Italy,Italy; Piedmont; Turin,"April 15, 2020","June 15, 2020",Pregnant or parturient women,Adults (18-64 years),164,10.40%,,,Sequential,"Boditech Med Inc, Gang-won-do, Korea
Diasorin, Italy",,"IgG,IgM,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,https://dx.doi.org/10.1016/j.jri.2021.103285,4/4/2021,4/17/2021
201202_Lombardy_IRCCSRozzano_overall,12/2/2020,Regional,Italy,"Italy; Lombardy; Milan, Varese, Castellanza","April 28, 2020","May 16, 2020",Health care workers and caregivers,Multiple groups,3985,13.35%,,,Convenience,DiaSorin,,IgG,90.40%,98.50%,Moderate,Preprint,Maria Teresa Sandri,IRCCS,https://www.medrxiv.org/content/10.1101/2020.05.24.20111245v2.full.pdf,4/7/2021,4/26/2021
200826_Veneto_UniversityHospitalOfPadova,8/26/2020,Regional,Italy,Italy; Veneto,"February 22, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),8285,4.60%,4.10%,5.00%,Unclear,SNIBE – Shenzhen New Industries Biomedical Engineering Co.,,"IgG,IgM",73.00%,98.00%,High,Journal Article (Peer-Reviewed),Mario Plebani,University Hospital Of Padova,https://www.degruyter.com/document/doi/10.1515/cclm-2020-1236/html,4/8/2021,4/26/2021
210324_NorthernItaly_UniversitàDegliStudiDelPiemonteOrientale_HCW,3/24/2021,Local,Italy,Italy; Piedmont; Vercelli,"May 8, 2020","June 3, 2020",Health care workers and caregivers,Adults (18-64 years),2250,17.11%,15.55%,18.67%,Convenience,DiaSorin,,"IgG,Neutralizing ",97.90%,98.50%,Moderate,Journal Article (Peer-Reviewed),Chiara Airoldi,Università degli Studi del Piemonte Orientale,http://dx.doi.org/10.3390/ijerph18073343,4/9/2021,4/17/2021
210226_Turin_UniversityofTurin_Pharmacists,2/26/2021,Regional,Italy,Italy; Turin,"July 1, 2020","July 31, 2020",Essential non-healthcare workers,Adults (18-64 years),286,3.50%,,,Self-referral,Prima Lab,,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Francesca Baratta,University of Turin,https://dx.doi.org/10.3390/ijerph18052302,4/9/2021,4/19/2021
210325_Rome_UniversityofRomeTorVergata_IBDPatients,3/25/2021,Sublocal,Italy,Italy,"May 27, 2020","July 21, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),218,1.37%,,,Convenience,Abbott Diagnostics,,IgG,,,High,Journal Article (Peer-Reviewed),Ludovica Scucchi,University o fRome Tor Vergata,https://dx.doi.org/10.26355/eurrev_202103_25283,4/9/2021,4/9/2021
201105_Veneto_UniversityofVerona_overall_unadj,,Regional,Italy,Italy; Veneto,"May 18, 2020","July 29, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,339,2.10%,,,Sequential,"Menarini Diagnostics, IT",,"IgG,IgM",97.20%,100.00%,High,Journal Article (Peer-Reviewed),Massimiliano Bonifacio,University of Verona,http://dx.doi.org/10.1182/blood-2020-140032,4/11/2021,4/11/2021
210125_TerreRoveresche_UniversityOfUrbinoCarloBo_Overall,1/25/2021,Local,Italy,Italy; Le Marche Region; Municipality of Terre Roveresche,"March 15, 2020","June 15, 2020",Household and community samples,Multiple groups,341,14.40%,,,Convenience,Diagnostic Bioprobes Srl,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Mauro De Santi,University of Urbino Carlo Bo,https://dx.doi.org/10.23750/abm.v92i1.10847,4/13/2021,4/16/2021
210225_Brescia_UniversityofBrescia_HCW,2/25/2021,Sublocal,Italy,Italy; Lombardy; Brescia,"April 26, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1893,22.90%,,,Convenience,DiaSorin,,IgG,95.70%,98.50%,Moderate,Journal Article (Peer-Reviewed),Agnese Comelli,University of Brescia,https://dx.doi.org/10.3390/microorganisms9030488,4/15/2021,4/15/2021
210224_Castiglioned'Adda_UniversityofMilan_Overall,2/24/2021,Local,Italy,Italy; Lombardy; Castiglione D’Adda,"May 18, 2020","June 7, 2020",Household and community samples,Multiple groups,4143,22.20%,,,Entire sample,Prisma Lab,,IgG,100.00%,96.00%,Low,Journal Article (Peer-Reviewed),Gabriele Pagani,University of Milan,https://dx.doi.org/10.1371/journal.pone.0246513,4/16/2021,4/17/2021
210226_UniversityOfTurin_Turin,2/26/2021,Sublocal,Italy,Italy; Piedmont; Turin,"April 16, 2020","June 22, 2020",Pregnant or parturient women,Adults (18-64 years),164,9.70%,,,Convenience,"Boditech Med Inc, Gang-won-do, Korea",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,https://dx.doi.org/10.3390/diagnostics11030398,4/16/2021,4/16/2021
201020_Milan_UniversitàdegliStudidiMilano_Physicians2_Overall,10/20/2020,Sublocal,Italy,Italy; Lombardy; Milan,"April 15, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,34,5.88%,,,Convenience,"Abbott Laboratories, Diasorin",,IgG,,,Unclear,Journal Article (Peer-Reviewed),Andrea Sartore Bianchi,Università degli Studi di Milano,http://dx.doi.org/10.1177/0300891620953388,4/20/2021,4/26/2021
200721_Lodi_A.S.S.T.Lodi_HCW_overall,7/21/2020,Sublocal,Italy,Italy; Lombardy Region,"April 23, 2020","May 5, 2020",Health care workers and caregivers,Adults (18-64 years),2415,16.80%,,,Convenience,DiaSorin,,IgG,,,High,Journal Article (Peer-Reviewed),Alessandro  Baracco,A.S.S.T. Lodi ,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227,4/20/2021,4/23/2021
200721_Lodi_A.S.S.T.Lodi_genpop,7/21/2020,Local,Italy,Italy; Lombardy region; Lodi,"April 23, 2020","May 5, 2020",Household and community samples,Multiple groups,1792,29.80%,,,Simplified probability,DiaSorin,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Alessandro  Baracco,A.S.S.T.Lodi,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227,4/20/2021,4/23/2021
210309_Benevento_UniversitàdegliStudidelSannio_Overall,3/9/2021,Local,Italy,Italy; Campania; NR,"September 1, 2020","September 30, 2020",Household and community samples,Seniors (65+ years),1383,4.70%,,,Unclear,LEPU MEDICAL TECHNOLOGY Co. ,,"IgG,IgM",98.60%,97.60%,Moderate,Journal Article (Peer-Reviewed),Immacolata Polvere,Università degli Studi del Sannio,https://dx.doi.org/10.3390/diagnostics11030483,4/21/2021,4/21/2021
210404_Marche_UniversitàPolitecnicadelleMarche_ConfirmationAssay,4/4/2021,Sublocal,Italy,Italy; Marche; Ancona,"July 1, 2020","October 26, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,949,0.70%,,,Sequential,Zhejiang Orient Gene Biotech; Shenzen YHLO BioTech Co. Ltd. ,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luca Cantini,Università Politecnica delle Marche,http://dx.doi.org/10.3390/jcm10071503,4/21/2021,4/25/2021
200505_Kobe_KobeMedicalCenterGeneralHospital_Outpatients_PopAdj,5/5/2020,Local,Japan,Japan; Hyogo Prefecture; Kobe,"March 31, 2020","April 7, 2020",Residual sera,Multiple groups,1000,2.70%,1.80%,3.90%,Simplified probability,Kurabo Industries,LFIA: Lateral flow immunoassay,IgG,76.38%,100.00%,High,Preprint,Asako Doi,Kobe City Medical Center General Hospital,https://www.medrxiv.org/content/10.1101/2020.04.26.20079822v2,5/1/2020,4/26/2021
200721_Tokyo_NavitasClinicTachikawa_Overall,"6/4/2020, 7/21/2020",Local,Japan,"Japan; Kantō, Chūbu ; Tokyo, Kangawa, Saitama, Chiba, Yamanashi","April 20, 2020","May 20, 2020",Household and community samples,Multiple groups,1071,3.83%,2.76%,5.16%,Self-referral,Kurabo Industries,Rapid immunochromatographic test,IgG,76.40%,100.00%,High,"Preprint, Journal Article (Peer-Reviewed)","Morihito Takita, Morihito Takita",Navitas Clinic Tachikawa,"https://www.medrxiv.org/content/10.1101/2020.06.03.20121020v1, https://dx.doi.org/10.1177/2150132720942695",7/16/2020,4/26/2021
210226_Iwate_IwatePrefecturalCentralHospital_HCW_Abbot&Roche,2/26/2021,Sublocal,Japan,Japan; Honshu; Morioka,"May 18, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),1000,0.00%,,,Convenience,Abbott Laboratories: Roche,"Chemiluminescence Immunoassay,Electro chemiluminescence immunoassay",IgG,,,High,Journal Article (Peer-Reviewed),Akihiro Nakamura,Iwate Prefectural Central Hospital,https://dx.doi.org/10.5387/fms.2020-21,7/16/2020,4/26/2021
200621_Japan_SoftBank_Overall,"6/21/2020, 6/10/2020",Sublocal,Japan,Japan,"May 12, 2020","May 18, 2020",Multiple populations,Not reported,44066,0.43%,,,Convenience,"Innovita, ""Zhejiang Orient Gene Biotech Co., LTD""",Not reported,Not reported,,,Unclear,"News and Media, News and Media","Simon Denyer, Kyodo Jiji",SoftBank,"https://www.google.com/url?rct=j&sa=t&url=https://www.lmtonline.com/news/article/Japanese-firm-s-blanket-testing-of-employees-15355433.php&ct=ga&cd=CAEYHCoUMTM4NjAwODY3NjE3NzkyOTU2ODYyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNGl9_tc35Q3fUbB67SoWaNsH2ltMw, https://www.japantimes.co.jp/news/2020/06/10/national/softbank-coronavirus-antibody-tests/",7/24/2020,4/26/2021
200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_popadj,7/26/2020,Local,Japan,Japan; Kantō; Utsunomiya City,"June 14, 2020","July 5, 2020",Household and community samples,Multiple groups,742,1.23%,0.17%,1.23%,Simplified probability,Shenzhen YHLO Biotech Co,Chemiluminescence Immunoassay,IgG,97.30%,96.30%,Moderate,Preprint,Nobutoshi Nawa,Tokyo Medical and Dental University,https://www.medrxiv.org/content/10.1101/2020.07.20.20155945v1,9/23/2020,4/26/2021
200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMay2020,7/30/2020,Sublocal,Japan,Japan; Hokkaido; Sapporo,"May 1, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,300,0.00%,0.00%,0.00%,Unclear,Roche Diagnostics,Electro chemiluminescence immunoassay,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Goki Suda,Hokkaido University Graduate School of Medicine,https://dx.doi.org/10.1111/hepr.13551,10/1/2020,4/26/2021
200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMarch2020,7/30/2020,Sublocal,Japan,Japan; Hokkaido; Sapporo,"March 1, 2020","March 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,300,0.30%,0.00%,1.80%,Unclear,Roche Diagnostics,Electro chemiluminescence immunoassay,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Goki Suda,Hokkaido University Graduate School of Medicine,https://dx.doi.org/10.1111/hepr.13551,10/1/2020,4/26/2021
200911_Osaka_ToyonakaMunicipalHospital_Overall,9/11/2020,Sublocal,Japan,Japan; Kansai; Osaka,"June 12, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),925,0.43%,0.17%,1.10%,Convenience,Abbott,Chemiluminsescent microparticle immunoassay,IgG,100.00%,99.60%,Moderate,Preprint,Tsutomu Nishida,Toyonaka Municipal Hospital,https://www.medrxiv.org/content/10.1101/2020.09.10.20191866v1,10/22/2020,4/26/2021
200826_Japan_KanenokumaHospital_Overall_June,8/26/2020,Sublocal,Japan,Japan; Kyushu; Fukuoka City,"June 12, 2020","June 15, 2020",Assisted living and long-term care facilities,Multiple groups,108,2.80%,,,Convenience,Hangzhou Alltest Biotech Co. Ltd.,Rapid immunochromatographic test,IgG,,,High,Preprint,Yong Chong,Kanenokuma Hospital,https://www.researchsquare.com/article/rs-64266/v1,10/27/2020,4/26/2021
201008_Fujisawa_ShonanFujisawaTokushukaiHospital_MedicalStaff,10/8/2020,Sublocal,Japan,Japan; Kanagawa; Fujisawa,"June 1, 2020","July 30, 2020",Health care workers and caregivers,Adults (18-64 years),806,0.74%,0.27%,1.61%,Convenience,Abbott,Chemiluminescence Immunoassay,IgG,100.00%,,Unclear,Journal Article (Peer-Reviewed),M. Hibino,Shonan Fujisawa Tokushukai Hospital,https://dx.doi.org/10.1016/j.jhin.2020.10.001,11/24/2020,4/26/2021
201023_Tokyo_JuntendoUniversity_Overall,10/23/2020,Sublocal,Japan,Japan; Kantō; Tokyo,"July 6, 2020","August 21, 2020",Health care workers and caregivers,Multiple groups,4147,0.34%,0.18%,0.57%,Convenience,Roche Diagnostics,,"IgA,IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Hiroshi Fukuda,Juntendo Univesity,10.21203/rs.3.rs-96870/v1,1/8/2021,4/26/2021
201207_Kyoto_NationalHospitalOrganizationKyotoMedicalCenter,12/7/2020,Sublocal,Japan,Japan; Kansai; Kyoto,"April 10, 2020","April 20, 2020",Health care workers and caregivers,Adults (18-64 years),92,5.40%,,,Convenience,"DRG international, Inc. ",,IgG,,,High,Journal Article (Peer-Reviewed),Kohei Fujita,National Hospital Organization Kyoto Medical Center,https://dx.doi.org/10.3389/fpubh.2020.595348,2/1/2021,4/26/2021
201120_Japan_TokyoNationalHospital_overall,11/20/2020,Sublocal,Japan,Japan,"June 1, 2020","October 30, 2020",Patients seeking care for non-COVID-19 reasons,Seniors (65+ years),93,16.10%,,,Convenience,"1) Roche Diagnostics,
2) GenBody",,"IgG,IgM",,,High,Preprint,Shomi Oka,Tokyo National Hospital,https://www.researchsquare.com/article/rs-112294/v1,2/6/2021,4/26/2021
210113_Wakayama_WakayamaMedicalUniversity_overall,1/13/2021,Sublocal,Japan,Japan,"July 7, 2020","September 15, 2020",Health care workers and caregivers,Multiple groups,1528,0.79%,0.34%,1.22%,Convenience,Kurabo Industries Ltd,,IgG,76.40%,100.00%,High,Preprint,Sadahiro Iwabuchi,Wakayama Medical University,https://www.medrxiv.org/content/10.1101/2021.01.10.21249421v1,2/7/2021,3/31/2021
201230_Fukushima_ HirataCentralHospital_CLIA_IgG,12/30/2020,Sublocal,Japan,Japan; Fukushima Prefecture; Hirata,"May 8, 2020","May 28, 2020",Health care workers and caregivers,Multiple groups,637,0.94%,,,Unclear,"YHLO Biotech Shenzhen, China",,IgG,,,High,Journal Article (Peer-Reviewed),Yurie Kobashi, Hirata Central Hospital,https://dx.doi.org/10.1016/j.intimp.2020.107360,2/15/2021,4/26/2021
210120_Japan_ResearchInstituteOfTuberculosis_GenPop,1/20/2021,National,Japan,Japan,"June 1, 2020","June 7, 2020",Household and community samples,Multiple groups,7950,0.10%,0.04%,0.20%,Stratified probability,"Roche Diagnostics, Abbott Laboratories",,"Total Antibody,IgG",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Takashi Yoshiyama,Government of Japan,https://dx.doi.org/10.3201/eid2702.204088,2/28/2021,4/2/2021
210129_Hyogo_KobeUniversityGraduateSchoolOfMedicine_Overall,1/29/2021,Regional,Japan,Japan; Kansai,"August 6, 2020","October 1, 2020",Residual sera,Multiple groups,10377,0.60%,,,Sequential,"1) Roche Diagnostics

2) Sysmex",,IgG,,,Moderate,Journal Article (Peer-Reviewed),Koichi Furukawa,Kobe University Graduate School of Medicine,https://dx.doi.org/10.31662/jmaj.2020-0094,3/20/2021,4/19/2021
210128_Tokyo_NationalCenterforGlobalHealthandMedicine_EitherTest,1/28/2021,Sublocal,Japan,Japan; Kantō; Tokyo,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1228,0.16%,0.02%,0.59%,Unclear,Abbott Laboratories; Roche Diagnostics,,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Akihito Tanaka,National Center for Global Health and Tropical Medicine,http://dx.doi.org/10.1016/j.jinf.2021.01.010,3/23/2021,3/30/2021
210206_YokohamaCity_YokohamaCityUniversity,,Sublocal,Japan,Japan; Kanagawa Prefecture; Yokohama City,"June 1, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),432,3.90%,,,Sequential,NR,,IgG,,,High,Journal Article (Peer-Reviewed),Shigeta Miyake,Yokohama City University,http://dx.doi.org/10.1111/den.13945,4/4/2021,4/4/2021
210211_Okinawa_OkinawaInstituteOfScienceAndTechnology,2/11/2021,Sublocal,Japan,Japan; Okinawa Prefecture; Okinawa,"August 1, 2020","August 31, 2020",Multiple populations,Adults (18-64 years),634,0.00%,,,Convenience,N/A - institution designed,ELISA,Not reported,92.50%,100.00%,High,Preprint,Melissa Matthews,Okinawa Institute of Science and Technology,https://www.medrxiv.org/content/10.1101/2020.10.09.20209858v2,4/5/2021,4/26/2021
210127_Tokyo_MedicalCorporationKoshikai,1/27/2021,Local,Japan,Japan,"May 26, 2020","August 25, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),615,34.30%,,,Convenience,Aurora Biomed,Not reported,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai,https://www.medrxiv.org/content/10.1101/2020.09.21.20198796v2,4/5/2021,4/26/2021
200920_Tokyo_NationalCenterForGlobalHealthAndMedicine_Overall,9/9/2020,Sublocal,Japan,Japan,"February 14, 2020","April 3, 2020",Health care workers and caregivers,Adults (18-64 years),49,0.00%,,,Convenience,N/A - in house,,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tetsuya Suzuki,National Center for Global Health and Medicine,http://dx.doi.org/10.1016/j.jiac.2020.09.006,4/10/2021,4/23/2021
210330_Tokyo_JapanMinistryOfHealth1_overall,3/30/2021,Regional,Japan,Japan; Tokyo Prefecture,"December 14, 2020","December 26, 2020",Household and community samples,Not reported,3399,1.35%,,,Unclear,Not reported,,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/10/2021,4/10/2021
210330_Osaka_JapanMinistryOfHealth2_overall,3/30/2021,Regional,Japan,Japan; Osaka Prefecture,"December 14, 2020","December 26, 2020",Household and community samples,Not reported,2746,0.69%,,,Unclear,Not reported,,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/10/2021,4/10/2021
210330_ Aichi_JapanMinistryOfHealth3_overall,3/30/2021,Regional,Japan,Japan; Aichi Prefecture,"December 14, 2020","December 26, 2020",Household and community samples,Not reported,2960,0.71%,,,Unclear,Not reported,,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/10/2021,4/10/2021
210330_Miyagi_JapanMinistryOfHealth4_overall,3/30/2021,Regional,Japan,Japan; Miyagi Prefecture,"December 14, 2020","December 26, 2020",Household and community samples,Not reported,2860,0.14%,,,Unclear,Not reported,,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/10/2021,4/10/2021
210330_ Fukuoka_JapanMinistryOfHealth5_overall,3/30/2021,Regional,Japan,Japan; Fukuoka Prefecture,"December 14, 2020","December 26, 2020",Household and community samples,Not reported,3078,0.42%,,,Unclear,Not reported,,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/10/2021,4/10/2021
210206_Yokohama_YokohamaCityUniversity_overall,2/6/2021,Sublocal,Japan,Japan; Kanagawa prefecture; Yokohama,"June 1, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,432,3.90%,,,Convenience,N/A - in house,,Not reported,,,High,Journal Article (Peer-Reviewed),Shigeta Miyake,Yokohama City University,http://dx.doi.org/10.1111/den.13945,4/11/2021,4/11/2021
200727_Japan_HealthandWelfareDepartment_primary,7/27/2020,Regional,Japan,Japan; prefecture 3,"June 15, 2020","June 28, 2020",Residual sera,Multiple groups,3000,0.00%,,,Convenience,NR,,IgG,,,Unclear,News and Media,Okuda,Health and Welfare Department,http://wave.pref.wakayama.lg.jp/news/kensei/shiryo.php?sid=31587,4/22/2021,4/25/2021
200520_Jersey_JerseyStatistics_Round2_GenPop_TestAdj,6/9/2020,Regional,Jersey,Jersey; Jersey,"May 15, 2020","May 27, 2020",Household and community samples,Multiple groups,1062,4.20%,2.90%,5.50%,Stratified probability,CTK Biotech ,Rapid immunochromatographic test,"IgG,IgM",90.00%,99.39%,Moderate,Institutional Report,Statistics Jersey,Statistics Jersey,https://www.gov.je/SiteCollectionDocuments/Government%20and%20administration/R%20Prevalence%20of%20antibodies%2020200609%20SJ.pdf,7/25/2020,4/26/2021
210305_Jordan_KingHusseinCancerCenter_Grp1,3/5/2021,National,Jordan,Jordan,"January 15, 2020","June 15, 2020",Blood donors,Adults (18-64 years),746,0.00%,0.00%,0.51%,Sequential,Roche Diagnostics,,Total Antibody,100.00%,99.80%,Moderate,Preprint,Maher Sughayer,King Hussein Cancer Center,https://www.medrxiv.org/content/10.1101/2021.03.02.21252448v1.full-text,3/27/2021,3/31/2021
210305_Jordan_KingHusseinCancerCenter_Grp2,3/5/2021,National,Jordan,Jordan,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),348,0.00%,0.00%,0.51%,Sequential,Roche Diagnostics,,Total Antibody,100.00%,99.80%,High,Preprint,Maher Sughayer,King Hussein Cancer Center,https://www.medrxiv.org/content/10.1101/2021.03.02.21252448v1.full-text,3/27/2021,3/31/2021
210305_Jordan_KingHusseinCancerCenter_Grp3_TestAdj,3/5/2021,National,Jordan,Jordan,"January 28, 2021","February 5, 2021",Blood donors,Adults (18-64 years),292,27.32%,22.50%,32.90%,Sequential,Roche Diagnostics,,Total Antibody,100.00%,99.80%,Moderate,Preprint,Maher Sughayer,King Hussein Cancer Center,https://www.medrxiv.org/content/10.1101/2021.03.02.21252448v1.full-text,3/27/2021,3/31/2021
210217_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj,2/17/2021,National,Kenya,Kenya,"September 30, 2020","October 23, 2020",Essential non-healthcare workers,Adults (18-64 years),830,42.30%,38.40%,46.30%,Convenience,NR,,IgG,93.00%,99.00%,Moderate,Preprint,E Wangeci Kagucia,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2021.02.12.21251294v1,3/16/2021,4/7/2021
210212_Kenya_KEMRI-WellcomeTrustResearchProgramme_overall_adj,2/12/2021,National,Kenya,Kenya,"April 30, 2020","September 30, 2020",Blood donors,Adults (18-64 years),9922,7.90%,6.70%,9.00%,Sequential,N/A - in-house,,IgG,92.70%,99.00%,Low,Preprint,Ifedayo M.O. Adetifa,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2021.02.09.21251404v1,3/26/2021,4/26/2021
210208_Kenya_KEMRI-WellcomeTrust_Nairobi_Overall_TestAdj,2/8/2021,Sublocal,Kenya,Kenya,"July 30, 2020","August 25, 2020",Pregnant or parturient women,Adults (18-64 years),196,49.90%,42.70%,58.00%,Sequential,N/A - in house,,IgG,92.70%,99.00%,High,Preprint,R. Lucinde,KEMRI-Wellcome Trust,10.1101/2021.02.05.21250735,4/15/2021,4/15/2021
210208_Kenya_KEMRI-WellcomeTrust_Kilifi_Overall_TestAdj,2/8/2021,Sublocal,Kenya,Kenya,"November 1, 2020","November 24, 2020",Pregnant or parturient women,Adults (18-64 years),154,11.00%,6.20%,16.70%,Sequential,N/A - in house,,IgG,92.70%,99.00%,High,Preprint,R. Lucinde,KEMRI-Wellcome Trust,10.1101/2021.02.05.21250735,4/15/2021,4/15/2021
201205_Kuwait_KuwaitUniversity_Overall_unadj,12/5/2020,National,Kuwait,Kuwait,"May 23, 2020","June 26, 2020",Essential non-healthcare workers,Adults (18-64 years),525,38.10%,34.00%,42.30%,Stratified probability,"Biozek Medical, Netherlands",,"IgG,IgM",66.00%,97.00%,High,Journal Article (Peer-Reviewed),Walid Q. Alali,University of Kuwait,https://dx.doi.org/10.1093/jtm/taaa223,1/23/2021,4/26/2021
210107_Latvia_UniversityCollegeLondon_PaediatricHCW,1/27/2021,Sublocal,Latvia,Latvia; NR; NR,"May 19, 2020","June 20, 2020",Health care workers and caregivers,Adults (18-64 years),177,0.00%,0.00%,2.14%,Convenience,"Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)",,IgG,,,High,Journal Article (Peer-Reviewed),D. Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,4/9/2021
200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers,5/26/2020,Local,Libya,Libya; Libya; Alzintan City,"April 2, 2020","May 18, 2020",Health care workers and caregivers,Multiple groups,77,0.00%,,,Stratified probability,Guangzhou Wondfo Biotech,LFIA: Lateral flow immunoassay,"IgM,IgG",86.40%,99.60%,High,Preprint,Abdulwahab Kammon,Al-Zintan University,https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1,5/29/2020,4/26/2021
200526_AlzintanCity_Al-ZintanUniversity_GenPopulation,5/26/2020,Local,Libya,Libya; Libya; Alzintan City,"April 2, 2020","May 18, 2020",Multiple populations,Multiple groups,142,4.23%,,,Simplified probability,Guangzhou Wondfo Biotech,LFIA: Lateral flow immunoassay,"IgM,IgG",86.40%,99.60%,High,Preprint,Abdulwahab Kammon,Al-Zintan University,https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1,5/29/2020,4/26/2021
200929_Benghazi_TheCenterOfInfectiousDiseases-Benghazi_overall,9/29/2020,Local,Libya,Libya,"May 2, 2020","May 7, 2020",Household and community samples,Multiple groups,600,0.00%,,,Stratified probability,Biotest,,"IgG,IgM",81.70%,96.70%,Moderate,Journal Article (Peer-Reviewed),Amal A Elfakhri,The Center of Infectious Diseases- Benghazi,https://preventive-medicine.imedpub.com/populationbased-random-survey-for-detection-of-covid19-infection-and-seroprevalence-in-benghazi-libya-may2020.pdf,4/26/2021,4/27/2021
201209_Liechtenstein_KantonsspitalGraubunden_Overall,12/9/2020,National,Liechtenstein,Liechtenstein,"June 2, 2020","October 6, 2020",Multiple populations,Not reported,1159,7.80%,6.40%,9.50%,Convenience,"Roche Diagnostics, Rotkreuz, Switzerland
Abbott Diagnostics Baar, Switzerland
Diasorin
Euroimmun",,"IgG,IgM",97.60%,99.80%,Unclear,Journal Article (Peer-Reviewed),Anna Schaffner,Kantonsspital Graunbunden,https://dx.doi.org/10.3390/jcm9123989,1/28/2021,4/26/2021
210107_Lithuania_UniversityCollegeLondon_PaediatricHCW,1/27/2021,Sublocal,Lithuania,Lithuania; NR; NR,"June 1, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),300,0.66%,0.18%,2.40%,Convenience,"Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)",,IgG,,,High,Journal Article (Peer-Reviewed),D. Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,4/9/2021
210206_Kaunas_HospitalofLithuanianUniversityofHealthSciencesKaunoKlinikos_LFIAIgG,2/6/2021,Local,Lithuania,Lithuania,"June 15, 2020","September 21, 2020",Health care workers and caregivers,Multiple groups,432,1.16%,,,Convenience,AMEDA Labordiagnostik GmbH,,IgG,91.80%,96.40%,High,Journal Article (Peer-Reviewed),Laura Pereckaitė ,The Hospital of Lithuanian University of Health Sciences Kauno Klinikos,https://dx.doi.org/10.3390/medicina57020148,3/15/2021,3/31/2021
200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgGPopAdj,5/18/2020,National,Luxembourg,Luxembourg,"April 15, 2020","May 5, 2020",Household and community samples,Multiple groups,1820,2.09%,1.37%,2.82%,Stratified probability,EUROIMMUN,ELISA,IgG,85.70%,97.80%,Moderate,Preprint,Chantal Snoeck,Luxembourg Institute of Health,https://www.medrxiv.org/content/10.1101/2020.05.11.20092916v1,7/12/2020,4/26/2021
200805_Blantyre_Malawi-Liverpool-WellcomeTrust_HCW_TestAdj,8/5/2020,National,Malawi,Malawi; Southern Region Malawi; Blantyre,"May 22, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),500,12.30%,8.20%,16.50%,Convenience,Omega diagnostics,ELISA,IgG,88.10%,93.20%,High,Preprint,Marah Chibwana,Malawi-Liverpool-Wellcome Trust Clinical Research Programme,https://www.medrxiv.org/content/10.1101/2020.07.30.20164970v3.full.pdf,8/7/2020,4/26/2021
200813_Selangor_UniversityMalaya_OverallPopAdj,8/13/2020,Regional,Malaysia,Malaysia; Selangor; Kuala Lumpur,"January 29, 2020","June 6, 2020",Residual sera,Multiple groups,588,0.40%,0.00%,0.93%,Convenience,Author-designed,ELISA,IgG,97.00%,100.00%,High,Journal Article (Peer-Reviewed),I-Ching Sam,University Malaya,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26426,10/2/2020,4/26/2021
210321_KlangValley_MalaysianMinistryofHealth_HCW,3/21/2021,Sublocal,Malaysia,Malaysia; Klang Valley,"April 13, 2020","May 12, 2020",Health care workers and caregivers,Adults (18-64 years),400,0.00%,0.00%,0.01%,Convenience,GenScript Biotech,,Not reported,91.30%,100.00%,High,Journal Article (Peer-Reviewed),Yuan Woon,Malaysian Ministry of Health,https://dx.doi.org/10.1016/j.lanwpc.2021.100123,4/18/2021,4/18/2021
210118_Nouakchott_CentreHospitalierNationalDeNouakchott_Overall,1/18/2021,Sublocal,Mauritania,Mauritania,"May 5, 2020","May 27, 2020",Health care workers and caregivers,Adults (18-64 years),835,1.67%,,,Convenience,Biotime,,"IgG,IgM",96.40%,98.70%,High,Journal Article (Peer-Reviewed),Mohamed Lemine Ould Salem,Centre Hospitalier National de Nouakchott,http://dx.doi.org/10.11604/pamj.2021.38.55.24259,4/13/2021,4/16/2021
201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_TestAdj,11/2/2020,Local,Mexico,Mexico; Nuevo Leon; Guadalupe,"July 9, 2020","July 23, 2020",Multiple populations,Multiple groups,3268,5.70%,4.90%,6.60%,Convenience,Roche elecsys,Chemiluminescence Immunoassay,"IgM,IgG",99.50%,99.80%,Moderate,Preprint,Cristina Díaz-Salazar,Universidad Autonoma de Nuevo Leon,https://www.researchsquare.com/article/rs-84890/v1,11/27/2020,4/26/2021
201021_VeracruzCity_UniversidadVeracruzana_unadj,10/21/2020,Sublocal,Mexico,Mexico,"June 1, 2020","July 31, 2020",Residual sera,Multiple groups,2174,29.50%,27.59%,31.47%,Sequential,"Abbott, Ortho-Clinical Diagnostics",,IgG,,,High,Preprint,Jose María Remes-Troche,Universidad Veracruzana,https://www.medrxiv.org/content/10.1101/2020.10.19.20215558v1,1/17/2021,4/26/2021
201202_MexicoCity_InstitutoNacionaldeRehabilitacion_HCW_overall,12/2/2020,Sublocal,Mexico,Mexico,"August 10, 2020","September 9, 2020",Health care workers and caregivers,Adults (18-64 years),300,13.70%,,,Stratified probability,"LFA: Hangzhou Biotest Biotech Co. Ltd.,
ELISA: (Euroimmun Medizinische Labordiagnostika",,"IgM,IgG",,,Moderate,Preprint,Esteban Cruz-Arenas,Instituto Nacional de Rehabilitacion,https://www.medrxiv.org/content/10.1101/2020.11.30.20241331v1,1/22/2021,4/26/2021
201130_NuevoLeon_AutonomousUniversityofNuevoLeon_primary,11/30/2020,Regional,Mexico,Mexico; Nuevo Leon,"January 1, 2020","August 30, 2020",Blood donors,Adults (18-64 years),1968,3.99%,,,Sequential,Abbott Laboratories,,IgG,,,High,Preprint,Natalia Martinez-Acuña,Autonomous University of Nuevo Leon,https://www.medrxiv.org/content/10.1101/2020.11.28.20240325v1.full,2/4/2021,4/26/2021
210305_MexicoCity_ InstitutoNacionaldeRehabilitacion_primary_ELISA,3/5/2021,Sublocal,Mexico,Mexico,"August 10, 2020","September 9, 2020",Health care workers and caregivers,Adults (18-64 years),299,13.00%,,,Simplified probability,"Euroimmun Medizinische
Labordiagnostika, AG",,IgG,,,High,Preprint,Esteban Cruz-Arenas, Instituto Nacional de Rehabilitacion,https://www.medrxiv.org/content/10.1101/2020.11.30.20241331v2,4/8/2021,4/26/2021
200616_PrincipalityofMonaco_Monaco_genpop,6/16/2020,National,Monaco,Monaco,"May 26, 2020","June 16, 2020",Household and community samples,Multiple groups,35000,2.80%,,,Self-referral,NR,,,,,Unclear,News and Media,NR,Principality of Monaco,https://www.tellerreport.com/news/2020-06-16-monaco-has-tested-its-population-and-the-seroprevalence-rate-is-very-low.SJ66VJ4UT8.html,4/25/2021,4/26/2021
201112_Netherlands_AmsterdamUMC_GenPop_Overall_1Test,11/12/2020,National,Netherlands,Netherlands,"April 1, 2020","April 15, 2020",Blood donors,Multiple groups,7361,3.40%,,,Sequential,Wantai Biological Pharmacy Enterprise,ELISA,"IgG,IgA,IgM",100.00%,99.10%,Moderate,Journal Article (Peer-Reviewed),Ed Slot,Amsterdam UMC,https://www.nature.com/articles/s41467-020-19481-7,5/25/2020,4/26/2021
200824_Rotterdam_ErasmusMedicalCentre_1_March,8/24/2020,Sublocal,Netherlands,Netherlands,"March 2, 2020","March 6, 2020",Residual sera,Multiple groups,879,0.10%,,,Convenience,Author-designed,Not reported,IgG,,100.00%,High,Preprint,Brenda Westerhuis,Erasmus Medical Centre,https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1,10/18/2020,4/26/2021
200824_Rotterdam_ErasmusMedicalCentre_2_April,8/24/2020,Sublocal,Netherlands,Netherlands,"April 3, 2020","April 7, 2020",Residual sera,Multiple groups,729,2.30%,,,Convenience,Author-designed,Not reported,IgG,,100.00%,High,Preprint,Brenda Westerhuis,Erasmus Medical Centre,https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1,10/18/2020,4/26/2021
201128_Netherlands_CentreforInfectiousDiseaseControl_genpop_overall,11/28/2020,National,Netherlands,Netherlands,"March 31, 2020","May 11, 2020",Household and community samples,Multiple groups,2637,2.80%,2.10%,3.70%,Stratified probability,NR,,IgG,84.40%,99.00%,Low,Journal Article (Peer-Reviewed),Eric Vos,Centre for Infectious Disease Control,https://dx.doi.org/10.1136/jech-2020-215678,1/24/2021,4/26/2021
201128_Netherlands_CentreforInfectiousDiseaseControl_LowVaccineCoverage_overall,11/28/2020,National,Netherlands,Netherlands,"March 31, 2020","May 11, 2020",Household and community samples,Multiple groups,570,2.90%,1.40%,6.30%,Stratified probability,NR,,IgG,84.40%,99.00%,Low,Journal Article (Peer-Reviewed),Eric Vos,Centre for Infectious Disease Control,https://dx.doi.org/10.1136/jech-2020-215678,1/24/2021,4/26/2021
210312_Amsterdam_PublicHealthServiceOfAmsterdam_overall,3/12/2021,Local,Netherlands,Netherlands,"June 24, 2020","October 9, 2020",Household and community samples,Multiple groups,2483,9.10%,,,Stratified probability,Wantai Biological Pharmacy Enterprise Co,,"IgG,IgA,IgM",,,High,Preprint,Liza Coyer,Public Health Service of Amsterdam,10.1101/2021.03.08.21252788,4/2/2021,4/2/2021
201023_NewZealand_SouthernCommunityLaboratories_MultipleTest,10/23/2020,Regional,New Zealand,New Zealand; Southern Region,"June 4, 2020","August 4, 2020",Contacts of COVID patients,Multiple groups,1127,0.70%,,,Convenience,"Abbott, Beijing Wantai Biological Pharmacy Enterprise, Euroimmun, ",,IgG,,,High,Journal Article (Peer-Reviewed),Alyson Craigie,Southern Community Laboratories,https://www.medrxiv.org/content/10.1101/2020.10.20.20215616v1,1/23/2021,4/26/2021
210301_Nicaragua_NationalAutonomousUniversityofNicaragua_overall_unadj,,Local,Nicaragua,Nicaragua,"September 15, 2020","October 15, 2020",Household and community samples,Multiple groups,1351,33.75%,,,Unclear,In-house; author designed,,"IgG,IgA,IgM",,,High,Preprint,Fredman Gonzalez,National Autonomous University of Nicaragua,https://dx.doi.org/10.1101/2021.02.25.21252447,4/3/2021,4/3/2021
200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgG_T1,7/24/2020,Sublocal,Nigeria,Nigeria; Cross River State; Calabar,"June 17, 2020","June 24, 2020",Multiple populations,Adults (18-64 years),66,26.00%,,,Unclear,Healgen Scientific,LFIA: Lateral flow immunoassay,IgG,,,High,Preprint,Marcus Inyama Asuquo,Joseph Ukpo Hospitals and Research Institutes,https://www.medrxiv.org/content/10.1101/2020.07.02.20145441v2,9/26/2020,4/26/2021
200805_Niger_IbrahimBadamasiBabangidaUniversity_IgG_GenPop_UnAdj,8/5/2020,Regional,Nigeria,Nigeria; Niger State,"June 26, 2020","June 30, 2020",Household and community samples,Multiple groups,185,25.41%,,,Stratified probability,Cambridge Network,Colloidal Gold Immunochromatography Assay (LFIA),IgG,100.00%,100.00%,Moderate,Preprint,Hussaini Majiya,Ibrahim Badamasi Babangida University,https://www.medrxiv.org/content/10.1101/2020.08.04.20168112v1.full.pdf,10/14/2020,4/26/2021
200615_Bergen_UniversityofBergen_HouseholdMembers,6/15/2020,Local,Norway,Norway; Western Norway; Bergen,"February 28, 2020","April 4, 2020",Contacts of COVID patients,Not reported,77,31.17%,,,Entire sample,Amant et al. ,ELISA,"IgM,IgG,IgA",,,High,Journal Article (Peer-Reviewed),Rebecca Cox,University of Bergen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295487/,7/18/2020,4/26/2021
200626_Norway_NorwegianInstituteofPublicHealth_OverallAdj,6/26/2020,National,Norway,Norway,"April 20, 2020","May 17, 2020",Residual sera,Multiple groups,900,1.00%,0.10%,2.40%,Sequential,""" Department of Immunology, Oslo University Hospital""",Flow cytometry assay,IgG,86.00%,100.00%,Moderate,Institutional Report,Gro Tunheim,Norwegian Institute of Public Health,https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2020/covid-19/seroprevalence-of-sars-cov-2-in-the-norwegian-population_report-26-06-2020.pdf,10/6/2020,4/26/2021
201104_Norway_UniversityOfBergen_HouseholdContacts_Overall,11/4/2020,Local,Norway,Norway; Hordaland; Bergen,"February 28, 2020","April 4, 2020",Contacts of COVID patients,Multiple groups,179,45.30%,,,Convenience,N/A - Author Designed,,IgG,,,High,Preprint,Kanika Kuwelker,University of Bergen,https://www.medrxiv.org/content/10.1101/2020.11.02.20224485v1,1/19/2021,4/26/2021
201128_Bergen_UniversityofBergen_primaryest_HCW,11/28/2020,Local,Norway,Norway; Midhordland; Bergen,"March 6, 2020","April 9, 2020",Health care workers and caregivers,Multiple groups,607,5.27%,,,Convenience,Sigma-Aldrich,,IgG,,,High,Journal Article (Peer-Reviewed),Mai-Chi Trieu,University of Bergen,https://dx.doi.org/10.1093/infdis/jiaa737,1/29/2021,4/26/2021
210115_Norway_NorwegianArmedForcesJointMedicalServices_primary,1/15/2021,National,Norway,Norway,"April 19, 2020","April 27, 2020",Essential non-healthcare workers,Adults (18-64 years),1170,0.70%,,,Convenience,Roche,,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Einar Kristian Borud,Norwegian Armed Forces Joint Medical Services,https://dx.doi.org/10.1002/hsr2.233,2/27/2021,4/14/2021
210223_Lorenskog_AkershusUniversityHospital_Overall,2/23/2021,Sublocal,Norway,Norway,"May 11, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),360,3.30%,,,Convenience,"Roche Diagnostics, Basel, Switzerland",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Nina Handal,"Akershus University Hospital, Lorenskog, Norway",https://dx.doi.org/10.1080/23744235.2021.1885734,3/23/2021,3/31/2021
210107_WestBank_ArabAmericanUniversity_Households_overall_adj,1/7/2021,Local,"occupied Palestinian territory, including east Jerusalem","occupied Palestinian territory, including east Jerusalem","June 15, 2020","June 30, 2020",Household and community samples,Multiple groups,1355,0.00%,0.00%,0.43%,Stratified probability,Roche ,,Total Antibody,83.87%,100.00%,Low,Journal Article (Peer-Reviewed),Nouar Qutob,Arab American University ,https://dx.doi.org/10.1136/bmjopen-2020-044552,2/18/2021,3/31/2021
210107_WestBank_ArabAmericanUniversity_LabReferrals_overall_adj,1/7/2021,Local,"occupied Palestinian territory, including east Jerusalem","occupied Palestinian territory, including east Jerusalem","May 1, 2020","July 9, 2020",Residual sera,Multiple groups,1136,0.35%,0.13%,1.16%,Convenience,Roche,,Total Antibody,100.00%,83.87%,High,Journal Article (Peer-Reviewed),Nouar Qutob,Arab American University ,https://dx.doi.org/10.1136/bmjopen-2020-044552,2/18/2021,3/31/2021
200720_Lahore_ChughtaiInstituteofPathology_Overall,8/19/2020,Local,Pakistan,Pakistan,"May 20, 2020","May 30, 2020",Essential non-healthcare workers,Adults (18-64 years),154,15.60%,,,Convenience,Abbott,Chemiluminescence Immunoassay,IgG,96.77%,99.00%,High,Journal Article (Peer-Reviewed),Omar Chughtai,Chughtai Institute of Pathology,https://jcpsp.pk/article-detail/frequency-of-covid19-igg-antibodies-among-special-police-squad-lahore-pakistan,10/3/2020,4/26/2021
200824_Karachi_NationalInstituteofBloodDiseases&BoneMarrowTransplantation_Overall,8/24/2020,Local,Pakistan,Pakistan; Sindh; Karachi,"May 15, 2020","July 15, 2020",Blood donors,Adults (18-64 years),370,34.60%,,,Sequential,Roche Diagnostics,Electro chemiluminescence immunoassay,"IgA,IgM,IgG",,,High,Journal Article (Peer-Reviewed),Amber Younas,National Institute of Blood Diseases & Bone Marrow Transplantation,https://dx.doi.org/10.1016/j.transci.2020.102923,10/20/2020,4/26/2021
200917_Karachi_NationalInstituteofBloodDiseasesandBoneMarrowTransplant_Overall,9/17/2020,Local,Pakistan,Pakistan,"May 15, 2020","July 15, 2020",Multiple populations,Adults (18-64 years),1675,36.05%,,,Convenience,Roche Diagnostics,Electro chemiluminescence immunoassay,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Samreen Zaidi,National Institute of Blood Diseases and Bone Marrow Transplant,http://dx.doi.org/10.1093/pubmed/fdaa170,11/12/2020,4/26/2021
201109_ Peshawar_HayatabadMedicalComplex_Overall,11/9/2020,Sublocal,Pakistan,Pakistan; Khyber Pakhtunkhwa; Peshawar,"July 13, 2020","July 15, 2020",Health care workers and caregivers,Multiple groups,1011,30.76%,,,Stratified probability,Roche,,"IgG,IgM",87.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mohammad Noor,Hayatabad Medical Complex,https://dx.doi.org/10.7759/cureus.11389,1/17/2021,4/26/2021
200930_PeshawarCity_RiphahInternationalUniversity_Overall,9/30/2020,Local,Pakistan,Pakistan; Khyber Pakhtunkhwa; Peshawar City,"June 15, 2020","June 29, 2020",Health care workers and caregivers,Adults (18-64 years),1011,30.70%,27.80%,33.60%,Stratified non-probability,Roche Diagnostics,,Total Antibody,98.80%,100.00%,Moderate,Preprint,Mohsina Haq,Riphah International University,https://www.medrxiv.org/content/10.1101/2020.09.29.20203125v1,1/19/2021,4/26/2021
201228_Karachi_AgaKhanUniversity_Phase1DistrictMalir_PopTestAdj,12/28/2020,Sublocal,Pakistan,Pakistan; Sindh; Karachi,"April 15, 2020","April 25, 2020",Household and community samples,Multiple groups,500,0.20%,0.00%,0.70%,Simplified probability,Roche,,"IgG,IgM",100.00%,99.80%,Moderate,Preprint,Muhammad Nisar,Aga Khan University,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/9/2021,4/26/2021
201228_Karachi_AgaKhanUniversity_Phase1_DistrictEast_PopTestAdj,12/28/2020,Sublocal,Pakistan,Pakistan; Sindh; Karachi,"April 15, 2020","April 25, 2020",Household and community samples,Multiple groups,500,0.40%,0.00%,1.30%,Simplified probability,Roche,,"IgG,IgM",100.00%,99.80%,Moderate,Preprint,Muhammad Nisar,Aga Khan University,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/9/2021,4/26/2021
201228_Karachi_AgaKhanUniversity_Phase2DistrictEast_PopTestAdj,12/28/2020,Sublocal,Pakistan,Pakistan; Sindh; Karachi,"June 25, 2020","July 11, 2020",Household and community samples,Multiple groups,500,15.10%,9.40%,21.70%,Simplified probability,Roche,,"IgG,IgM",100.00%,99.80%,Moderate,Preprint,Muhammad Nisar,Aga Khan University,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/9/2021,4/26/2021
201228_Karachi_AgakhanUniversity_Phase2DistrictMalir_PopTestAdj,12/28/2020,Sublocal,Pakistan,Pakistan; Sindh; Karachi,"June 25, 2020","July 11, 2020",Household and community samples,Multiple groups,504,8.70%,5.10%,13.10%,Simplified probability,Roche,,"IgG,IgM",100.00%,99.80%,Moderate,Preprint,Muhammad Nisar,Aga Khan University,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/9/2021,4/26/2021
201228_Karachi_AgaKhanUniversity_Phase3DistrictEast_PopTestAdj,12/28/2020,Sublocal,Pakistan,Pakistan; Sindh; Karachi,"August 17, 2020","August 22, 2020",Household and community samples,Multiple groups,500,21.50%,15.60%,28.00%,Simplified probability,Roche,,"IgG,IgM",100.00%,99.80%,Moderate,Preprint,Muhammad Nisar,Aga Khan University,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/10/2021,4/26/2021
201228_Karachi_AgaKhanUniversity_Phase3DistrictMalir_PopTestAdj,12/28/2020,Sublocal,Pakistan,Pakistan; Sindh; Karachi,"August 17, 2020","August 22, 2020",Household and community samples,Multiple groups,501,12.80%,8.30%,17.70%,Simplified probability,Roche,,"IgG,IgM",100.00%,99.80%,Moderate,Preprint,Muhammad Nisar,Aga Khan University,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/10/2021,4/26/2021
210103_Pakistan_LiaquatUniversity_primary,1/3/2021,Sublocal,Pakistan,Pakistan,"June 15, 2020","August 15, 2020",Multiple populations,Multiple groups,728,10.80%,,,Convenience,nr,,Not reported,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Sheeba Ansari,Liaquat University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854312/,2/19/2021,3/31/2021
210101_Pakistan_ColSultan’sLab_Overall,1/1/2021,Sublocal,Pakistan,Pakistan; NR; NR,"June 13, 2020","July 8, 2020",Multiple populations,Not reported,453,63.80%,,,Self-referral,Roche Holding AG,,Not reported,,,High,Journal Article (Peer-Reviewed),Sidra Ghazanfer,Col Sultan’s Lab,https://dx.doi.org/10.29271/jcpsp.2021.01.S55,4/10/2021,4/13/2021
201210_Panama_INDICASAT-AIP_HealthyDonors2_overall,12/10/2020,National,Panama,Panama,"April 30, 2020","July 7, 2020",Blood donors,Multiple groups,255,11.72%,8.30%,16.30%,Unclear,N/A - Author Designed,,"IgG,IgM",87.01%,98.89%,High,Preprint,Alcibiades Villarreal,Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP),https://www.medrxiv.org/content/10.1101/2020.09.25.20201459v4,3/17/2021,4/26/2021
201210_Panama_INDICASAT-AIP_HCW1_overall,12/10/2020,National,Panama,Panama,"April 30, 2020","July 7, 2020",Health care workers and caregivers,Multiple groups,351,12.82%,8.60%,15.40%,Unclear,N/A - Author Designed,,"IgG,IgM",87.01%,98.89%,High,Preprint,Alcibiades Villarreal,Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP),https://www.medrxiv.org/content/10.1101/2020.09.25.20201459v4,3/17/2021,4/26/2021
210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_BloodDonors,3/2/2021,Regional,Panama,Panama,"April 30, 2020","July 7, 2020",Blood donors,Multiple groups,255,13.33%,,,Unclear,"Dr. Chong Li’s group from Institute of Biophysics, Chinese Academy of Science",,"IgG,IgM",87.01%,98.89%,High,Journal Article (Peer-Reviewed),Alcibiades Villarreal,Instituto de Investigaciones Científicas y Servicios de Alta Tecnología,https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full,4/7/2021,4/26/2021
210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_HCWs,3/2/2021,Regional,Panama,Panama,"April 30, 2020","July 7, 2020",Health care workers and caregivers,Multiple groups,351,12.82%,,,Unclear,"Dr. Chong Li’s group from Institute of Biophysics, Chinese Academy of Science",,"IgG,IgM",87.01%,98.89%,Moderate,Journal Article (Peer-Reviewed),Alcibiades Villarreal,Instituto de Investigaciones Científicas y Servicios de Alta Tecnología,https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full,4/7/2021,4/26/2021
201215_CiudaddelEste_MinisteriodeSaludPública_primary,12/15/2020,Local,Paraguay,Paraguay,"November 29, 2020","December 15, 2020",Household and community samples,Multiple groups,1675,30.00%,,,Unclear,NR,,Not reported,,,Unclear,News and Media,Not reported,Ministerio de Salud Pública,https://www.ultimahora.com/el-30-testeados-el-este-tuvieron-covid-n2918654.html,4/22/2021,4/25/2021
200726_Peru_NationalCenterforEpidemiology_Overall,"7/27/2020, 7/27/2020, 7/26/2020",Local,Peru,"Peru; Lima, Callao; Lima, Callao","June 28, 2020","July 9, 2020",Household and community samples,Multiple groups,3118,21.60%,18.70%,24.60%,Stratified probability,Not reported,Rapid immunochromatographic test,"IgG,IgM",40.00%,,High,"News and Media, News and Media, News and Media","Peruvian Government, Centro Nacional de Epidemiologia, Ministerio de Salud","National Center for Epidemiology, Prevention and Control of Diseases","https://gestion.pe/peru/coronavirus-peru-minsa-divulga-ficha-tecnica-del-estudio-que-revela-que-el-253-de-lima-y-callao-adquirio-el-covid-19-cuarentena-estado-de-emergencia-nndc-noticia/, https://www.dge.gob.pe/portalnuevo/informativo/prensa/estudio-de-prevalencia-determina-que-el-253-de-la-poblacion-de-lima-y-callao-adquirio-la-infeccion-por-sars-cov2/, https://www.gob.pe/institucion/minsa/noticias/216013-estudio-de-prevalencia-determina-que-el-25-3-de-la-poblacion-de-lima-y-callao-estaria-infectada-de-covid-19",10/20/2020,4/26/2021
201129_Lima_INS_unadj,9/9/2020,Local,Peru,Peru; Lima; Lima,"April 23, 2020","May 2, 2020",Household and community samples,Multiple groups,236,53.00%,,,Stratified non-probability,Core Technology Co. Ltd,,"IgG,IgM",97.60%,100.00%,Moderate,Preprint,Yolanda Angulo-Bazán,National Institute of Health (INS),https://www.medrxiv.org/content/10.1101/2020.09.06.20189456v2,1/13/2021,4/26/2021
210120_Cusco_UniversidadCientíficadelSur_PopAdj,1/20/2021,Regional,Peru,Peru; Cusco,"September 12, 2020","September 27, 2020",Household and community samples,Multiple groups,1924,33.10%,30.10%,36.40%,Stratified probability,Roche Diagnostics,,"IgM,IgG",99.80%,99.50%,Low,Preprint,Charles Huamaní,Universidad Científica del Sur,https://www.medrxiv.org/content/10.1101/2021.01.17.21249990v1,2/5/2021,3/31/2021
210120_Iquitos_DIRESA_baseline_overall_adj,1/20/2021,Local,Peru,Peru,"July 15, 2020","August 15, 2020",,Multiple groups,716,70.00%,67.00%,73.40%,Stratified probability,"Zhejiang Orient Gene (Biotech Co LTD, China)",,"IgG,IgM",95.80%,100.00%,Low,Preprint,Carlos Álvarez-Antonio,Universidad de Ingeniería y Tecnología,https://www.medrxiv.org/content/10.1101/2021.01.17.21249913v1,2/11/2021,3/31/2021
210120_Iquitos_DIRESA_1monthFollowUp_overall_adj,1/20/2021,Local,Peru,Peru,"July 15, 2020","August 15, 2020",,Multiple groups,621,66.00%,62.00%,70.10%,Stratified probability,"Zhejiang Orient Gene (Biotech Co LTD, China)",,"IgG,IgM",95.80%,100.00%,,Preprint,Carlos Álvarez-Antonio,Universidad de Ingeniería y Tecnología,https://www.medrxiv.org/content/10.1101/2021.01.17.21249913v1,2/11/2021,3/31/2021
210331_Lima_PeruvianMinistryOfHealth_Overall_PopAdj_TestAdj,3/31/2021,Local,Peru,Peru; Lima and Callao; Lima metropolitan area,"June 28, 2020","July 9, 2020",Household and community samples,Multiple groups,3212,20.80%,17.20%,23.50%,Stratified probability,SD BIOSENSOR,,"IgG,IgM",96.94%,96.23%,Low,Journal Article (Peer-Reviewed),Mary F. Reyes-Vega,Peruvian Ministry of Health,https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00081-X/fulltext#%20,4/10/2021,4/10/2021
201130_Warsaw_TheChildrensMemorialHealthInstitute_HCW,11/30/2020,Sublocal,Poland,Poland; Masovia; Warsaw,"July 1, 2020","August 9, 2020",Health care workers and caregivers,Adults (18-64 years),1879,0.85%,,,Convenience,Abbott Laboratories,,IgG,100.00%,99.00%,Moderate,Preprint,Beata Kasztelewicz,The Children’s Memorial Health Institute,https://www.medrxiv.org/content/10.1101/2020.11.28.20239848v1,1/23/2021,4/26/2021
201011_Mazowieckie_MedicalUniversityofWarsaw_IgG_Overall,10/11/2020,Regional,Poland,Poland; Mazowieckie Province,"June 22, 2020","July 8, 2020",Essential non-healthcare workers,Multiple groups,5082,4.30%,3.70%,4.90%,Stratified probability,Vircell S.L,,IgG,97.00%,94.00%,Moderate,Journal Article (Peer-Reviewed),Mariusz Gujski,Medical University of Warsaw,http://dx.doi.org/10.3390/jcm9103245,1/29/2021,4/26/2021
210205_Poland_CentralClinicalHospital_IBDPatients_IgG,2/5/2021,National,Poland,Poland,"May 1, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,432,4.60%,,,Sequential,Vircell Microbiologists,,IgG,,,High,Journal Article (Peer-Reviewed),Michał Łodyga,Central Clinical Hospital of the Ministry of the Interior and Administration,https://dx.doi.org/10.20452/pamw.15796,2/22/2021,3/31/2021
210205_Poland_CentralClinicalHospital_HCWs_IgG,2/5/2021,National,Poland,Poland,"May 1, 2020","June 15, 2020",Health care workers and caregivers,Not reported,432,1.60%,,,Stratified non-probability,Vircell Microbiologists,,IgG,,,High,Journal Article (Peer-Reviewed),Michał Łodyga,Central Clinical Hospital of the Ministry of the Interior and Administration,https://dx.doi.org/10.20452/pamw.15796,2/22/2021,3/31/2021
201222_Warsaw_CentralClinicalHospitalMSWiA,12/22/2020,Sublocal,Poland,Poland,"April 1, 2020","October 31, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),61,16.39%,,,Sequential,"Vircell Microbiologist, Granada, Spain: ",,"IgA,IgG,IgM",100.00%,95.00%,High,Journal Article (Peer-Reviewed),Piotr Ciechanowicz,Central ClinicalHospital MSWiA,https://dx.doi.org/10.1080/09546634.2020.1861177,3/7/2021,4/26/2021
200902_Lisbon_UniversityofLisbon_Overall,9/2/2020,Sublocal,Portugal,Portugal; Estremadura; Lisbon,"May 13, 2020","July 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),2571,1.50%,,,Convenience,"Krammer, et al. [Independent third party]",ELISA,"IgG,IgM,IgA",94.74%,98.00%,Moderate,Preprint,Patricia Figueiredo-Campos,University of Lisbon,https://www.medrxiv.org/content/10.1101/2020.08.30.20184309v1,10/19/2020,4/26/2021
201218_Lisbon_NovaUniversityofLisbon,12/18/2020,Sublocal,Portugal,Portugal; Lisboa Region; Lisbon,"June 15, 2020","June 30, 2020",Non-essential workers and unemployed persons,Multiple groups,1636,3.05%,,,Convenience,NOVA University of Lisbon,,IgG,94.74%,99.53%,Moderate,Journal Article (Peer-Reviewed),Juliana Gonçalves,NOVA University of Lisbon,https://dx.doi.org/10.3389/fmed.2020.603996,1/23/2021,4/26/2021
210201_Portugal_InstitutoNacionalDeSaúdeDoutorRicardoJorge_overall_TestAdj_PopAdj,2/1/2021,National,Portugal,"Portugal; Norte Region, Centro Region, Lisboa Region, Alentejo Region, Algarve Region, Madeira, Azores","May 21, 2020","July 8, 2020",Residual sera,Multiple groups,2301,1.70%,0.00%,3.30%,Stratified non-probability,"1) Wantai

2) EUROIMMUN",,"IgG,IgM",96.00%,98.70%,Moderate,Journal Article (Peer-Reviewed),Irina Kislaya, Instituto Nacional de Saúde Doutor Ricardo Jorge,https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15122,3/11/2021,4/26/2021
201021_UniversidadeDeLisboa_UniversidadeDeLisboa_overall,10/21/2020,Sublocal,Portugal,Portugal,"May 13, 2020","July 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),2715,2.60%,,,Convenience,N/A - author designed,,IgG,99.00%,100.00%,High,Journal Article (Peer-Reviewed),Patrícia Figueiredo‐Campos,Universidade de Lisboa,https://onlinelibrary.wiley.com/doi/10.1002/eji.202048970,3/22/2021,4/26/2021
210302_Porto_UniversityofPorto_OverallTestAdj,,Local,Portugal,Portugal; Norte; Porto,"May 21, 2020","July 31, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),4592,2.50%,0.10%,5.30%,Convenience,SD Biosensor,,"IgG,IgM",94.50%,95.70%,Moderate,Preprint,Paula Meireles,University of Porto,https://www.medrxiv.org/content/10.1101/2021.02.28.21252628v1,3/30/2021,3/31/2021
200928_Qatar_CornellUniversity_Overall,9/28/2020,National,Qatar,Qatar,"June 21, 2020","September 9, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),4970,64.40%,63.00%,65.70%,Self-referral,Roche Diagnostics,,Total Antibody,,99.80%,High,Preprint,Andrew Jeremijenko,Cornell University ,https://www.medrxiv.org/content/10.1101/2020.09.24.20200543v2,1/19/2021,4/26/2021
201124_Qatar_MinistryofPublicHealth_Overall_popadj,11/24/2020,National,Qatar,Qatar,"July 26, 2020","September 9, 2020",Non-essential workers and unemployed persons,Multiple groups,2641,55.30%,53.30%,57.30%,Stratified probability,"Roche, Switzerland",,Total Antibody,95.00%,99.80%,Moderate,Preprint,MohamedH.Al-Thani,Ministry of Public Health,https://www.medrxiv.org/content/10.1101/2020.11.24.20237719v1,1/23/2021,4/26/2021
201214_Qatar_CornellUniversity-Qatar_Overall,12/14/2020,National,Qatar,Qatar,"July 26, 2020","September 9, 2020",Essential non-healthcare workers,Adults (18-64 years),394,46.50%,41.60%,51.40%,Self-referral,"Roche, Switzerland
Shenzhen Mindray Bio-Medical Electronics Co., China
BioMérieux, Marcy-l’Etoile, France",,IgG,,,High,Preprint,Gheyath Nasrallah,Cornell University - Qatar,https://www.medrxiv.org/content/10.1101/2020.12.14.20248163v1.full,1/23/2021,4/26/2021
210106_Qatar_HamadMedicalCorporation_overall,1/6/2021,Sublocal,Qatar,Qatar,"May 12, 2020","September 9, 2020",Residual sera,Multiple groups,112941,13.30%,13.10%,13.60%,Sequential,Roche,,Total Antibody,,,Moderate,Preprint,Peter V. Coyle,Hamad Medical Corporation,10.1101/2021.01.05.21249247,2/1/2021,3/31/2021
210309_Qatar_HamadMedicalCorporation_MortuaryWorkers,3/9/2021,Sublocal,Qatar,Qatar; NR; NR,"September 17, 2020","September 17, 2020",Essential non-healthcare workers,Adults (18-64 years),32,25.00%,,,Convenience,"Roche, Switzerland",,Not reported,,,High,Journal Article (Peer-Reviewed),,Hamad Medical Corporation,http://dx.doi.org/10.1016/j.ijid.2021.03.012,4/15/2021,4/15/2021
210309_Qatar_HamadMedicalCorporation_CemetaryWorkers,3/9/2021,Sublocal,Qatar,Qatar; NR; NR,"September 1, 2020","September 1, 2020",Essential non-healthcare workers,Adults (18-64 years),64,34.38%,,,Convenience,"Roche, Switzerland",,Not reported,,,High,Journal Article (Peer-Reviewed),,Hamad Medical Corporation,http://dx.doi.org/10.1016/j.ijid.2021.03.012,4/15/2021,4/15/2021
200709_Korea_KoreaCentersforDiseaseControlandPrevention_Total,"7/9/2020, 7/10/2020",National,Republic of Korea,Republic of Korea; Korea,,"July 9, 2020",Household and community samples,Not reported,3055,0.03%,,,Unclear,Not reported,Not reported,Not reported,,,Unclear,"News and Media, News and Media","Ock Hyun-ju, Yang Ji-Ho",Korea Centers for Disease Control and Prevention,"https://www.google.com/url?rct=j&sa=t&url=http://www.koreaherald.com/view.php%3Fud%3D20200709000787&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG8AlCeBcx2rR4FfgC726ll5TtgUw, http://english.chosun.com/site/data/html_dir/2020/07/10/2020071001864.html",7/31/2020,4/26/2021
200716_Daegu_DaeguCatholicUniversityHospital_Overall,7/16/2020,Local,Republic of Korea,Republic of Korea; North Gyeongsang; Daegu,"May 25, 2020","June 5, 2020",Multiple populations,Multiple groups,198,7.60%,,,Convenience,Shin Jin Medics Inc,Solid phase immunochromatography,IgG,100.00%,92.00%,High,Journal Article (Peer-Reviewed),Suk-Kyoon Song,Daegu Catholic University Hospital,https://dx.doi.org/10.3346/jkms.2020.35.e269,9/25/2020,4/26/2021
200824_Seoul_KoreaUniversity_Overall,8/24/2020,Local,Republic of Korea,Republic of Korea,"May 25, 2020","May 29, 2020",Residual sera,Multiple groups,1500,0.07%,,,Convenience,Roche elecsys,Chemiluminescence Immunoassay,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Ji Noh,Korea University,https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e311,10/4/2020,4/26/2021
201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_DesHCW_ELISA1,11/20/2020,National,Republic of Korea,Republic of Korea,"April 26, 2020","May 9, 2020",Health care workers and caregivers,Adults (18-64 years),309,0.32%,,,Convenience,PCL Inc,,Total Antibody,98.20%,100.00%,High,Journal Article (Peer-Reviewed),Jae-Hoon Ko,Sungkyunkwan University School of Medicine,https://dx.doi.org/10.3389/fmicb.2020.587613,2/23/2021,4/26/2021
201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_NonDesHCW_ELISA1,11/20/2020,National,Republic of Korea,Republic of Korea,"April 26, 2020","May 9, 2020",Health care workers and caregivers,Adults (18-64 years),123,0.00%,,,Convenience,PCL Inc,,Total Antibody,98.20%,100.00%,High,Journal Article (Peer-Reviewed),Jae-Hoon Ko,Sungkyunkwan University School of Medicine,https://dx.doi.org/10.3389/fmicb.2020.587613,2/23/2021,4/26/2021
201123_Korea_KoreaDiseaseControlAndPreventionAgency_genpop,11/23/2020,National,Republic of Korea,Republic of Korea,"August 15, 2020","October 15, 2020",Household and community samples,Multiple groups,1379,0.22%,,,Unclear,NR,,Not reported,,,Unclear,News and Media,KBS World,Korea Disease Control and Prevention Agency,https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801,3/6/2021,4/26/2021
201123_Korea_KoreaDiseaseControlAndPreventionAgency_military,11/23/2020,National,Republic of Korea,Republic of Korea,"August 15, 2020","October 15, 2020",Essential non-healthcare workers,Adults (18-64 years),6900,0.36%,,,Unclear,NR,,Not reported,,,Unclear,News and Media,KBS World,Korea Disease Control and Prevention Agency,https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801,3/7/2021,4/26/2021
200424_Romania_MedLife_HCW,4/24/2020,National,Romania,"Romania; Nord-Est, Sud-Est, Sud-Mutenia, Sud-Vest Oltenia, Vest, Nord-Vest, Centru, Bucuresti-Ilfov; Bucharest, Arad, Brasov, Sibiu, Piatra Neamt, Braila, Timisoara, Pitesti, Galati, Targoviste, Ploiesti","March 24, 2020","April 21, 2020",Health care workers and caregivers,Multiple groups,371,2.96%,,,Convenience,"Abbott, Maglumi, YHLO","Chemiluminescence,ELISA","IgG,IgM",,,Unclear,Institutional Report,MedLife,MedLife,https://www.medlife.ro/comunicat-de-presa/concluzii-preliminare-studiu-medlife-cel-mai-probabil-populatia-nu-are-imunitate-dobandita-natural-pentru-covid-19-respectarea-masurilor-de-protectie-si-extinderea-testarii-reprezinta-sansa-noastra-de-a-functiona-in-siguranta-si-de-a,6/27/2020,4/26/2021
210104_Romania_CarolDavilaUniversityofMedicineAndPharmacy_Overall_adj,1/4/2021,Sublocal,Romania,Romania,"May 17, 2020","December 1, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),546,6.00%,,,Convenience,LIAISON,,"IgG,IgM",90.70%,98.60%,High,Preprint,,Carol Davila University of Medicine and Pharmacy,10.20944/preprints202101.0024.v1,1/23/2021,3/31/2021
210107_Romania_UniversityCollegeLondon_PaediatricHCW,1/27/2021,Sublocal,Romania,Romania; NR; NR,"May 14, 2020","May 27, 2020",Health care workers and caregivers,Adults (18-64 years),124,0.81%,0.14%,4.30%,Convenience,"Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)",,IgG,,,High,Journal Article (Peer-Reviewed),D. Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,4/9/2021
200611_Russia_NationalCouncilCombatingCoronavirus_GenPop,6/10/2020,National,Russian Federation,Russian Federation,,"June 10, 2020",Household and community samples,Multiple groups,650000,14.00%,,,Unclear,Invitro,Not reported,Not reported,95.00%,98.00%,Moderate,News and Media,Sergei Kiselyov,Russian National Council for Combating Coronavirus,https://www.themoscowtimes.com/2020/06/10/1-in-7-russians-have-coronavirus-immunity-official-a70540 ; https://www.interfax.ru/russia/712617,6/27/2020,4/26/2021
200626_Moscow_CityofMoscow,6/26/2020,Local,Russian Federation,Russian Federation; Central Russia; Moscow,"June 5, 2020","June 18, 2020",Household and community samples,Not reported,90000,19.90%,,,Simplified probability,Not reported,Not reported,Not reported,,,High,News and Media,Jonny Tickle,City of Moscow,https://www.google.com/url?rct=j&sa=t&url=https://www.rt.com/russia/493055-moscow-mass-antibody-testing/&ct=ga&cd=CAEYESoUMTExMTExNDMxMTUyMzY3OTYzMDcyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNHh2eLjbkaY212mSAjMBempJCE7bA,7/31/2020,4/26/2021
201007_MinistryofHealthofRussianFederation_employees,10/7/2020,Sublocal,Russian Federation,Russian Federation,"April 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),1589,8.90%,,,Unclear,"""NMITs Hematology"" Ministry of Health of the Russian Federation",,IgG,,,Unclear,Journal Article (Peer-Reviewed),LV Krechetova,Ministry of Health of Russia,http://dx.doi.org/10.18565/aig.2020.7.122-128,1/15/2021,4/26/2021
201104_SaintPetersburg_EuropeanUniversity_ELISA_Overall_PopTestAdj,11/4/2020,Local,Russian Federation,Russian Federation,"May 27, 2020","June 26, 2020",Household and community samples,Multiple groups,988,9.10%,7.20%,10.90%,Simplified probability,Genetico,,Total Antibody,98.70%,100.00%,Low,Preprint,Anton Barchuk,European University At St Petersburg,https://www.medrxiv.org/content/10.1101/2020.11.02.20221309v1,1/23/2021,4/26/2021
210205_Ekaterinburg_RussianAcademyOfSciences_overall,2/5/2021,Local,Russian Federation,Russian Federation,"May 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),157,11.50%,,,Convenience,VECTOR-BEST,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),M. Sarapultseva,Russian Academy of Sciences,https://dx.doi.org/10.1177/2380084421993099,2/20/2021,3/28/2021
200920_Leningrad_Saint-PetersburgPasteurResearchInstitute_Overall,9/16/2020,Regional,Russian Federation,Russian Federation; Northwestern Federal District,"June 23, 2020","June 26, 2020",Household and community samples,Multiple groups,3130,20.70%,,,Simplified probability,State Scientific Center of Applied Microbiology and Biotechnology (Obolensk),,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology,https://journal.microbe.ru/jour/article/view/1371/1150#,3/11/2021,4/26/2021
201019_Irkutsk_SaintPetersburgPasteurResearchInstitute_Overall,10/10/2020,Regional,Russian Federation,Russian Federation; Irkutsk Region,"June 28, 2020","July 19, 2020",Household and community samples,Multiple groups,2674,5.80%,5.35%,6.25%,Simplified probability,State Scientific Center Applied Microbiology and Biotechnology,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute,https://journal.microbe.ru/jour/article/view/1370/1149,3/14/2021,4/26/2021
200923_Saint-Petersburg_Saint-PetersburgPasteurResearchInstituteofEpidemiologyandMicrobiology_Overall,9/23/2020,Local,Russian Federation,Russian Federation,"June 15, 2020","June 20, 2020",Household and community samples,Multiple groups,2713,26.00%,24.30%,27.70%,Simplified probability,State Scientific Center for Applied Microbiology and Biotechnologies (Obolensk),,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology,https://journal.microbe.ru/jour/article/view/1372/1151,3/19/2021,4/26/2021
201001_TyumenRegion_SaintPetersburgPasteurInstitute,10/1/2020,Regional,Russian Federation,Russian Federation; Tyumen region,"June 7, 2020","June 20, 2020",Household and community samples,Multiple groups,2758,24.50%,22.90%,26.10%,Simplified probability,State Research Center for Applied Microbiology and Biotechnology of Rospotrebnadzor,,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint Petersburg Pasteur Institute,https://microbiol.elpub.ru/jour/article/view/890/520,3/19/2021,4/26/2021
210119_Kaliningrad_RussianAcademyOfSciences_overall,1/19/2021,Regional,Russian Federation,Russian Federation; Kaliningrad Region,"August 3, 2020","August 7, 2020",Household and community samples,Multiple groups,2939,50.20%,49.03%,51.10%,Stratified probability,"FBSI"" State Research Center for Applied Microbiology and Biotechnology",,IgG,,,Moderate,Journal Article (Peer-Reviewed),A. Yu. Popova,The Russian Academy of Sciences ,http://dx.doi.org/10.22625/2072-6732-2020-12-5-62-71,3/25/2021,3/31/2021
20201231_Moscow_MoscowResearchInstituteofEpidemiologyAndMicrobiology_Overall,10/14/2020,Regional,Russian Federation,Russian Federation; Central Russia; Moscow Region,"June 22, 2020","July 11, 2020",Household and community samples,Multiple groups,2688,21.00%,,,Simplified probability,"FBSI ""State scientific center for applied microbiology and biotechnology""",,IgG,,,Unclear,Journal Article (Peer-Reviewed),A Popova,Moscow Research Insistute of Epidemiology and Microbiology named after V.I G.N Gabrichevsky,http://dx.doi.org/10.20953/1729-9225-2020-4-17-26,4/26/2021,4/26/2021
200906_Madinah_KingFahadGeneralHospital_HCWs_Overall,9/6/2020,Local,Saudi Arabia,Saudi Arabia; Hejaz; Madinah,"April 18, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),330,24.24%,,,Unclear,Vircell Microbiologists,ELISA,"IgM,IgA,IgG",,,High,Journal Article (Peer-Reviewed),Suliman Alharbi,King Fahad General Hospital,https://assets.cureus.com/uploads/original_article/pdf/39817/1599507536-20200907-8365-icotwh.pdf,9/28/2020,4/26/2021
201120_SaudiArabia_SaudiCDC_Overall,11/20/2020,National,Saudi Arabia,"Saudi Arabia; Hail, Najran, Baha, Qassim, Norther Border, Jazan, Riyadh, Emirate of the Eastern Province, Aseer, Madinah, Makkah","May 20, 2020","May 30, 2020",Health care workers and caregivers,Adults (18-64 years),12621,2.36%,,,Convenience,Abbott Laboratories,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Haleema Ali Alserehi,Saudi Center for Disease Prevention and Control,https://dx.doi.org/10.1016/j.diagmicrobio.2020.115273,1/23/2021,4/26/2021
210112_Dammam_KingFahadSpecialistHospital_Overall,1/12/2021,Local,Saudi Arabia,Saudi Arabia; Eastern Province; Dammam,"August 15, 2020","October 12, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),72,12.50%,,,Sequential,"DIasorine, Abbott Laboratories",,IgG,97.60%,99.30%,High,Preprint,Alanoud Alshami,King Fahad Specialist Hospital,https://assets.researchsquare.com/files/rs-140932/v1/a7cb2461-27b8-4eca-bf34-171b60bb1272.pdf,2/4/2021,3/28/2021
210116_SaudiArabia_MinistryofHealth_overall,1/16/2021,National,Saudi Arabia,Saudi Arabia,"May 20, 2020","May 25, 2020",Blood donors,Adults (18-64 years),837,1.40%,,,Sequential,Roche Diagnostics,,Total Antibody,99.80%,99.50%,Moderate,Journal Article (Peer-Reviewed),Ayman Banjar,Ministry of Health (Saudi Arabia),https://dx.doi.org/10.1016/j.ijid.2021.01.028,2/7/2021,3/31/2021
210105_Jeddah_KingAbdulazizUniversity_overall,1/5/2021,Sublocal,Saudi Arabia,Saudi Arabia,"January 1, 2020","May 31, 2020",Blood donors,Adults (18-64 years),956,1.50%,,,Sequential,Authors,,IgG,100.00%,98.40%,High,Journal Article (Peer-Reviewed),Thamir Alandijany,King Abdulaziz University,https://dx.doi.org/10.3390/healthcare9010051,2/9/2021,3/31/2021
201206_Al-Madinah_TaibahUniversity_Overall,12/6/2020,Local,Saudi Arabia,Saudi Arabia,"May 15, 2020","July 15, 2020",Blood donors,Adults (18-64 years),1212,19.31%,17.12%,21.64%,Convenience,"In-house, NR",,IgG,,,High,Journal Article (Peer-Reviewed),Waleed Mahallawi,Taibah University,https://dx.doi.org/10.1016/j.sjbs.2020.12.009,2/17/2021,4/26/2021
210131_SaudiArabia_KingAbdullahInternationalMedicalResearchCenter_genpop_overall,1/31/2021,National,Saudi Arabia,"Saudi Arabia; Riyadh, Jazan, Qassim, Hail, Al-Ahsa, Makkah","June 20, 2020","November 20, 2020",Multiple populations,Multiple groups,11275,10.90%,10.30%,11.60%,Convenience,"1) N/A - author designed

2) EUROIMMUN",,IgG,,,Moderate,Preprint,Naif Khalaf Alharbi,King Abdullah International Medical Research Center,10.1101/2021.01.28.21250598,3/4/2021,4/22/2021
210131_Riyadh_KingAbdullahInternationalMedicalResearchCenter_HCW_overall,1/31/2021,Local,Saudi Arabia,Saudi Arabia,"June 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),400,7.50%,4.95%,10.16%,Unclear,N/A - Author designed,,IgG,,,High,Preprint,Naif Khalaf Alharbi,King Abdullah International Medical Research Center,10.1101/2021.01.28.21250598,3/4/2021,4/22/2021
210213_Makkah_KingAbdulazizUniversity_HCW,2/13/2021,Sublocal,Saudi Arabia,Saudi Arabia; Mecca Province; Makkah (Mecca),"June 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),204,6.30%,,,Convenience,"In-House
MN assay unclear (GeurtsvanKessel et al., 2020; Kohmeret al., 2021; Lisboa Bastos et al., 2020).",,IgG,100.00%,98.40%,High,Journal Article (Peer-Reviewed),Waleed Ahmed,King Abdulaziz University,https://dx.doi.org/10.1016/j.jksus.2021.101366,3/28/2021,4/2/2021
200429_Singapore_NCID_GeneralPopulation,4/29/2020,Local,Singapore,Singapore,"February 15, 2020","April 15, 2020",Household and community samples,Multiple groups,774,0.00%,,,Unclear,Not reported,Not reported,Not reported,,,Unclear,News and Media,Rei Kurohi,Singapore National Centre for Infectious Diseases,https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says,5/2/2020,4/26/2021
200429_Singapore_Singapore_NCID_HCW,4/29/2020,Sublocal,Singapore,Singapore,"February 15, 2020","April 15, 2020",Health care workers and caregivers,Not reported,1096,0.00%,,,Unclear,Not reported,Not reported,Not reported,,,Unclear,News and Media,Rei Kurohi,Singapore National Centre for Infectious Diseases,https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says,5/2/2020,4/26/2021
210209_Singapore_MinistryOfHealthSingapore,2/9/2021,Sublocal,Singapore,Singapore; NR; Singapore,"March 25, 2020","July 25, 2020",Multiple populations,Adults (18-64 years),135760,60.10%,,,Convenience,"Siemens, Abbott, or Roche",,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Iain Tan,Ministry of Health Singapore,https://dx.doi.org/10.1001/jama.2020.24071,3/5/2021,4/9/2021
201102_Singapore_NationalCentreForInfectiousDiseases_overall,11/2/2020,National,Singapore,Singapore,"January 23, 2020","April 3, 2020",Contacts of COVID patients,Multiple groups,1150,3.80%,,,Entire sample,N/A - author designed,,Neutralizing ,98.90%,100.00%,Moderate,Journal Article (Peer-Reviewed),Oon Tek Ng,"National Centre for Infectious Diseases, Singapore",https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30833-1/fulltext?dgcid=raven_jbs_etoc_email,3/12/2021,4/26/2021
200928_CapeTown_UniversityofCapeTown_overall_testadj,9/20/2020,Local,South Africa,South Africa,"June 15, 2020","August 7, 2020",Residual sera,Adults (18-64 years),2791,44.60%,42.60%,46.60%,Sequential,Roche Diagnostics,,"IgG,IgM",91.20%,99.70%,High,Institutional Report,Marvin Hsiao, University of Cape Town,https://www.nicd.ac.za/wp-content/uploads/2020/09/COVID-19-Special-Public-Health-Surveillance-Bulletin_Issue-5.pdf,3/3/2021,4/26/2021
210107_CapeTown_UniversityCollegeLondon_PaediatricHCW,1/27/2021,Sublocal,South Africa,South Africa; NR; Capetown,"June 10, 2020","August 17, 2020",Health care workers and caregivers,Adults (18-64 years),222,10.36%,7.00%,15.07%,Convenience,"Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)",,IgG,,,High,Journal Article (Peer-Reviewed),D. Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,4/9/2021
210212_SouthAfrica_SouthAfricanNationalBloodService_NorthernCapePopAdj,2/12/2021,Regional,South Africa,South Africa; Northern Cape,"January 7, 2021","January 25, 2021",Blood donors,Multiple groups,463,31.80%,25.30%,38.30%,Sequential,Roche Diagnostics,,Total Antibody,98.00%,99.80%,High,Preprint,Wendy Sykes,South African National Blood Service,https://pubmed.ncbi.nlm.nih.gov/33594353/,3/20/2021,3/31/2021
210212_SouthAfrica_SouthAfricanNationalBloodService_EasternCapePopAdj,2/12/2021,Regional,South Africa,South Africa; Eastern Cape,"January 7, 2021","January 25, 2021",Blood donors,Multiple groups,1457,62.50%,58.90%,66.10%,Sequential,Roche Diagnostics,,Total Antibody,98.00%,99.80%,Moderate,Preprint,Wendy Sykes,South African National Blood Service,https://pubmed.ncbi.nlm.nih.gov/33594353/,3/22/2021,3/31/2021
210212_SouthAfrica_SouthAfricanNationalBloodService_FreeStatePopAdj,2/12/2021,Regional,South Africa,South Africa; Free State,"January 7, 2021","January 25, 2021",Blood donors,Multiple groups,831,45.50%,39.90%,51.10%,Sequential,Roche Diagnostics,,Total Antibody,98.00%,99.80%,Moderate,Preprint,Wendy Sykes,South African National Blood Service,https://pubmed.ncbi.nlm.nih.gov/33594353/,3/22/2021,3/31/2021
210212_SouthAfrica_SouthAfricanNationalBloodService_KwaZuluPopAdj,2/12/2021,Regional,South Africa,South Africa; KwaZulu Natal,"January 7, 2021","January 25, 2021",Blood donors,Multiple groups,2107,52.10%,49.10%,55.20%,Sequential,Roche Diagnostics,,Total Antibody,98.00%,99.80%,Moderate,Preprint,Wendy Sykes,South African National Blood Service,https://pubmed.ncbi.nlm.nih.gov/33594353/,3/22/2021,3/31/2021
210225_CapeTown_StellenboschUniversity_Overall,2/25/2021,Sublocal,South Africa,South Africa,"August 17, 2020","September 4, 2020",Essential non-healthcare workers,Adults (18-64 years),405,23.70%,,,Convenience,Abbott Laboratories,,IgG,,98.54%,High,Journal Article (Peer-Reviewed),Jane Shaw,Stellenbosch University,https://dx.doi.org/10.1371/journal.pone.0247852,3/27/2021,4/26/2021
210312_Juba_JohnsHopkins_overall,3/12/2021,Local,South Sudan,South Sudan,"August 10, 2020","September 11, 2020",Household and community samples,Multiple groups,1840,38.50%,32.10%,46.80%,Stratified probability,N/A - in house,,IgG,64.70%,100.00%,Low,Preprint,Kirsten E. Wiens,Johns Hopkins,10.1101/2021.03.08.21253009,4/2/2021,4/2/2021
200616_Madrid_UniversidadAutónomadeMadrid_TotalPop,6/16/2020,Local,Spain,Spain; Community of Madrid; Madrid,"April 26, 2020","May 16, 2020",Multiple populations,Multiple groups,674,13.80%,,,Sequential,PCL Inc.,Rapid immunochromatographic test,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Vicente Soriano, Universidad Autónoma de Madrid,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa769/5858269,6/18/2020,4/26/2021
200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ImmunoAssay,7/6/2020,National,Spain,Spain,"April 27, 2020","May 11, 2020",Household and community samples,Multiple groups,51958,4.60%,4.30%,5.00%,Stratified probability,Abbott,Chemiluminescence Immunoassay,IgG,89.70%,100.00%,Low,Journal Article (Peer-Reviewed),Marina Pollán,Institute of Health Carlos III,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31483-5/fulltext,7/21/2020,4/26/2021
200606_Leon_UniversidadedeLeon_HCWs_TestAdj2,6/6/2020,Local,Spain,Spain; Léon; Léon,"April 1, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),676,7.40%,5.50%,10.00%,Convenience,Hangzhou All Test Biotech Co Ltd,RDT,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Vicente Martin,"Gerencia de Atención Primaria del Área de Salud de León, Spain",https://dx.doi.org/10.1016/j.semerg.2020.05.014,7/29/2020,4/26/2021
200806_Valencia_HospitalClínicoUniversitario_HCWs_IgG_and_IgM,8/6/2020,Local,Spain,Spain; Valencia; Valencia,"April 13, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),1153,3.50%,,,Unclear,Snibe Diagnostic,Chemiluminescence Immunoassay,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Arantxa Valdivia,Hospital Clínico Universitario,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26400,9/26/2020,4/26/2021
200810_Spain_CostadelSolHospital_HCW_IgGANDORIgM,8/10/2020,Sublocal,Spain,Spain,"April 15, 2020","April 25, 2020",Health care workers and caregivers,Adults (18-64 years),498,2.20%,,,Self-referral,"""Zhejiang Orient Gene Biotech Co., LTD""",Solid phase immunochromatography,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Julián Olalla, Hospital Costa del Sol ,http://dx.doi.org/10.1093/qjmed/hcaa238,10/3/2020,4/26/2021
200617_TorrejonDeArdoz_MunicipalityOfTorrejonDeArdoz_IgGIgM,6/17/2020,Local,Spain,Spain,"May 29, 2020","June 3, 2020",Household and community samples,Multiple groups,104299,23.07%,,,Entire sample,Not reported,Not reported,"IgG,IgM",,,Moderate,Institutional Report,Daniel Flores,Municipality of Torrejon de Ardoz,https://www.rtve.es/noticias/20200617/test-serologicos-torrejon-ardoz-arrojan-2018-habitantes-tiene-anticuerpos-coronavirus/2018787.shtml,10/7/2020,4/26/2021
200831_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Overall_UnAdj,8/31/2020,Sublocal,Spain,Spain; Community of Madrid; Torrejon de Ardoz,"June 1, 2020","June 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,229,31.40%,,,Convenience,Hangzhou Testsea Biotechnology,Not reported,"IgG,IgM",96.00%,100.00%,High,Journal Article (Peer-Reviewed),Luis Cabezón-Gutiérrez,Hospital General Universitario Gregorio Maranon,https://dx.doi.org/10.1016/j.ctrv.2020.102102,10/20/2020,4/26/2021
200918_Madrid_UniversityHospitalGregorioMarañón_Overall,9/18/2020,Local,Spain,Spain,"May 6, 2020","May 21, 2020",Pregnant or parturient women,Adults (18-64 years),100,13.00%,,,Sequential,Abbott,Chemiluminsescent microparticle immunoassay,IgG,,,High,Journal Article (Peer-Reviewed),Maria Viñuela,University Hospital Gregorio Marañón,http://dx.doi.org/10.37201/req/088.2020,11/12/2020,4/26/2021
200806_Barcelona_UniversitatdeBarcelona_PregnantWomen_Overall,8/6/2020,Sublocal,Spain,Spain,"April 14, 2020","May 5, 2020",Pregnant or parturient women,Adults (18-64 years),874,14.00%,,,Convenience,"Vircell Microbiologist, Ortho Clinical Diagnostics",,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Francesca Crovetto,Universitat de Barcelona,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31714-1/fulltext,1/3/2021,4/26/2021
200911_Santiago_HospitalClinicoUniversitariodeSantiagodeCompostela_Overall,9/11/2020,Sublocal,Spain,Spain; Galicia; Santiago de Compostela,"April 14, 2020","April 16, 2020",Health care workers and caregivers,Adults (18-64 years),175,4.00%,1.10%,6.90%,Convenience,Genobio Pharmaceutical (Shanghai; China),,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ana Dacosta-Urbieta,Hospital Clinico Universitario de Santiago de Compostela,http://dx.doi.org/10.3389/fped.2020.00547,1/5/2021,4/26/2021
201021_Spain_IVIRMA_Overall,9/1/2020,National,Spain,Spain,"April 27, 2020","June 26, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),6140,0.68%,,,Convenience,Epitope Diagnostics,,IgM,,,Unclear,Journal Article (Peer-Reviewed),Nicolás Prados,IVIRMA Global Headquarters,http://dx.doi.org/10.1016/j.fertnstert.2020.09.077,1/8/2021,4/26/2021
200911_Barcelona_SardenyaPrimaryHealthCareCenter_Overall,9/11/2020,Local,Spain,Spain; Catalonia; Barcelona,"April 21, 2020","April 24, 2020",Household and community samples,Multiple groups,311,5.47%,3.44%,8.58%,Stratified probability,"Livzlon, Lysine and Sure Screen",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Patricia Montenegro, Sardenya Primary Health Care Center,http://dx.doi.org/10.1093/fampra/cmaa096,1/8/2021,4/26/2021
201024_Madrid_HospitalUniversitarioPrincipeDeAsturias_HCW_Overall,10/29/2020,Sublocal,Spain,Spain,"May 1, 2020","May 30, 2020",Health care workers and caregivers,Adults (18-64 years),2424,22.40%,,,Convenience,AllTest Biotech,,"IgG,IgM",88.00%,100.00%,High,Journal Article (Peer-Reviewed),Felipe Perez-Garcia ,Hospital Universitario Príncipe de Asturias,https://dx.doi.org/10.1017/ice.2020.1303,1/8/2021,4/26/2021
201112_Barcelona_UniversityHospitalSantJoandeDeu_HHC_primaryest,11/12/2020,Local,Spain,Spain; Catalonia; Barcelona,"April 28, 2020","June 3, 2020",Contacts of COVID patients,Multiple groups,1084,17.99%,,,Convenience,Innovita Tangshan Biological Technology Co,,"IgM,IgG",83.30%,,Moderate,Journal Article (Peer-Reviewed),Pedro Brotons,University Hospital Sant Joan de Deu,https://dx.doi.org/10.1093/cid/ciaa1721,1/23/2021,4/26/2021
201125_Valencia_HospitalArnauDeVilanova_Overall,11/25/2020,Local,Spain,Spain; Valencia; Valencia,"May 2, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,166,1.80%,,,Sequential,DiaSorin,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Javier Garde-Noguera,"Hospital Arnau de Vilanova de Valencia, Spain",https://dx.doi.org/10.3390/cancers12123513,1/23/2021,4/26/2021
201130_Spain_UniversityofZaragoza_unadj,11/30/2020,Sublocal,Spain,Spain,"March 31, 2020","August 31, 2020",Pregnant or parturient women,Adults (18-64 years),260,6.92%,,,Sequential,"Biozek, Abbott, Vircell",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ricardo Savirón-Cornudella,University of Zaragoza,https://dx.doi.org/10.1016/j.ejogrb.2020.11.069,1/23/2021,4/26/2021
201026_Zaragoza_HospitalSanJuandeDios_HCW_primary,11/13/2020,Sublocal,Spain,Spain; Aragon; Zaragoza,"March 20, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),289,5.88%,,,Convenience,"Master Labor S.L., Madrid",,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Luis Antonio Moreno Borraz,Hospital San Juan de Dios,https://dx.doi.org/10.1016/j.regg.2020.10.005,1/27/2021,4/26/2021
201026_Zaragoza_HospitalSanJuandeDios_patients_primary,11/13/2020,Sublocal,Spain,Spain; Aragon; Zaragoza,"March 20, 2020","April 21, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,229,6.99%,,,Convenience,"Master Labor S.L., Madrid",,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Luis Antonio Moreno Borraz,Hospital San Juan de Dios,https://dx.doi.org/10.1016/j.regg.2020.10.005,1/27/2021,4/26/2021
201014_Alicante_COVID-19GroupoftheInfectionsCommission,10/14/2020,Sublocal,Spain,Spain; Alacant; Alicante,"April 24, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),4179,6.60%,5.80%,7.30%,Unclear,NR,,IgG,,,Unclear,Journal Article (Peer-Reviewed),Paula Gras-Valentí,COVID-19 Group of the Infections Commission,https://dx.doi.org/10.1016/j.eimc.2020.09.015,1/29/2021,4/26/2021
201228_Barcelona_InstitutCatalàdelaSalut_HCW_primary,12/28/2020,Local,Spain,Spain,"May 4, 2020","May 22, 2020",Health care workers and caregivers,Multiple groups,7563,10.30%,,,Self-referral,"DiaSorin, Vercelli, Italy; Abbott Diagnostics, Sligo, Italy",,IgG,,,High,Journal Article (Peer-Reviewed),Jaume Barallat,Institut Català de la Salut,https://dx.doi.org/10.1371/journal.pone.0244348,1/30/2021,4/26/2021
201202_Tenerife_ QuironsaludTenerifeHospital_patients_primary,12/2/2020,Sublocal,Spain,Spain; Canary Islands; Tenerife,"April 27, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,211,1.90%,0.07%,4.80%,Sequential,"Roche Diagnostics, Unclear",,Total Antibody,,,High,Journal Article (Peer-Reviewed),Alejandro Hernández Camba, Quironsalud Tenerife Hospital,https://dx.doi.org/10.17235/reed.2020.7434/2020,1/30/2021,4/26/2021
201130_Madrid_UniversidadComplutensedeMadrid,11/30/2020,Sublocal,Spain,Spain,"February 28, 2020","May 10, 2020",Pregnant or parturient women,Adults (18-64 years),769,11.20%,,,Sequential,NR,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Cecilia Villalaın,The Universidad Complutense de Madrid,https://dx.doi.org/10.1371/journal.pone.0243029,1/30/2021,4/26/2021
210114_Fuenlabrada_HospitalUniversitariodeFuenlabrada_HCW_IgG,1/14/2021,Sublocal,Spain,Spain,"May 13, 2020","April 14, 2020",Health care workers and caregivers,Adults (18-64 years),2439,16.90%,,,Convenience,Snibe diagnostic,,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Javier Fernandez,Hospital Universitario de Fuenlabrada,https://dx.doi.org/10.1371/journal.pone.0245001,2/3/2021,4/26/2021
210112_Spain_HMHospitales_overall,1/12/2021,National,Spain,Spain,"April 15, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,6038,11.00%,,,Convenience,Snibe Diagnostic,,IgG,91.21%,97.66%,Moderate,Journal Article (Peer-Reviewed),Jose F. Varona,HM Hospidales,https://dx.doi.org/10.1093/ije/dyaa277,2/6/2021,3/31/2021
201221_Spain_HospitalClínicoUniversitarioLozanoBlesa,12/21/2020,Sublocal,Spain,Spain; Zaragoza; Zaragoza,"April 27, 2020","May 29, 2020",Pregnant or parturient women,Adults (18-64 years),169,8.28%,,,Unclear,"Guangzhou Wondfo Biotech Co. , Abbott, Vircell Microbiologists",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),M Fabre,Hospital Clínico Universitario Lozano Blesa,https://dx.doi.org/10.1177/0004563220980495,2/6/2021,4/26/2021
210127_Madrid_UH-FundacionJimenezDiazUAM_primary,1/27/2021,Sublocal,Spain,Spain; Community of Madrid; Madrid,"March 1, 2020","March 30, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,28,42.90%,,,Convenience,Vircell,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Maria Soledad Pizarro-Sánchez,UH-Fundacion Jimenez Diaz UAM,https://dx.doi.org/10.1159/000512535,2/27/2021,3/31/2021
210209_Madrid_HospitalUniversitarioVirgendelRocio,2/9/2021,Sublocal,Spain,Spain; Community of Madrid; Madrid,"March 15, 2020","May 15, 2020",Contacts of COVID patients,Children and Youth (0-17 years),113,41.60%,,,Convenience,Vircell,,IgG,,,High,Journal Article (Peer-Reviewed),Ana Mendez-Echevarria,Hospital Universitario Virgen del Rocio,https://dx.doi.org/10.1097/INF.0000000000003088,3/11/2021,4/18/2021
210119_Madrid_HospitalInfantilUniversitarioNiñoJesús,1/19/2021,Sublocal,Spain,Spain; Community of Madrid; Madrid,"April 13, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),1292,17.20%,15.16%,19.35%,Convenience,All Test,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Eva Escribano Ceruelo,Hospital Infantil Universitario Niño Jesús,https://dx.doi.org/10.1016/j.eimc.2020.12.011,3/16/2021,3/31/2021
210318_Barcelona_UniversitatDeBarcelona_overall,3/18/2021,Local,Spain,Spain,"March 5, 2020","May 31, 2020",Pregnant or parturient women,Adults (18-64 years),2225,14.10%,,,Sequential,"1) Vircell

2) Ortho Clinical Diagnostics

3) N/A - institution designed",,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Francesca Crovetto,Universitat de Barcelona,https://dx.doi.org/10.1093/cid/ciab104,3/17/2021,3/28/2021
201218_Madrid_HospitalUniversitarioFundaciónAlcorcón_HCW_Overall,12/18/2020,Sublocal,Spain,Spain,"April 14, 2020","April 27, 2020",Health care workers and caregivers,Adults (18-64 years),2590,31.60%,,,Convenience,Palex,,IgG,88.90%,91.80%,High,Journal Article (Peer-Reviewed),Isabel Galán,Hospital Universitario Fundación Alcorcón,https://dx.doi.org/10.1016/j.eimc.2020.11.015,3/24/2021,4/26/2021
210216_Alicante_UniversityofAlicante_overall_PopAdj_TestAdj,2/16/2021,Sublocal,Spain,Spain; Alicante; Alicante,"July 6, 2020","July 22, 2020",Multiple populations,Adults (18-64 years),1479,2.89%,2.06%,3.73%,Stratified probability,"Cellex Inc., Durham, NC, USA",,"IgG,IgM",87.80%,99.90%,Moderate,Journal Article (Peer-Reviewed),Jose Tuells,University of Alicante,http://dx.doi.org/10.3390/ijerph18041908,3/27/2021,4/11/2021
210223_Barcelona_UniversitatDeBarcelona_primary,2/23/2021,Sublocal,Spain,Spain,"September 29, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),507,16.40%,13.30%,19.90%,Simplified probability,N/A - in house,,"IgA,IgG,IgM",95.78%,100.00%,Moderate,Preprint,Natalia Ortega,Universitat de Barcelona ,10.1101/2021.02.22.21252150,3/31/2021,3/31/2021
210226_Mallorca_SonLlatzerUniversityHospital_overall,2/26/2021,Sublocal,Spain,Spain,"April 28, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),2210,2.80%,2.50%,3.10%,Convenience,Abbott ,,"IgG,IgM",96.70%,99.60%,Moderate,Journal Article (Peer-Reviewed),Adrian Rodriguez,Son Llatzer University Hospital,https://dx.doi.org/10.1016/j.ijid.2021.02.104,4/1/2021,4/1/2021
210312_Spain_ InstitutoDeSalud CarlosIII_overall_Abbott,3/12/2021,National,Spain,Spain,"November 16, 2020","November 29, 2020",Household and community samples,Multiple groups,5827,4.90%,,,Stratified probability,Abbott,,IgG,99.60%,100.00%,Low,Preprint,Mayte Pérez-Olmeda, Instituto de Salud Carlos III,10.1101/2021.03.11.21253142,4/3/2021,4/3/2021
200702_Stockhom_KTHRoyalInstituteofTechnology_genpop,7/2/2020,Local,Sweden,Sweden; Uppland; Stockholm,"April 1, 2020","May 21, 2020",Household and community samples,Multiple groups,878,5.40%,,,Simplified probability,Author-designed,Multiplex immunoassay,"IgG,IgM",100.00%,100.00%,Moderate,Preprint,Niclas Roxhed,KTH Royal Institute of Technology,https://www.medrxiv.org/content/10.1101/2020.07.01.20143966v1,7/14/2020,4/26/2021
200720_Uppsala_UppsalaUniversity_Total,7/20/2020,Regional,Sweden,Sweden; Uppsala,"May 27, 2020","June 25, 2020",Health care workers and caregivers,Multiple groups,8679,6.60%,,,Entire sample,Abbott,Chemiluminescence Immunoassay,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna-Karin Lidström,Uppsala University ,https://dx.doi.org/10.1080/03009734.2020.1793039,7/31/2020,4/26/2021
200723_Sweden_Werlabs_GenPop,7/23/2020,Local,Sweden,"Sweden; Skåne, Västra Götaland, Uppland; Stockholm, Gothenburg, Malmo","July 1, 2020","July 22, 2020",Household and community samples,Not reported,83000,14.40%,,,Unclear,Werlabs,Not reported,Not reported,,,High,News and Media,The Local,Werlabs,https://www.google.com/url?rct=j&sa=t&url=https://www.thelocal.se/20200723/14-of-antibody-tests-positive-in-sweden&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHl1If-XI0aCeB5tGakbaJvFktByQ,8/2/2020,4/26/2021
200805_Stockholm_UppsalaUniversity_CaregiversOverall_IgGORIgM,8/5/2020,Local,Sweden,Sweden,"April 1, 2020","April 20, 2020",Health care workers and caregivers,Adults (18-64 years),1005,22.90%,20.40%,25.70%,Convenience,Zhejiang Orient Gene Biotech Co Ltd,LFIA: Lateral flow immunoassay,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Johanna Lindahl,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1789036,10/14/2020,4/26/2021
200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_TotalAbpositive,8/11/2020,Sublocal,Sweden,"Sweden; Södermanland, Uppland; Stockholm","June 17, 2020","June 18, 2020",Household and community samples,Adults (18-64 years),123,4.10%,0.60%,7.60%,Simplified probability,Zhejiang Orient Gene Biotech Co Ltd,Rapid point-of care,"IgG,IgM",100.00%,95.50%,High,Journal Article (Peer-Reviewed),Åke Lundkvist,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1806505,10/15/2020,4/26/2021
200811_Stockholm_UppsalaUniversity_Tensta_TotalAbPositive,8/11/2020,Sublocal,Sweden,"Sweden; Södermanland, Uppland; Stockholm","June 17, 2020","June 18, 2020",Household and community samples,Adults (18-64 years),90,30.00%,20.30%,39.70%,Simplified probability,Zhejiang Orient Gene Biotech Co Ltd,Rapid point-of care,"IgG,IgM",100.00%,95.50%,High,Journal Article (Peer-Reviewed),Åke Lundkvist,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1806505,10/15/2020,4/26/2021
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week17_Overall,6/18/2020,National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","April 20, 2020","April 26, 2020",Residual sera,Multiple groups,1200,5.30%,3.80%,7.10%,Stratified non-probability,Sci LifeLab / KTH,Multiplex immunoassay,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Authority,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/24/2020,4/26/2021
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week18_Overall,6/18/2020,National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","April 27, 2020","May 3, 2020",Residual sera,Multiple groups,1200,4.00%,2.71%,5.67%,Stratified non-probability,Sci LifeLab / KTH,Multiplex immunoassay,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Authority,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,4/26/2021
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week19_Overall,6/18/2020,National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","May 4, 2020","May 10, 2020",Residual sera,Multiple groups,1200,3.90%,2.61%,5.42%,Stratified non-probability,Sci LifeLab / KTH,Multiplex immunoassay,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Authority,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,4/26/2021
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week20_Overall,6/18/2020,National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","May 11, 2020","May 17, 2020",Residual sera,Multiple groups,1200,4.50%,3.07%,6.15%,Stratified non-probability,Sci LifeLab / KTH,Multiplex immunoassay,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Authority,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,4/26/2021
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week21_Overall,6/18/2020,National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","May 18, 2020","May 24, 2020",Residual sera,Multiple groups,1200,5.20%,3.67%,7.00%,Stratified non-probability,Sci LifeLab / KTH,Multiplex immunoassay,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Authority,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,4/26/2021
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week22_Overall,6/18/2020,National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","May 25, 2020","May 31, 2020",Residual sera,Multiple groups,1200,5.70%,3.98%,7.72%,Stratified non-probability,Sci LifeLab / KTH,Multiplex immunoassay,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Authority,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,4/26/2021
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week23_Overall,6/18/2020,National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","June 1, 2020","June 7, 2020",Residual sera,Multiple groups,1200,6.80%,5.07%,8.80%,Stratified non-probability,Sci LifeLab / KTH,Multiplex immunoassay,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Authority,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,4/26/2021
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week24_Overall,6/18/2020,National,Sweden,"Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","June 8, 2020","June 14, 2020",Residual sera,Multiple groups,1200,5.20%,3.74%,7.06%,Stratified non-probability,Sci LifeLab / KTH,Multiplex immunoassay,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Authority,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,4/26/2021
200716_Stockholm_RegionStockholm,7/16/2020,Local,Sweden,Sweden; Uppland; Stockholm,"June 15, 2020","July 15, 2020",Household and community samples,Multiple groups,149616,17.60%,,,Self-referral,Not reported,Not reported,Not reported,,,High,Institutional Report,Stockholm Region,Sweden Public Health Authority,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/07/16-juli-lagesrapport-om-arbetet-med-det-nya-coronaviruset/,10/25/2020,4/26/2021
201008_Stockholm_DanderydHospital,10/8/2020,Sublocal,Sweden,Sweden; Sodermanland; Stockholm,"April 14, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),2149,19.10%,,,Convenience,Author designed,,IgG,99.20%,99.80%,Moderate,Journal Article (Peer-Reviewed),Ann-Sofie Rudberg,Danderyd Hospital,http://dx.doi.org/10.1038/s41467-020-18848-0,12/9/2020,4/26/2021
201222_Stockholm_KarolinskaUniversityHospital_LTCFstaff_primary,12/22/2020,Sublocal,Sweden,Sweden,"May 11, 2020","June 17, 2020",Assisted living and long-term care facilities,Multiple groups,403,20.10%,,,Convenience,(Luminex Corp),,IgG,99.20%,99.80%,High,Preprint,Sadaf Sakina Hassan,Karolinska University Hospital,https://www.medrxiv.org/content/10.1101/2020.12.18.20248511v1,2/2/2021,4/26/2021
201226_Stockholm_KarolinskaInstitutet,12/26/2020,Local,Sweden,Sweden; Uppland; Stockholm,"March 14, 2020","December 11, 2020",Multiple populations,Adults (18-64 years),4100,14.80%,12.20%,18.00%,Simplified probability,NR - In-house,,IgG,,,High,Preprint,Xaquin Castro Dopico,Karolinska Institutet,https://www.medrxiv.org/content/10.1101/2020.12.24.20248821v1,2/3/2021,4/26/2021
210129_Stockholm_KarolinskaInstitutet_HCW,1/29/2021,Sublocal,Sweden,Sweden; Uppland; Stockholm,"May 11, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),3981,17.70%,,,Convenience,NR,,IgG,99.20%,99.80%,Moderate,Preprint,Susanna Klevebro,Karolinska Institutet,https://doi.org/10.1101/2021.01.28.21250664,2/21/2021,4/2/2021
201124_Vasteras_HospitalofVastmanland_HCW,11/24/2020,Sublocal,Sweden,Sweden,"May 4, 2020","August 19, 2020",Health care workers and caregivers,Adults (18-64 years),131,19.08%,,,Convenience,Abbott,,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Mulki Rashid-Abdi,The Hospital of Vastmanland ,https://dx.doi.org/10.1080/23744235.2020.1849787,2/22/2021,4/26/2021
210121_Sweden_CopenhagenUniversityHospital_Sweden,1/21/2021,National,Sweden,Sweden,"June 22, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),1248,8.30%,,,Convenience,"Livson Diagnostics, Zhuhai, Gunangdong, China; Guangzhou Wondfo Biotech",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jannie Laursen,Copenhagen University Hospital,https://dx.doi.org/10.3390/ijerph18030923,2/25/2021,4/26/2021
210309_SkåneRegion_LundUniversity_UniversityEmployees,3/9/2021,Sublocal,Sweden,Sweden; Skåne Region; Lund,"September 8, 2020","November 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),192,6.00%,,,Convenience,Zeta Gene Ltd.,,IgG,,,High,Journal Article (Peer-Reviewed),David Nygren,Lund University,https://dx.doi.org/10.1080/23744235.2021.1892819,4/1/2021,4/1/2021
210309_SkåneRegion_LundUniversity_HCWs,3/9/2021,Sublocal,Sweden,Sweden; Skåne Region,"September 8, 2020","November 10, 2020",Health care workers and caregivers,Adults (18-64 years),271,5.90%,,,Convenience,Zeta Gene Ltd.,,IgG,,,High,Journal Article (Peer-Reviewed),David Nygren,Lund University,https://dx.doi.org/10.1080/23744235.2021.1892819,4/1/2021,4/1/2021
210304_Stockholm_KarolinskaUniversityHospital_Overall,3/4/2021,Sublocal,Sweden,Sweden,"April 23, 2020","May 22, 2020",Health care workers and caregivers,Adults (18-64 years),12928,11.50%,10.90%,11.80%,Convenience,N/A - in house,,IgG,99.20%,99.80%,Moderate,Journal Article (Peer-Reviewed),Joakim Dillner,Karolinska University Hospital,https://dx.doi.org/10.1038/s41598-021-84356-w,4/17/2021,4/18/2021
200807_Zurich_UniversityofZurich_USZCohort_MarchQDA,8/7/2020,Local,Switzerland,Switzerland; Zurich; Zurich,"March 1, 2020","March 31, 2020",Residual sera,Adults (18-64 years),3806,0.30%,0.10%,0.50%,Sequential,Author-designed,Tripartite Automated Blood Immunoassay,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,1 March 2020,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/26/2020,4/26/2021
200807_Zurich_UniversityofZurich_USZCohort_AprilQDA,8/7/2020,Local,Switzerland,Switzerland; Zurich; Zurich,"April 1, 2020","April 30, 2020",Residual sera,Adults (18-64 years),4275,1.40%,1.00%,1.70%,Sequential,Author-designed,Tripartite Automated Blood Immunoassay,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/26/2020,4/26/2021
200807_Zurich_UniversityofZurich_USZCohort_May-JulyAveQDA,8/7/2020,Local,Switzerland,Switzerland; Zurich; Zurich,"May 15, 2020","July 15, 2020",Residual sera,Adults (18-64 years),12831,0.90%,,,Sequential,Author-designed,Tripartite Automated Blood Immunoassay,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/26/2020,4/26/2021
200807_Zurich_UniversityofZurich_BDSCohort_AprilQDA,8/7/2020,Local,Switzerland,Switzerland; Zurich; Zurich,"April 1, 2020","April 30, 2020",Blood donors,Adults (18-64 years),1469,1.20%,0.70%,,Sequential,Author-designed,Tripartite Automated Blood Immunoassay,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/26/2020,4/26/2021
200807_Zurich_UniversityofZurich_BDSCohort_earlyJulyQDA,8/7/2020,Local,Switzerland,Switzerland; Zurich; Zurich,"July 1, 2020","July 15, 2020",Blood donors,Adults (18-64 years),1067,0.70%,0.30%,1.20%,Sequential,Author-designed,Tripartite Automated Blood Immunoassay,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/26/2020,4/26/2021
200918_Zurich_UniversityofZurich_AdultSampleOverall,9/18/2020,Local,Switzerland,Switzerland; Zurich; Zurich,"June 16, 2020","July 9, 2020",Household and community samples,Adults (18-64 years),577,3.30%,1.40%,5.50%,Simplified probability,"Centre Hospitalier Universitaire Vaudois, Swiss Federal Institute of Technology in Lausanne, Swiss Vaccine Center",,"IgG,IgA",98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.09.18.20191254v1,1/12/2021,4/26/2021
201213_Switzerland_CantonalHospitalStGallen_hcw_primaryest,12/13/2020,Regional,Switzerland,Switzerland; Canton of St. Gallen,"June 22, 2020","August 15, 2020",Health care workers and caregivers,Multiple groups,4664,3.00%,,,Convenience,"ECLIA: Roche Diagnostics, Rotkreuz, Switzerland
ELISA: Euroimmune, Germany",,"IgA,IgG,Total Antibody",,,Moderate,Preprint,Christian R. Kahlert,Cantonal Hospital St Gallen,https://www.medrxiv.org/content/10.1101/2020.11.10.20229005v3,1/13/2021,4/26/2021
201008_StGallen_CantonalHospitalStGallen_hcw,10/8/2020,Regional,Switzerland,Switzerland; St. Gallen; St. Gallen,"March 19, 2020","April 3, 2020",Health care workers and caregivers,Adults (18-64 years),1012,0.99%,,,Convenience,"lateral flow immunochromatographic assay
(LFIA, Sugentech, Yuseong-gu, Daejeon, Republic of Korea), a
chemiluminescence microparticle immunoassay (CMIA, Abbott
Diagnostics, Lake Bluff, IL), and an electro-chemiluminescence
immunoassay (ECLIA, Roche Diagnostics, Basel, Switzerland)",,IgG,,,High,Journal Article (Peer-Reviewed),Phillipp Kohler,Cantonal Hospital St. Gallen,https://dx.doi.org/10.1017/ice.2020.1244,1/17/2021,4/26/2021
201108_Geneva_GenevaUniversityHospital_Overall,11/8/2020,Sublocal,Switzerland,Switzerland,"April 1, 2020","April 30, 2020",Residual sera,Children and Youth (0-17 years),208,8.70%,,,Sequential,"Euroimmun, N/A, N/A",,IgG,,,High,Journal Article (Peer-Reviewed),Klara Posfay-Barbe,Geneva University Hospital,https://dx.doi.org/10.1093/cid/ciaa1702,1/17/2021,4/26/2021
201104_Geneva_JohnHopkins_Overall,1/16/2021,Regional,Switzerland,Switzerland; Geneva,"April 3, 2020","June 30, 2020",Household and community samples,Multiple groups,4534,6.57%,6.00%,7.00%,Convenience,Euroimmun,,IgG,93.00%,99.00%,Moderate,Preprint,Qifang Bi,Johns Hopkins Bloomberg School of Public Health,https://www.medrxiv.org/content/10.1101/2020.11.04.20225573v2,1/17/2021,4/26/2021
201103_Vaud_UniversityofLausanne_GenPop1_Roche,11/3/2020,Regional,Switzerland,Switzerland; Vaud,"May 4, 2020","June 27, 2020",Household and community samples,Multiple groups,311,3.90%,,,Simplified probability,Roche,,Total Antibody,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Craig Fenwick,Lausanne University Hospital and University of Lausanne,http://dx.doi.org/10.1128/JVI.01828-20,1/23/2021,4/26/2021
201103_Vaud_UniversityofLausanne_CloseContacts2_Roche,11/3/2020,Regional,Switzerland,Switzerland; Vaud,"May 4, 2020","June 27, 2020",Contacts of COVID patients,Multiple groups,177,32.20%,,,Unclear,Roche,,Total Antibody,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Craig Fenwick,Lausanne University Hospital and University of Lausanne,http://dx.doi.org/10.1128/JVI.01828-20,1/23/2021,4/26/2021
201130_Vaud_ UniversityofLausanne_Household1_adj,11/30/2020,Regional,Switzerland,Switzerland; Vaud,"May 4, 2020","June 27, 2020",Contacts of COVID patients,Multiple groups,302,57.20%,49.50%,64.30%,Simplified probability,"Lausanne University Hospital, Switzerland",,IgG,96.70%,99.20%,Moderate,Preprint,Julien Dupraz,University of Lausanne,https://www.medrxiv.org/content/10.1101/2020.11.27.20239244v1,1/23/2021,4/26/2021
201130_Vaud_ UniversityofLausanne_CloseContactsOutsideHousehold2_adj,11/30/2020,Regional,Switzerland,Switzerland; Vaud,"May 4, 2020","June 27, 2020",Contacts of COVID patients,Multiple groups,69,19.00%,10.00%,33.20%,Simplified probability,"Lausanne University Hospital, Switzerland",,IgG,96.70%,99.20%,Moderate,Preprint,Julien Dupraz,University of Lausanne,https://www.medrxiv.org/content/10.1101/2020.11.27.20239244v1,1/23/2021,4/26/2021
201222_Zurich_UniversityofZurich_Time1,12/22/2020,Regional,Switzerland,Switzerland; Zurich; Zurich,"June 16, 2020","July 15, 2020",Household and community samples,Children and Youth (0-17 years),2496,3.00%,,,Stratified probability,Institute of Medical Virology (IMV) of the University of Zurich,,"IgG,IgM,IgA",94.30%,99.00%,Low,Preprint,Agne Ulyte,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.12.19.20248513v1,2/1/2021,4/26/2021
201222_Zurich_UniversityofZurich_OverallAdj,12/22/2020,Regional,Switzerland,Switzerland; Zurich; Zurich,"June 16, 2020","November 19, 2020",Household and community samples,Children and Youth (0-17 years),2507,7.80%,6.20%,9.50%,Stratified probability,Institute of Medical Virology (IMV) of the University of Zurich,,"IgG,IgM,IgA",94.30%,99.00%,Low,Preprint,Agne Ulyte,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.12.19.20248513v1,2/27/2021,4/26/2021
210201_Geneva_GenevaUniversityHospitals_overall_adj,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Multiple groups,4000,21.10%,19.20%,23.10%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_age65-74,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Seniors (65+ years),276,14.90%,10.90%,19.50%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_age50-64,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Adults (18-64 years),729,21.20%,18.10%,24.60%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_age35-49,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Adults (18-64 years),1237,23.60%,20.80%,26.40%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_age25-34,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Adults (18-64 years),336,25.90%,21.80%,30.20%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_age18-24,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Adults (18-64 years),206,25.40%,19.80%,31.50%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_age12-17,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Children and Youth (0-17 years),400,23.60%,19.60%,28.00%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_age6-11,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Children and Youth (0-17 years),395,22.80%,18.70%,27.10%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_age0-5,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Children and Youth (0-17 years),219,14.90%,10.70%,19.60%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_female,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Multiple groups,2134,20.40%,18.30%,22.50%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_male,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Multiple groups,1866,21.90%,19.60%,24.30%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
210201_Geneva_GenevaUniversityHospitals_age75+,2/1/2021,Local,Switzerland,Switzerland,"November 23, 2020","December 23, 2020",Household and community samples,Seniors (65+ years),202,9.30%,5.50%,13.70%,Stratified probability,Roche,,Total Antibody,,,Low,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,4/19/2021
201130_Fribourg_UniversitéDeFribourg_overall,11/30/2020,Regional,Switzerland,Switzerland; Canton of Fribourg,"July 8, 2020","October 14, 2020",Household and community samples,Multiple groups,418,8.00%,4.00%,12.00%,Simplified probability,"N/A - institutionally designed (Centre Hospitalier Universitaire Vaudois (CHUV), l'École Polytechnique Fédérale de Lausanne (EPFL) et l’Institut Suisse de Recherche sur les Vaccins)",,"IgG,IgA",96.60%,99.70%,Moderate,Institutional Report,Daniela Anker,Université de Fribourg,https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2020-PopHealthLab-Corona-Immunitas-E1.pdf,3/12/2021,4/26/2021
201218_Geneva_GenevaUniversityHospitals_overall_adj,12/18/2020,Regional,Switzerland,Switzerland; Canton of Geneva,"April 6, 2020","June 30, 2020",Household and community samples,Multiple groups,8344,7.80%,6.80%,8.90%,Stratified probability,Euroimmun,,IgG,93.00%,100.00%,Low,Preprint,Aude Richard,Geneva University Hospital,https://www.medrxiv.org/content/10.1101/2020.12.16.20248180v1.full.pdf,3/21/2021,4/26/2021
210317_Zurich_UniversityofZurich_OverallAdj ,3/17/2021,Regional,Switzerland,Switzerland; Canton of Zurich,"June 16, 2020","November 19, 2020",Students and Daycares,Children and Youth (0-17 years),2776,7.80%,6.20%,9.50%,Stratified probability,Institute of Medical Virology (IMV) of the University of Zurich,,"IgG,IgM,IgA",94.30%,99.00%,Low,Journal Article (Peer-Reviewed),Agne Ulyte,University of Zurich,https://www.bmj.com/content/372/bmj.n616,4/6/2021,4/26/2021
210419_Fribourg_UniversitédeFribourg_Overall,4/1/2021,Regional,Switzerland,Switzerland; Canton of Fribourg,"November 30, 2020","February 5, 2021",Household and community samples,Multiple groups,449,19.00%,15.00%,23.00%,Simplified probability,N/A - Institution designed,,"IgG,IgA",96.60%,99.70%,Moderate,Institutional Report,,Université de Fribourg,https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2021-PopHealthLab-Corona-Immunitas-E2.pdf,4/19/2021,4/19/2021
200929_Ticino_InstituteofPublicHealth_primary,9/29/2020,Local,Switzerland,Switzerland,"July 1, 2020","July 31, 2020",Household and community samples,Adults (18-64 years),647,11.00%,,,Simplified probability,Centre Hospitalier Universitaire Vaudois (CHUV) in collaboration with the Swiss Federal Institute of Technology in Lausanne (EFPL) and the Swiss Centre for Vaccine Research.,,Not reported,,,Unclear,News and Media,Universita della Svizzera Italiana,The Institute of Public Health on the Università della Svizzera italiana,https://www.biomed.usi.ch/en/feeds/8913,4/23/2021,4/25/2021
210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseII_overall,1/15/2021,Regional,Switzerland,Switzerland; Canton of Neuchâtel ,"August 21, 2020","October 29, 2020",Household and community samples,Multiple groups,381,4.90%,2.38%,8.14%,Stratified probability,"CHUV, the Swiss Federal Institute of Technology in Lausanne (EPFL) and the Swiss Vaccine Center",,"IgG,IgA",96.60%,99.70%,Moderate,News and Media,Republique et Canton de Neuchatel,École suisse de santé publique,https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx,4/27/2021,4/27/2021
210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseIII,1/15/2021,Regional,Switzerland,Switzerland; Canton of Neuchâtel ,"December 17, 2020","January 15, 2021",Household and community samples,Multiple groups,198,17.30%,,,Stratified probability,"CHUV, the Swiss Federal Institute of Technology in Lausanne (EPFL) and the Swiss Vaccine Center",,"IgG,IgA",96.60%,99.70%,Moderate,News and Media,Republique et Canton de Neuchatel,École suisse de santé publique,https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx,4/27/2021,4/27/2021
210204_Bern_InstituteofPrimaryHealthCare(BIHAM),2/4/2021,Regional,Switzerland,Switzerland,"December 14, 2020","January 20, 2021",Household and community samples,Multiple groups,263,14.00%,,,Unclear,NR,,Not reported,,,Unclear,News and Media,Universitat Bern,Institute of Primary Health Care (BIHAM),https://www.unibe.ch/news/media_news/media_relations_e/media_releases/2021/media_releases_2021/only_14_of_the_bernese_population_have_antibodies_against_coronavirus/index_eng.html,4/29/2021,4/29/2021
200704_Thailand_ChulalongkornUniversity_OverallAdj,7/4/2020,National,Thailand,Thailand,"April 8, 2020","June 26, 2020",Multiple populations,Adults (18-64 years),857,6.30%,,,Convenience,Baiya Phytopharm,Rapid immunochromatographic test,IgM,94.10%,98.00%,Moderate,Preprint,Tanawin Nopsopon,Chulalongkorn University,https://www.medrxiv.org/content/10.1101/2020.06.24.20139188v3,10/7/2020,4/26/2021
200717_Ranong_ChulalongkornUniversity_overall,7/17/2020,Sublocal,Thailand,Thailand; Ranong,"April 17, 2020","May 17, 2020",Health care workers and caregivers,Adults (18-64 years),844,0.80%,0.40%,1.70%,Convenience,"Baya Phytopharm, Thailand",,"IgG,IgM",94.10%,98.00%,Moderate,Preprint,Tanawin Nopsopon,Chulalongkorn University,https://www.medrxiv.org/content/10.1101/2020.07.13.20151944v1,3/19/2021,4/26/2021
210401_Ranong_ChulalongkornUniversity,4/1/2021,Sublocal,Thailand,Thailand; Ranong,"April 17, 2020","May 17, 2020",Health care workers and caregivers,Adults (18-64 years),844,0.80%,0.40%,1.70%,Convenience,"Baiya Phytopharm, Thailand",,"IgG,IgM",94.10%,98.00%,Moderate,Journal Article (Peer-Reviewed),Tanawin Nopsopon,Chulalongkorn University,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238088,4/5/2021,4/26/2021
200520_England_RutherfordHealth_HCW_IgG,5/20/2020,Local,The United Kingdom,"The United Kingdom; England; Reading, Newport, Liverpool, Bedlington","April 14, 2020","April 24, 2020",Health care workers and caregivers,Adults (18-64 years),161,1.24%,,,Convenience,Sugentech,Colloidal Gold Immunochromatography Assay (LFIA),IgG,,,High,Preprint,Karol Sikora,Rutherford Health,https://www.medrxiv.org/content/10.1101/2020.05.16.20099408v1.full.pdf+html,5/21/2020,4/26/2021
200617_Gibraltar_GibraltarGovernment_HCW,6/17/2020,Regional,The United Kingdom,The United Kingdom; Gibraltar,"June 3, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),1247,1.40%,,,Convenience,Not reported,Not reported,IgG,,,Unclear,News and Media,Priya Gulraj,Gibraltar Government ,https://www.google.com/url?rct=j&sa=t&url=https://www.chronicle.gi/after-in-house-gha-screening-programme-govt-rethinks-its-plans-for-anti-body-tests/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWZarBh_XNDZ6O6KvR5YUdioFyGg,6/23/2020,4/26/2021
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_FebMarch,8/21/2020,National,The United Kingdom,The United Kingdom; England,"February 1, 2020","March 31, 2020",Residual sera,Children and Youth (0-17 years),443,0.80%,0.00%,2.50%,Stratified probability,Abbott,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,4/26/2021
200821_England_PHE_WhatsTheStory_TestAdj_FebMarch,8/21/2020,National,The United Kingdom,The United Kingdom; England,"February 1, 2020","March 31, 2020",Household and community samples,Children and Youth (0-17 years),106,0.50%,0.00%,3.60%,Stratified probability,Abbott,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,4/26/2021
200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week13,8/28/2020,Regional,The United Kingdom,The United Kingdom; England; London,"March 26, 2020","March 27, 2020",Blood donors,Adults (18-64 years),757,2.60%,1.10%,4.40%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,4/26/2021
200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week23to27,7/9/2020,National,The United Kingdom,The United Kingdom; England,"June 1, 2020","June 28, 2020",Blood donors,Multiple groups,10318,7.20%,6.60%,7.80%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,4/26/2021
200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week19to22,7/9/2020,National,The United Kingdom,The United Kingdom; England,"May 4, 2020","May 31, 2020",Blood donors,Adults (18-64 years),7686,8.30%,7.50%,9.20%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,4/26/2021
200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week15to16,8/28/2020,Regional,The United Kingdom,The United Kingdom; England; London,"April 9, 2020","April 13, 2020",Blood donors,Adults (18-64 years),1085,11.10%,8.90%,13.60%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,4/26/2021
200807_England_PHE_RCGP_GenPop_TestPopAdj_Overall_euroimmun,8/7/2020,National,The United Kingdom,The United Kingdom; England,"March 16, 2020","June 30, 2020",Residual sera,Seniors (65+ years),6000,3.90%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,4/26/2021
200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week14,8/28/2020,Regional,The United Kingdom,The United Kingdom; England,"April 2, 2020","April 3, 2020",Blood donors,Adults (18-64 years),916,2.40%,1.00%,4.00%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,4/26/2021
200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week17_Mid,8/28/2020,Regional,The United Kingdom,The United Kingdom; England,"April 23, 2020","April 24, 2020",Blood donors,Adults (18-64 years),1043,7.30%,5.40%,9.40%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,4/26/2021
200603_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week17_South,8/28/2020,Regional,The United Kingdom,The United Kingdom; England,"April 24, 2020","April 26, 2020",Blood donors,Adults (18-64 years),865,5.00%,3.20%,7.00%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,4/26/2021
200527_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week16,8/28/2020,Regional,The United Kingdom,The United Kingdom; England,"April 14, 2020","April 16, 2020",Blood donors,Adults (18-64 years),1017,4.60%,3.00%,6.40%,Stratified probability,EUROIMMUN,ELISA,IgG,79.00%,99.00%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,4/26/2021
200527_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week16to17,8/28/2020,Regional,The United Kingdom,The United Kingdom; England,"April 15, 2020","April 20, 2020",Blood donors,Adults (18-64 years),936,6.20%,4.40%,8.40%,Stratified probability,EUROIMMUN,ELISA,IgG,79.00%,99.00%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,4/26/2021
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_May,9/11/2020,National,The United Kingdom,The United Kingdom; England,"May 1, 2020","May 31, 2020",Residual sera,Children and Youth (0-17 years),1061,7.30%,5.60%,9.20%,Stratified probability,Abbott,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,4/26/2021
200821_England_PHE_WhatsTheStory_TestAdj_April,8/21/2020,National,The United Kingdom,The United Kingdom; England,"April 1, 2020","April 30, 2020",Household and community samples,Children and Youth (0-17 years),201,3.80%,1.20%,7.50%,Stratified probability,Abbott,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,4/26/2021
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_April,8/21/2020,National,The United Kingdom,The United Kingdom; England,"April 1, 2020","April 30, 2020",Residual sera,Children and Youth (0-17 years),647,6.10%,4.10%,8.40%,Stratified probability,Abbott,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,4/26/2021
200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_HCW,7/7/2020,Sublocal,The United Kingdom,The United Kingdom; England,"May 4, 2020","May 6, 2020",Health care workers and caregivers,Adults (18-64 years),281,6.00%,,,Convenience,Snibe Diagnostic,Chemiluminescence Immunoassay,IgG,,,High,Journal Article (Peer-Reviewed),Dimitrios Poulikakos,Salford Royal NHS Foundation Trust,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338856/,7/19/2020,4/26/2021
200709_London_UniversityCollegeLondonHospitals_HCW,7/9/2020,Sublocal,The United Kingdom,The United Kingdom; England; London,"March 26, 2020","April 8, 2020",Health care workers and caregivers,Adults (18-64 years),181,45.30%,,,Convenience,in-house flow cytometry and ELISA assays developed as part of the Crick-COVID-Consortium,"ELISA,Flow cytometry assay","IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Catherine Houlihan,University College London Hospitals,https://dx.doi.org/10.1016/S0140-6736(20)31484-7,7/29/2020,4/26/2021
200717_England_OfficeofNationalStatistics_GenPop_PopAdj,,National,The United Kingdom,The United Kingdom; England,"April 26, 2020","July 8, 2020",Household and community samples,Multiple groups,4309,6.30%,5.00%,7.80%,Stratified probability,University of Oxford,ELISA,IgG,99.10%,99.00%,Moderate,,,Office of National Statistics,,8/1/2020,4/25/2021
201004_SEEngland_King’sCollegeLondon,10/14/2020,Regional,The United Kingdom,The United Kingdom; South East England,"April 27, 2020","June 2, 2020",Household and community samples,Multiple groups,431,12.00%,9.10%,15.20%,Unclear,Imperial College London,ELISA,"IgG,IgM",90.00%,100.00%,High,Journal Article (Peer-Reviewed),Philippa M Wells,King’s College London,http://dx.doi.org/10.1016/j.jinf.2020.10.011,9/27/2020,4/26/2021
200725_UK_TheQueenElizabethHospital_HealthCareWorkers_UnAdj,7/25/2020,Sublocal,The United Kingdom,The United Kingdom; England; King's Lynn,"June 1, 2020","June 7, 2020",Health care workers and caregivers,Adults (18-64 years),70,21.40%,,,Unclear,Unclear,Luminex,IgG,,,High,Journal Article (Peer-Reviewed),D.M. Favara,The Queen Elizabeth Hospital,https://dx.doi.org/10.1016/j.clon.2020.07.015,9/28/2020,4/26/2021
200808_UK_PortlandHospitalforWomenandChildren_HCW,8/8/2020,Sublocal,The United Kingdom,The United Kingdom; England; London,"May 15, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),190,22.00%,,,Convenience,Abbott,ELISA,IgG,96.90%,99.90%,High,Journal Article (Peer-Reviewed),Asma Khalil,St George’s University of London,http://dx.doi.org/10.1093/cid/ciaa893,10/3/2020,4/26/2021
200810_London_UniversityCollegeLondon_Total,8/10/2020,Sublocal,The United Kingdom,The United Kingdom; England; London,"May 11, 2020","June 5, 2020",Health care workers and caregivers,Multiple groups,200,14.50%,9.90%,20.10%,Unclear,Abbott,Chemiluminescence Immunoassay,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),S. Bampoe,University College London,https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/full/10.1111/anae.15229,10/4/2020,4/26/2021
200729_London_WhittingtonHealthNHSTrust_Overall,8/4/2020,Sublocal,The United Kingdom,The United Kingdom; England; London,"May 15, 2020","June 5, 2020",Health care workers and caregivers,Multiple groups,2004,31.60%,,,Self-referral,Roche Diagnostics,Electro chemiluminescence immunoassay,"IgG,IgM",,99.80%,High,Journal Article (Peer-Reviewed),Joseph Grant,Whittington Health NHS Trust,https://dx.doi.org/10.1017/ice.2020.402,10/5/2020,4/26/2021
200922_Gateshead_NHSFoundationTrust_Overall,9/22/2020,Sublocal,The United Kingdom,The United Kingdom; England; Gateshead,"May 28, 2020","June 8, 2020",Health care workers and caregivers,Adults (18-64 years),2521,19.40%,,,Convenience,Roche,Chemiluminescence Immunoassay,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Salman Razvi,Gateshead Health NHS Foundation Trust,https://dx.doi.org/10.7861/clinmed.2020-0566,10/14/2020,4/26/2021
200731_England_OfficeofNationalStatistics,,National,The United Kingdom,The United Kingdom; England,"April 26, 2020","July 26, 2020",Household and community samples,Multiple groups,4840,6.20%,5.00%,7.60%,Stratified probability,University of Oxford,ELISA,IgG,99.10%,99.00%,Moderate,,,Office of National Statistics,,10/19/2020,3/1/2021
200814_England_OfficeofNationalStatistics,,National,The United Kingdom,The United Kingdom; England,"April 26, 2020","July 26, 2020",Household and community samples,Multiple groups,5248,6.20%,5.10%,7.50%,Stratified probability,University of Oxford,ELISA,IgG,99.10%,99.00%,Moderate,,,Office of National Statistics,,10/19/2020,3/28/2021
200807_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week27to31,8/7/2020,National,The United Kingdom,The United Kingdom; England,"June 29, 2020","July 28, 2020",Blood donors,Multiple groups,9388,5.90%,5.30%,6.50%,Stratified probability,EUROIMMUN,ELISA,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,10/19/2020,4/26/2021
200930_Scotland_PublicHealthScotland_BloodDonors_Overall_TestAdj,9/30/2020,National,The United Kingdom,The United Kingdom; Scotland,"June 29, 2020","August 9, 2020",Blood donors,Multiple groups,3220,3.10%,2.50%,3.80%,Sequential,Not reported,Not reported,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/30-september-2020/,10/25/2020,4/25/2021
200724_UK_ChelseaandWestminsterHospital_HCW,7/24/2020,Local,The United Kingdom,The United Kingdom; England; London,"April 8, 2020","June 12, 2020",Health care workers and caregivers,Multiple groups,504,10.60%,7.60%,13.60%,Convenience,"CTK Biotech , Zhuhai Encode Medical Engineering",LFIA: Lateral flow immunoassay,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Scott Pallett,Chelsea and Westminster Hospital NHS Trust,https://dx.doi.org/10.1016/S2213-2600(20)30315-5,10/28/2020,4/26/2021
200911_Birmingham_UniversityHospitalsBirminghamNHSFoundationTrust_Overall,9/11/2020,Sublocal,The United Kingdom,The United Kingdom; England; Birmingham,"April 24, 2020","April 25, 2020",Health care workers and caregivers,Adults (18-64 years),516,24.40%,,,Self-referral,University of Birmingham Clinical Immunology Service,ELISA,"IgA,IgG,IgM",100.00%,97.80%,High,Journal Article (Peer-Reviewed),Adrian Shields,University Hospitals Birmingham NHS Foundation Trust,http://dx.doi.org/10.1136/thoraxjnl-2020-215414,11/3/2020,4/26/2021
200920_EasternUK_CambridgeUniversityHospitalsNHSFoundationTrust_Day1Luminex,9/20/2020,Regional,The United Kingdom,The United Kingdom; East of England,"June 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),434,18.40%,,,Convenience,Cambridge University Hospitals,,IgG,84.00%,100.00%,High,Preprint,David Favara,Cambridge University Hospitals NHS Foundation Trust,https://www.medrxiv.org/content/10.1101/2020.09.18.20197590v1,1/14/2021,4/26/2021
201113_London_ImperialCollegeLondon_KidneyTransplantPatients,"11/13/2020, 11/25/2020",Sublocal,The United Kingdom,The United Kingdom; Greater London; London,"June 1, 2020","July 3, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),855,10.40%,8.50%,12.60%,Sequential,"Abbott, Fortress Diagnostics",,"IgG,Total Antibody",,,High,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Michelle Willicombe, Maria Prendecki",Imperial College London,"https://dx.doi.org/10.1097/TP.0000000000003526, https://dx.doi.org/10.1681/ASN.2020081152",1/16/2021,4/26/2021
201113_Cambridge_RoyalPapworthHospitalNHSTrust_HCW,11/13/2020,Sublocal,The United Kingdom,The United Kingdom; England; Cambridge,"April 20, 2020","June 10, 2020",Health care workers and caregivers,Adults (18-64 years),500,14.00%,,,Convenience,Addenbrookes Hospital NHS Trust,,IgG,97.00%,100.00%,High,Preprint,Helen Baxendale,Royal Papworth Hospital NHS Trust,https://www.medrxiv.org/content/10.1101/2020.11.12.20145318v1,1/16/2021,4/26/2021
201012_UnitedKingdom_RoyalBelfastHospitalForSickChildren,11/10/2020,National,The United Kingdom,"The United Kingdom; Ireland, Wales, Scotland, England; Belfast, Cardiff, Glasgow, London, Manchester","April 16, 2020","July 3, 2020",Family of essential workers,Children and Youth (0-17 years),992,6.90%,5.40%,8.60%,Convenience,"Abbott, Roche, DiaSorin",,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Thomas Waterfield,Royal Belfast Hospital for Sick Children,https://dx.doi.org/10.1136/archdischild-2020-320558,1/17/2021,4/26/2021
201002_Tayside_NinewellsHospitalandMedicalSchool_HCWOverall,10/2/2020,Regional,The United Kingdom,The United Kingdom; Scotland,"May 28, 2020","September 2, 2020",Health care workers and caregivers,Adults (18-64 years),2062,14.50%,,,Convenience,Siemens,,Total Antibody,95.00%,,High,Preprint,Hani Abo-Leyah,Ninewells Hospital and Medical School,https://www.medrxiv.org/content/10.1101/2020.10.02.20205641v1,1/19/2021,4/26/2021
201002_Tayside_NinewellsHospitalandMedicalSchool_GenPop,10/2/2020,Regional,The United Kingdom,The United Kingdom; Scotland,"May 28, 2020","September 2, 2020",Residual sera,Adults (18-64 years),231,4.80%,,,Stratified probability,Siemens,,Total Antibody,95.00%,,High,Preprint,Hani Abo-Leyah,Ninewells Hospital and Medical School,https://www.medrxiv.org/content/10.1101/2020.10.02.20205641v1,1/19/2021,4/26/2021
201022_Oxford_UniversityOfOxford_unadj,10/22/2020,Local,The United Kingdom,The United Kingdom,"April 14, 2020","June 15, 2020",Pregnant or parturient women,Adults (18-64 years),1000,5.30%,4.00%,6.90%,Sequential,University of Oxford,,IgG,99.10%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sheila F Lumley,University of Oxford,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.41.2001721,1/20/2021,4/26/2021
201027_England_ImperialCollegeLondon_SamplingPeriod2_TotalAdj,10/27/2020,National,The United Kingdom,The United Kingdom,"July 31, 2020","August 13, 2020",Household and community samples,Multiple groups,105829,4.83%,4.67%,5.00%,Simplified probability,"Fortress Diagnostics, Northern Ireland",,IgG,84.40%,98.60%,Moderate,Preprint,Helen Ward,Imperial College London,https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf,1/20/2021,4/26/2021
201027_England_ImperialCollegeLondon_SamplingPeriod3_TotalAdj,10/27/2020,National,The United Kingdom,The United Kingdom,"September 15, 2020","September 28, 2020",Household and community samples,Multiple groups,159367,4.38%,4.25%,4.51%,Simplified probability,"Fortress Diagnostics, Northern Ireland",,IgG,84.40%,98.60%,Moderate,Preprint,Helen Ward,Imperial College London,https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf,1/20/2021,4/26/2021
201117_UK_ImmunisationAndCountermeasuresDivision_ChildrenOfHCW,11/17/2020,National,The United Kingdom,The United Kingdom,"May 1, 2020","May 31, 2020",Contacts of COVID patients,Children and Youth (0-17 years),44,36.20%,9.00%,63.40%,Convenience,Abbott Commerce,,IgG,,,High,Journal Article (Peer-Reviewed),Shamez Ladhani,Immunisation and Countermeasures Division,https://dx.doi.org/10.1093/cid/ciaa1737,1/22/2021,4/26/2021
200904_England_PHE_BloodDonors_Overall_TestPopAdj_Week31to35,9/11/2020,National,The United Kingdom,The United Kingdom; England,"July 27, 2020","August 30, 2020",Blood donors,Multiple groups,8764,5.30%,4.80%,5.80%,Stratified probability,EUROIMMUN,,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,4/26/2021
201103_London_PHE_LTCStaff,11/3/2020,Sublocal,The United Kingdom,The United Kingdom; Greater London; London,"June 3, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,327,47.10%,,,Convenience,Abbott,,IgG,93.90%,100.00%,High,Journal Article (Peer-Reviewed),Thomas Rowland,Public Health England,https://dx.doi.org/10.1016/j.jinf.2020.10.035,1/23/2021,4/26/2021
201223_Oxford_OxfordUniversityHospitals_HCW_Spike,12/23/2020,Local,The United Kingdom,The United Kingdom,"April 23, 2020","November 30, 2020",Health care workers and caregivers,Multiple groups,12541,10.08%,,,Entire sample,University of Oxford,,IgG,99.10%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sheila Lumley,Oxford University Hospitals,https://dx.doi.org/10.1056/NEJMoa2034545,1/23/2021,4/26/2021
201119_UK_QueensUniversityBelfast_adj,11/19/2020,National,The United Kingdom,The United Kingdom,"June 26, 2020","August 15, 2020",Family of essential workers,Children and Youth (0-17 years),849,7.66%,6.05%,9.64%,Convenience,"Roche, Basel, Switzerland; DiaSorin, Saluggia, Italy",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Cathal Roarty,Queens University Belfast,https://dx.doi.org/10.1016/S1473-3099(20)30884-7,1/23/2021,4/26/2021
200911_England_PHE_WhatsTheStory_Summary_5_May_August,9/11/2020,National,The United Kingdom,The United Kingdom; England,"May 1, 2020","August 5, 2020",Household and community samples,Children and Youth (0-17 years),568,5.20%,3.20%,7.80%,Stratified probability,Abbott,,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,4/26/2021
201002_England_PHE_BloodDonors_Summary_Final,10/2/2020,National,The United Kingdom,The United Kingdom; England,"August 24, 2020","September 18, 2020",Blood donors,Multiple groups,8230,6.10%,5.40%,6.80%,Stratified probability,EUROIMMUN,,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,4/26/2021
201002_England_PHE_RCGP_Collection_Summary_Final_week25to33_abbott,10/2/2020,National,The United Kingdom,The United Kingdom; England,"June 15, 2020","August 16, 2020",Residual sera,Seniors (65+ years),4315,6.50%,5.50%,7.60%,Stratified probability,Abbott,,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,4/26/2021
201002_England_PHE_SeroepiUnitPaedsSurvey_6_Final_week25to33_Abbott,10/2/2020,National,The United Kingdom,The United Kingdom; England,"June 15, 2020","August 16, 2020",Residual sera,Multiple groups,1212,5.20%,3.90%,7.00%,Stratified probability,Abbott,,IgG,95.70%,99.10%,Low,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,4/26/2021
200826_London_ImperialCollegeLondon_LTC,8/26/2020,Sublocal,The United Kingdom,The United Kingdom; Greater London; London,"June 1, 2020","June 30, 2020",Assisted living and long-term care facilities,Seniors (65+ years),241,71.80%,66.00%,77.00%,Convenience,Abbott,,IgG,93.90%,100.00%,High,Journal Article (Peer-Reviewed),Neil Graham,Imperial College London,https://www.journalofinfection.com/article/S0163-4453(20)30574-0/fulltext,1/23/2021,4/26/2021
201109_UK_WatfordGeneralHospital_ACU,11/9/2020,Sublocal,The United Kingdom,The United Kingdom; NR; Watford,"March 27, 2020","June 8, 2020",Residual sera,Multiple groups,443,1.58%,,,Sequential,NR,,Not reported,,,High,Journal Article (Peer-Reviewed),Muhammad Arif,Watford General Hospital,https://dx.doi.org/10.7759/cureus.11398,1/23/2021,4/26/2021
201215_Leicester_UniversityHospitalsofLeicesterNHSTrust,12/15/2020,Sublocal,The United Kingdom,The United Kingdom; England; Leicester ,"May 29, 2020","August 3, 2020",Health care workers and caregivers,Adults (18-64 years),200,12.00%,,,Convenience,Abbott Laboratories,,IgG,92.70%,100.00%,High,Journal Article (Peer-Reviewed),John Black,University Hospitals of Leicester NHS Trust,https://dx.doi.org/10.1111/tri.13791,1/26/2021,4/26/2021
201130_Bristol_NorthBristolNHSTrust_hcw,11/30/2020,Sublocal,The United Kingdom,"The United Kingdom; England; Bristol, South Gloucestershire, North Somerset","January 15, 2020","June 15, 2020",Health care workers and caregivers,Multiple groups,6858,9.30%,,,Self-referral,Abbott laboratories; RocheDiagnostics,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Christopher Jones,North Bristol NHS Trust,https://www.journalofinfection.com/article/S0163-4453(20)30755-6/fulltext,1/30/2021,4/26/2021
201222_Newcastle_Newcastle-upon-TyneHospitalsNHSTrust,12/22/2020,Sublocal,The United Kingdom,The United Kingdom; England ; Newcastle-Upon-Tyne,"May 29, 2020","July 6, 2020",Health care workers and caregivers,Adults (18-64 years),11103,8.40%,,,Convenience,Roche Diagnostics,,IgG,,,High,Preprint,Aidan Hanrath,Newcastle-upon-Tyne Hospitals NHS Trust,https://www.medrxiv.org/content/10.1101/2020.12.22.20242362v1,2/2/2021,4/26/2021
201211_London_RichmondPharmacologyLtd,12/11/2020,Local,The United Kingdom,The United Kingdom; England; London,"March 19, 2020","December 2, 2020",Multiple populations,Multiple groups,6061,6.40%,,,Unclear,NR,,IgG,,,High,Preprint,Jorg Taubel,Richmond Pharmacology Ltd,https://www.medrxiv.org/content/10.1101/2020.12.08.20245894v2,2/3/2021,4/26/2021
201226_Glasgow_FrancisCrickInstitute_primaryadj,12/26/2020,Local,The United Kingdom,The United Kingdom; Scotland; Glasgow,"March 16, 2020","May 24, 2020",Residual sera,Multiple groups,6635,5.29%,0.13%,15.10%,Sequential,Francis Crick Institute,,IgG,95.31%,97.20%,Moderate,Journal Article (Peer-Reviewed),Ellen C. Hughes,The Francis Crick Institute,https://dx.doi.org/10.1093/infdis/jiaa788,2/4/2021,4/26/2021
201023_England_PHE_HCW&OfficeStaff&LabStaff_Euroimmun,10/23/2020,Sublocal,The United Kingdom,The United Kingdom,"March 23, 2020","August 20, 2020",Health care workers and caregivers,Adults (18-64 years),2247,12.10%,,,Convenience,Euroimmun,,IgG,72.00%,99.00%,Moderate,Preprint,Ross Harris,Public Health England,https://doi.org/10.1101/2020.10.21.20216689,2/6/2021,4/26/2021
201022_Scotland_UniversityOfOxford_overall,10/22/2020,Regional,The United Kingdom,The United Kingdom; Scotland,"March 17, 2020","May 18, 2020",Blood donors,Adults (18-64 years),3500,3.17%,,,Simplified probability,N/A - Author designed,,Not reported,94.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Craig P Thompson,University of Oxford,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.42.2000685,2/6/2021,4/26/2021
210111_UK_PublicHealthEngland_Round1_overall,1/20/2021,National,The United Kingdom,The United Kingdom; England,"June 1, 2020","June 15, 2020",Multiple populations,Multiple groups,2198,13.60%,12.40%,15.10%,Simplified probability,Abbott ,,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/10/2021,3/29/2021
210111_UK_PublicHealthEngland_Round2_overall ,1/20/2021,National,The United Kingdom,The United Kingdom; England,"July 7, 2020","July 21, 2020",Household and community samples,Multiple groups,1431,12.10%,10.50%,13.90%,Simplified probability,Abbott ,,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/11/2021,3/29/2021
210111_UK_PublicHealthEngland_Round3_overall,1/20/2021,National,The United Kingdom,The United Kingdom; England,"November 17, 2020","November 30, 2020",Household and community samples,Multiple groups,1216,10.40%,8.80%,12.30%,Simplified probability,Abbott ,,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/11/2021,3/29/2021
201104_Cambridge_CambridgeUniversityHospitalsNHSFoundationTrust_HCW&HospitalStaff,11/4/2020,Sublocal,The United Kingdom,The United Kingdom; England; Cambridge,"June 10, 2020","August 7, 2020",Health care workers and caregivers,Multiple groups,5698,7.20%,,,Convenience,Siemens Healthcare Limited,,Total Antibody,98.10%,99.90%,Moderate,Preprint,Daniel Cooper,Cambridge University Hospitals NHS Foundation Trust,https://doi.org/10.1101/2020.11.03.20220699,2/13/2021,4/26/2021
201116_Leicester_UniversityofLeicester_HCW,11/16/2020,Sublocal,The United Kingdom,The United Kingdom; East Midlands; Leicester,"May 29, 2020","July 13, 2020",Health care workers and caregivers,Adults (18-64 years),10662,10.77%,,,Convenience,Abbott,,IgG,93.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Christopher Martin,University of Leicester,https://dx.doi.org/10.1093/pubmed/fdaa199,2/13/2021,4/26/2021
210203_England_TheUniversityofNottingham_HCW_primary,2/3/2021,Sublocal,The United Kingdom,The United Kingdom; East Midlands,"April 24, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),633,18.00%,,,Convenience,Study authors,,"IgG,IgA,IgM",,,High,Preprint,Simon Craxford,The University of Nottingham,https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1,2/17/2021,3/31/2021
210203_England_TheUniversityofNottingham_HHC_primary,2/3/2021,Local,The United Kingdom,The United Kingdom; England,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),178,7.30%,,,Convenience,Study authors,,"IgG,IgA,IgM",,,High,Preprint,Simon Craxford,The University of Nottingham,https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1,2/17/2021,3/31/2021
201021_London_BartsHealthNHSTrust_primary,10/21/2020,Sublocal,The United Kingdom,The United Kingdom,"May 1, 2020","June 4, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,1253,18.00%,,,Convenience,Roche,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Kieran McCafferty,Barts Health NHS Trust ,http://dx.doi.org/10.1111/hdi.12883,2/23/2021,4/26/2021
210126_London_ImperialCollegeLondon_HemodialysisPt_Overall,1/26/2021,Sublocal,The United Kingdom,The United Kingdom; England; London,"February 24, 2020","January 1, 2021",Patients seeking care for non-COVID-19 reasons,Not reported,301,2.56%,,,Unclear,Abbott,,IgG,,,High,Preprint,Candice Clarke,Imperial College London,10.1101/2021.01.22.21249865,2/25/2021,4/1/2021
210203_UK_LondonSchoolofHygiene&TropicalMedicine_OrthodoxJews,2/3/2021,Sublocal,The United Kingdom,The United Kingdom,"October 17, 2020","December 13, 2020",Household and community samples,Multiple groups,1242,64.30%,61.60%,67.00%,Simplified probability,"MSD, Rockville, MD",,IgG,96.20%,97.40%,Moderate,Preprint,Katherine Gaskell,London School of Hygiene & Tropical Medicine,https://doi.org/10.1101/2021.02.01.21250839,2/27/2021,3/31/2021
210101_London_LewishamGreenwichNHSTrust_HCW_Overall,1/1/2021,Local,The United Kingdom,"The United Kingdom; England; Lewisham, Greenwich ","May 27, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),6212,26.00%,,,Convenience,Abbott,,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mehool Patel,Lewisham and greenwich NHS Trust ,https://dx.doi.org/10.7861/clinmed.2020-0619,2/28/2021,3/29/2021
201101_London_PublicHealthEngland_Overall,"11/1/2020, 10/2/2020",Local,The United Kingdom,The United Kingdom; England; London,"April 10, 2020","April 13, 2020",Assisted living and long-term care facilities,Multiple groups,394,77.90%,73.60%,81.70%,Convenience,In House: PHE England,,Not reported,99.20%,,High,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Shamez Ladhani, Joan Shang",Public Health England,"https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30341-2/fulltext, http://dx.doi.org/10.1038/s41577-020-00463-1",3/5/2021,4/26/2021
0717_QueenElizabethHospital_QueenElizabethHospital_unadj_overall,,Sublocal,The United Kingdom,The United Kingdom,"June 1, 2020","June 5, 2020",Multiple populations,Adults (18-64 years),70,21.42%,,,Convenience,Unknown,,IgG,84.00%,100.00%,High,Journal Article (Peer-Reviewed),D M Favara,Queen Elizabeth Hospital,10.1016/j.clon.2020.07.015,3/8/2021,3/8/2021
200626_UK_OfficeforNationalStatistics_May_June2020_England_Genpop,6/25/2020,Regional,The United Kingdom,The United Kingdom; England,"May 8, 2020","June 4, 2020",Household and community samples,Multiple groups,1575,6.30%,4.50%,8.70%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
200726_UK_OfficeforNationalStatistics_June_July2020_England_Genpop,7/31/2020,Regional,The United Kingdom,The United Kingdom; England,"June 5, 2020","July 2, 2020",Household and community samples,Multiple groups,2392,4.18%,,,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
200826_UK_OfficeforNationalStatistics_July_020_England_genpop,8/28/2020,Regional,The United Kingdom,The United Kingdom; England,"July 3, 2020","July 30, 2020",Household and community samples,Multiple groups,3236,6.50%,5.20%,8.10%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
200826_UK_OfficeforNationalStatistics_July_August2020_England_genpop,8/28/2020,Regional,The United Kingdom,The United Kingdom; England,"July 31, 2020","August 27, 2020",Household and community samples,Multiple groups,6189,5.60%,4.70%,6.50%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
200926_UK_OfficeforNationalStatistics_August_Sept2020_England_genpop,9/25/2020,Regional,The United Kingdom,The United Kingdom; England,"August 28, 2020","September 24, 2020",Household and community samples,Multiple groups,8742,5.80%,5.10%,6.50%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_England_Genpop,10/23/2020,Regional,The United Kingdom,The United Kingdom; England,"September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,15687,6.90%,6.40%,7.50%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_England_genpop,11/26/2020,Regional,The United Kingdom,The United Kingdom; England,"October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,15834,8.70%,8.10%,9.40%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_England_genpop,12/24/2020,Regional,The United Kingdom,The United Kingdom; England,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,21684,10.10%,9.60%,10.60%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_England_Genpop,1/29/2021,Regional,The United Kingdom,The United Kingdom; England,"December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,24150,15.30%,14.70%,15.90%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
210226_UK_OfficeforNationalStatistics_Jan_Feb2021_England_genpop,2/26/2021,Regional,The United Kingdom,The United Kingdom; England,"January 15, 2021","February 11, 2021",Household and community samples,Multiple groups,30345,23.30%,22.70%,23.90%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/antibodydatafortheukjanuary2021,3/12/2021,3/31/2021
200926_UK_OfficeforNationalStatistics_August_Sept2020_Wales_Genpop,9/25/2020,Regional,The United Kingdom,The United Kingdom; Wales,"August 28, 2020","September 24, 2020",Household and community samples,Multiple groups,236,4.70%,2.00%,9.20%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,"High, High, High",Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_NorthernIreland_genpop,10/23/2020,Regional,The United Kingdom,The United Kingdom; Northern Ireland,"September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,249,2.80%,1.20%,5.50%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Scotland_Genpop,10/23/2020,Regional,The United Kingdom,"The United Kingdom; Scotland
","September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,383,6.80%,4.30%,10.20%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Wales_Genpop,10/23/2020,Regional,The United Kingdom,The United Kingdom; Wales,"September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,473,4.70%,2.90%,7.30%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,"High, High, High",Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201126_UK_OfficeforNationalStatistics_Oct_Nov2020 _Scotland_Genpop,11/26/2020,Regional,The United Kingdom,"The United Kingdom; Scotland
","October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,397,7.80%,5.00%,11.70%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_NorthernIreland_Genpop,11/26/2020,Regional,The United Kingdom,The United Kingdom; Northern Ireland,"October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,333,3.50%,1.60%,6.40%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_Wales_genpop,11/26/2020,Regional,The United Kingdom,The United Kingdom; Wales,"October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,497,6.10%,4.00%,9.00%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,"High, High, High",Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_NortherIreland_genpop,12/24/2020,Regional,The United Kingdom,The United Kingdom; Northern Ireland,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,248,3.70%,1.70%,7.10%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Scotland_genpop,12/24/2020,Regional,The United Kingdom,The United Kingdom; Scotland,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,1034,5.90%,4.40%,7.60%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Wales_genpop,12/24/2020,Regional,The United Kingdom,The United Kingdom; Wales,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,631,7.20%,5.10%,9.90%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,"Moderate, Moderate, Moderate",Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_NortherIreland_genpop,1/29/2021,Regional,The United Kingdom,The United Kingdom; Northern Ireland,"December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,313,12.00%,7.80%,17.40%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Scotland_genpop,1/29/2021,Regional,The United Kingdom,"The United Kingdom; Scotland
","December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,1832,10.70%,9.10%,12.40%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Wales_genpop,1/29/2021,Regional,The United Kingdom,The United Kingdom; Wales,"December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,732,11.50%,8.60%,14.90%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,"Moderate, Moderate, Moderate",Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,4/26/2021
210226_UK_OfficeforNationalStatistics_Jan_Feb2021_NorthernIreland_genpop,2/26/2021,Regional,The United Kingdom,The United Kingdom; Northern Ireland,"January 15, 2021","February 11, 2021",Household and community samples,Multiple groups,575,15.90%,12.80%,19.50%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/antibodydatafortheukjanuary2021,3/12/2021,3/31/2021
210226_UK_OfficeforNationalStatistics_Jan_Feb2021_Scotland_genpop,2/26/2021,Regional,The United Kingdom,"The United Kingdom; Scotland
","January 15, 2021","February 11, 2021",Household and community samples,Multiple groups,2632,13.10%,11.60%,14.70%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/antibodydatafortheukjanuary2021,3/12/2021,3/31/2021
210226_UK_OfficeforNationalStatistics_Jan_Feb2021_Wales_genpop,2/26/2021,Regional,The United Kingdom,The United Kingdom; Wales,"January 15, 2021","February 11, 2021",Household and community samples,Multiple groups,1268,16.40%,14.00%,19.00%,Stratified probability,University of Oxford,,IgG,99.00%,99.10%,"Moderate, Moderate, Moderate",Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/antibodydatafortheukjanuary2021,3/12/2021,3/31/2021
210107_London_UniversityCollegeLondon_June_PaediatricHCW,1/27/2021,Sublocal,The United Kingdom,The United Kingdom; England; London,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),1134,16.93%,14.86%,19.22%,Convenience,"Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)",,IgG,,,High,Journal Article (Peer-Reviewed),D. Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,4/9/2021
210107_London_UniversityCollegeLondon_May_PaediatricHCW,1/27/2021,Sublocal,The United Kingdom,The United Kingdom; England; London,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1754,15.34%,13.73%,17.10%,Convenience,"Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)",,IgG,,,High,Journal Article (Peer-Reviewed),D. Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,4/9/2021
210210_England_ImperialCollegeLondon_Overall_TestAdjPopAdj,2/10/2021,National,The United Kingdom,The United Kingdom; England,"June 20, 2020","July 13, 2020",Household and community samples,Multiple groups,99908,6.00%,5.80%,6.10%,Simplified probability,"Fortress Diagnostics, Northern Ireland",,IgG,84.40%,98.60%,Low,Journal Article (Peer-Reviewed),Helen Ward,Imperial College London,https://dx.doi.org/10.1038/s41467-021-21237-w,3/14/2021,4/23/2021
210219_England_PHE_UniversityStudents_Overall,2/19/2021,Regional,The United Kingdom,The United Kingdom; England,"December 2, 2020","December 11, 2020",Students and Daycares,Adults (18-64 years),2905,17.80%,16.50%,19.30%,Convenience,Abbott Laboratories; In-House (PHE),,IgG,92.70%,99.90%,Moderate,Preprint,Amoolya Vusirikala,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3787684,3/14/2021,3/28/2021
210127_UK_UniversityCollegeLondon_overall,1/27/2021,Regional,The United Kingdom,The United Kingdom; England; Nottingham; London,"March 23, 2020","June 13, 2020",Health care workers and caregivers,Adults (18-64 years),1364,19.94%,,,Convenience,Euroimmun; Roche Diagnostics; In House ELISA,,IgG,96.20%,100.00%,High,Preprint,Ana Valdes,University College London,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3754805,3/17/2021,3/28/2021
210115_UK_UKBiobank_Overall,1/15/2021,National,The United Kingdom,"The United Kingdom; England, Scotland, Wales","May 27, 2020","December 4, 2020",Household and community samples,Multiple groups,18893,8.99%,,,Convenience,NR,,Not reported,,,Unclear,Institutional Report,UK Biobank,UK Biobank,https://www.ukbiobank.ac.uk/media/x0nd5sul/ukb_serologystudy_report_revised_6months_jan21.pdf,3/19/2021,3/31/2021
210301_London_King’sCollegeHospital_primary,3/1/2021,Sublocal,The United Kingdom,The United Kingdom,"April 22, 2020","April 24, 2020",Health care workers and caregivers,Adults (18-64 years),625,21.00%,,,Convenience,NR,,Total Antibody,,,High,Journal Article (Peer-Reviewed),Kat El Bouzidi,King’s College Hospital,https://dx.doi.org/10.1097/CCM.0000000000004878,3/19/2021,3/31/2021
210127_London_King'sCollegeLondon_September_PostgradStudents&Staff,1/27/2021,Sublocal,The United Kingdom,The United Kingdom,"September 1, 2020","September 30, 2020",Essential non-healthcare workers,Adults (18-64 years),1675,5.40%,,,Convenience,SureScreen Diagnostics ,,"IgG,IgM",,,High,Preprint,Daniel Leightley,King's College London,https://doi.org/10.1101/2021.01.26.21249744,3/21/2021,3/31/2021
210225_England_ImperialCollegeLondon_Round4_overall_adj,2/25/2021,National,The United Kingdom,The United Kingdom; England,"October 27, 2020","November 10, 2020",Household and community samples,Multiple groups,161537,5.56%,5.43%,5.71%,Stratified probability,Fortress Diagnostics,,IgG,84.40%,98.60%,Moderate,Institutional Report,Helen Ward,Imperial College London ,https://spiral.imperial.ac.uk/handle/10044/1/86241,3/23/2021,4/9/2021
210119_Lacashire_PublicHealthEngland_overall,1/19/2021,Sublocal,The United Kingdom,The United Kingdom; England; Lacashire,"June 3, 2020","June 4, 2020",Essential non-healthcare workers,Adults (18-64 years),195,9.20%,,,Convenience,Roche,,Total Antibody,,,High,Journal Article (Peer-Reviewed),Ranya Mulchandani,Public Health England,http://dx.doi.org/10.1016/j.jcv.2021.104739,3/25/2021,4/16/2021
210202_UK_SalfordRoyalNHS_primary,2/2/2021,Sublocal,The United Kingdom,The United Kingdom,"March 15, 2020","October 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,237,5.10%,,,Convenience,SNIBE and Siemens,,IgG,,,High,Preprint,Olivia Wickens,Salford Royal NHS ,https://www.researchsquare.com/article/rs-154513/v1,3/26/2021,4/11/2021
210212_Oxford_UniversityofOxford,2/12/2021,Sublocal,The United Kingdom,The United Kingdom,"April 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,404,3.00%,,,Sequential,Abbott,,IgG,,,High,Journal Article (Peer-Reviewed),Colleen GC McGregor,University of Oxford,https://dx.doi.org/10.1136/gutjnl-2021-324116,3/27/2021,4/19/2021
210303_London_NorthMiddlesexUniversityHospitalNHSTrust_Overall,3/3/2021,Sublocal,The United Kingdom,The United Kingdom; England; London,"June 4, 2020","July 3, 2020",Health care workers and caregivers,Adults (18-64 years),3285,35.70%,,,Convenience,NR,,Not reported,,,High,Journal Article (Peer-Reviewed),Emily Martin,North Middlesex University Hospital NHS Trust,https://dx.doi.org/10.1016/j.jinf.2021.02.027,3/31/2021,3/31/2021
210211_UnitedKingdom_ImperialCollegeNHSTrust_GlomerularDiseasePatients,2/11/2021,Sublocal,The United Kingdom,The United Kingdom,"May 19, 2020","July 21, 2020",Patients seeking care for non-COVID-19 reasons,Not reported,493,7.70%,,,Sequential,Abbott,,IgG,,,High,Journal Article (Peer-Reviewed),Tabitha Turner-Stokes,Imperial College Healthcare NHS Trust,https://dx.doi.org/10.1016/j.ekir.2021.02.006,4/2/2021,4/11/2021
201105_London_ImperialCollegeLondon,11/5/2020,Sublocal,The United Kingdom,The United Kingdom; England; London,"June 1, 2020","July 27, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),161,11.20%,,,Convenience,Imperial College London,,Total Antibody,94.80%,,High,Journal Article (Peer-Reviewed),Simone Claudiani,Imperial College London,http://dx.doi.org/10.1182/blood-2020-142454,4/4/2021,4/26/2021
210210_London_KingsCollegeLondon,2/10/2021,Sublocal,The United Kingdom,The United Kingdom; England; London,"June 1, 2020","June 30, 2020",Multiple populations,Adults (18-64 years),1882,7.00%,,,Convenience,Sure Screen Diagnostics,,"IgG,IgM",94.00%,96.30%,High,Preprint,Katrina Davis,King's College London,https://www.medrxiv.org/content/10.1101/2020.12.07.20245183v2,4/5/2021,4/26/2021
210322_TheUnitedKingdom_RoyalDevonAndExeterNHSFoundationTrust_Overall,3/22/2021,National,The United Kingdom,The United Kingdom,"September 22, 2020","December 23, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,6935,4.30%,3.80%,4.80%,Sequential,Roche,,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Nicholas Kennedy,Royal Devon and Exeter NHS Foundation Trust,https://dx.doi.org/10.1136/gutjnl-2021-324388,4/9/2021,4/9/2021
210212_London_RoyalFreeHospital,2/12/2021,Sublocal,The United Kingdom,The United Kingdom,"March 26, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),43,18.60%,,,Unclear,NR,,,,,High,Journal Article (Peer-Reviewed),Natarajan Angamuthu,Royal Free Hospital,https://dx.doi.org/10.1016/j.surge.2021.01.007,4/10/2021,4/27/2021
210401_London_PublicHealthEngland_Overall,4/1/2021,Local,The United Kingdom,The United Kingdom,"March 30, 2020","July 21, 2020",Health care workers and caregivers,Multiple groups,1069,29.00%,26.00%,32.00%,Unclear,Roche,,"IgG,IgM,IgA",,,Unclear,Journal Article (Peer-Reviewed),Madhumita Shrotri,Public Health England,https://dx.doi.org/10.3201/eid2704.204554,4/11/2021,4/25/2021
210302_London_UniversityCollegeLondon_HCW_Overall,3/2/2021,Local,The United Kingdom,The United Kingdom; England; London,"March 23, 2020","August 17, 2020",Health care workers and caregivers,Adults (18-64 years),729,21.50%,,,Convenience,"1) Euroimmun

2) Roche",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charlotte Manisty,University College London,https://dx.doi.org/10.1016/j.ebiom.2021.103259,4/12/2021,4/12/2021
210302_London_UniversityCollegeLondon_HCW_Euroimmun,3/2/2021,Local,The United Kingdom,The United Kingdom; England; London,"March 23, 2020","August 17, 2020",Health care workers and caregivers,Adults (18-64 years),729,19.50%,,,Convenience,Euroimmun,,IgG,,,High,Journal Article (Peer-Reviewed),Charlotte Manisty,University College London,https://dx.doi.org/10.1016/j.ebiom.2021.103259,4/12/2021,4/12/2021
210226_WestMidlands_BirminghamCommunityHealthcareTrust_Baseline,2/26/2021,Regional,The United Kingdom,The United Kingdom,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),1507,16.32%,,,Convenience,"The Binding Site (TBS), Birmingham",,"IgG,IgM,IgA",98.60%,98.30%,Moderate,,Adrian Shields,Birmingham Community Healthcare Trust,10.1101/2021.02.24.21252368,4/15/2021,4/15/2021
210316_Sussex_UniversityofSussex_RocheBSUH,3/16/2021,Sublocal,The United Kingdom,The United Kingdom; England; Brighton and Sussex,"May 19, 2020","September 29, 2020",Health care workers and caregivers,Adults (18-64 years),14473,12.99%,,,Convenience,Roche Diagnostics,,"IgG,IgM",99.50%,99.80%,High,Journal Article (Peer-Reviewed),Alyss Robinson,University of Sussex,https://dx.doi.org/10.7861/clinmed.2020.1007,4/15/2021,4/15/2021
210316_Sussex_UniversityofSussex_AbbottWSHT,3/16/2021,Sublocal,The United Kingdom,The United Kingdom; England; West Sussex,"May 19, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),12388,7.89%,,,Convenience,Abbott Laboratories,,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Alyss Robinson,University of Sussex,https://dx.doi.org/10.7861/clinmed.2020.1007,4/15/2021,4/15/2021
210417_Leicestershire_UniversityofLeicester_Diasorin+Siemens,3/17/2021,Local,The United Kingdom,The United Kingdom; England; NR,"October 1, 2019","March 31, 2020",Residual sera,Multiple groups,428,0.00%,,,Simplified probability,Diasorin Ltd.; Siemens,,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Paul Bird,University of Leicester,https://dx.doi.org/10.1016/j.jinf.2021.03.007,4/16/2021,4/16/2021
210323_Surrey_RoyalHollowayUniversityofLondon,3/23/2021,Sublocal,The United Kingdom,The United Kingdom; England; Surrey,"October 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),3119,19.65%,,,Convenience,Abbott Laboratories,,IgG,82.50%,95.00%,High,Journal Article (Peer-Reviewed),Gie Ken-Dror,Royal Holloway University of London,https://dx.doi.org/10.7861/clinmed.2020-1096,4/16/2021,4/17/2021
210212_London_UniversityofOxford_Overall,2/12/2021,Sublocal,The United Kingdom,The United Kingdom,"April 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,236,8.47%,,,Sequential,Abbott,,IgG,,,High,Journal Article (Peer-Reviewed),Colleen GC McGregor,University of Oxford,https://dx.doi.org/10.1136/gutjnl-2021-324116,4/19/2021,4/19/2021
201113_London_ImperialCollegeLondon_KidneyTransplantPatients copy,"11/13/2020, 11/25/2020",Sublocal,The United Kingdom,The United Kingdom; Greater London; London,"June 1, 2020","July 3, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),855,8.10%,6.40%,10.10%,Sequential,Abbott,,IgG,68.40%,100.00%,High,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Michelle Willicombe, Maria Prendecki",Imperial College London,"https://dx.doi.org/10.1097/TP.0000000000003526, https://dx.doi.org/10.1681/ASN.2020081152",4/21/2021,4/26/2021
210316_Lancashire_LancashireTeachingHospitalsNHSTrust_OverallHCW,3/16/2021,Sublocal,The United Kingdom,"The United Kingdom; England; Chorley, Preston, South Ribble","May 29, 2020","July 4, 2020",Health care workers and caregivers,Adults (18-64 years),4474,17.40%,,,Convenience,Roche Diagnostics,,Total Antibody,92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Robert Shorten ,Lancashire Teaching Hospitals NHS Foundation Trust,https://dx.doi.org/10.1136/bmjopen-2020-045384,4/21/2021,4/21/2021
200930_Scotland_PublicHealthScotland_ResidualSera_Overall_UnAdj,9/30/2020,National,The United Kingdom,The United Kingdom; Scotland,"April 20, 2020","August 9, 2020",Residual sera,Multiple groups,9802,4.89%,,,Stratified non-probability,Not reported,,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/30-september-2020/,4/22/2021,4/23/2021
200807_Lome_UniversiteDeLome_Overall,8/7/2020,Local,Togo,Togo,"April 23, 2020","May 8, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),955,0.90%,0.40%,1.80%,Convenience,"""Hangzhou Clongene Biotech Co, Ltd.""",LFIA: Lateral flow immunoassay,"IgM,IgG",77.10%,95.40%,High,Journal Article (Peer-Reviewed),Wemboo Halatoko,Universite de Lome,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242124,9/23/2020,4/26/2021
200822_Turkey_UniversityofHealthSciences_HCWOverall,8/22/2020,Local,Turkey,Turkey,"May 30, 2020","June 6, 2020",Health care workers and caregivers,Adults (18-64 years),813,2.70%,,,Convenience,Abbott,Chemiluminsescent microparticle immunoassay,IgG,,,Moderate,Preprint,Gizem Alkurt,University of Health Sciences,https://www.medrxiv.org/content/10.1101/2020.08.19.20178095v1,10/12/2020,4/26/2021
210920_Serdivan_SakaryaUniversity,,Sublocal,Turkey,Turkey; Sakarya; Serdivan,"April 7, 2020","May 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),198,3.50%,,,Unclear,NR,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Cemil Bilir,Sakarya University ,http://dx.doi.org/10.19193/0393-6384_2021_1_103,3/27/2021,4/18/2021
210303_Turkey_UniversityofHealthSciences_Overall,3/3/2021,National,Turkey,Turkey; NR,"May 30, 2020","June 6, 2020",Health care workers and caregivers,Adults (18-64 years),813,2.70%,,,Convenience,Abbott Laboratories,,IgG,,,High,Journal Article (Peer-Reviewed),Gizem Alkurt,University of Health Sciences,https://dx.doi.org/10.1371/journal.pone.0247865,4/17/2021,4/17/2021
200107_Unclear_Turkey_genpop,7/2/2020,National,Turkey,Turkey,"June 15, 2020","June 25, 2020",Household and community samples,Multiple groups,132000,0.81%,,,Unclear,NR,,,,,Unclear,News and Media,NR,Unclear (Turkey Ministry of Health),https://www.sozcu.com.tr/2020/saglik/saglik-bakani-fahrettin-koca-turkiyenin-antikor-testi-sonuclarini-acikladi-5906832/,4/25/2021,4/26/2021
200424_Brevard_OMNI_GeneralPopulation,"4/24/2020, 4/17/2020",Local,United States of America,United States of America; Florida,"April 17, 2020","April 24, 2020",Household and community samples,Not reported,1000,1.00%,,,Self-referral,Not reported,LFIA: Lateral flow immunoassay,"IgM,IgG",100.00%,100.00%,High,"News and Media, News and Media","Alessandro Sassoon, Jim Waymer",OMNI Healthcare,"https://www.floridatoday.com/story/news/2020/04/24/omni-covid-19-immunity-testing-data-brevard-county-florida-antibody/3022571001/, https://www.floridatoday.com/story/news/2020/04/17/omni-healthcare-announces-coronavirus-immunity-testing/5147092002/",5/2/2020,4/26/2021
200422_Idaho_CrushTheCurveIdaho_Patients,4/22/2020,Regional,United States of America,United States of America; Idaho,,"April 22, 2020",Residual sera,Multiple groups,1946,1.75%,,,Self-referral,University of Washington,Not reported,IgG,100.00%,99.60%,High,News and Media,Ryan Morrison,Crush The Curve Idaho,https://idahonews.com/news/coronavirus/crushthecurveidaho-finds-small-population-with-antibodies-we-are-far-from-herd-immunity,5/2/2020,4/26/2021
200423_BatonRouge_BatonRougeGeneralHospital_GenPop,4/28/2020,Local,United States of America,United States of America; Louisiana; Baton Rouge,,"April 21, 2020",Household and community samples,Not reported,432,4.40%,,,Unclear,Mayo Clinic,Not reported,Not reported,,98.60%,Unclear,News and Media,Blake Paterson,Baton Rouge General Hospital,https://www.theadvocate.com/baton_rouge/news/coronavirus/article_b499efa0-8983-11ea-a3f1-af936ecb1d2c.html,5/2/2020,4/26/2021
200508_Seattle_UniversityofWashington_Adults,5/8/2020,Local,United States of America,United States of America; Washington; Seattle,"March 1, 2020","March 31, 2020",Residual sera,Adults (18-64 years),221,0.40%,,,Convenience,Not reported,Not reported,Not reported,,,High,Institutional Report,Anne Schuchat,University of Washington,https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6918e2-H.pdf,5/2/2020,4/26/2021
200503_SaltLakeCity_UniversityofUtah_HCW,5/3/2020,Sublocal,United States of America,United States of America; Utah; Salt Lake City,"April 13, 2020","April 19, 2020",Health care workers and caregivers,Adults (18-64 years),270,5.90%,,,Self-referral,EUROIMMUN,ELISA,IgG,95.40%,98.30%,High,Journal Article (Peer-Reviewed),Troy Madsen,University of Utah,https://www.ajemjournal.com/article/S0735-6757(20)30306-5/fulltext,5/13/2020,4/26/2021
200506_Atlanta_GeorgiaStateUniversity_GeneralPop_IgG,5/6/2020,Local,United States of America,United States of America; Georgia; Atlanta,"April 17, 2020","April 27, 2020",Household and community samples,Not reported,127,2.36%,,,Convenience,Author-designed,ELISA,IgG,,,High,Preprint,Jun Zou,Georgia State University,https://www.medrxiv.org/content/10.1101/2020.05.01.20087478v1,5/13/2020,4/26/2021
200515_Winona_WinonaHealth_GeneralPopulation,5/15/2020,Local,United States of America,United States of America; Minnesota; Winona,"May 10, 2020","May 15, 2020",Household and community samples,Multiple groups,1000,7.00%,,,Self-referral,NR,Not reported,IgG,,,High,News and Media,Mal Meyer,Winona Health,https://www.google.com/url?rct=j&sa=t&url=https://www.news8000.com/new-covid-19-antibody-testing-in-winona-gives-health-officials-a-better-picture-of-the-spread/&ct=ga&cd=CAEYDyoTMTE4NjM1MjEyMTUyMjIzNTE5ODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNE5fpVM7tRmIsEhSRedRkru-TpZOA,5/18/2020,4/26/2021
200513_Indiana_IndianaUniversity_Wave1GenPop_PopAdj,"7/24/2020, 5/13/2020, 5/17/2020",Regional,United States of America,United States of America; Indiana,"April 25, 2020","April 29, 2020",Household and community samples,Multiple groups,3518,1.09%,0.80%,1.50%,Stratified probability,"Author derived
",Chemiluminescence Immunoassay,IgG,100.00%,99.60%,Moderate,"Institutional Report, News and Media, News and Media","Nir Menachemi, Aaron Carroll, Dariush Shafa",Indiana University Fairbanks School of Public Health,"https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w, https://www.nytimes.com/2020/05/13/opinion/indiana-reopening-coronavirus-testing.html, https://www.google.com/url?rct=j&sa=t&url=https://www.perrycountynews.com/content/study-projects-only-9-covid-19-cases-detected&ct=ga&cd=CAAYHDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEf69_TglEJjU9g7rkvZNMTUfoqoQ",5/19/2020,4/26/2021
200518_LosAngelesCounty_StanfordUniversity_GenPopWeighted_TestAdj,5/18/2020,Local,United States of America,United States of America; California,"April 10, 2020","April 14, 2020",Household and community samples,Multiple groups,863,4.65%,2.52%,7.07%,Stratified probability,Premier Biotech,LFIA: Lateral flow immunoassay,"IgG,IgM",82.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Neeraj Sood,Stanford University School of Medicine,https://jamanetwork.com/journals/jama/fullarticle/2766367,5/20/2020,4/26/2021
200515_Boston_BostonPublicHealthCommission_BostonGenPop,"5/15/2020, 5/18/2020",Local,United States of America,United States of America; Massachusetts; Boston,,"May 15, 2020",Household and community samples,Adults (18-64 years),750,9.90%,,,Simplified probability,Not reported,Not reported,Not reported,,,Moderate,"News and Media, News and Media","Adam Gaffin, City of Boston",Boston Public Health Commission ,"https://www.universalhub.com/2020/initial-antibody-testing-four-zip-codes-shows-one, https://www.boston.gov/news/results-released-antibody-and-covid-19-testing-boston-residents",5/23/2020,4/26/2021
200523_SouthCarolina_MUSCHealthLancaster_HCW,5/23/2020,Sublocal,United States of America,United States of America; South Carolina; Lancaster,"March 16, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),230,2.17%,,,Unclear,Abbott,Not reported,Not reported,,,High,News and Media,Lisa Geraci ,MUSC Health-Lancaster,https://www.google.com/url?rct=j&sa=t&url=https://www.thelancasternews.com/content/antibody-tests-show-just-2-exposure-rate-covid-19&ct=ga&cd=CAEYFSoSNjI0MTExNTA1MzQ0Mjc2MzA2Mho5MGRlYTk4OTk0ZTkxODU5OmNvbTplbjpVUw&usg=AFQjCNEYxEO1T-WE8tAinlY5KZVTRufQSA,5/25/2020,4/27/2021
200520_Iowa_IowaDepartmentofPublicHealth_IowaStateGeneralPopulation,5/20/2020,Regional,United States of America,United States of America; Iowa,"April 1, 2021","May 20, 2020",Household and community samples,Adults (18-64 years),18160,10.00%,,,Self-referral,Not reported,Not reported,IgG,,,High,News and Media,Jeff Montgomery,Iowa Department of Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.telegraphherald.com/coronavirus/article_b5f56348-317d-5f49-abee-0e7cff653cbb.html&ct=ga&cd=CAAYBDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG6tWk8Wg2dbYV27AKz5iI4DLM97Q,5/30/2020,4/26/2021
200617_NewYork_StateUniversityofNewYork_GeneralPopTestPopAdj,6/17/2020,Regional,United States of America,United States of America; New York,"April 19, 2020","April 28, 2020",Household and community samples,Multiple groups,15101,14.00%,13.30%,14.70%,Convenience,NYSDOH Wadsworth Center,Microsphere immunoassay,IgG,87.90%,99.75%,Moderate,Journal Article (Peer-Reviewed),Eli Rosenberg,New York State Department of Health,https://dx.doi.org/10.1016/j.annepidem.2020.06.004,5/30/2020,4/26/2021
200510_US_StanfordUniversity_MajorLeagueBaseballEmployees,"5/10/2020, 5/11/2020",National,United States of America,United States of America,"April 8, 2020","April 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),5603,0.70%,0.28%,1.15%,Convenience,Not reported,Not reported,Not reported,,,Unclear,"News and Media, News and Media","Susan Slusser, John McCormack",Stanford University,"https://www.sfchronicle.com/athletics/article/MLB-antibody-study-7-percent-exposed-to-15260314.php, https://www.nationalreview.com/2020/05/coronavirus-antibody-study-major-league-baseball-herd-immunity/",6/2/2020,4/26/2021
200601_LongHillTownship_SummitMedicalCenter_FirstResponders,6/1/2020,Sublocal,United States of America,United States of America; New Jersey; Long Hill Township,"May 1, 2020","May 14, 2020",Essential non-healthcare workers,Adults (18-64 years),70,4.29%,,,Self-referral,Not reported,Not reported,Not reported,,,High,News and Media,Alex Parker-Magyar,Summit Medical Center,https://www.google.com/url?rct=j&sa=t&url=https://www.newjerseyhills.com/echoes-sentinel/news/few-among-long-hill-first-responders-test-positive-for-covid-19-antibodies/article_007ac367-b3b2-5375-b471-f0a817998f62.html&ct=ga&cd=CAAYFDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWg839bXiyzOxO1Y7-QOECGMRCMw,6/2/2020,4/26/2021
200602_NewYork_IcahnSchoolofMedicineatMountSinai_HealthCareWorkers,6/3/2020,Local,United States of America,United States of America; New York; New York City,"March 24, 2020","April 4, 2020",Health care workers and caregivers,Multiple groups,285,32.63%,,,Self-referral,Not reported,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mayce Mansour,Icahn School of Medicine at Mount Sinai,https://link.springer.com/article/10.1007/s11606-020-05926-8,6/4/2020,4/26/2021
200602_HumboldtCounty_HumboldtCountyDepartmentofHealthandHumanServices_GenPop,6/2/2020,Local,United States of America,United States of America; California,,"May 26, 2020",Household and community samples,Not reported,1000,1.00%,,,Unclear,Not reported,Not reported,Not reported,,,High,News and Media,Shomik Mukherjee ,Humboldt County Department of Health and Human Services,https://www.google.com/url?rct=j&sa=t&url=https://www.times-standard.com/1-of-early-humboldt-county-coronavirus-tests-show-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFdl7jBbUfA1cB9ZXhwgAM8IvQmrA,6/7/2020,4/26/2021
200612_Guam_USNavy,6/12/2020,Sublocal,United States of America,United States of America; Guam,"April 20, 2020","April 24, 2020",Essential non-healthcare workers,Adults (18-64 years),382,59.70%,,,Convenience,CDC,ELISA,"IgG,IgM,IgA",96.00%,99.30%,High,Journal Article (Peer-Reviewed),Daniel Payne,US Navy,https://www.cdc.gov/mmwr/volumes/69/wr/mm6923e4.htm,6/12/2020,4/26/2021
200612_NewJersey_MonmouthMedicalCentre_HealthCareWorkersUnadj,6/12/2020,Sublocal,United States of America,United States of America; New Jersey; Long Branch,"May 14, 2020","May 19, 2020",Health care workers and caregivers,Adults (18-64 years),121,0.83%,,,Convenience,SD Biosensor,LFIA: Lateral flow immunoassay,IgG,96.20%,96.60%,High,Journal Article (Peer-Reviewed),Mohsin Mughal ,Monmouth Medical Centre,https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/prevalence-of-sarscov2-igg-antibodies-in-intensive-care-unit-icu-healthcare-personnel-hcp-and-its-implications-a-singlecenter-prospective-pilot-study/296957BF678E512283D4A3770467FFB7,6/13/2020,4/26/2021
200614_SteamboatSprings_RouttCountyBoardofHealth_GenPop,6/14/2020,Local,United States of America,United States of America; Colorado; Steamboat Springs,,"June 10, 2020",Household and community samples,Not reported,649,2.60%,,,Self-referral,Not reported,Not reported,Not reported,,,High,News and Media,Kari Harden ,Routt County Board of Health,https://www.google.com/url?rct=j&sa=t&url=https://www.steamboatpilot.com/news/one-new-positive-covid-19-case-in-routt-county-antibody-testing-ramping-up/&ct=ga&cd=CAEYBSoTNzg3MTAwMjkzNzU0ODU4ODgzODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGVI81Ue1Rqm7AhmKKlvb0xWvQDKQ,6/15/2020,4/26/2021
200617_Indiana_IndianaUniversity_Wave2GenPop,6/17/2020,Regional,United States of America,United States of America; Indiana,"June 3, 2020","June 8, 2020",Household and community samples,Multiple groups,3600,1.50%,,,Stratified probability,Not reported,Not reported,Not reported,,,Moderate,News and Media,Shari Rudavsky,Indiana University Fairbanks School of Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.indystar.com/story/news/health/2020/06/17/indiana-coronavirus-fairbanks-study-indicates-spread-has-slowed/3208509001/&ct=ga&cd=CAAYETIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNH4O6wDIVkk1hAyMEzD78OGtB7YoQ,6/23/2020,4/26/2021
200622_TruckeeMeadows_TruckeeMeadowsFireProtectionDistrict_FirstResponders,6/22/2020,Sublocal,United States of America,United States of America; Nevada,"May 1, 2020","May 31, 2020",Essential non-healthcare workers,Adults (18-64 years),132,14.00%,,,Convenience,Not reported,Not reported,Not reported,,,High,News and Media,Anh Gray,Truckee Meadows Fire Protection District,https://www.kunr.org/post/prevalence-covid-19-antibodies-washoe-co-expected-be-low#stream/0,6/24/2020,4/26/2021
200504_SouthCarolina_MedicalUniversitySouthCarolina_HealthcareWorkers_FirstResponders,5/4/2020,Sublocal,United States of America,United States of America; South Carolina; Charleston,"April 27, 2020","May 2, 2020",Multiple populations,Adults (18-64 years),920,2.00%,,,Unclear,Abbott,Not reported,Not reported,,,High,News and Media,Nick Reagan,Medical University South Carolina,https://www.live5news.com/2020/05/04/results-show-tested-musc-staff-have-covid-antibodies/,6/27/2020,4/26/2021
200523_CoralSprings_CoralSpringsCityGovernment_CityEmployees,5/22/2020,Local,United States of America,United States of America; Florida; Coral Springs,"May 17, 2020","May 22, 2020",Essential non-healthcare workers,Not reported,700,0.00%,,,Self-referral,Cellex,Not reported,Not reported,,,Unclear,News and Media,Jenny Staletovich,Coral Springs City Government,https://www.google.com/url?rct=j&sa=t&url=https://www.wlrn.org/post/south-florida-cities-begin-testing-employees-covid-19-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHc4oWG79OOMovZOpWOY8qd-gm3kw,6/27/2020,4/26/2021
200520_LosAngeles_UniSouthernCalifornia_GenPop,5/20/2020,Local,United States of America,United States of America; California,"May 8, 2020","May 12, 2020",Household and community samples,Not reported,1014,2.10%,,,Self-referral,Not reported,Not reported,Not reported,,,Unclear,News and Media,CBS Los Angeles,University of Southern California,https://www.google.com/url?rct=j&sa=t&url=https://losangeles.cbslocal.com/2020/05/20/la-county-still-far-away-from-herd-immunity-new-antibody-numbers-show/&ct=ga&cd=CAAYCDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGRZYAUZKxAbfGM7Yh_03xi5M8tDg,6/27/2020,4/26/2021
200520_Madison_UWHealth_UniWisconsinHealthClinic,5/20/2020,Local,United States of America,United States of America; Wisconsin; Madison,"May 13, 2020","May 20, 2020",Household and community samples,Not reported,5303,1.50%,,,Self-referral,Not reported,Not reported,Not reported,,,Unclear,News and Media,Michelle Alfini,UW Health,https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ,6/27/2020,4/26/2021
200520_Madison_UWHealth_UnityPointClinic,5/20/2020,Local,United States of America,United States of America; Wisconsin; Madison,"May 13, 2020","May 20, 2020",Household and community samples,Not reported,433,0.30%,,,Self-referral,Not reported,Not reported,Not reported,,,Unclear,News and Media,Michelle Alfini,UW Health,https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ,6/27/2020,4/26/2021
200624_BaskingRidge_FellowshipVillage_Residents2_Overall,6/24/2020,Sublocal,United States of America,United States of America; New Jersey; Basking Ridge,"April 15, 2020","May 6, 2020",Assisted living and long-term care facilities,Seniors (65+ years),371,34.77%,,,Entire sample,NR,,"IgG,IgM",,,Unclear,News and Media,Tim Regan,Fellowship Village,https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g,6/29/2020,4/26/2021
201103_NewYorkCity_MountSinai_RoutineCare_1 _Overall,11/3/2020,Local,United States of America,United States of America; New York; New York City,"February 2, 2020","July 5, 2020",Residual sera,Multiple groups,6590,11.10%,,,Sequential,Mount Sinai Hospital New York,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Daniel Stadlbauer,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.1038/s41586-020-2912-6,6/29/2020,4/26/2021
200529_NorthCarolina_Psalms/SolidRockMedicineGroup_GenPop,5/29/2020,Local,United States of America,United States of America; North Carolina,"May 29, 2020","May 29, 2020",Household and community samples,Not reported,329,1.52%,,,Self-referral,Not reported,Not reported,Not reported,,,Unclear,News and Media,Steve Ohnesorge,Psalms/Solid Rock Medicine Group,https://www.google.com/url?rct=j&sa=t&url=https://www.wbtv.com/2020/05/29/antibody-testing-continues-burke-county/&ct=ga&cd=CAAYGTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEvSO7bk5TLI9MT5-BeF8ILKdseXA,7/4/2020,4/26/2021
200529_CoachellaValley_Desert Healthcare District_GenPop,5/29/2020,Local,United States of America,United States of America; California,,"May 28, 2020",Household and community samples,Not reported,896,6.00%,,,Self-referral,Phamatech,LFIA: Lateral flow immunoassay,"IgG,IgM",,,Unclear,News and Media,Nicole Hayden,Desert Healthcare District,https://www.google.com/url?rct=j&sa=t&url=https://www.desertsun.com/story/news/health/2020/05/29/coachella-valley-far-covid-19-herd-immunity-preliminary-antibody-tests-show/5280021002/&ct=ga&cd=CAAYKzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFQxOqwjTX2Kz2_mnj1RV7Upa8rEg,7/4/2020,4/26/2021
200528_Michigan_MichiganDepartmentofCorrections_ParnallCFa,5/28/2020,Sublocal,United States of America,United States of America; Michigan,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Not reported,1248,92.00%,,,Convenience,Not reported,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/5/2020,4/26/2021
200528_Michigan_MichiganDepartmentofCorrections_MacombCF,5/28/2020,Sublocal,United States of America,United States of America; Michigan; Lenox Township,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Not reported,1201,65.60%,,,Convenience,Not reported,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/5/2020,4/26/2021
200528_Michigan_MichiganDepartmentofCorrections_DetroitRC,5/28/2020,Sublocal,United States of America,United States of America; Michigan; Detroit,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Not reported,57,35.00%,,,Convenience,Not reported,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/5/2020,4/26/2021
200528_Michigan_MichiganDepartmentofCorrections_GRobertCottonCF,5/28/2020,Sublocal,United States of America,United States of America; Michigan,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Not reported,867,12.22%,,,Convenience,Not reported,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/5/2020,4/26/2021
200707_Lousiana_TulaneUniversity_AllChildren,7/8/2020,Local,United States of America,United States of America; Louisiana; Orleans,"March 18, 2020","May 15, 2020",Residual sera,Children and Youth (0-17 years),812,7.60%,,,Convenience,Author-designed,ELISA,IgG,,,High,Preprint,Monika Dietrich,Tulane University,https://www.medrxiv.org/content/10.1101/2020.07.07.20147884v1,7/9/2020,4/26/2021
200729_Philadelphia_UniversityofPennsylvania_TotalSampleTestAdj,7/29/2020,Local,United States of America,United States of America; Pennsylvania; Philadelphia,"April 4, 2020","June 3, 2020",Pregnant or parturient women,Adults (18-64 years),1293,5.20%,,,Sequential,Author-designed,ELISA,"IgG,IgM",100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Dustin Flannery,University of Pennsylvania,https://immunology.sciencemag.org/content/5/49/eabd5709,7/13/2020,4/26/2021
200529_Washington_CDC_KnownContacts,5/29/2020,Regional,United States of America,United States of America; Washington,"January 20, 2020","February 3, 2020",Contacts of COVID patients,Multiple groups,32,0.00%,,,Convenience,Author-designed,ELISA,Not reported,96.00%,99.00%,High,Journal Article (Peer-Reviewed),Victoria Chu,US Centers for Disease Control and Prevention,https://wwwnc.cdc.gov/eid/article/26/8/20-1423_article,7/16/2020,4/26/2021
200507_Boise_UniversityofWashington_GenPop,5/7/2020,Local,United States of America,United States of America; Idaho; Boise,"April 20, 2020","April 26, 2020",Household and community samples,Multiple groups,4856,1.79%,,,Self-referral,Abbott,Chemiluminescence Immunoassay,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Andrew Bryan,University of Washington School of Medicine,https://jcm.asm.org/content/early/2020/05/07/JCM.00941-20,7/18/2020,4/26/2021
200509_NewYork_ColumbiaUniversityIrvingMedicalCenter_HCW,6/9/2020,Sublocal,United States of America,United States of America; New York; New York City,"March 1, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),91,12.10%,,,Convenience,"""Zhejiang Orient Gene Biotech Co., LTD""",LFIA: Lateral flow immunoassay,"IgG,IgM",93.10%,99.20%,High,Journal Article (Peer-Reviewed),Miguel Morcuende,Columbia University Irving Medical Center,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302070/,7/18/2020,4/26/2021
200717_Chittenden_UniversityVermont_GenPop,7/17/2020,Local,United States of America,United States of America; Vermont,,"June 30, 2020",Household and community samples,Not reported,455,2.20%,,,Convenience,University of Vermont,Not reported,Not reported,,,High,News and Media,Cat Viglienzoni,University of Vermont,https://www.google.com/url?rct=j&sa=t&url=https://www.wcax.com/2020/07/17/early-results-of-uvm-research-tracking-covids-spread-in-vermont/&ct=ga&cd=CAAYCzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEblNmlKeakOFmkRkZMbbLnjhptxw,8/1/2020,4/26/2021
200708_WashoeCounty_WashoeCountyHealthDistrict_GenPop,7/8/2020,Local,United States of America,United States of America; Nevada,"June 9, 2020","June 10, 2020",Household and community samples,Adults (18-64 years),234,2.30%,,,Stratified probability,Abbott,Not reported,Not reported,,99.60%,High,News and Media,Mary Hynes,Washoe County Health District,https://www.google.com/url?rct=j&sa=t&url=https://www.reviewjournal.com/local/local-nevada/nevada-covid-19-infection-rate-5-times-higher-antibody-tests-show-2070094/&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGG4t16ng9mGv7ghgkKQP4Qm3hotw,8/1/2020,4/26/2021
200614_Ohio_OhioStateUniversity_Period 2,6/14/2020,Sublocal,United States of America,United States of America; Ohio; Columbus,"April 23, 2020","April 23, 2020",Health care workers and caregivers,Adults (18-64 years),110,20.00%,,,Convenience,Epitope Diagnostics,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Miranda Kiefer,Ohio State University College of Medicine,https://www.ajog.org/article/S0002-9378(20)30649-9/fulltext,8/1/2020,4/26/2021
200715_WashintonDC_DCPublicHealth_GenPop,7/15/2020,Local,United States of America,United States of America; District of Columbia; Washington DC,"June 15, 2020","July 15, 2020",Household and community samples,Not reported,13706,5.90%,,,Self-referral,"DiaSorin LIAISON, Abbot Alinity i",Chemiluminescence Immunoassay,Not reported,,,High,News and Media,Julie Zauzmer,Washington DC Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.washingtonpost.com/dc-md-va/2020/07/15/dc-health-lab-has-tested-13706-blood-samples-only-809-people-carried-coronavirus-antibodies/&ct=ga&cd=CAAYKTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFVGZ6aDeXqXAEUfikIfjfhDgkSVw,8/2/2020,4/26/2021
200715_Massachusetts_HarvardMedicalSchool_Overall_IgG/IgM,7/15/2020,Sublocal,United States of America,United States of America; Massachusetts,"April 1, 2020","April 6, 2020",Assisted living and long-term care facilities,Multiple groups,140,10.70%,,,Convenience,BioMedomics,LFIA: Lateral flow immunoassay,"IgG,IgM",90.10%,99.74%,High,Journal Article (Peer-Reviewed),Scott Goldberg,Harvard Medical School,https://dx.doi.org/10.1093/cid/ciaa991,8/2/2020,4/26/2021
200721_Idaho_UniversityofWashington_TotalPopTestAdj,7/21/2020,Local,United States of America,United States of America; Idaho,"May 4, 2020","May 19, 2020",Household and community samples,Multiple groups,917,23.10%,19.80%,26.50%,Self-referral,Abbott,Chemiluminescence Immunoassay,IgG,92.90%,99.60%,Moderate,Preprint,Colleen McLaughlin, University of Washington,https://www.medrxiv.org/content/10.1101/2020.07.19.20157198v1,8/3/2020,4/26/2021
200513_Indiana_IndianaUniversity_Wave1_NonRandom_PopAdj,"7/24/2020, 5/13/2020, 5/17/2020",Local,United States of America,United States of America; Indiana; Indianapolis,"May 2, 2020","May 3, 2020",Household and community samples,Multiple groups,898,5.80%,,,Self-referral,"Author derived
",Chemiluminescence Immunoassay,IgG,100.00%,99.60%,High,"Institutional Report, News and Media, News and Media","Nir Menachemi, Aaron Carroll, Dariush Shafa",Indiana University Fairbanks School of Public Health,"https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w, https://www.nytimes.com/2020/05/13/opinion/indiana-reopening-coronavirus-testing.html, https://www.google.com/url?rct=j&sa=t&url=https://www.perrycountynews.com/content/study-projects-only-9-covid-19-cases-detected&ct=ga&cd=CAAYHDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEf69_TglEJjU9g7rkvZNMTUfoqoQ",8/4/2020,4/26/2021
201028_Connecticut_YaleSchoolOfMedicine_GenPop1_Overall_PopAdj,10/28/2020,Regional,United States of America,United States of America; Connecticut,"June 4, 2020","June 23, 2020",Household and community samples,Multiple groups,567,4.00%,2.00%,6.00%,Simplified probability,Ortho-Clinical Diagnostics,Chemiluminescence Immunoassay,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,9/23/2020,4/26/2021
200804_Miami_DaVitaClinicalResearch_HemodialysisPatients_Overall,8/4/2020,Local,United States of America,United States of America; Florida; Miami,"April 23, 2020","April 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,677,5.60%,4.00%,7.60%,Convenience,Diazyme Laboratories Inc,Chemiluminescence Immunoassay,"IgG,IgM",57.10%,85.00%,High,Preprint,Dena Cohen,DaVita Clinical Research,https://doi.org/10.1101/2020.08.03.20163642,9/24/2020,4/26/2021
200729_RiversideCounty_RiversideUniversityHealthSystem_GenPop,"7/27/2020, 7/29/2020, 7/27/2020",Local,United States of America,United States of America; California,"July 6, 2020","July 20, 2020",Household and community samples,Not reported,1726,5.90%,,,Simplified probability,Not Reported,Not reported,Not reported,,,Unclear,"News and Media, News and Media, News and Media","Nicole Hayden, Rob McMillan, ABC7.com staff",Riverside University Health System,"https://eu.desertsun.com/story/news/health/2020/07/27/riverside-county-estimates-175-000-residents-could-have-been-infected/5522612002/, https://abc7.com/riverside-county-covid-update-coronavirus-ie-covid-19/6340600/, https://abc7.com/health/riverside-county-may-have-100000-covid-19-cases-study-says/6337677/",9/26/2020,4/26/2021
200721_NewYork_ShermanAbramsLaboratory_Overall,7/21/2020,Local,United States of America,United States of America; New York; New York,"May 15, 2020","June 15, 2020",Residual sera,Multiple groups,28523,44.00%,,,Unclear,DiaSorin LIAISON,Chemiluminescence Immunoassay,IgG,,,High,Journal Article (Peer-Reviewed),Josh Reifer,Sherman Abrams Laboratory ,https://dx.doi.org/10.1016/j.diagmicrobio.2020.115128,9/26/2020,4/26/2021
200726_RhodeIsland_NewYorkBloodCenter_BloodDonors,7/26/2020,Regional,United States of America,United States of America; Rhode Island,"April 27, 2020","May 11, 2020",Blood donors,Multiple groups,1996,3.86%,,,Sequential,"Ortho-Clinical Diagnostics, SD Biosensor","Chemiluminescence Immunoassay,LFIA: Lateral flow immunoassay","IgG,IgM",,,Moderate,Preprint,Daniel Nesbitt,New York Blood Center,https://www.medrxiv.org/content/10.1101/2020.07.20.20157743v1,9/27/2020,4/26/2021
200904_USA_CDC_HCWs_Overall,9/4/2020,National,United States of America,"United States of America; New York, Massachusetts, Tennessee, Colorado, California, Washington, Minnesota, Maryland, Oregon, North Carolina, Utah, Ohio; Bronx, Springfield, Nashville, Aurora, Boston, Los Angeles, Seattle, Minneapolis, Baltimore, Portland, Winston-Salem, Murray, Columbus","April 3, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),3248,5.97%,,,Convenience,CDC,ELISA,Total Antibody,96.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Wesley Self,CDC COVID-19 Response Team,https://www.cdc.gov/mmwr/volumes/69/wr/mm6935e2.htm,9/28/2020,4/26/2021
200723_JeffersonCounty_UniversityofLouisville_genpop,7/23/2020,Local,United States of America,United States of America; Kentucky,"June 10, 2020","June 19, 2020",Household and community samples,Multiple groups,2237,4.00%,,,Self-referral,Not reported,Not reported,Not reported,,,High,News and Media,Spectrum News Staff, University of Louisville,https://spectrumnews1.com/ky/louisville/news/2020/07/23/uofl-coimmunity-project-phase-2-results,9/29/2020,4/26/2021
200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Overall_PopAdj,7/24/2020,Local,United States of America,United States of America; Georgia,"April 28, 2020","May 3, 2020",Household and community samples,Multiple groups,696,2.50%,1.40%,4.50%,Stratified probability,Ortho-Clinical Diagnostics,Not reported,"IgG,IgA,IgM",93.20%,99.00%,Moderate,Journal Article (Peer-Reviewed),Holly Biggs,CDC COVID-19 Response Team,https://dx.doi.org/10.15585/mmwr.mm6929e2,10/1/2020,4/26/2021
200803_Indiana_IndianaUniversity_healthcareworkers,8/3/2020,Regional,United States of America,United States of America; Indiana; Indianapolis,"April 29, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),734,1.63%,,,Convenience,Abbott,Chemiluminescence Immunoassay,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Benton Hunter, Indiana University,https://dx.doi.org/10.1017/ice.2020.390,10/3/2020,4/26/2021
200730_Louisiana_OschnerClinicFoundation_Overall_PopWeighted,7/30/2020,Local,United States of America,United States of America; Louisiana,"May 9, 2020","May 15, 2020",Household and community samples,Adults (18-64 years),2640,6.90%,6.80%,6.90%,Stratified probability,Abbott,Chemiluminescence Immunoassay,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amy K Feehan,Oschner Clinic Foundation,https://dx.doi.org/10.3201/eid2611.203029,10/5/2020,4/26/2021
200814_NewYorkCity_MemorialSloanKetteringCancerCenter_CancerPatients,8/14/2020,Sublocal,United States of America,United States of America; New York; New York City,"May 7, 2020","June 25, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,952,5.46%,,,Convenience,Abbott,chemiluminescent microparticle immunoassay,IgG,,,High,Preprint,Sean McBride,Memorial Sloan Kettering Cancer Center,https://www.medrxiv.org/content/10.1101/2020.08.11.20172551v1,10/8/2020,4/26/2021
200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_UnAdj,8/6/2020,Sublocal,United States of America,United States of America; Florida,"April 16, 2020","April 17, 2020",Essential non-healthcare workers,Multiple groups,203,8.90%,,,Convenience,BioMedomics,LFIA: Lateral flow immunoassay,"IgG,IgM",88.66%,90.63%,High,Journal Article (Peer-Reviewed),Alberto J Caban-Martinez,University of Miami,http://dx.doi.org/10.1136/oemed-2020-106676,10/9/2020,4/26/2021
200811_NewYork_StFrancisHospital_Overall,8/11/2020,Sublocal,United States of America,United States of America; New York; New York City,"March 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),1699,9.80%,,,Convenience,"EUROIMMUN, Abbott",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Allen Jeremias,St Francis Hospital,http://dx.doi.org/10.1001/jamainternmed.2020.4214,10/9/2020,4/26/2021
200814_Oregon_OregonHealthAuthority_Overall_UnAdj,8/14/2020,Regional,United States of America,United States of America; Oregon,"May 11, 2020","June 15, 2020",Residual sera,Multiple groups,897,1.00%,0.20%,1.80%,Stratified probability,Abbott,chemiluminescent microparticle immunoassay,IgG,96.80%,99.10%,High,Journal Article (Peer-Reviewed),Melissa Sutton,Oregon Health Authority,https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a4.htm,10/9/2020,4/26/2021
200918_UnitedStates_Vitalant_Overall,9/18/2020,National,United States of America,"United States of America; New Mexico, Montana, Wyoming, Colorado, Texas, North Dakota, Louisiana, Nevada, Tennessee, Arizona, South Dakota, California, Washington, Mississippi; Albuquerque, Billings, Cheyenne, Denver, El Paso, Fargo, Lafayette, Las Vegas, Lubbock, McAllen, Memphis, Phoenix, Rapid City, Reno, Sacramento, San Francisco, Spokane, Tupelo, ventura, Newark","June 1, 2020","July 31, 2020",Blood donors,Multiple groups,252882,1.83%,,,Sequential,Ortho-Clinical Diagnostics,Chemiluminescence Immunoassay,"IgA,IgG,IgM,Total Antibody",,,Moderate,Preprint,Ralph Vassallo ,Vitalant,https://www.medrxiv.org/content/10.1101/2020.09.17.20195131v1.full.pdf,10/13/2020,4/26/2021
200818_Cambridge_CambridgeHealthAllianceOverall,8/18/2020,Sublocal,United States of America,United States of America; Massachusetts; Cambridge,"April 13, 2020","May 24, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),24,16.70%,,,Convenience,"Abbott, DiaSorin, EUROIMMUN",Not reported,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Robert Stavert,Cambridge Health Alliance,http://dx.doi.org/10.1016/j.jaad.2020.08.049,10/15/2020,4/26/2021
200818_SanFrancisco_UniversityofCaliforniaSanFrancisco,8/21/2020,Local,United States of America,United States of America; California; San Francisco,"April 25, 2020","April 28, 2020",Household and community samples,Multiple groups,3861,3.40%,2.90%,4.10%,Self-referral,Abbott,chemiluminescent microparticle immunoassay,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gabriel Chamie,"University of California, San Francisco",http://dx.doi.org/10.1093/cid/ciaa1234,10/16/2020,4/26/2021
200818_Oregon_EarleA.ChilesResearchInstitute_Overall,8/18/2020,Regional,United States of America,"United States of America; Oregon; Portland, Oregon City, Medford, Seaside, Hood River, Newberg, Milwaukie","April 8, 2020","May 22, 2020",Health care workers and caregivers,Multiple groups,10019,2.53%,,,Convenience,Author-designed,ELISA,IgG,80.00%,100.00%,High,Preprint,Rom Leidner,Chiles Research Institute,https://www.medrxiv.org/content/10.1101/2020.08.16.20176107v1,10/18/2020,4/26/2021
200826_NewYorkCity_JacobiMedicalCenter_HealthCareWorkers,8/26/2020,Sublocal,United States of America,United States of America; New York; New York City,"April 28, 2020","May 4, 2020",Health care workers and caregivers,Multiple groups,1700,19.20%,,,Convenience,Abbott,chemiluminescent microparticle immunoassay,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Elana Sydney,Jacobi Medical Center,http://dx.doi.org/10.1017/ice.2020.437,10/21/2020,4/26/2021
200828_LosAngeles_VeteransAffairsHealthcareSystem_Residents,8/28/2020,Sublocal,United States of America,United States of America; California; Los Angeles,"June 5, 2020","June 12, 2020",Assisted living and long-term care facilities,Multiple groups,150,17.30%,,,Convenience,DiaSorin,Chemiluminescence Immunoassay,IgG,92.00%,98.00%,High,Journal Article (Peer-Reviewed),Amy V Dora,Veterans Affairs Healthcare System,http://dx.doi.org/10.1093/cid/ciaa1286,10/21/2020,4/26/2021
200909_Chelsea_MassachusettsGeneralHospital_Overall_TestAdj,9/9/2020,Local,United States of America,United States of America; Massachusetts; Chelsea,"April 14, 2020","April 15, 2020",Household and community samples,Adults (18-64 years),200,32.80%,27.20%,38.80%,Convenience,BioMedomics,ELISA,"IgM,IgG",90.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Vivek Naranbhai,Massachusetts General Hospital,http://dx.doi.org/10.1093/infdis/jiaa579,10/21/2020,4/26/2021
200821_NewYorkCityHealthSystem_AlbertEinsteinCollegeofMedicine,8/21/2020,Local,United States of America,United States of America; New York; New York City,"April 4, 2020","April 20, 2020",Health care workers and caregivers,Adults (18-64 years),98,15.30%,,,Convenience,Epitope Diagnostics,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ariel D. Stock,Albert Einstein College of Medicine,https://dx.doi.org/10.3389/fmed.2020.00471,10/24/2020,4/26/2021
200920_NewYorkState_DonaldAndBarbaraZuckerSchoolOfMedicine_Patients_Overall,9/2/2020,Regional,United States of America,United States of America; New York,"May 27, 2020","July 24, 2020",Pregnant or parturient women,Adults (18-64 years),1671,16.10%,,,Unclear,Roche,,IgG,,,High,Journal Article (Peer-Reviewed),Lylach Haizler-Cohen,Donald and Barbara Zucker School of Medicine,https://dx.doi.org/10.1016/j.ajog.2020.09.022,10/30/2020,4/26/2021
200911_NewYorkCity_WeillCornellMedicine_IgGorIgM,9/11/2020,Local,United States of America,United States of America; New York; New York City,"April 17, 2020","May 7, 2020",Health care workers and caregivers,Adults (18-64 years),2274,35.40%,,,Convenience,ET Healthcare,Cyclic enhanced fluorescence assay (CEFA),"IgG,IgM",,98.80%,Moderate,Journal Article (Peer-Reviewed),Sabrina Racine-Brzostek,Weill Cornell Medicine,http://dx.doi.org/10.1093/ajcp/aqaa142,11/2/2020,4/26/2021
201023_BatonRouge_LouisianaStateUniversity_Total_popadj,10/23/2020,Local,United States of America,United States of America; Louisiana; Baton Rouge,"July 15, 2020","July 31, 2020",Household and community samples,Multiple groups,2138,3.60%,2.80%,4.40%,Stratified probability,Abbott,Chemiluminescence Immunoassay,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amy K. Feehan,Louisiana State University,https://dx.doi.org/10.3201/eid2701.203808,11/4/2020,4/26/2021
200917_SanFrancisco_UniversityofCalifornia_BloodDonors,9/17/2020,Local,United States of America,United States of America; California; San Francisco,"March 1, 2020","March 31, 2020",Blood donors,Multiple groups,1000,,0.00%,0.56%,Sequential,"Abbott, Ortho-Clinical Diagnostics","Chemiluminescence Immunoassay,Neutralization assay",IgG,,,Moderate,Journal Article (Peer-Reviewed),Dianna Ng,"University of California, San Francisco",https://dx.doi.org/10.1038/s41467-020-18468-8,11/6/2020,4/26/2021
200917_SanFrancisco_UniversityofCalifornia_Patients,9/17/2020,Local,United States of America,United States of America; California; San Francisco,"March 17, 2020","April 13, 2020",Residual sera,Multiple groups,387,0.26%,0.00%,0.76%,Convenience,Abbott,Chemiluminescence Immunoassay,IgG,99.00%,99.80%,High,Journal Article (Peer-Reviewed),Dianna Ng,"University of California, San Francisco",https://dx.doi.org/10.1038/s41467-020-18468-8,11/6/2020,4/26/2021
200925_UnitedStates_StanfordUniversity_OverallPopAdj,9/25/2020,National,United States of America,United States of America,"June 15, 2020","June 15, 2020",Residual sera,Multiple groups,28503,9.30%,8.80%,9.90%,Stratified probability,Siemens Healthineers,Chemiluminescence,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Shuchi Anand,Stanford University,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32009-2/fulltext,11/22/2020,4/26/2021
200923_AnnArbor_VeteransAffairsAnnArborHealthcareSystem,9/23/2020,Local,United States of America,United States of America; Michigan,"June 8, 2020","July 8, 2020",Health care workers and caregivers,Multiple groups,1476,4.90%,3.80%,6.10%,Self-referral,Abbott,Chemiluminsescent microparticle immunoassay,IgG,100.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Derek Dimcheff,Veterans Affairs Ann Arbor Healthcare System,https://dx.doi.org/10.1017/ice.2020.1220,11/22/2020,4/26/2021
200918_Arizona_VincereCancerCenter_Total,9/18/2020,Regional,United States of America,"United States of America; Arizona; Phoenix, Tempe, Glendale, Surprise, Peoria, Chandler","April 24, 2020","May 21, 2020",Essential non-healthcare workers,Multiple groups,3326,1.50%,,,Self-referral,Ray Biotech,LFIA: Lateral flow immunoassay,IgG,90.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Vershalee Shukla,Vincere Cancer Center,https://dx.doi.org/10.1097/JOM.0000000000002027,11/23/2020,4/26/2021
200914_UnitedStates_AmericanRedCrossScientificAffairs_Overall,9/14/2020,National,United States of America,United States of America,"June 15, 2020","June 15, 2020",Blood donors,Multiple groups,953926,1.82%,,,Sequential,Ortho-Clinical Diagnostics,Not reported,Total Antibody,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Roger Dodd,American Red Cross Scientific Affairs,http://dx.doi.org/10.1001/jama.2020.18598,11/23/2020,4/26/2021
200917_Nashville_VanderbiltUniversityMedicalCenter_60DaysOverall,9/17/2020,Sublocal,United States of America,United States of America; Tennessee; Nashville,"June 2, 2020","June 27, 2020",Health care workers and caregivers,Multiple groups,230,3.48%,,,Convenience,CDC,ELISA,Total Antibody,96.00%,99.00%,High,Journal Article (Peer-Reviewed),Manish Patel,Vanderbilt University Medical Center,http://dx.doi.org/10.1001/jama.2020.18796,11/24/2020,4/26/2021
200921_Detroit_Region2SouthHealthcareCoalition_Overall,9/21/2020,Local,United States of America,United States of America; Michigan; Detroit,"May 18, 2020","June 13, 2020",Health care workers and caregivers,Adults (18-64 years),16397,6.90%,6.50%,7.30%,Convenience,Ortho Clinical Diagnostics,,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Lara Akinbami,Region 2 South Healthcare Coalition,https://dx.doi.org/10.3201/eid2612.203764,12/4/2020,4/26/2021
200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC2_Overall,9/29/2020,Regional,United States of America,United States of America; North Carolina,"March 3, 2020","June 4, 2020",Residual sera,Adults (18-64 years),1449,0.70%,,,Unclear,Abbott Laboratories,,IgG,100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Amir Barzin,University of North Carolina Chapel Hill,http://dx.doi.org/10.1128/mBio.02426-20,12/7/2020,4/26/2021
200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC_OverallAdj,9/29/2020,Regional,United States of America,United States of America; North Carolina,"April 28, 2020","June 19, 2020",Residual sera,Adults (18-64 years),2973,0.00%,0.00%,0.90%,Unclear,Abbott Laboratories,,IgG,100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Amir Barzin,University of North Carolina Chapel Hill,http://dx.doi.org/10.1128/mBio.02426-20,12/7/2020,4/26/2021
201001_Atlanta_EmoryUniversity_OverallHCW,10/1/2020,Sublocal,United States of America,United States of America; Georgia; Atlanta,"April 16, 2020","May 18, 2020",Health care workers and caregivers,Adults (18-64 years),300,4.70%,,,Unclear,NR,,IgG,,,Unclear,Journal Article (Peer-Reviewed),C. R. Morris,Emory University,http://dx.doi.org/10.1016/j.annemergmed.2020.09.336,12/15/2020,4/26/2021
200816_SaltLakeCityMilwaukee_CentersforDiseaseControl_householdcontacts,8/16/2020,Local,United States of America,"United States of America; Utah, Wisconsin; Salt Lake City, Milwaukee","March 22, 2020","April 25, 2020",Contacts of COVID patients,Multiple groups,178,25.80%,,,Convenience,CDC,,Not reported,,,High,Journal Article (Peer-Reviewed),Nathaniel M. Lewis,Centers for Disease Control ,https://dx.doi.org/10.1093/cid/ciaa1166,12/16/2020,4/26/2021
201127_Utah_UniversityOfUtah_GenPop_testadj_popadj,10/27/2020,Regional,United States of America,United States of America; Utah,"May 4, 2020","June 30, 2020",Household and community samples,Multiple groups,8108,0.80%,0.10%,1.60%,Stratified probability,Abbott,,IgG,86.40%,99.60%,Moderate,Preprint,Matthew Samore,University of Utah,https://www.medrxiv.org/content/10.1101/2020.10.26.20219907v1,12/16/2020,4/26/2021
201116_Tennessee_VanderbiltUniversity_HCW_Overall,11/16/2020,Regional,United States of America,United States of America; Tennessee,"May 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),11787,0.98%,,,Convenience,Abbott,,IgG,,,High,Preprint,Peter Rebeiro,Vanderbilt University,https://www.medrxiv.org/content/10.1101/2020.11.12.20230912v1,12/16/2020,4/26/2021
201105_Michigan_OaklandUniversity_testadj,11/5/2020,Sublocal,United States of America,"United States of America; Michigan; Dearborn, Farmington Hills, Grosse Pointe, Royal Oak, Taylor, Trenton, Troy, Wayne, Canton","April 13, 2020","May 28, 2020",Health care workers and caregivers,Multiple groups,20614,8.10%,6.80%,8.90%,Convenience,EUROIMMUN Lübeck,,IgG,98.14%,99.35%,Moderate,Journal Article (Peer-Reviewed),Matthew D Sims,Oakland University,https://dx.doi.org/10.1093/cid/ciaa1684,12/17/2020,4/26/2021
201030_Indianapolis_IndianaUniversity_Overall,10/30/2020,Local,United States of America,United States of America; Indiana; Indianapolis ,"May 1, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),31,3.20%,,,Convenience,"Abnova, Eli Lilly and Co & IUSM, Mount Sinai medical center",,"IgM,IgG",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Corina Nailescu,Indiana University ,https://dx.doi.org/10.3389/fped.2020.601327,12/17/2020,4/26/2021
201201_NewHeaven_Yale_SchoolofMedicine_newborns,12/12/2020,Sublocal,United States of America,United States of America; Connecticut; New Haven,"February 19, 2020","May 26, 2020",Residual sera,Children and Youth (0-17 years),3048,5.90%,,,Sequential,In-house,,IgG,,,High,Journal Article (Peer-Reviewed),Feimei  Liu,Yale School of Medicine,https://dx.doi.org/10.1097/INF.0000000000002918,12/17/2020,4/26/2021
201021_NewYork_Serimmune_Overall,10/21/2020,Local,United States of America,United States of America; New York; New York City,"March 1, 2020","July 7, 2020",Blood donors,Multiple groups,1559,4.36%,,,Sequential,Serimmune,,IgG,91.00%,99.30%,High,Preprint,Kathy Kamath,Serimmune,https://www.medrxiv.org/content/10.1101/2020.10.19.20215368v1,12/17/2020,4/26/2021
201107_Lubbock_TexasTechUniversity_Overall,11/7/2020,Local,United States of America,United States of America; Texas; Lubbock,"May 12, 2020","May 13, 2020",Essential non-healthcare workers,Multiple groups,683,0.70%,,,Convenience,Abbott,,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Kenneth Iwuji,Texas Tech University,https://dx.doi.org/10.1177/2150132720971390,12/18/2020,4/26/2021
201107_NewYorkCity_NewYorkBloodCenter_BloodDonors_OrthoAND/ORAbbot_,11/7/2020,Local,United States of America,United States of America; New York; New York City,"June 15, 2020","July 15, 2020",Blood donors,Multiple groups,1000,12.80%,,,Sequential,"Ortho Clinical Diagnostics, Abbott Labs",,"IgG,Total Antibody",,,High,Preprint,Daniel Jin,New York Blood Centre,https://www.medrxiv.org/content/10.1101/2020.11.06.20220087v1,12/18/2020,4/26/2021
201013_PimaCounty_UniversityofArizona_Overall,10/13/2020,Local,United States of America,United States of America; Arizona,"April 30, 2020","May 7, 2020",Household and community samples,Multiple groups,5882,1.24%,,,Self-referral,NR,,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Tyler Ripperger,University of Arizona,http://dx.doi.org/10.1016/j.immuni.2020.10.004,12/18/2020,4/26/2021
200901_UtahMassachusetts_IgenomixUS_Overall,9/1/2020,Regional,United States of America,"United States of America; Utah, Massachusetts","June 18, 2020","July 30, 2020",Multiple populations,Multiple groups,337,1.48%,,,Sequential,Abbott ,,IgG,,,High,Journal Article (Peer-Reviewed),Russell Foulk,Igenomix US,http://dx.doi.org/10.1016/j.fertnstert.2020.09.069,12/18/2020,4/26/2021
201015_NewYorkCity_NYCHealth+Hospitals/Lincoln_Overall,10/15/2020,Local,United States of America,United States of America; New York; New York City,"March 1, 2020","May 1, 2020",Health care workers and caregivers,Adults (18-64 years),500,27.00%,,,Convenience,Abbott Laboratories,,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Usha Venugopal,NYC Health + Hospitals/Lincoln,http://dx.doi.org/10.1016/j.ijid.2020.10.036,12/19/2020,4/26/2021
201030_Cleveland_CaseWesternReserveUniversity_Overall,10/30/2020,Local,United States of America,United States of America; Ohio; Cleveland,"April 20, 2020","May 19, 2020",Essential non-healthcare workers,Adults (18-64 years),296,5.40%,3.10%,8.60%,Convenience,"Epitope Diagnostics, Inc",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yasir Tarabichi,Case Western Reserve University,https://dx.doi.org/10.1080/10903127.2020.1831668,12/21/2020,4/26/2021
201118_Chicago_NorthwesternUniversity_Overall,11/18/2020,Local,United States of America,United States of America; Illinois; Chicago,"June 24, 2020","September 6, 2020",Household and community samples,Adults (18-64 years),1545,19.80%,,,Convenience,In-House,,IgG,,,High,Preprint,Alexis Demonbreun,Northwestern University,https://www.medrxiv.org/content/10.1101/2020.11.17.20233452v1,12/22/2020,4/20/2021
201026_UpstateNewYork_BassettMedicalCenter_Overall,10/26/2020,Local,United States of America,United States of America; New York; Upstate New York,"May 4, 2020","May 29, 2020",Health care workers and caregivers,Multiple groups,764,2.00%,,,Unclear,Abbott Laboratories,,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Wendy M. Brunner,Bassett Medical Center,https://dx.doi.org/10.1017/ice.2020.1296,12/27/2020,4/26/2021
201027_Indiana_Harvard_Overall_testadj,11/27/2020,Sublocal,United States of America,United States of America; Indiana; St. John Township,"July 15, 2020","July 20, 2020",Essential non-healthcare workers,Multiple groups,753,1.70%,0.27%,3.30%,Self-referral,Abbott Alinity,,IgG,100.00%,99.00%,Moderate,Preprint,Lilah Lopez,Harvard Medical School,https://www.medrxiv.org/content/10.1101/2020.10.23.20218651v1,1/4/2021,4/26/2021
201119_LosAngeles_CedarsSinaiMedicalCenter_Overall,11/19/2020,Local,United States of America,United States of America; California; Los Angeles,"May 11, 2020","June 28, 2020",Health care workers and caregivers,Adults (18-64 years),6201,3.50%,,,Self-referral,Abbott,,IgG,96.90%,99.90%,Moderate,Journal Article (Peer-Reviewed),Magali Rivas,Cedars-Sinai Medical Center,https://dx.doi.org/10.1172/JCI145157,1/5/2021,4/26/2021
201120_Rochester_MayoClinic_HighRiskCohort_1_Overall,11/20/2020,Sublocal,United States of America,United States of America; Minnesota; Rochester,"May 25, 2020","July 9, 2020",Health care workers and caregivers,Adults (18-64 years),320,0.63%,,,Unclear,"EUROIMMUN, Ortho-Clinical Diagnostics, Roche Diagnostics",,IgG,,,High,Journal Article (Peer-Reviewed),Vishal Shah,Mayo Clinic,https://dx.doi.org/10.1017/ice.2020.1341,1/5/2021,4/26/2021
201120_Rochester_MayoClinic_LowRiskCohort_2_Overall,11/20/2020,Sublocal,United States of America,United States of America; Minnesota; Rochester,"May 25, 2020","July 9, 2020",Health care workers and caregivers,Adults (18-64 years),248,0.00%,,,Unclear,"EUROIMMUN, Ortho-Clinical Diagnostics, Roche Diagnostics",,IgG,,,High,Journal Article (Peer-Reviewed),Vishal Shah,Mayo Clinic,https://dx.doi.org/10.1017/ice.2020.1341,1/5/2021,4/26/2021
201004_USA_RedCross_genpop_unadj,10/4/2020,National,United States of America,United States of America,"June 15, 2020","July 27, 2020",Blood donors,Multiple groups,573586,1.50%,,,Sequential,Ortho,,IgG,,,High,Journal Article (Peer-Reviewed),Bryan Spencer,American Red Cross,https://aabb.confex.com/aabb/2020/meetingapp.cgi/Paper/8581,1/6/2021,4/26/2021
200810_USA_Illinois_PhysicianPractice_Overall,8/6/2020,Sublocal,United States of America,United States of America; Illinois; Chicago,"April 22, 2020","May 26, 2020",Residual sera,Multiple groups,113,15.90%,,,Convenience,CLUNGENE,,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Gerald Osher,BioSolutions Services LLC,https://lymphosign.com/doi/full/10.14785/lymphosign-2020-0007,1/6/2021,4/26/2021
201027_Illinois_CDC_Contacts,10/27/2020,Sublocal,United States of America,United States of America; Illinois,"March 3, 2020","March 6, 2020",Contacts of COVID patients,Adults (18-64 years),59,0.00%,,,Convenience,CDC,,"IgG,IgM,IgA",96.00%,99.00%,High,Journal Article (Peer-Reviewed),Tristan McPherson,US Centers for Disease Control and Prevention,https://dx.doi.org/10.1177/0033354920966064,1/6/2021,4/26/2021
201013_Pittsburgh_UniversityPittsburgh_PedImmunocompPatients_Overall,10/13/2020,Sublocal,United States of America,United States of America; Pennsylvania; Pittsburgh,"March 15, 2020","July 4, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),485,1.00%,0.30%,2.40%,Convenience,"Euroimmun, Beckman Coulter, Siemens",,IgG,,,High,Journal Article (Peer-Reviewed),Megan Freeman,University of Pittsburgh School of Medicine,http://dx.doi.org/10.1093/jpids/piaa123,1/6/2021,4/26/2021
201201_LosAngeles_UniversityofSouthernCalifornia_UniversityStudents_Overall,12/1/2020,Sublocal,United States of America,United States of America; California; Los Angeles,"April 29, 2020","May 8, 2020",Students and Daycares,Adults (18-64 years),790,4.00%,3.00%,5.10%,Convenience,EUROIMMUN,,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kimberly Tilley,University of Southern California,http://dx.doi.org/10.1016/j.jadohealth.2020.09.001,1/7/2021,4/26/2021
201103_NewYorkCity_MountSinai_UrgentCare_2_Overall,11/3/2020,Local,United States of America,United States of America; New York; New York City,"February 2, 2020","July 5, 2020",Residual sera,Multiple groups,4101,26.00%,,,Sequential,Mount Sinai Hospital New York,,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Daniel Stadlbauer,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.1038/s41586-020-2912-6,1/8/2021,4/26/2021
200624_BaskingRidge_FellowshipVillage_Staff1_Overall,6/24/2020,Sublocal,United States of America,United States of America; New Jersey; Basking Ridge,"April 15, 2020","May 6, 2020",Assisted living and long-term care facilities,Adults (18-64 years),305,23.60%,,,Entire sample,NR,,"IgG,IgM",,,Unclear,News and Media,Tim Regan,Fellowship Village,https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g,1/9/2021,4/26/2021
201015_BronxNY_AlbertEinsteinCollegeofMedicine_KidneyTransplantlPatients,10/15/2020,Sublocal,United States of America,United States of America; New York; New York City,"May 3, 2020","July 29, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),912,16.66%,,,Convenience,Abbott,,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Yorg Azzi,Albert Einstein College of Medicine,http://dx.doi.org/10.1016/j.kint.2020.10.004,1/13/2021,4/26/2021
210105_USA_ClinicalReferenceLaboratory_GenPop_Overall,1/5/2021,National,United States of America,United States of America,"May 12, 2020","December 6, 2020",Residual sera,Multiple groups,126587,5.87%,,,Convenience,Roche,,Total Antibody,100.00%,99.80%,High,Preprint,Robert Stout,Clinical Reference Laboratory Inc.,https://www.medrxiv.org/content/10.1101/2020.11.10.20215145v3.full.pdf,1/17/2021,4/26/2021
201120_LosAngeles_TheLundquistInstitute_genpop,11/25/2020,Local,United States of America,United States of America; California,"April 21, 2020","May 22, 2020",Multiple populations,Not reported,244,20.90%,,,Unclear,Hangzhou Testsea Biotechnology Co.,,"IgG,IgM",96.00%,100.00%,High,Journal Article (Peer-Reviewed),Khadije Ahmad,The Lundquist Institute ,https://dx.doi.org/10.1007/s10096-020-04111-3,1/19/2021,4/26/2021
201130_USA_AmericanRedCross_BloodDonors,11/30/2020,National,United States of America,"United States of America; Massachusetts, California, Connecticut, Iowa, Michigan, Oregon, Rhode Island, Washington, Wisconsin","December 13, 2019","January 17, 2020",Blood donors,Multiple groups,7389,1.40%,,,Sequential,CDC,,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Sridhar V. Basavaraju,American Red Cross,https://dx.doi.org/10.1093/cid/ciaa1785,1/19/2021,4/26/2021
201123_OrangeCounty_StJudeMedicalCenter_Overall,11/23/2020,Local,United States of America,United States of America; California; Fullerton,"July 15, 2020","July 27, 2020",Residual sera,Multiple groups,865,9.40%,8.00%,12.00%,Sequential,Abbott Laboratories,,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Jason Yamaki,St. Jude Medical Center,https://dx.doi.org/10.1007/s40615-020-00918-0,1/20/2021,4/26/2021
201121_LosAngeles_UniversityofCaliforniaLosAngeles_HCW,11/21/2020,Local,United States of America,United States of America; California,"April 8, 2020","August 31, 2020",Health care workers and caregivers,Multiple groups,1108,3.90%,,,Unclear,NR,,IgG,,,Moderate,Preprint,Megan Halbrook,University of California Los Angeles,https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1,1/20/2021,4/26/2021
201121_LosAngeles_UniversityofCaliforniaLosAngeles_FirstResponders,11/21/2020,Local,United States of America,United States of America; California,"May 19, 2020","August 31, 2020",Essential non-healthcare workers,Multiple groups,679,8.10%,,,Unclear,NR,,IgG,,,Moderate,Preprint,Megan Halbrook,University of California Los Angeles,https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1,1/20/2021,4/26/2021
201127_DistrictofColumbia_DCHealth_Overall,11/27/2020,Local,United States of America,United States of America,"May 28, 2020","July 15, 2020",Essential non-healthcare workers,Adults (18-64 years),310,3.55%,,,Self-referral,DiaSorin Inc.,,IgG,97.00%,,High,Preprint,Jacqueline Reuben,District of Columbia Department of Health (DC Health),https://www.medrxiv.org/content/10.1101/2020.11.25.20225490v1,1/21/2021,4/26/2021
201130_SanFrancisco_StanfordUniversity_Overall,11/30/2020,Local,United States of America,United States of America; California; San Francisco,"April 20, 2020","June 8, 2020",Health care workers and caregivers,Adults (18-64 years),12418,0.90%,0.70%,1.10%,Self-referral,Stanford Health Care,,IgG,,99.75%,High,Journal Article (Peer-Reviewed),Catherine Hogan,Stanford University,https://dx.doi.org/10.3201/eid2701.203892,1/21/2021,4/26/2021
200622_Brooklyn_ColumbiaUniversityMedicalCenter_Overall,6/22/2020,Sublocal,United States of America,United States of America; New York; New York City,"February 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),50,46.00%,,,Convenience,Abbott Laboratories,,IgG,,,High,Journal Article (Peer-Reviewed),Jordan Jeong,Columbia University Medical Center,https://dx.doi.org/10.1016/j.annemergmed.2020.06.038,1/22/2021,4/26/2021
201210_Atlanta_CDC_Community_OverallPopTestAdj,12/10/2020,Local,United States of America,United States of America; Georgia; Atlanta,"April 28, 2020","May 3, 2020",Household and community samples,Multiple groups,669,3.18%,1.49%,6.67%,Stratified probability,Centers for Disease Control and Prevention (CDC),,Total Antibody,96.00%,99.30%,Low,Journal Article (Peer-Reviewed),Kristina Bajema,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciaa1804,1/22/2021,4/26/2021
201210_Atlanta_CDC_Lab_OverallPopTestAdj,12/10/2020,Local,United States of America,United States of America; Georgia; Atlanta,"April 27, 2020","May 1, 2020",Residual sera,Multiple groups,1343,4.94%,3.34%,6.64%,Convenience,Centers for Disease Control and Prevention (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciaa1804,1/22/2021,4/26/2021
201215_SanDiego_SharpHealthCare_Overall,12/15/2020,Local,United States of America,United States of America; California; San Diego,"May 20, 2020","June 8, 2020",Health care workers and caregivers,Multiple groups,1770,2.20%,,,Convenience,Roche Diagnostics,,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Norihiro Yogo,Sharp Healthcare,https://dx.doi.org/10.1017/ice.2020.1370,1/23/2021,4/26/2021
210101_Seattle_SeattleChildren'sResearchInstitute_FollowUp_Overall,1/1/2021,Sublocal,United States of America,United States of America; Washington ; Seattle,"July 6, 2020","August 7, 2020",Health care workers and caregivers,Adults (18-64 years),481,1.00%,,,Convenience,Abbott Laboratories,,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Yekaterina Tokareva,Seattle Childrens Research Institute,https://dx.doi.org/10.1542/hpeds.2020-003517,1/23/2021,3/29/2021
201119_USA_QuestDiagnostics_Overall,11/19/2020,National,United States of America,United States of America,"April 21, 2020","July 10, 2020",Household and community samples,Multiple groups,2402282,11.81%,,,Sequential,"Abbott Laboratories, Ortho-Clinical Diagnostics, EUROIMMUN",,IgG,,,High,Journal Article (Peer-Reviewed),Harvey W. Kaufman,Quest Diagnostics,http://dx.doi.org/10.1089/pop.2020.0256,1/23/2021,4/26/2021
201214_VirginaUSA_VirginiaCommonwealthUniversity_Overall,12/14/2020,Sublocal,United States of America,United States of America; Virginia; Richmond,"July 27, 2020","October 2, 2020",Health care workers and caregivers,Multiple groups,1962,1.37%,,,Convenience,Abbott Laboratories,,IgG,,,High,Journal Article (Peer-Reviewed),Emily Godbout,Virginia Commonwealth University,https://dx.doi.org/10.1017/ice.2020.1374,1/23/2021,4/26/2021
201207_Massachusetts_MassachusettsGeneralHospital_Cohabitants,12/7/2020,Sublocal,United States of America,United States of America; Massachusetts; Boston,"May 29, 2020","July 23, 2020",Multiple populations,Multiple groups,143,6.30%,,,Sequential,Massachusetts General Hospital,,IgG,99.70%,100.00%,High,Journal Article (Peer-Reviewed),E. Klawiter,Massachusetts General Hospital,https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1,1/26/2021,4/26/2021
201207_Massachusetts_MassachusettsGeneralHospital_MS,12/7/2020,Local,United States of America,United States of America; Massachusetts; Boston,"May 29, 2020","July 23, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,227,3.50%,,,Sequential,Massachusetts General Hospital,,IgG,99.70%,100.00%,High,Journal Article (Peer-Reviewed),E. Klawiter,Massachusetts General Hospital,https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1,1/26/2021,4/26/2021
201203_AraphoeCounty_UniversityofColorado,12/3/2020,Local,United States of America,United States of America; Colorado,"July 15, 2020","August 15, 2020",Essential non-healthcare workers,Adults (18-64 years),264,4.00%,,,Convenience,Exsera BioLabs,,IgG,85.00%,98.60%,High,Journal Article (Peer-Reviewed),Katherine Sabourin,University of Colorado,https://pubmed.ncbi.nlm.nih.gov/33298759/,1/28/2021,4/26/2021
200901_NewYorkCity_NorthwellHealthCOVID-19ResearchConsortium,12/8/2020,Local,United States of America,United States of America; New York ; New York City,"April 20, 2020","June 23, 2020",Health care workers and caregivers,Multiple groups,40329,13.70%,,,Convenience,"Euroimmun, AnshLabs, Abbott Laboratories, Ortho Clinical Diagnostics, DiaSorin, Roche",,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Joseph Moscola,Northwell Health COVID-19 Research Consortium,https://pubmed.ncbi.nlm.nih.gov/32780804/,1/28/2021,4/26/2021
201230_SanDiego_ScrippsClinic_Overall,12/30/2020,Local,United States of America,United States of America; California; San Diego,"April 14, 2020","July 28, 2020",Health care workers and caregivers,Adults (18-64 years),11993,0.94%,,,Convenience,"Diazyme, Abbott Laboratories",,IgG,,,High,Journal Article (Peer-Reviewed),Laura Nicholson,Scripps Clinic,https://dx.doi.org/10.1016/j.ajic.2020.12.017,1/28/2021,4/26/2021
201222_Wisconsin_UniversityofWisconsin_WaveI_overall_popadj,12/22/2020,Regional,United States of America,United States of America; Wisconsin,"July 1, 2020","August 31, 2020",Household and community samples,Multiple groups,996,1.60%,0.60%,2.50%,Stratified probability,Abbott,,IgG,,99.60%,Moderate,Preprint,Kristen Maleck,University of Wisconsin,https://doi.org/10.1101/2020.12.18.20248479,2/3/2021,4/26/2021
201222_Wisconsin_UniversityofWisconsin_WaveII_overall_popadj,12/22/2020,Regional,United States of America,United States of America; Wisconsin,"October 18, 2020","December 14, 2020",Household and community samples,Multiple groups,994,6.80%,4.30%,9.40%,Stratified probability,Abbott,,IgG,,99.60%,Moderate,Preprint,Kristen Maleck,University of Wisconsin,https://doi.org/10.1101/2020.12.18.20248479,2/3/2021,4/26/2021
210105_USA_MayoClinic_overall,1/5/2021,Sublocal,United States of America,United States of America; Minnesota; Rochester,"May 16, 2020","May 17, 2020",Essential non-healthcare workers,Adults (18-64 years),255,1.20%,,,Convenience,N/A  - Author designed,,IgG,88.10%,99.60%,High,Journal Article (Peer-Reviewed),Sarayna S. McGuire,Mayo Clinic,https://dx.doi.org/10.1017/S1049023X2000151X,2/3/2021,3/31/2021
201209_SantaClara_StanfordHealthCare,12/9/2020,Local,United States of America,United States of America; California; San Francisco Bay Area,"April 20, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),10449,1.30%,,,Convenience,Stanford Clinical Laboratory,,IgG,87.00%,99.75%,High,Journal Article (Peer-Reviewed),Joelle Rosser,Stanford Health Care,https://dx.doi.org/10.1017/ice.2020.1358,2/3/2021,4/26/2021
201223_NewYork_MemorialSloanKetteringCancerCenter,12/23/2020,Sublocal,United States of America,United States of America; New York; New York City,"May 5, 2020","September 10, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),257,7.80%,,,Sequential,Abbott,,IgG,,,High,Journal Article (Peer-Reviewed),Lauren Jimenez-Kurlander,Memorial Sloan Kettering Cancer Center,https://dx.doi.org/10.1002/pbc.28857,2/3/2021,4/26/2021
210119_NewJersey_CooperUniversityHospital_overall,1/19/2021,Sublocal,United States of America,United States of America; New Jersey ,"June 10, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),172,5.20%,2.40%,9.70%,Convenience,1) Roche 2) EUROIMMUN,,Total Antibody,,,High,Journal Article (Peer-Reviewed),Snehal Gandhi,Cooper University Hospital,https://dx.doi.org/10.1007/s11606-020-06462-1,2/3/2021,3/28/2021
201106_Utah_UniversityofUtah_immunosupressed_primary,11/6/2020,Sublocal,United States of America,United States of America; Utah,"April 18, 2020","May 21, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,39,2.60%,,,Unclear,in house - ARUP,,IgG,,,High,Preprint,Quinn Pritchett,University of Utah,https://acrabstracts.org/abstract/assessing-cytokine-profiles-and-covid-serology-in-patients-on-immunosuppression-to-guide-care-recommendations/,2/4/2021,4/26/2021
210111_Michigan_ UniversityofMichigan_overall,1/11/2021,Sublocal,United States of America,United States of America; Michigan,"August 17, 2020","September 4, 2020",Health care workers and caregivers,Adults (18-64 years),,1.88%,,,Convenience,"Siemens, Eagle Bioscience",,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Jeffrey J. Fletcher,Metro Health University of Michigan Health,http://dx.doi.org/10.1017/ice.2020.1438,2/4/2021,3/28/2021
201031_NewJersey_RutgersRobertWoodJohnsonMedicalSchool,10/31/2020,Sublocal,United States of America,"United States of America; New Jersey; New Brunswick, Somerville","April 28, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),3907,9.60%,,,Convenience,Abbott Laboratories,,IgG,96.90%,99.60%,Moderate,Journal Article (Peer-Reviewed),Emily Barrett,Rutgers Robert Wood Johnson Medical School,https://dx.doi.org/10.1093/ofid/ofaa534,2/5/2021,4/26/2021
210120_USA_BostonHeartDiagnostics_IgG,1/20/2021,National,United States of America,United States of America,"April 6, 2020","September 1, 2020",Household and community samples,Adults (18-64 years),79005,5.29%,,,Unclear,Diazyme Laboratories,,IgG,98.40%,97.40%,Unclear,Preprint,Ernst J. Schaefer,Boston Heart Diagnostics ,https://www.medrxiv.org/content/10.1101/2021.01.19.21249604v1.full-text,2/10/2021,3/31/2021
210115_Massachusetts_HarvardUniversity_Overall,1/15/2021,Regional,United States of America,United States of America; Massachusetts,"June 16, 2020","August 24, 2020",Multiple populations,Multiple groups,1872,3.15%,,,Convenience,Euroimmun,,IgG,,,Moderate,Preprint,Aishani Aatresh,Harvard University,10.1101/2021.01.14.21249824,2/11/2021,3/29/2021
210202_Indiana_IndianaUniversity_GenPop_PopAdjTestAdj,2/2/2021,Regional,United States of America,United States of America; Indiana,"April 25, 2020","April 29, 2020",Household and community samples,Multiple groups,3625,2.60%,2.08%,3.35%,Stratified probability,Abbott,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Constantin Yiannoutsos,Indiana University,https://dx.doi.org/10.1073/pnas.2013906118,2/13/2021,3/29/2021
201216_Seattle_WashingtonUniversity_fishermen_unadjusted copy,10/21/2020,Sublocal,United States of America,United States of America; Washington; Seattle,"May 1, 2020","May 31, 2020",Essential non-healthcare workers,Adults (18-64 years),120,2.50%,,,Entire sample,"Abbott, unclear",,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Amin Addetia,University of Washington,https://jcm.asm.org/content/58/11/e02107-20,2/16/2021,4/26/2021
201209_Chicago_NorthwesternUniversity_OverallPopAdj,12/9/2020,Local,United States of America,United States of America; Illinois; Chicago,"May 28, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,6510,5.30%,4.80%,5.90%,Convenience,Abbott ,,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),John T. Wilkins,Northwestern University ,https://dx.doi.org/10.1093/ofid/ofaa582,2/18/2021,4/26/2021
210129_Philadelphia_UniversityofPennsylvania_overallmother_unadj,1/29/2021,Sublocal,United States of America,United States of America; Pennsylvania; Philadelphia,"April 9, 2020","August 8, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1471,6.00%,,,Convenience,Authors,,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Dustin D Flannery,University of Pennsylvania,https://dx.doi.org/10.1001/jamapediatrics.2021.0038,2/19/2021,4/9/2021
210117_Maryland_UniversityofMaryland_overall_adj,1/17/2021,Local,United States of America,United States of America; Maryland; Baltimore,"June 3, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),8399,3.52%,3.01%,3.98%,Convenience,"1) Ortho Vitros 
2) N/A - institution desgined",,"IgG,IgM,IgA",100.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Kristin E Mullins,University of Maryland,http://dx.doi.org/10.1016/j.clinbiochem.2021.01.004,2/21/2021,3/28/2021
210131_USA_NIH_primary,1/31/2021,National,United States of America,United States of America,"April 1, 2020","August 4, 2020",Household and community samples,Multiple groups,8058,4.60%,2.60%,6.50%,Stratified non-probability,N/A - author designed,,"IgG,IgM,IgA",,,Moderate,Preprint,Heather Kalish,National Institute of Health,10.1101/2021.01.27.21250570,2/22/2021,4/20/2021
210129_NorthCarolina_WakeForestUniversity_primary,1/29/2021,Local,United States of America,"United States of America; North Carolina; Wake Forest, Charlotte","April 16, 2020","January 4, 2021",Household and community samples,Multiple groups,11468,10.20%,,,Convenience,"1) Syntron Bioresearch Inc.

2) Innovita Biological Technology Co.",,"IgM,IgG",,,Moderate,Preprint, David Herrington,Wake Forest University ,10.1101/2021.01.27.21250615,2/23/2021,4/9/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_primary_adj,2/4/2021,Local,United States of America,United States of America; California; San Francisco,"March 28, 2020","June 26, 2020",Residual sera,Multiple groups,4735,4.20%,2.10%,6.30%,Stratified non-probability,"1: N/A - Author designed
2: Luminex",,IgG,94.00%,99.80%,Low,Preprint,Isobel Routledge,University of California San Fransisco,10.21203/rs.3.rs-180966/v1,2/23/2021,3/28/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_male,2/4/2021,Local,United States of America,United States of America; California; San Francisco,"March 28, 2020","June 26, 2020",Residual sera,Multiple groups,2231,5.31%,3.73%,6.61%,Stratified non-probability,"N/A - Author designed
2: luminex",,IgG,94.00%,99.80%,Low,Preprint,Isobel Routledge,University of California San Fransisco,10.21203/rs.3.rs-180966/v1,2/23/2021,3/28/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_80+,2/4/2021,Local,United States of America,United States of America; California; San Francisco,"March 28, 2020","June 26, 2020",Residual sera,Seniors (65+ years),481,3.63%,1.55%,5.80%,Stratified non-probability,"N/A - Author designed
2: luminex",,IgG,94.00%,99.80%,Low,Preprint,Isobel Routledge,University of California San Fransisco,10.21203/rs.3.rs-180966/v1,2/23/2021,3/28/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_60-79,2/4/2021,Local,United States of America,United States of America; California; San Francisco,"March 28, 2020","June 26, 2020",Residual sera,Seniors (65+ years),1390,2.80%,1.10%,4.04%,Stratified non-probability,"N/A - Author designed
2: luminex",,IgG,94.00%,99.80%,Low,Preprint,Isobel Routledge,University of California San Fransisco,10.21203/rs.3.rs-180966/v1,2/23/2021,3/28/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_40-59,2/4/2021,Local,United States of America,United States of America; California; San Francisco,"March 28, 2020","June 26, 2020",Residual sera,Adults (18-64 years),1322,5.46%,3.64%,7.13%,Stratified non-probability,"1: N/A - author designed
2:luminex
",,IgG,94.00%,99.80%,Low,Preprint,Isobel Routledge,University of California San Fransisco,10.21203/rs.3.rs-180966/v1,2/23/2021,3/28/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_20-39,2/4/2021,Local,United States of America,United States of America; California; San Francisco,"March 28, 2020","June 26, 2020",Residual sera,Adults (18-64 years),1261,3.99%,2.29%,5.45%,Stratified non-probability,"N/A - Author designed
2: luminex",,IgG,94.00%,99.80%,Low,Preprint,Isobel Routledge,University of California San Fransisco,10.21203/rs.3.rs-180966/v1,2/23/2021,3/28/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_0-19,2/4/2021,Local,United States of America,United States of America; California; San Francisco,"March 28, 2020","June 26, 2020",Residual sera,Children and Youth (0-17 years),281,4.10%,1.60%,6.90%,Stratified non-probability,"N/A - Author designed
2: luminex",,IgG,94.00%,99.80%,Low,Preprint,Isobel Routledge,University of California San Fransisco,10.21203/rs.3.rs-180966/v1,2/23/2021,3/28/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_female,2/4/2021,Local,United States of America,United States of America; California; San Francisco,"March 28, 2020","June 26, 2020",Residual sera,Multiple groups,2491,2.70%,1.09%,3.61%,Stratified non-probability,"N/A - Author designed
2: luminex",,IgG,94.00%,99.80%,Low,Preprint,Isobel Routledge,University of California San Fransisco,10.21203/rs.3.rs-180966/v1,2/23/2021,3/28/2021
210201_Minnesota_UniversityofMinnesota_HCW_Primary,2/1/2021,Regional,United States of America,United States of America; Minnesota,"April 13, 2020","May 21, 2020",Health care workers and caregivers,Multiple groups,1282,2.96%,2.04%,3.89%,Convenience,N/A - author designed,,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Stefani Thomas,University of Minnesota,https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010,2/25/2021,4/24/2021
210201_Minnesota_UniversityofMinnesota_OutPatients_Primary ,2/1/2021,Regional,United States of America,United States of America; Minnesota,"April 13, 2020","May 21, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,2379,4.46%,3.63%,5.28%,Convenience,N/A - author designed,,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Stefani Thomas,University of Minnesota,https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010,2/25/2021,4/24/2021
201026_UpstateNewYork_BassettMedicalCenter_Overall copy,10/26/2020,Local,United States of America,United States of America; New York; Upstate New York,"May 4, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),762,4.50%,,,Unclear,"Ortho-Clinical Diagnostics, Linden, NJ",,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Wendy M. Brunner,Bassett Medical Center,https://dx.doi.org/10.1017/ice.2020.1296,2/27/2021,4/26/2021
210129_ParrisIsland_IcahnSchoolOfMedicine,1/29/2021,Sublocal,United States of America,United States of America; South Carolina; Port Royal,"May 3, 2020","August 3, 2020",Multiple populations,Adults (18-64 years),,7.30%,,,Convenience,Author designed,,IgG,,100.00%,High,Preprint,Andrew Letizia,Icahn School of Medicine at Mount Sinai,10.1101/2021.01.26.21250535,3/3/2021,3/31/2021
0201_Washington_ChildrensNationalHospital_Overall_TestAdj,2/1/2021,Local,United States of America,"United States of America; Washington, D.C, Maryland, Virginia, West Virginia; Washington D.C","July 7, 2020","October 29, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),385,9.46%,6.68%,13.00%,Convenience,Diasorin,,IgG,97.60%,99.30%,High,Journal Article (Peer-Reviewed),Burak Bahar,Children's National Hospital,https://www.medrxiv.org/content/10.1101/2021.01.30.21250830v1.full-text,3/4/2021,3/31/2021
210203_NewYorkCity_IcahnSchoolOfMedicine_Overall,2/3/2021,Sublocal,United States of America,United States of America; New York; New York City,"April 20, 2020","August 15, 2020",Pregnant or parturient women,Adults (18-64 years),696,15.00%,,,Convenience,Icahn School of Medicine at Mount Sinai (FDA EUA),,IgG,95.00%,100.00%,Moderate,Preprint,Nina Molenaar,Icahn School of Medicine at Mount Sinai,10.1101/2021.02.01.21250943,3/4/2021,3/31/2021
210125_NewYork_CDC+NewYorkCity_Total,1/25/2021,Local,United States of America,United States of America; New York; New York City,"May 18, 2020","July 2, 2020",Essential non-healthcare workers,,22647,22.50%,21.90%,23.00%,Convenience,"ORTHO Clinical Diagnostics Inc., https://www.orthoclinicaldiagnostics.com",,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Samira Sami,CDC and New York City Department of Health and Mental Hygiene,https://dx.doi.org/10.3201/eid2703.204340,3/4/2021,3/29/2021
201220_NorthCarolina_WakeForestBaptistMedicalCenter_overall,12/20/2020,Regional,United States of America,United States of America; North Carolina,"April 15, 2020","December 9, 2020",Household and community samples,Multiple groups,8006,9.30%,,,Stratified probability,NR,,Not reported,,,Unclear,News and Media,Richard Craver,Wake Forest Baptist Medical Center,https://journalnow.com/news/local/wake-forest-baptists-covid-19-antibodies-study-expands-to-triangle-eastern-n-c/article_b8e94704-3e1e-11eb-8742-470dc9941f17.html,3/5/2021,4/26/2021
201214_Maricopa_MaricopaCountyDepartmentOfPublicHealth_overall,12/14/2020,Local,United States of America,United States of America; Arizona,"September 11, 2020","September 21, 2020",Household and community samples,Multiple groups,260,10.70%,,,Stratified probability,NR,,Not reported,,,Unclear,News and Media,Fountain Hills Times,Maricopa County Department of Public Health,https://www.fhtimes.com/news/local_news/maricopa-county-covid-19-serosurvey-results-reported/article_6be4ab0a-3983-11eb-ab22-a3b73c8957c7.html,3/6/2021,4/26/2021
201203_Florida_FloridaDepartmentOfHealth_primary,12/3/2020,Regional,United States of America,United States of America; Florida,"May 1, 2020","November 30, 2020",Household and community samples,Multiple groups,630838,11.03%,,,Self-referral,NR,,"IgG,Total Antibody",,,Unclear,News and Media,Frank Jolley,Florida Department of Health,https://www.dailycommercial.com/story/news/2020/12/03/area-residents-covid-antibody-below-state-average/6475413002/,3/6/2021,4/26/2021
201005_Wisconsin_UW-Madison_overall,10/5/2020,Regional,United States of America,United States of America; Wisconsin,"July 15, 2020","August 15, 2020",Household and community samples,Multiple groups,1056,1.60%,,,Stratified probability,NR,,Not reported,,,Unclear,News and Media,Madeline Heim,UW-Madison,https://www.postcrescent.com/story/news/2020/10/05/wisconsin-covid-19-less-than-2-of-state-population-have-antibodies/3457334001/,3/7/2021,4/26/2021
200830_VenturaCounty_OxnardFireDepartment_overall,8/30/2020,Local,United States of America,United States of America; California,"June 22, 2020","July 6, 2020",Household and community samples,Multiple groups,6794,1.30%,,,Self-referral,"1) Abbott
2) Bio-Rad",,Not reported,,,High,News and Media,Jeremy Childs,Oxnard Fire Department,https://www.vcstar.com/story/news/2020/08/30/covid-19-data-coronavirus-antibodies-ventura-county/3436858001/,3/7/2021,4/26/2021
200824_Louiseville_UniversityOfLouiseville_HCW_July,8/24/2020,Local,United States of America,United States of America; Kentucky; Louiseville,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1100,2.20%,,,Convenience,NR,,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/,3/8/2021,4/26/2021
201124_JeffersonCounty_UniversityofLouiseville_ProbabilitySampling,11/24/2020,Local,United States of America,United States of America; Kentucky,"November 9, 2020","November 16, 2020",Household and community samples,Not reported,1091,2.00%,,,Stratified probability,NR,,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/,3/8/2021,4/26/2021
201124_JeffersonCounty_UniversityofLouiseville_SelfReferal_overall,11/24/2020,Local,United States of America,United States of America; Kentucky,"November 9, 2020","November 16, 2020",Household and community samples,Not reported,1709,3.30%,,,Self-referral,NR,,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/,3/8/2021,4/26/2021
200824_Louiseville_UniversityOfLouiseville_HCW_AprilMay,8/24/2020,Local,United States of America,United States of America; Kentucky; Louiseville,"April 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1372,1.00%,,,Convenience,NR,,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/,3/9/2021,4/26/2021
210123_Norfolk_NavalMedicalCenterPortsmouth_Overall,1/23/2021,Sublocal,United States of America,United States of America; Virginia; Norfolk,"April 28, 2020","May 12, 2020",Essential non-healthcare workers,Adults (18-64 years),432,3.01%,1.61%,5.09%,Convenience,"LakePharma, Inc",,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Tahaniyat Lalani,Naval Medical Center Portsmouth,https://dx.doi.org/10.1093/ofid/ofaa654,3/12/2021,3/31/2021
201028_Connecticut_YaleSchoolOfMedicine_Black2Overall_PopAdj,10/28/2020,Regional,United States of America,United States of America; Connecticut,"June 23, 2020","July 22, 2020",Household and community samples,Multiple groups,148,6.40%,0.90%,11.90%,Simplified probability,Ortho-Clinical Diagnostics,,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,3/13/2021,4/26/2021
201028_Connecticut_YaleSchoolOfMedicine_Hispanic3_Overall_PopAdj,10/28/2020,Regional,United States of America,United States of America; Connecticut,"June 23, 2020","July 22, 2020",Household and community samples,Multiple groups,171,19.90%,13.20%,26.60%,Simplified probability,Ortho-Clinical Diagnostics,,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,3/13/2021,4/26/2021
210122_USA_YourCareChoice_GenPop,1/22/2021,National,United States of America,United States of America,"April 24, 2020","May 13, 2020",Household and community samples,Multiple groups,407,21.62%,,,Stratified probability,NR,,Not reported,,,High,Journal Article (Peer-Reviewed),Robert Morlock,YourCareChoice,https://dx.doi.org/10.1371/journal.pone.0245586,3/13/2021,4/11/2021
210203_StLouis_WashingtonUniversitySchoolofMedicine_Children_overall_adj,2/3/2021,Sublocal,United States of America,United States of America; Missouri; St Louis,"April 14, 2020","May 8, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),15,1.71%,0.04%,3.38%,Sequential,Authors,,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany K Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.01207-20,3/13/2021,3/31/2021
210203_StLouis_WashingtonUniversitySchoolofMedicine_Adults_overall_adj,2/3/2021,Sublocal,United States of America,United States of America; Missouri; St Louis,"April 27, 2020","May 12, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,21,3.11%,0.92%,5.32%,Sequential,Authors,,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany K Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.01207-20,3/13/2021,3/31/2021
210212_Arizona_KingmanRegionalMedicalCenter_Overall,2/12/2021,Local,United States of America,United States of America; Arizona; Kingman,"September 28, 2020","October 9, 2020",Household and community samples,Adults (18-64 years),566,8.00%,,,Convenience,Ortho-Clinical Diagnostics Inc.,,IgG,87.50%,100.00%,High,Journal Article (Peer-Reviewed),Anthony Santarelli,Kingman Regional Medical Center,https://dx.doi.org/10.1515/jom-2020-0287,3/13/2021,3/29/2021
210120_NorthDakota_NorthDakotaStateUniversity_PharmacyPersonnel,1/20/2021,Regional,United States of America,"United States of America; North Dakota; Fargo, Grand Forks","July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),247,14.60%,10.40%,19.60%,Convenience,BioSys Laboratories,,"IgG,IgM",93.50%,100.00%,High,Journal Article (Peer-Reviewed),Amanda Johnson,North Dakota State University,https://dx.doi.org/10.1016/j.japh.2021.01.023,3/14/2021,3/31/2021
210225_Denver_UniversityofColorado_NewOnsetDiabetes,2/25/2021,Sublocal,United States of America,United States of America; Colorado; Denver,"January 3, 2020","October 16, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,129,0.80%,0.10%,4.20%,Sequential,In-House: University of Colorado,,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,4/9/2021
210225_Denver_UniversityofColorado_EstablishedDiabetes,2/25/2021,Sublocal,United States of America,United States of America; Colorado; Denver,"January 3, 2020","October 16, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,94,4.30%,1.70%,10.40%,Sequential,In-House: University of Colorado,,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,4/9/2021
210225_Denver_UniversityofColorado_GenPopChildren,2/25/2021,Local,United States of America,United States of America; Colorado; Denver,"July 8, 2020","October 23, 2020",Household and community samples,Children and Youth (0-17 years),562,2.80%,1.80%,4.60%,Convenience,In-House: University of Colorado,,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,4/9/2021
210225_Denver_UniversityofColorado_GenPopAdults,2/25/2021,Local,United States of America,United States of America; Colorado; Denver,"July 8, 2020","October 23, 2020",Household and community samples,Adults (18-64 years),102,3.90%,1.50%,9.70%,Convenience,In-House: University of Colorado,,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,4/9/2021
210208_Mississippi_CDCCOVID-19ResponseTeam_Overall,2/8/2021,Regional,United States of America,United States of America; Mississippi,"May 17, 2020","September 19, 2020",Residual sera,Children and Youth (0-17 years),1603,10.90%,9.40%,12.40%,Sequential,Ortho Clinical Diagnostics; Centers for Disease and Control (CDC In-House),,Total Antibody,,,High,Preprint,Charlotte Hobbs,CDC COVID-19 Response Team,https://www.medrxiv.org/content/10.1101/2021.02.05.21250792v1,3/16/2021,4/16/2021
210209_Atlanta_EmoryUniversity,2/9/2021,Local,United States of America,United States of America; Georgia; Atlanta,"May 6, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),353,6.50%,,,Convenience,NR,,IgG,86.70%,99.30%,High,Journal Article (Peer-Reviewed),Jessica Howard-Anderson,Emory University,https://dx.doi.org/10.1017/ice.2021.54,3/17/2021,3/31/2021
210216_USA_CityUniversityOfNewYork_overall_TestAdj,2/16/2021,National,United States of America,United States of America,"May 15, 2020","January 15, 2021",Household and community samples,Multiple groups,4459,6.30%,5.50%,7.10%,Stratified non-probability,"1) Bio-Rad Platelia

2) EUROIMMUN",,"Total Antibody,IgG",98.00%,99.30%,Moderate,Preprint,Denis Nash,City University of New York,10.1101/2021.02.12.21251659,3/17/2021,3/28/2021
210202_ParrisIsland_IcahnSchoolofMedicineatMountSinai,2/2/2021,Sublocal,United States of America,United States of America; North Carolina; Parris Island,"May 11, 2020","September 7, 2020",Essential non-healthcare workers,Adults (18-64 years),3196,9.00%,,,Convenience,"Independent authors, Amanat et al",,IgG,96.08%,97.14%,Moderate,Journal Article (Peer-Reviewed),Andrew Letizia,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.3201/eid2704.204732,3/17/2021,4/4/2021
210226_CentreCounty_PennsylvaniaStateUniversity_Students,2/26/2021,Sublocal,United States of America,United States of America; Pennsylvania,"October 26, 2020","November 23, 2020",Students and Daycares,Adults (18-64 years),625,31.20%,,,Convenience,In-House: Pennsylvania State University,,IgG,93.30%,99.00%,Moderate,Preprint,Callum Arnold,Pennsylvania State University,https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3,3/17/2021,3/31/2021
210226_CentreCounty_PennsylvaniaStateUniversity_Community,2/26/2021,Local,United States of America,United States of America; Pennsylvania,"August 7, 2020","December 20, 2020",Household and community samples,Adults (18-64 years),345,8.20%,,,Convenience,In-House: Pennsylvania State University,,IgG,93.30%,99.00%,High,Preprint,Callum Arnold,Pennsylvania State University,https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3,3/17/2021,3/31/2021
210204_UnitedStates_DaVitaClinicalResearch_Overall,2/4/2021,National,United States of America,United States of America,"May 27, 2020","July 1, 2020",Residual sera,Multiple groups,12932,,5.40%,6.20%,Simplified probability,"Diazyme Laboratories, Inc",,IgG,,,Moderate,Journal Article (Peer-Reviewed),Adam Walker,DaVita Clinical Research,https://dx.doi.org/10.1016/j.xkme.2021.01.002,3/18/2021,3/31/2021
210201_NewYorkCity_ColumbiaUniversity,2/1/2021,Sublocal,United States of America,"United States of America; New York
; New York City","June 24, 2020","July 16, 2020",Pregnant or parturient women,Adults (18-64 years),47,40.40%,,,Sequential,NR,,"IgG,IgM",92.00%,,High,Journal Article (Peer-Reviewed),Caitlin Baptiste,Columbia University,http://dx.doi.org/10.1016/j.ajog.2020.12.944,3/18/2021,4/19/2021
210208_Virginia_UniversityOfVirginia_Overall_PopAdj,2/8/2021,Regional,United States of America,United States of America; Virginia,"June 1, 2020","August 14, 2020",Residual sera,Multiple groups,4675,2.40%,1.80%,3.10%,Convenience,Abbott,,IgG,92.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Elizabeth T. Rogawski McQuade,University of Virginia ,https://dx.doi.org/10.1001/jamanetworkopen.2020.35234,3/18/2021,4/4/2021
210130_USA_UniversityofArizona_primary,1/30/2021,Local,United States of America,United States of America,"May 17, 2020","July 2, 2020",Health care workers and caregivers,Multiple groups,40938,16.20%,15.90%,16.60%,Self-referral,VITROS Immunodiagnostic Products,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lara J Akinbami,University of Arizona ,https://dx.doi.org/10.1093/cid/ciab080,3/19/2021,4/2/2021
210129_Atlanta_EmoryUniversityHospital_primary,1/29/2021,Local,United States of America,United States of America; Georgia; Atlanta,"April 19, 2020","June 26, 2020",Health care workers and caregivers,Adults (18-64 years),10275,3.80%,3.40%,4.30%,Self-referral,Emory University,,IgG,97.50%,98.00%,Moderate,Journal Article (Peer-Reviewed),Julia M. Baker,Emory University Hospital,https://dx.doi.org/10.7326/M20-7145,3/19/2021,4/26/2021
210218_WashingtonDC_GovernmentOfTheDistrictOfColumbia_overall,2/18/2021,Local,United States of America,United States of America,"July 27, 2020","August 21, 2020",Household and community samples,Multiple groups,671,7.60%,5.70%,9.90%,Convenience,DiaSorin,,IgG,97.00%,,High,Preprint,Adrienne Sherman,Government of the District of Columbia,10.1101/2021.02.15.21251764,3/19/2021,3/31/2021
210129_NewYork_NorthwellHealth,1/29/2021,Regional,United States of America,United States of America; New York,"May 27, 2020","August 23, 2020",Pregnant or parturient women,Adults (18-64 years),2930,15.30%,,,Sequential,NR,,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Lylach Haizler-Cohen,Northwell Health,http://dx.doi.org/10.1016/j.ajog.2020.12.631,3/19/2021,3/31/2021
201124_USA_CDC_July/August1_Alaska,11/24/2020,Regional,United States of America,United States of America; Alaska,"August 6, 2020","August 11, 2020",Residual sera,Multiple groups,242,0.30%,0.00%,1.12%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Alaska,11/24/2020,Regional,United States of America,United States of America; Alaska,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,704,1.30%,0.50%,2.33%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Alaska,11/24/2020,Regional,United States of America,United States of America; Alaska,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,610,1.00%,0.24%,2.17%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Alaska,11/24/2020,Regional,United States of America,United States of America; Alaska,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,681,0.40%,0.11%,0.82%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Alabama,11/24/2020,Regional,United States of America,United States of America; Alabama,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,955,9.90%,7.19%,12.79%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Arkansas,11/24/2020,Regional,United States of America,United States of America; Arkansas,"August 24, 2020","September 8, 2020",Residual sera,Multiple groups,992,4.90%,3.50%,6.41%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Arizona,11/24/2020,Regional,United States of America,United States of America; Arizona,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,1030,4.90%,3.05%,7.11%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_California,11/24/2020,Regional,United States of America,United States of America; California,"August 28, 2020","September 9, 2020",Residual sera,Multiple groups,983,6.00%,4.20%,7.82%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Connecticut,11/24/2020,Regional,United States of America,United States of America; Connecticut,"August 26, 2020","September 4, 2020",Residual sera,Multiple groups,983,4.30%,2.90%,5.69%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Colorado,11/24/2020,Regional,United States of America,United States of America; Colorado,"August 24, 2020","September 4, 2020",Residual sera,Multiple groups,1025,3.60%,2.31%,5.09%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_WashingtonD.C,11/24/2020,Regional,United States of America,United States of America; Washington D.C,"August 27, 2020","September 10, 2020",Residual sera,Multiple groups,643,5.00%,2.83%,7.55%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Florida,11/24/2020,Regional,United States of America,United States of America; Florida,"August 27, 2020","September 9, 2020",Residual sera,Multiple groups,981,5.70%,3.93%,7.49%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Iowa,11/24/2020,Regional,United States of America,United States of America; Iowa,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,1006,8.40%,6.15%,10.74%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Delaware,11/24/2020,Regional,United States of America,United States of America; Delaware,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,914,4.50%,2.42%,7.12%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Georgia,11/24/2020,Regional,United States of America,United States of America; Georgia,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,1020,8.70%,6.69%,11.14%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Idaho,11/24/2020,Regional,United States of America,United States of America; Idaho,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,790,5.70%,2.90%,9.70%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Maine,11/24/2020,Regional,United States of America,United States of America;  Maine,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,759,1.50%,0.44%,3.22%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Kansas,11/24/2020,Regional,United States of America,United States of America; Kansas,"August 24, 2020","September 3, 2020",Residual sera,Multiple groups,1025,2.90%,1.57%,4.31%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Massachusetts,11/24/2020,Regional,United States of America,United States of America;  Massachusetts,"August 27, 2020","September 5, 2020",Residual sera,Multiple groups,981,3.60%,2.36%,5.08%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Indiana,11/24/2020,Regional,United States of America,United States of America; Indiana,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,984,2.40%,1.36%,3.52%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Maryland,11/24/2020,Regional,United States of America,United States of America;  Maryland,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,980,7.90%,5.72%,10.35%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Minnesota,11/24/2020,Regional,United States of America,United States of America;  Minnesota,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,974,9.20%,6.71%,11.95%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Michigan,11/24/2020,Regional,United States of America,United States of America;  Michigan,"August 26, 2020","September 3, 2020",Residual sera,Multiple groups,976,3.40%,2.16%,4.95%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Illinois,11/24/2020,Regional,United States of America,United States of America; Illinois,"August 26, 2020","September 3, 2020",Residual sera,Multiple groups,979,5.60%,3.90%,7.67%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Missouri,11/24/2020,Regional,United States of America,United States of America;  Missouri,"August 24, 2020","September 10, 2020",Residual sera,Multiple groups,1024,2.90%,1.74%,4.17%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Louisiana,11/24/2020,Regional,United States of America,United States of America;  Louisiana,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,1001,8.60%,6.65%,11.30%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Kentucky,11/24/2020,Regional,United States of America,United States of America;  Kentucky,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,983,3.10%,1.91%,4.33%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Mississippi,11/24/2020,Regional,United States of America,United States of America;  Mississippi,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,987,8.40%,4.89%,12.73%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_NewHampshire,11/24/2020,Regional,United States of America,United States of America;  New Hampshire,"August 26, 2020","September 3, 2020",Residual sera,Multiple groups,1147,1.60%,0.73%,2.84%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Ohio,11/24/2020,Regional,United States of America,United States of America;  Ohio,"August 27, 2020","September 10, 2020",Residual sera,Multiple groups,983,5.00%,3.17%,7.14%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Nebraska,11/24/2020,Regional,United States of America,United States of America;  Nebraska,"August 24, 2020","September 10, 2020",Residual sera,Multiple groups,938,6.30%,4.47%,8.27%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Virginia,11/24/2020,Regional,United States of America,United States of America;  Virginia,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,1007,3.50%,1.97%,5.26%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_NewMexico,11/24/2020,Regional,United States of America,United States of America;  New Mexico,"August 25, 2020","September 8, 2020",Residual sera,Multiple groups,985,3.70%,2.28%,5.55%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Vermont,11/24/2020,Regional,United States of America,United States of America;  Vermont,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,485,0.40%,0.00%,0.94%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Oregon,11/24/2020,Regional,United States of America,United States of America;  Oregon,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,968,1.90%,0.92%,2.94%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_PuertoRico,11/24/2020,Regional,United States of America,United States of America; Puerto Rico,"August 24, 2020","September 3, 2020",Residual sera,Multiple groups,980,2.50%,1.36%,3.76%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_NewJersey,11/24/2020,Regional,United States of America,United States of America;  New Jersey,"August 26, 2020","September 7, 2020",Residual sera,Multiple groups,944,12.80%,10.49%,15.35%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_SouthDakota,11/24/2020,Regional,United States of America,United States of America;  South Dakota,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,97,0.70%,0.00%,2.47%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_NewYork,11/24/2020,Regional,United States of America,United States of America;  New York,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,1043,19.50%,16.88%,22.38%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Montana,11/24/2020,Regional,United States of America,United States of America;  Montana,"August 24, 2020","September 9, 2020",Residual sera,Multiple groups,518,0.90%,0.23%,1.82%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Nevada,11/24/2020,Regional,United States of America,United States of America;  Nevada,"August 27, 2020","August 29, 2020",Residual sera,Multiple groups,980,6.50%,4.63%,8.58%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_NorthCarolina,11/24/2020,Regional,United States of America,United States of America;  North Carolina,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,982,3.80%,2.33%,5.26%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Tennessee,11/24/2020,Regional,United States of America,United States of America;  Tennessee,"August 25, 2020","September 8, 2020",Residual sera,Multiple groups,950,5.40%,3.62%,7.31%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_SouthCarolina,11/24/2020,Regional,United States of America,United States of America;  South Carolina,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,927,7.20%,5.12%,9.57%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_RhodeIsland,11/24/2020,Regional,United States of America,United States of America;  Rhode Island,"August 27, 2020","September 10, 2020",Residual sera,Multiple groups,786,3.10%,1.73%,4.64%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Oklahoma,11/24/2020,Regional,United States of America,United States of America;  Oklahoma,"August 24, 2020","September 1, 2020",Residual sera,Multiple groups,979,5.40%,3.83%,7.29%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Utah,11/24/2020,Regional,United States of America,United States of America;  Utah,"August 24, 2020","September 8, 2020",Residual sera,Multiple groups,1104,4.90%,2.82%,7.67%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_NorthDakota,11/24/2020,Regional,United States of America,United States of America;  North Dakota,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,109,0.20%,0.00%,0.99%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Texas,11/24/2020,Regional,United States of America,United States of America;  Texas,"August 25, 2020","September 2, 2020",Residual sera,Multiple groups,979,5.80%,4.04%,7.92%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Pennsylvania,11/24/2020,Regional,United States of America,United States of America;  Pennsylvania,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,845,9.50%,6.58%,13.56%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Washington,11/24/2020,Regional,United States of America,United States of America;  Washington,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,820,4.50%,2.63%,6.94%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_Wisconsin,11/24/2020,Regional,United States of America,United States of America;  Wisconsin,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,976,2.60%,1.48%,3.95%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August/September3_WestVirginia,11/24/2020,Regional,United States of America,United States of America;  West Virginia,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,1128,1.50%,0.78%,2.38%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Minnesota,11/24/2020,Regional,United States of America,United States of America;  Minnesota,"August 11, 2020","August 27, 2020",Residual sera,Multiple groups,978,4.50%,3.05%,5.87%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_WestVirginia,11/24/2020,Regional,United States of America,United States of America;  West Virginia,"August 13, 2020","August 27, 2020",Residual sera,Multiple groups,637,2.20%,0.52%,4.90%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Wisconsin,11/24/2020,Regional,United States of America,United States of America;  Wisconsin,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,838,3.30%,2.03%,4.72%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Washington,11/24/2020,Regional,United States of America,United States of America;  Washington,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,1238,3.00%,1.79%,4.47%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Arizona,11/24/2020,Regional,United States of America,United States of America; Arizona,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,1304,4.70%,2.70%,7.61%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Pennsylvania,11/24/2020,Regional,United States of America,United States of America;  Pennsylvania,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,887,10.10%,7.53%,13.74%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_California,11/24/2020,Regional,United States of America,United States of America; California,"August 13, 2020","August 19, 2020",Residual sera,Multiple groups,980,4.30%,2.85%,6.06%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Missouri,11/24/2020,Regional,United States of America,United States of America;  Missouri,"August 12, 2020","August 21, 2020",Residual sera,Multiple groups,1021,3.50%,2.23%,5.06%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Iowa,11/24/2020,Regional,United States of America,United States of America; Iowa,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,980,9.40%,7.12%,11.63%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Georgia,11/24/2020,Regional,United States of America,United States of America; Georgia,"August 13, 2020","August 26, 2020",Residual sera,Multiple groups,1031,7.40%,5.52%,9.51%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_NewYork,11/24/2020,Regional,United States of America,United States of America;  New York,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1122,20.60%,18.04%,23.14%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_NewJersey,11/24/2020,Regional,United States of America,United States of America;  New Jersey,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1127,12.20%,10.15%,14.53%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Nevada,11/24/2020,Regional,United States of America,United States of America;  Nevada,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,972,7.90%,6.13%,9.83%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Indiana,11/24/2020,Regional,United States of America,United States of America; Indiana,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,906,3.10%,1.53%,4.76%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Ohio,11/24/2020,Regional,United States of America,United States of America;  Ohio,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,985,2.10%,1.06%,3.29%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Idaho,11/24/2020,Regional,United States of America,United States of America; Idaho,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,651,4.60%,1.67%,9.05%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_NorthDakota,11/24/2020,Regional,United States of America,United States of America;  North Dakota,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,135,0.60%,0.00%,1.45%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Florida,11/24/2020,Regional,United States of America,United States of America; Florida,"August 14, 2020","August 14, 2020",Residual sera,Multiple groups,978,4.50%,3.15%,6.06%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Alabama,11/24/2020,Regional,United States of America,United States of America; Alabama,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,974,7.60%,5.33%,9.76%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Vermont,11/24/2020,Regional,United States of America,United States of America;  Vermont,"August 13, 2020","August 27, 2020",Residual sera,Multiple groups,382,0.30%,0.00%,0.81%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_SouthCarolina,11/24/2020,Regional,United States of America,United States of America;  South Carolina,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,1063,6.00%,4.37%,7.95%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Virginia,11/24/2020,Regional,United States of America,United States of America;  Virginia,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1243,4.70%,2.51%,7.22%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_PuertoRico,11/24/2020,Regional,United States of America,United States of America; Puerto Rico,"August 10, 2020","August 17, 2020",Residual sera,Multiple groups,986,2.20%,1.18%,3.26%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Massachusetts,11/24/2020,Regional,United States of America,United States of America;  Massachusetts,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,980,3.70%,2.27%,5.21%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_RhodeIsland,11/24/2020,Regional,United States of America,United States of America;  Rhode Island,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,570,3.60%,1.69%,5.89%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Delaware,11/24/2020,Regional,United States of America,United States of America; Delaware,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,1004,8.50%,5.79%,11.25%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Texas,11/24/2020,Regional,United States of America,United States of America;  Texas,"August 12, 2020","August 24, 2020",Residual sera,Multiple groups,1001,6.50%,4.69%,8.47%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Michigan,11/24/2020,Regional,United States of America,United States of America;  Michigan,"August 12, 2020","August 25, 2020",Residual sera,Multiple groups,983,4.20%,2.88%,5.76%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Oregon,11/24/2020,Regional,United States of America,United States of America;  Oregon,"August 10, 2020","August 27, 2020",Residual sera,Multiple groups,1086,2.40%,1.41%,3.60%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Kansas,11/24/2020,Regional,United States of America,United States of America; Kansas,"August 11, 2020","August 25, 2020",Residual sera,Multiple groups,1016,3.70%,2.02%,5.47%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Maine,11/24/2020,Regional,United States of America,United States of America;  Maine,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,609,0.60%,0.00%,1.44%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Montana,11/24/2020,Regional,United States of America,United States of America;  Montana,"August 12, 2020","August 24, 2020",Residual sera,Multiple groups,383,1.30%,0.38%,2.49%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Maryland,11/24/2020,Regional,United States of America,United States of America;  Maryland,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1174,7.00%,4.92%,9.33%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Tennessee,11/24/2020,Regional,United States of America,United States of America;  Tennessee,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,1029,6.70%,5.11%,8.57%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_NorthCarolina,11/24/2020,Regional,United States of America,United States of America;  North Carolina,"August 11, 2020","August 27, 2020",Residual sera,Multiple groups,982,3.80%,2.33%,5.29%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Kentucky,11/24/2020,Regional,United States of America,United States of America;  Kentucky,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,1126,3.10%,2.05%,4.49%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_NewMexico,11/24/2020,Regional,United States of America,United States of America;  New Mexico,"August 10, 2020","August 27, 2020",Residual sera,Multiple groups,976,2.50%,1.47%,3.79%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Mississippi,11/24/2020,Regional,United States of America,United States of America;  Mississippi,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,968,10.00%,6.69%,14.71%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Oklahoma,11/24/2020,Regional,United States of America,United States of America;  Oklahoma,"August 10, 2020","August 18, 2020",Residual sera,Multiple groups,979,4.00%,2.72%,5.51%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Utah,11/24/2020,Regional,United States of America,United States of America;  Utah,"August 15, 2020","August 25, 2020",Residual sera,Multiple groups,871,5.50%,2.94%,8.71%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Colorado,11/24/2020,Regional,United States of America,United States of America; Colorado,"August 10, 2020","August 25, 2020",Residual sera,Multiple groups,1019,3.30%,1.83%,4.80%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_NewHampshire,11/24/2020,Regional,United States of America,United States of America;  New Hampshire,"August 13, 2020","August 25, 2020",Residual sera,Multiple groups,1125,0.80%,0.30%,1.22%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Washington D.C,11/24/2020,Regional,United States of America,United States of America; Washington D.C,"August 13, 2020","August 27, 2020",Residual sera,Multiple groups,781,6.80%,4.59%,9.21%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Louisiana,11/24/2020,Regional,United States of America,United States of America;  Louisiana,"August 12, 2020","August 25, 2020",Residual sera,Multiple groups,989,11.80%,9.27%,14.81%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_SouthDakota,11/24/2020,Regional,United States of America,United States of America;  South Dakota,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,83,0.00%,0.00%,4.35%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Wyoming,11/24/2020,Regional,United States of America,United States of America;  Wyoming,"August 13, 2020","August 24, 2020",Residual sera,Multiple groups,86,0.80%,0.00%,3.11%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Illinois,11/24/2020,Regional,United States of America,United States of America; Illinois,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,985,4.90%,3.40%,6.65%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Connecticut,11/24/2020,Regional,United States of America,United States of America; Connecticut,"August 11, 2020","August 24, 2020",Residual sera,Multiple groups,983,2.40%,1.45%,3.52%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Arkansas,11/24/2020,Regional,United States of America,United States of America; Arkansas,"August 11, 2020","August 25, 2020",Residual sera,Multiple groups,998,3.00%,1.76%,4.35%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_August2_Nebraska,11/24/2020,Regional,United States of America,United States of America;  Nebraska,"August 11, 2020","August 25, 2020",Residual sera,Multiple groups,990,7.90%,5.51%,10.61%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Pennsylvania,11/24/2020,Regional,United States of America,United States of America;  Pennsylvania,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,575,10.20%,5.71%,17.21%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_SouthCarolina,11/24/2020,Regional,United States of America,United States of America;  South Carolina,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,840,8.10%,5.79%,10.69%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_NewJersey,11/24/2020,Regional,United States of America,United States of America;  New Jersey,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,871,14.80%,12.23%,17.57%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Texas,11/24/2020,Regional,United States of America,United States of America;  Texas,"July 29, 2020","August 5, 2020",Residual sera,Multiple groups,986,5.90%,4.04%,7.95%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_NewYork,11/24/2020,Regional,United States of America,United States of America;  New York,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,846,23.30%,20.07%,26.32%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Montana,11/24/2020,Regional,United States of America,United States of America;  Montana,"July 29, 2020","August 10, 2020",Residual sera,Multiple groups,199,0.50%,0.00%,1.67%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_PuertoRico,11/24/2020,Regional,United States of America,United States of America; Puerto Rico,"July 27, 2020","August 7, 2020",Residual sera,Multiple groups,984,1.10%,0.43%,1.80%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Washington D.C,11/24/2020,Regional,United States of America,United States of America; Washington D.C,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,717,3.90%,2.18%,5.76%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Vermont,11/24/2020,Regional,United States of America,United States of America;  Vermont,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,346,0.50%,0.00%,1.84%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Maine,11/24/2020,Regional,United States of America,United States of America;  Maine,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,598,0.50%,0.00%,1.16%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_NewHampshire,11/24/2020,Regional,United States of America,United States of America;  New Hampshire,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,809,0.80%,0.22%,1.48%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Nevada,11/24/2020,Regional,United States of America,United States of America;  Nevada,"July 30, 2020","August 2, 2020",Residual sera,Multiple groups,979,5.10%,3.63%,6.66%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_NorthCarolina,11/24/2020,Regional,United States of America,United States of America;  North Carolina,"July 29, 2020","August 10, 2020",Residual sera,Multiple groups,928,2.50%,1.31%,3.72%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Idaho,11/24/2020,Regional,United States of America,United States of America; Idaho,"August 4, 2020","August 11, 2020",Residual sera,Multiple groups,246,4.50%,1.80%,7.99%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Colorado,11/24/2020,Regional,United States of America,United States of America; Colorado,"July 30, 2020","August 7, 2020",Residual sera,Multiple groups,1001,2.40%,0.89%,4.53%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Florida,11/24/2020,Regional,United States of America,United States of America; Florida,"July 31, 2020","August 3, 2020",Residual sera,Multiple groups,980,4.30%,2.77%,5.86%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Nebraska,11/24/2020,Regional,United States of America,United States of America;  Nebraska,"July 28, 2020","August 13, 2020",Residual sera,Multiple groups,954,7.40%,5.25%,9.75%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Kentucky,11/24/2020,Regional,United States of America,United States of America;  Kentucky,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,975,2.40%,1.32%,3.62%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_WestVirginia,11/24/2020,Regional,United States of America,United States of America;  West Virginia,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,317,1.20%,0.23%,2.50%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Alabama,11/24/2020,Regional,United States of America,United States of America; Alabama,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,938,5.80%,4.16%,7.71%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Mississippi,11/24/2020,Regional,United States of America,United States of America;  Mississippi,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,769,7.10%,3.75%,11.09%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Louisiana,11/24/2020,Regional,United States of America,United States of America;  Louisiana,"July 28, 2020","August 13, 2020",Residual sera,Multiple groups,1002,9.60%,6.88%,12.29%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Kansas,11/24/2020,Regional,United States of America,United States of America; Kansas,"July 29, 2020","August 8, 2020",Residual sera,Multiple groups,962,1.60%,0.70%,2.80%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Massachusetts,11/24/2020,Regional,United States of America,United States of America;  Massachusetts,"July 30, 2020","August 10, 2020",Residual sera,Multiple groups,978,4.20%,2.89%,5.81%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Indiana,11/24/2020,Regional,United States of America,United States of America; Indiana,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,579,2.20%,1.10%,3.63%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Oklahoma,11/24/2020,Regional,United States of America,United States of America;  Oklahoma,"July 28, 2020","August 4, 2020",Residual sera,Multiple groups,979,1.60%,0.85%,2.49%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Wisconsin,11/24/2020,Regional,United States of America,United States of America;  Wisconsin,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,814,1.80%,0.76%,3.18%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Delaware,11/24/2020,Regional,United States of America,United States of America; Delaware,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,804,5.70%,3.55%,8.22%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Iowa,11/24/2020,Regional,United States of America,United States of America; Iowa,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,811,8.60%,5.98%,11.34%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Maryland,11/24/2020,Regional,United States of America,United States of America;  Maryland,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,783,9.70%,7.26%,12.87%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Connecticut,11/24/2020,Regional,United States of America,United States of America; Connecticut,"July 30, 2020","August 3, 2020",Residual sera,Multiple groups,994,3.40%,2.04%,4.72%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Michigan,11/24/2020,Regional,United States of America,United States of America;  Michigan,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,982,3.40%,2.16%,4.84%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_NewMexico,11/24/2020,Regional,United States of America,United States of America;  New Mexico,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,964,2.00%,1.09%,3.02%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Arizona,11/24/2020,Regional,United States of America,United States of America; Arizona,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,591,8.20%,4.11%,13.59%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Missouri,11/24/2020,Regional,United States of America,United States of America;  Missouri,"July 28, 2020","August 10, 2020",Residual sera,Multiple groups,979,2.50%,1.44%,3.61%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Tennessee,11/24/2020,Regional,United States of America,United States of America;  Tennessee,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,1003,6.30%,4.41%,8.25%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Washington,11/24/2020,Regional,United States of America,United States of America;  Washington,"July 29, 2020","August 11, 2020",Residual sera,Multiple groups,684,2.10%,0.81%,3.70%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Virginia,11/24/2020,Regional,United States of America,United States of America;  Virginia,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,730,4.10%,1.80%,6.93%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Georgia,11/24/2020,Regional,United States of America,United States of America; Georgia,"August 2, 2020","August 11, 2020",Residual sera,Multiple groups,985,6.80%,4.83%,8.81%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_RhodeIsland,11/24/2020,Regional,United States of America,United States of America;  Rhode Island,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,684,3.00%,1.23%,5.51%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Illinois,11/24/2020,Regional,United States of America,United States of America; Illinois,"July 29, 2020","August 10, 2020",Residual sera,Multiple groups,1004,3.90%,2.52%,5.21%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_NorthDakota,11/24/2020,Regional,United States of America,United States of America;  North Dakota,"July 29, 2020","August 12, 2020",Residual sera,Multiple groups,121,7.30%,1.30%,14.28%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Arkansas,11/24/2020,Regional,United States of America,United States of America; Arkansas,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,937,4.10%,2.74%,5.63%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Utah,11/24/2020,Regional,United States of America,United States of America;  Utah,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,880,3.20%,1.70%,5.03%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Ohio,11/24/2020,Regional,United States of America,United States of America;  Ohio,"July 29, 2020","August 11, 2020",Residual sera,Multiple groups,786,2.30%,1.11%,3.61%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_California,11/24/2020,Regional,United States of America,United States of America; California,"July 30, 2020","August 5, 2020",Residual sera,Multiple groups,980,5.70%,4.05%,7.77%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Minnesota,11/24/2020,Regional,United States of America,United States of America;  Minnesota,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,879,3.50%,2.06%,5.01%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_July/August1_Oregon,11/24/2020,Regional,United States of America,United States of America;  Oregon,"August 5, 2020","August 11, 2020",Residual sera,Multiple groups,658,2.30%,1.03%,3.84%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Connecticut,11/24/2020,Regional,United States of America,United States of America; Connecticut,"September 9, 2020","September 14, 2020",Residual sera,Multiple groups,982,3.10%,2.06%,4.37%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Wisconsin,11/24/2020,Regional,United States of America,United States of America;  Wisconsin,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,976,3.80%,2.20%,5.73%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_NorthCarolina,11/24/2020,Regional,United States of America,United States of America;  North Carolina,"September 9, 2020","September 17, 2020",Residual sera,Multiple groups,925,6.80%,4.83%,8.87%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_NewHampshire,11/24/2020,Regional,United States of America,United States of America;  New Hampshire,"September 9, 2020","September 17, 2020",Residual sera,Multiple groups,1034,0.70%,0.26%,1.32%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Ohio,11/24/2020,Regional,United States of America,United States of America;  Ohio,"September 10, 2020","September 22, 2020",Residual sera,Multiple groups,978,2.80%,1.69%,4.16%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_PuertoRico,11/24/2020,Regional,United States of America,United States of America; Puerto Rico,"September 8, 2020","September 15, 2020",Residual sera,Multiple groups,970,3.00%,1.78%,4.27%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_NorthDakota,11/24/2020,Regional,United States of America,United States of America;  North Dakota,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,113,1.20%,0.00%,3.40%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Michigan,11/24/2020,Regional,United States of America,United States of America;  Michigan,"September 8, 2020","September 22, 2020",Residual sera,Multiple groups,980,3.70%,2.54%,4.93%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Minnesota,11/24/2020,Regional,United States of America,United States of America;  Minnesota,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1033,8.00%,4.74%,11.43%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_SouthCarolina,11/24/2020,Regional,United States of America,United States of America;  South Carolina,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,975,7.80%,5.58%,10.19%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Florida,11/24/2020,Regional,United States of America,United States of America; Florida,"September 11, 2020","September 11, 2020",Residual sera,Multiple groups,979,8.50%,6.55%,10.68%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Washington D.C,11/24/2020,Regional,United States of America,United States of America; Washington D.C,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,976,6.50%,4.47%,8.29%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_WestVirginia,11/24/2020,Regional,United States of America,United States of America;  West Virginia,"September 9, 2020","September 22, 2020",Residual sera,Multiple groups,968,1.30%,0.51%,2.18%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_NewMexico,11/24/2020,Regional,United States of America,United States of America;  New Mexico,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,1014,2.40%,1.19%,3.65%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Arkansas,11/24/2020,Regional,United States of America,United States of America; Arkansas,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,990,6.30%,4.60%,8.03%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Nevada,11/24/2020,Regional,United States of America,United States of America;  Nevada,"September 9, 2020","September 12, 2020",Residual sera,Multiple groups,979,7.80%,5.90%,9.99%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_NewYork,11/24/2020,Regional,United States of America,United States of America;  New York,"September 11, 2020","September 24, 2020",Residual sera,Multiple groups,1168,17.00%,14.72%,19.23%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Maryland,11/24/2020,Regional,United States of America,United States of America;  Maryland,"September 10, 2020","September 23, 2020",Residual sera,Multiple groups,1242,10.20%,7.91%,12.68%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Colorado,11/24/2020,Regional,United States of America,United States of America; Colorado,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,1032,3.30%,1.90%,4.92%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Oregon,11/24/2020,Regional,United States of America,United States of America;  Oregon,"September 8, 2020","September 22, 2020",Residual sera,Multiple groups,971,2.60%,1.51%,4.06%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Oklahoma,11/24/2020,Regional,United States of America,United States of America;  Oklahoma,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,980,5.00%,3.44%,6.54%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Montana,11/24/2020,Regional,United States of America,United States of America;  Montana,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,508,2.20%,0.67%,4.38%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Kansas,11/24/2020,Regional,United States of America,United States of America; Kansas,"September 9, 2020","September 19, 2020",Residual sera,Multiple groups,1007,3.50%,2.31%,4.84%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Alabama,11/24/2020,Regional,United States of America,United States of America; Alabama,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,905,8.70%,6.19%,11.31%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Maine,11/24/2020,Regional,United States of America,United States of America;  Maine,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,987,0.50%,0.09%,0.87%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Georgia,11/24/2020,Regional,United States of America,United States of America; Georgia,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,1100,13.00%,10.51%,15.79%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Massachusetts,11/24/2020,Regional,United States of America,United States of America;  Massachusetts,"September 9, 2020","September 15, 2020",Residual sera,Multiple groups,988,3.70%,2.23%,5.16%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Wyoming,11/24/2020,Regional,United States of America,United States of America;  Wyoming,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,111,1.50%,0.00%,3.97%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Vermont,11/24/2020,Regional,United States of America,United States of America;  Vermont,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,497,1.70%,0.27%,4.15%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Illinois,11/24/2020,Regional,United States of America,United States of America; Illinois,"September 8, 2020","September 17, 2020",Residual sera,Multiple groups,992,4.50%,3.10%,6.07%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Nebraska,11/24/2020,Regional,United States of America,United States of America;  Nebraska,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,976,6.70%,4.80%,8.88%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Arizona,11/24/2020,Regional,United States of America,United States of America; Arizona,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1208,5.40%,3.08%,8.52%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Texas,11/24/2020,Regional,United States of America,United States of America;  Texas,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,988,8.20%,6.16%,10.47%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Louisiana,11/24/2020,Regional,United States of America,United States of America;  Louisiana,"September 9, 2020","September 19, 2020",Residual sera,Multiple groups,952,12.50%,10.02%,15.61%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_SouthDakota,11/24/2020,Regional,United States of America,United States of America;  South Dakota,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,99,1.80%,0.00%,4.82%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Tennessee,11/24/2020,Regional,United States of America,United States of America;  Tennessee,"September 8, 2020","September 16, 2020",Residual sera,Multiple groups,1028,6.70%,4.96%,8.57%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Hawaii,11/24/2020,Regional,United States of America,United States of America; Hawaii,"September 8, 2020","September 22, 2020",Residual sera,Multiple groups,516,0.80%,0.00%,2.18%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Indiana,11/24/2020,Regional,United States of America,United States of America; Indiana,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1155,4.00%,1.44%,8.79%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Utah,11/24/2020,Regional,United States of America,United States of America;  Utah,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,1022,5.10%,3.29%,7.90%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_RhodeIsland,11/24/2020,Regional,United States of America,United States of America;  Rhode Island,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,795,2.70%,1.15%,4.91%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Mississippi,11/24/2020,Regional,United States of America,United States of America;  Mississippi,"September 9, 2020","September 22, 2020",Residual sera,Multiple groups,980,7.90%,5.35%,10.87%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_California,11/24/2020,Regional,United States of America,United States of America; California,"September 10, 2020","September 16, 2020",Residual sera,Multiple groups,979,4.90%,3.17%,6.85%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Virginia,11/24/2020,Regional,United States of America,United States of America;  Virginia,"September 10, 2020","September 23, 2020",Residual sera,Multiple groups,1111,3.20%,1.81%,5.13%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Iowa,11/24/2020,Regional,United States of America,United States of America; Iowa,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,977,7.60%,5.56%,10.02%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Idaho,11/24/2020,Regional,United States of America,United States of America; Idaho,"September 8, 2020","September 18, 2020",Residual sera,Multiple groups,732,5.20%,2.74%,8.46%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Kentucky,11/24/2020,Regional,United States of America,United States of America;  Kentucky,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,980,3.60%,2.33%,5.21%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Delaware,11/24/2020,Regional,United States of America,United States of America; Delaware,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,980,7.50%,4.89%,10.50%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Missouri,11/24/2020,Regional,United States of America,United States of America;  Missouri,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,1031,3.50%,2.15%,5.01%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_NewJersey,11/24/2020,Regional,United States of America,United States of America;  New Jersey,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1050,15.10%,12.65%,17.63%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Pennsylvania,11/24/2020,Regional,United States of America,United States of America;  Pennsylvania,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1341,11.10%,8.85%,13.71%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
201124_USA_CDC_September4_Washington,11/24/2020,Regional,United States of America,United States of America;  Washington,"September 9, 2020","September 22, 2020",Residual sera,Multiple groups,968,2.50%,1.29%,3.83%,Stratified non-probability,"Roche, Abbott, Ortho-Clinical Diagnostics",,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,4/26/2021
210305_Chicago_NorthwesternUniversity_overall,3/5/2021,Local,United States of America,United States of America; Illinois; Chicago,"June 24, 2020","November 23, 2020",Household and community samples,Multiple groups,1667,18.70%,,,Stratified non-probability,In-House - Northwestern University,,IgG,,,Moderate,Preprint,Brian Mustanski,Northwestern University,https://www.medrxiv.org/content/10.1101/2021.03.02.21252767v1,3/22/2021,4/17/2021
210120_LosAngelesCounty_CedarsSinaiMedicalCenter_overall_adj,,Local,United States of America,United States of America,"May 11, 2020",,Health care workers and caregivers,Multiple groups,6062,4.10%,3.10%,5.70%,Convenience,Abbott,,IgG,88.30%,,Moderate,Journal Article (Peer-Reviewed),Joseph E Ebinger,Cedars-Sinai Medical Center,https://dx.doi.org/10.1136/bmjopen-2020-043584,3/22/2021,3/29/2021
210316_UnitedStates_ClinicalReferenceLaboratoryInc_OverallGenPop,3/16/2021,National,United States of America,United States of America,"September 1, 2020","September 30, 2020",Household and community samples,Multiple groups,61910,6.60%,,,Sequential,Roche Diagnostics,,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Robert Stout,Clinical Reference Laboratory Inc,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777502?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031621,3/22/2021,3/31/2021
210205_UnitedStates_BrownUniversity,2/5/2021,National,United States of America,United States of America,,"August 1, 2020",Assisted living and long-term care facilities,Seniors (65+ years),272,43.00%,,,Convenience,NR,,"IgG,IgM,Total Antibody",,,High,Journal Article (Peer-Reviewed),Elizabeth White,Brown University,http://dx.doi.org/10.1111/jgs.17061,3/22/2021,3/28/2021
210201_Indianapolis_IndianaUniversity_HCW_primary,2/1/2021,Sublocal,United States of America,United States of America; Indiana; Indianapolis,"April 1, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),34,35.00%,,,Convenience,"1) Abnova 
2-5) N/A (author or institutiona desgined)",,"IgG,IgM",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Jorge J. Canas ,Indiana University,https://dx.doi.org/10.1016/j.kint.2020.11.014,3/24/2021,4/5/2021
210201_Indianapolis_IndianaUniversity_HDpatients_primary,2/1/2021,Sublocal,United States of America,United States of America; Indiana; Indianapolis,"April 1, 2020","June 24, 2020",,Children and Youth (0-17 years),14,38.00%,,,Convenience,"1) Abnova 
2-5) N/A (author or institutiona desgined)",,"IgG,IgM",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Jorge J. Canas ,Indiana University,https://dx.doi.org/10.1016/j.kint.2020.11.014,3/24/2021,4/5/2021
210221_Iowa_UniversityofIowa,2/21/2021,Local,United States of America,United States of America; Iowa,"May 1, 2020","September 22, 2020",Pregnant or parturient women,Adults (18-64 years),1000,5.80%,,,Sequential,"DiaSorin
Roche",,IgG,,,High,Journal Article (Peer-Reviewed),Haley Steffen,University of Iowa,https://dx.doi.org/10.1055/s-0041-1723938,3/26/2021,3/28/2021
210310_USA_GeorgeWashingtonUniversity_CT,3/10/2021,Local,United States of America,United States of America,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,120,29.20%,21.00%,37.30%,Convenience,Epitope Diagnostics,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,3/31/2021
210310_USA_GeorgeWashingtonUniversity_CA,3/10/2021,Local,United States of America,United States of America,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,684,23.80%,20.60%,27.00%,Convenience,Epitope Diagnostics,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,3/31/2021
210310_USA_GeorgeWashingtonUniversity_MI,3/10/2021,Local,United States of America,United States of America,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,339,15.00%,11.20%,18.90%,Convenience,Epitope Diagnostics,,IgG,,,High,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,3/31/2021
210310_USA_GeorgeWashingtonUniversity_NJ,3/10/2021,Local,United States of America,United States of America,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,3323,32.50%,30.90%,34.10%,Convenience,Epitope Diagnostics,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,3/31/2021
210310_USA_GeorgeWashingtonUniversity_NY,3/10/2021,Regional,United States of America,United States of America; New York; New York City,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,2202,30.50%,28.50%,32.40%,Convenience,Epitope Diagnostics,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,3/31/2021
210310_USA_GeorgeWashingtonUniversity_OtherStates,3/10/2021,National,United States of America,"United States of America; Col;orado, Florida, Maryland, North Carolina, Ohio, Pennsylvania, Washington","May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,13,30.80%,5.70%,55.90%,Convenience,Epitope Diagnostics,,IgG,,,High,Journal Article (Peer-Reviewed),Israel Zyskind,George Washington University,https://dx.doi.org/10.1001/jamanetworkopen.2021.2816,3/27/2021,3/31/2021
120301_RhodeIsland_CDC,3/1/2021,Regional,United States of America,United States of America; Rhode Island,"July 17, 2020","August 28, 2020",Health care workers and caregivers,Multiple groups,9863,4.60%,4.20%,5.00%,Convenience,ORTHO Clinical Diagnostics,,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Lara J. Akinbami,Centers for Disease Control,https://dx.doi.org/10.3201/eid2703.204508,3/27/2021,3/28/2021
210208_Chicago_NorthwesternUniversity_overall,2/8/2021,Local,United States of America,United States of America; Illinois; Chicago,"June 24, 2020","November 11, 2020",Household and community samples,Multiple groups,3365,17.80%,,,Self-referral,N/A - in-house,,IgG,,,High,Preprint,Thomas McDade,Northwestern University,10.1101/2021.02.04.21251170,3/27/2021,4/18/2021
210215_USA_SpaceX_overall,2/15/2021,Sublocal,United States of America,United States of America; Multiple; Multiple,"April 1, 2020","June 10, 2020",,Adults (18-64 years),,2.80%,,,Convenience,NR,,IgG,99.50%,,Unclear,,Yannic Bartsch,"Ragon Institute of MGH, MIT and Harvard",https://dx.doi.org/10.1038/s41467-021-21336-8,3/27/2021,3/27/2021
210226_Washington_CentersforDiseaseControlandPrevention_Overall,2/26/2021,Regional,United States of America,United States of America; Washington,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7544,2.00%,,,Stratified probability,In-House (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,3/31/2021
210226_Florida_CentersforDiseaseControlandPrevention_Overall,2/26/2021,Regional,United States of America,United States of America; Florida,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7787,,,,Stratified probability,In-House (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,3/31/2021
210226_NewYork_CentersforDiseaseControlandPrevention_Overall,2/26/2021,Local,United States of America,United States of America; New York; New York City,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7746,17.20%,,,Stratified probability,In-House (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,3/31/2021
210226_Pennsylvania_CentersforDiseaseControlandPrevention_Overall,2/26/2021,Local,United States of America,United States of America; Pennsylvania; Philadelphia,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,8657,4.30%,,,Stratified probability,In-House (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,3/31/2021
210226_Missouri_CentersforDiseaseControlandPrevention_Overall,2/26/2021,Regional,United States of America,United States of America; Missouri,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,9356,2.50%,,,Stratified probability,In-House (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,3/31/2021
210226_Utah_CentersforDiseaseControlandPrevention_Overall,2/26/2021,Regional,United States of America,United States of America; Utah,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,8769,2.70%,,,Stratified probability,In-House (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,3/31/2021
210226_California_CentersforDiseaseControlandPrevention_Overall,2/26/2021,Local,United States of America,United States of America; California,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,4980,1.90%,,,Stratified probability,In-House (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,3/31/2021
210226_Connecticut_CentersforDiseaseControlandPrevention_Overall,2/26/2021,Regional,United States of America,United States of America; Connecticut,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,8929,5.70%,,,Stratified probability,In-House (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,3/31/2021
210226_Minnesota_CentersforDiseaseControlandPrevention_Overall,2/26/2021,Regional,United States of America,"United States of America; Minnesota; Minneapolis, St. Paul, St. Cloud","March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7944,4.90%,,,Stratified probability,In-House (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,3/31/2021
210226_Louisiana_CentersforDiseaseControlandPrevention_Overall,2/26/2021,Regional,United States of America,United States of America; Louisiana,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,2849,7.10%,,,Stratified probability,In-House (CDC),,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/27/2021,3/31/2021
210204_OrangeCounty_UniversityofCaliforniaIrvine_Overall_PopTestAdj,2/4/2021,Local,United States of America,United States of America; California,"July 10, 2020","August 16, 2020",Household and community samples,Multiple groups,2979,11.30%,8.10%,13.20%,Stratified probability,NR,,"IgG,IgM",94.00%,100.00%,Low,Journal Article (Peer-Reviewed),Tim Bruckner,University of California Irvine,https://dx.doi.org/10.1038/s41598-021-82662-x,3/27/2021,4/26/2021
210222_SantaClaraCounty_UniversityofStanford_GenPop_PopTestAdj,2/22/2021,Local,United States of America,United States of America; California,"April 3, 2020","April 4, 2020",Household and community samples,Multiple groups,3328,2.76%,1.32%,4.22%,Stratified non-probability,Premier Biotech,,"IgG,IgM",85.56%,99.53%,High,Journal Article (Peer-Reviewed),Eran Bendavid,Stanford University School of Medicine,https://dx.doi.org/10.1093/ije/dyab010,3/28/2021,4/26/2021
210117_OrangeCounty_HoagMemorialHospitalPresbyterian_HCW,1/17/2021,Local,United States of America,United States of America; California,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),2754,2.76%,2.18%,3.44%,Convenience,Ortho Diagnostics,,IgG,93.60%,100.00%,High,Journal Article (Peer-Reviewed),Michael Brant-Zawadzki,,https://dx.doi.org/10.1093/ofid/ofab015,3/28/2021,4/26/2021
210117_OrangeCounty_HoagMemorialHospitalPresbyterian_First_responders,1/17/2021,Local,United States of America,United States of America; California,"July 15, 2020","August 15, 2020",Essential non-healthcare workers,Adults (18-64 years),92,4.35%,1.20%,10.76%,Convenience,Ortho Diagnostics,,IgG,93.60%,100.00%,High,Journal Article (Peer-Reviewed),Michael Brant-Zawadzki,,https://dx.doi.org/10.1093/ofid/ofab015,3/28/2021,4/26/2021
210309_Massachusetts_UniversityofMassachusetts-Amherst_Primary,3/9/2021,Local,United States of America,United States of America; Massachusetts ; Amherst,"July 1, 2020","August 31, 2020",Students and Daycares,Adults (18-64 years),779,5.30%,3.10%,7.50%,Simplified probability,NR,,IgG,,,High,Preprint,Teah Snyder,University of Massachusetts-Amherst,https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf,3/29/2021,3/31/2021
210309_Massachusetts_UniversityofMassachusetts-Amherst_LocalPop_Primary,3/9/2021,Local,United States of America,United States of America; Massachusetts ; Amherst,"July 1, 2020","August 31, 2020",Multiple populations,Adults (18-64 years),292,4.00%,1.60%,6.50%,Simplified probability,NR,,IgG,,,High,Preprint,Teah Snyder,University of Massachusetts-Amherst,https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf,3/29/2021,3/31/2021
210321_Boston_HarvardMedicalSchool_Overall,3/8/2021,Local,United States of America,United States of America; Massachusetts; Boston,"December 17, 2020","February 23, 2021",Multiple populations,Adults (18-64 years),131,100.00%,,,Self-referral,Sino Biological; LakePharma; NR,,"IgG,IgM,IgA",,,High,Preprint,Kathryn Gray,Harvard Medical School,https://www.medrxiv.org/content/10.1101/2021.03.07.21253094v1.full.pdf,3/30/2021,4/1/2021
210312_Cincinnati_UniversityOfCincinnati_overall,3/12/2021,Local,United States of America,United States of America; Ohio; Greater Cincinnati Metropolitan Area,"August 13, 2020","December 8, 2020",Blood donors,Multiple groups,9550,8.40%,,,Simplified probability,N/A - in house,,IgG,,,Moderate,Preprint,Greg Davis,University of Cincinnati,10.1101/2021.03.11.21253263,3/31/2021,3/31/2021
210203_Monterey_UniversityofCalifornia_primary,2/3/2021,Local,United States of America,United States of America; California,"July 15, 2020","November 30, 2020",,Multiple groups,1058,18.99%,,,Convenience,researchers,,IgG,,,High,Preprint,Ana Mora," University of California, Berkely",10.1101/2021.02.01.21250963,4/1/2021,4/27/2021
210131_NorthernVirginia_InovaChildren’sHospital_primary,1/31/2021,Local,United States of America,United States of America; Virginia; Northern Virginia,"July 31, 2020","October 13, 2020",Multiple populations,Children and Youth (0-17 years),1038,8.50%,6.90%,10.30%,Convenience,Ortho diagnostics,,Total Antibody,,100.00%,High,Preprint,Rebecca E Levorson,Inova Children’s Hospital,10.1101/2021.01.28.21250466,4/1/2021,4/19/2021
210218_RhodeIsland_BrownUniversity_overall_adj,2/18/2021,Regional,United States of America,United States of America; Rhode Island,"May 5, 2020","May 22, 2020",Household and community samples,Multiple groups,1032,2.90%,1.00%,6.20%,Stratified probability,Abbot,,IgG,88.40%,99.60%,Low,Journal Article (Peer-Reviewed),Philip A. Chan,Brown University,https://dx.doi.org/10.2105/AJPH.2020.306115,4/1/2021,4/1/2021
210309_UnitedStates_StanfordUniversity_OverallPopAdj,3/9/2021,National,United States of America,United States of America,"January 1, 2021","January 31, 2021",Residual sera,Multiple groups,21424,21.30%,20.30%,22.30%,Entire sample,Siemens Healthineers,,Total Antibody,100.00%,99.80%,Low,Preprint,Shuchi Anand,Stanford University,https://doi.org/10.1101/2021.03.07.21252786,4/2/2021,4/2/2021
210321_NewYork_WeillCornellMedicine_Pediatrics,3/22/2021,Sublocal,United States of America,United States of America; New York ; New York City ,"April 9, 2020","August 31, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),1194,16.50%,14.40%,18.70%,Sequential,"ET Healthcare
COV2T",,IgG,,,High,Journal Article (Peer-Reviewed),He Yang,NewYork–Presbyterian Hospital/Weill Cornell Medical Center,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743,4/3/2021,4/8/2021
210321_NewYork_WeillCornellMedicine_Adults,3/22/2021,Sublocal,United States of America,United States of America; New York ; New York City ,"April 9, 2020","August 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,30232,18.60%,18.20%,19.10%,Sequential,"ET Healthcare
COV2T",,IgG,,,High,Journal Article (Peer-Reviewed),He Yang,NewYork–Presbyterian Hospital/Weill Cornell Medical Center,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743,4/3/2021,4/8/2021
210116_Philadelphia_UniversityofPennsylvania_Overall,1/16/2021,Sublocal,United States of America,United States of America; Pennsylvania; Philadelphia,"May 21, 2020","October 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,124,1.60%,,,Sequential,N/A - In house,,"IgG,IgM",,,High,Preprint,Lova Sun,University of Pennsylvania,https://dx.doi.org/10.1101/2021.01.15.21249810,4/5/2021,4/11/2021
210317_Chicago_NorthwesternUniversity_Overall ,3/17/2021,Local,United States of America,United States of America; Illinois; Chicago,"June 24, 2020","December 23, 2020",Household and community samples,Multiple groups,7935,17.90%,,,Stratified non-probability,N/A - in-house,,IgG,,,High,Preprint,Alexis R. Demonbreun,Northwestern University,https://www.medrxiv.org/content/10.1101/2020.11.17.20233452v3,4/6/2021,4/26/2021
200901_Seattle_FredHutchinsonCancerResearchCenter_Overall,9/1/2020,Sublocal,United States of America,United States of America; Washington; Seattle,"March 3, 2020","April 24, 2020",Residual sera,Children and Youth (0-17 years),1076,0.93%,,,Convenience,"N/A, Abbott",,IgG,,,High,Journal Article (Peer-Reviewed),Adam S. Dingens,Fred Hutchinson Cancer Research Center,https://www.nature.com/articles/s41467-020-18178-1,4/8/2021,4/26/2021
2010330_Bolinas_UniversityofCalifornia_Abbott+ELISA,10/30/2020,Local,United States of America,United States of America; California; Bolinas,"April 20, 2020","April 24, 2020",Household and community samples,Multiple groups,1880,0.63%,,,Self-referral,Abbott Laboratories; University of California,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Ayesha Appa,University of California San Francisco,http://dx.doi.org/10.1093/ofid/ofaa531,4/8/2021,4/26/2021
210305_EssexCounty_RutgersUniversity_overall_unadj,,Local,United States of America,United States of America; New Jersey,"September 20, 2020","December 22, 2020",Household and community samples,Adults (18-64 years),924,9.00%,,,Stratified probability,Wang et al. ,,IgG,,,Moderate,Preprint,Henry F Raymond,Rutgers University,10.1101/2021.03.02.21252766,4/8/2021,4/8/2021
210224_USA_NationalInstitutesofHealth_primary,2/24/2021,National,United States of America,United States of America,"January 1, 2020","August 26, 2020",Multiple populations,Multiple groups,3257478,11.60%,,,Convenience,NR,,"IgG,IgA,IgM",,,Moderate,Journal Article (Peer-Reviewed),Raymond Harvey,National Institutes of Health,https://dx.doi.org/10.1001/jamainternmed.2021.0366,4/9/2021,4/9/2021
210312_Atlanta_EmoryUniversitySchoolOfMedicine_Overall,3/12/2021,Local,United States of America,United States of America; Georgia; Atlanta,"April 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),642,4.00%,,,Convenience,"Emory University - In-House, Suthar et al., 2020.",,IgG,,,High,Journal Article (Peer-Reviewed),Claudia Morris,Emory University School of Medicine,https://dx.doi.org/10.1016/j.ijid.2021.03.017,4/9/2021,4/9/2021
210323_USA_JohnsHopkins_vaccinated,,National,United States of America,United States of America,"January 26, 2021","March 8, 2021",,Adults (18-64 years),123,74.00%,,,Self-referral,Roche ,,Not reported,,,High,Journal Article (Peer-Reviewed),Brian Boyarsky,Johns Hopkins University,https://dx.doi.org/10.1136/annrheumdis-2021-220289,4/10/2021,4/10/2021
210323_USA_JohnsHopkins_vaccinated_females,,National,United States of America,United States of America,"January 26, 2021","March 8, 2021",,Adults (18-64 years),117,74.36%,,,Self-referral,Roche ,,Not reported,,,High,Journal Article (Peer-Reviewed),Brian Boyarsky,Johns Hopkins University,https://dx.doi.org/10.1136/annrheumdis-2021-220289,4/10/2021,4/10/2021
210323_USA_JohnsHopkins_vaccinated_males,,National,United States of America,United States of America,"January 26, 2021","March 8, 2021",,Adults (18-64 years),6,75.00%,,,Self-referral,Roche ,,Not reported,,,High,Journal Article (Peer-Reviewed),Brian Boyarsky,Johns Hopkins University,https://dx.doi.org/10.1136/annrheumdis-2021-220289,4/10/2021,4/10/2021
210324_FortCollins_ColoradoStateUniversity,3/24/2021,Sublocal,United States of America,United States of America; Colorado; Fort Hills,"July 13, 2020","September 2, 2020",Essential non-healthcare workers,Multiple groups,508,0.39%,,,Convenience,Abbott,,IgG,,,High,Preprint,Tracy L. Nelson,Colorado State University,10.1101/2021.03.21.21251651,4/10/2021,4/10/2021
210302_NewYork_RenaissanceStonyBrookSchoolofMedicine,3/2/2021,Sublocal,United States of America,United States of America; New York,"April 2, 2020","April 18, 2020",Health care workers and caregivers,Adults (18-64 years),474,16.90%,13.60%,20.60%,Convenience,"Chembio Diagnostics, Inc Medford, New York, USA",,"IgG,IgM",84.30%,88.90%,High,Journal Article (Peer-Reviewed),Lilian Talbot,Renaissance Stony Brook School of Medicine,https://dx.doi.org/10.1186/s13741-021-00177-5,4/15/2021,4/18/2021
210226_SouthBronx_IcahnSchoolOfMedicine_Phase1_In-houseELISA,2/26/2021,Sublocal,United States of America,United States of America; New York; New York City,"May 1, 2020","May 31, 2020",Essential non-healthcare workers,Adults (18-64 years),501,28.40%,,,Convenience,Mount Sinai,,Not reported,95.00%,100.00%,High,Preprint,Juan Carreno,Icahn School of Medicine at Mount Sinai,10.1101/2021.02.24.21252340,4/16/2021,4/16/2021
210311_USA_IgenomixUSAandCanada_Overall,3/11/2021,National,United States of America,"United States of America; Utah, Massachuetts; NR","June 18, 2020","July 30, 2020",Multiple populations,Adults (18-64 years),337,1.48%,,,Convenience,Abbott Laboratories,,IgG,,99.40%,High,Journal Article (Peer-Reviewed),Russel Foulk,Igenomix USA and Canada,https://dx.doi.org/10.1016/j.ajog.2021.03.008,4/16/2021,4/16/2021
210317_Boston_HarvardMedicalSchool,3/17/2021,Sublocal,United States of America,United States of America; Massachusetts; Boston,"June 16, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),433,11.30%,,,Convenience,NR,,"IgG,IgM",80.00%,99.50%,High,Journal Article (Peer-Reviewed),Lou Ann Bruno-Murtha,Harvard Medical School ,https://dx.doi.org/10.1080/20477724.2021.1901041,4/17/2021,4/17/2021
201217_UnitedStates_UniversityofIowa,12/17/2020,National,United States of America,United States of America,"May 13, 2020","July 8, 2020",Health care workers and caregivers,Multiple groups,1606,1.74%,,,Stratified non-probability,"Abbott Laboratories, Chicago, IL
EUROIMMUN",,IgG,,,Moderate,Journal Article (Peer-Reviewed),Nicholas M. Mohr,University of Iowa,http://dx.doi.org/10.1016/j.annemergmed.2020.12.007,4/18/2021,4/23/2021
201125_Washington_GeorgeWashingtonUniversity_hcw,2/1/2021,Sublocal,United States of America,United States of America; District of Columbia; Washington ,"May 26, 2020","June 14, 2020",,Adults (18-64 years),138,5.07%,,,Entire sample,"1. Biolidics
2. Author",,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Eric Murakami,George Washington University,10.1016/j.ajem.2020.11.064,4/18/2021,4/27/2021
210111_Burlington_UniversityOfVermont_overall,1/11/2021,Local,United States of America,United States of America; Vermont; Burlington,"June 25, 2020","June 28, 2020",Household and community samples,Multiple groups,454,2.20%,0.80%,3.60%,Stratified probability,1) N/A - in house,,IgG,,,High,Journal Article (Peer-Reviewed),Eline M van den Broek-Altenburg,University of Vermont,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800904/,4/21/2021,4/22/2021
210305_Mississippi_CDCCOVID-19ResponseTeam_Overall,3/5/2021,Regional,United States of America,United States of America; Mississippi; NR,"May 17, 2020","September 19, 2020",Residual sera,Children and Youth (0-17 years),1603,10.90%,9.40%,12.40%,Sequential,Ortho Clinical Diagnostics; In-House (CDC),,Total Antibody,,,High,Journal Article (Peer-Reviewed),Charlotte Hobbs,CDC COVID-19 Response Team,https://dx.doi.org/10.15585/mmwr.mm7009a4,4/22/2021,4/22/2021
210312_NorthCarolina_WakeForestBaptistHealth,3/12/2021,Regional,United States of America,United States of America; North Carolina; NR,"April 16, 2020","December 20, 2020",Household and community samples,Adults (18-64 years),17688,32.60%,28.40%,35.00%,Stratified non-probability,Syntron Bioresearch Inc;  Innovita Biological Technology Co,,"IgM,IgG",,,Moderate,Preprint,John Williamson,Wake Forest Baptist Health,https://www.medrxiv.org/content/10.1101/2021.03.11.21253226v1,4/22/2021,4/22/2021
210303_MontereyCounty_UniversityofCaliforniaBerkeley_Overall,3/3/2021,Sublocal,United States of America,United States of America; California,"July 16, 2020","November 30, 2020",Essential non-healthcare workers,Adults (18-64 years),1058,19.00%,,,Self-referral,Authors,,IgG,94.02%,98.47%,High,Journal Article (Peer-Reviewed),Joseph A. Lewnard,"University of California, Berkeley",https://dx.doi.org/10.3201/eid2705.204949,4/23/2021,4/26/2021
200707_WashoeCounty_WashoeCountyHealthDistrict_overall,7/7/2020,Local,United States of America,United States of America; Nevada,"June 9, 2020","June 10, 2020",Household and community samples,Multiple groups,234,2.30%,0.40%,4.19%,Simplified probability,NR,,Not reported,,,High,Institutional Report,Washoe County Health District,Washoe County Health District,https://www.washoecounty.us/health/files/ephp/communicable-diseases/Seroprevalence_7.7.2020_FINAL.pdf,4/27/2021,4/27/2021
210203_VaticanCity_UniversitàCattolicadelSacroCuore_Overall,2/3/2021,National,Vatican City,Vatican City; Vatican City State; Vatican City,"June 8, 2020","January 4, 2021",Household and community samples,Multiple groups,1539,4.35%,,,Convenience,Siemens Healthineers AG,,Total Antibody,97.48%,99.80%,High,Journal Article (Peer-Reviewed),Massimo Ralli,Università Cattolica del Sacro Cuore,https://dx.doi.org/10.1016/j.ejim.2021.01.029,3/23/2021,4/4/2021
201118_HoChiMinhCity_OxfordUniversityClinicalResearchUnit_overall,11/18/2020,Sublocal,Viet Nam,Viet Nam; Đông Nam Bộ; Ho Chi Minh City,"August 23, 2020","August 30, 2020",Health care workers and caregivers,Adults (18-64 years),408,0.00%,,,Convenience,Roche Diagnostics,,Total Antibody,97.20%,99.80%,High,Journal Article (Peer-Reviewed),Nguyen Van Vinh Chau,Oxford University Clinical Research Unit,https://dx.doi.org/10.1016/j.jinf.2020.11.018,1/23/2021,4/26/2021
210302_Vietnam_UniversitatsklinikumTubingen_HCW,3/2/2021,Sublocal,Viet Nam,Viet Nam; Red River Delta; Hanoi,"March 20, 2020","January 8, 2021",Health care workers and caregivers,Adults (18-64 years),1065,0.56%,,,Unclear,"WANTAI Biological Pharmacy, Beijing, China",,Total Antibody,,,Unclear,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,4/10/2021,4/10/2021
210302_Vietnam_UniversitatsklinikumTubingen_patients,3/2/2021,Sublocal,Viet Nam,Viet Nam; Red River Delta; Hanoi,"March 1, 2020","January 8, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,288,0.00%,,,Unclear,"WANTAI Biological Pharmacy, Beijing, China",,Total Antibody,,,Unclear,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,4/10/2021,4/10/2021
210309_Zambia_ZambiaMinistryofHealth_overall,3/9/2021,National,Zambia,"Zambia; Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi","July 4, 2020","July 27, 2020",Household and community samples,Multiple groups,2704,2.10%,1.10%,3.10%,Stratified probability,PerkinElmer,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lloyd B Mulenga,Zambia Ministry of Health,https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00053-X/fulltext,3/12/2021,3/29/2021
210331_Bulawayo_UniversityofEdinburgh,3/31/2021,Regional,Zimbabwe,Zimbabwe; Bulawayo; NR,"June 9, 2020","June 22, 2020",Health care workers and caregivers,Multiple groups,635,8.90%,6.90%,11.50%,Convenience,Wuhan UNscience Biotechnology Companies,,"IgG,IgM",98.51%,88.21%,High,Journal Article (Peer-Reviewed),,University of Edinburgh,https://dx.doi.org/10.1371/journal.pntd.0009254,4/16/2021,4/16/2021